data_2luw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2luw _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.1 m120 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.866 0.365 . . . . 62.42 110.917 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -116.09 108.61 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 74.11 111.096 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.4 147.79 52.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.947 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 7.2 tptp -169.92 -37.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 75.41 110.926 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 12.6 t-20 -99.14 155.9 17.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 75.12 110.867 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 5.8 t30 81.54 -68.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 73.25 110.886 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.1 m -116.33 121.11 33.94 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 70.22 111.113 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 153.14 69.13 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.715 2.277 . . . . 74.25 112.348 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.24 114.4 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.45 111.119 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -81.85 158.26 24.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 64.33 110.83 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER 37.15 66.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 72.23 110.908 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.58 -169.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 74.11 110.935 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 p -145.8 139.39 26.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 73.13 111.136 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.68 65.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 64.5 112.485 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -76.57 139.89 40.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 74.24 110.924 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.28 -28.7 12.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 75.12 110.933 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.92 -49.7 0.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.749 . . . . 74.2 112.487 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -76.45 149.4 36.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 74.34 110.861 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -141.85 170.55 15.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 71.42 110.886 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.07 138.24 55.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 75.13 111.157 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -137.07 150.66 48.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 74.15 110.91 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -148.58 166.1 29.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 71.24 110.922 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 9.8 m -137.75 138.15 39.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 72.53 111.16 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.427 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -160.4 162.95 33.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 72.23 110.868 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.9 p -136.24 171.41 14.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 73.45 111.145 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.1 m -106.84 167.58 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 75.52 111.14 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -109.1 -48.23 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 72.53 110.834 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -125.56 156.93 38.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 73.03 110.874 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -80.06 115.22 19.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 71.21 110.845 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.47 144.61 34.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 75.05 111.139 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 t -98.8 107.24 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 74.43 111.148 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.95 148.27 45.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 64.14 111.071 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.74 110.67 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 72.22 111.144 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.51 140.86 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 74.54 111.15 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 24.2 p -140.63 167.72 21.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.55 110.844 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.71 149.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 75.43 111.194 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -179.85 -175.5 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 64.43 110.824 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.774 -0.727 . . . . 62.31 112.484 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.829 0.347 . . . . 65.45 110.912 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.13 121.55 44.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 73.43 111.102 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -87.68 159.35 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 75.32 110.843 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.93 130.56 53.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.41 110.928 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -125.82 147.75 49.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 74.03 110.901 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 tt -143.76 134.99 25.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 74.03 110.917 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -144.04 116.02 8.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 73.31 110.896 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.41 120.68 10.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 64.5 111.085 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.49 -80.89 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 62.03 112.469 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 m -98.14 -178.06 3.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.389 . . . . 75.02 110.862 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 134.68 31.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.534 0.683 . . . . 74.52 110.927 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 143.3 50.35 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.655 2.237 . . . . 74.44 112.319 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -104.45 178.72 4.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 72.23 111.137 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.8 p -65.15 -14.43 60.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.436 . . . . 75.44 111.152 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -119.99 -26.75 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 72.0 110.851 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.07 125.95 50.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 64.15 110.868 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.23 153.62 35.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 74.35 110.929 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -111.83 -24.49 9.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 74.13 110.877 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.3 m -143.75 123.78 13.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.864 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -176.88 118.74 0.27 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.606 0.717 . . . . 70.33 110.893 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 53.6 Cg_endo . . . . . 0 N--CA 1.465 -0.195 0 C-N-CA 122.684 2.256 . . . . 74.43 112.352 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.856 0.36 . . . . 75.11 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 t30 64.47 18.87 11.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.23 110.887 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.414 ' HG3' ' HG2' ' A' ' 63' ' ' PRO . 19.9 tt0 -119.61 85.82 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 62.14 110.921 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.464 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.9 m -133.11 169.68 16.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.24 110.857 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.24 155.22 33.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 54.1 110.875 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.23 106.55 8.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 70.22 110.864 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.1 t -151.17 149.81 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 74.13 111.134 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.8 p -73.55 102.5 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 74.32 110.86 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.51 137.42 34.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.113 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.47 141.37 22.57 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 74.53 111.09 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 132.2 22.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.71 2.273 . . . . 75.33 112.358 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.78 -18.93 4.01 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.741 . . . . 71.51 112.509 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.5 m -115.55 129.71 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 75.35 111.14 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.4 m -72.19 137.06 46.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 73.42 111.135 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -109.86 138.21 46.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 75.43 110.918 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -108.16 161.98 14.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 75.33 110.836 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.9 t -132.31 139.05 50.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 73.42 111.124 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.7 121.18 11.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 75.45 110.853 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 mm -115.64 116.17 51.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 75.05 111.113 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.7 128.99 56.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 73.11 110.896 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.43 159.5 13.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 75.11 112.499 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -98.83 -21.36 16.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.868 0.366 . . . . 74.34 110.899 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 91' ' ' ASN . 23.3 p -167.07 141.65 3.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 74.21 110.897 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 90' ' ' SER . 55.2 t-20 -35.64 107.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 75.2 110.889 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -160.11 116.85 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 61.42 110.921 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.1 p -119.62 161.25 20.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 73.12 110.892 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.45 22.85 2.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 73.15 112.49 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.49 147.03 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.909 0.385 . . . . 74.41 111.11 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.63 114.35 28.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.21 111.147 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.5 tp -99.44 144.01 29.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 72.04 110.91 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -153.16 164.92 37.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.32 110.892 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.54 140.58 29.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 72.12 110.881 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -100.43 111.17 23.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 73.32 110.885 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.7 p90 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.464 . . . . 71.43 110.922 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.865 0.364 . . . . 73.51 110.865 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 m -108.03 108.15 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 75.31 111.14 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.61 149.69 52.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 75.21 110.897 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 13.2 tptm -169.29 -38.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.876 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 8.8 t-20 -97.91 155.32 17.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 64.12 110.851 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 26.1 t30 82.0 -68.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 72.34 110.88 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 m -124.99 119.76 25.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.598 0.713 . . . . 74.45 111.163 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 154.73 67.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.682 2.255 . . . . 45.42 112.355 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 t -76.47 114.01 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.03 111.131 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.64 144.98 29.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 74.55 110.83 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.09 77.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 75.21 110.896 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.36 -172.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 72.1 110.902 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 p -136.55 137.95 40.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 75.51 111.15 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.18 60.73 0.55 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 75.42 112.529 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -77.07 163.04 27.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.373 . . . . 74.32 110.895 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -45.4 -69.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 75.43 110.913 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.67 -50.72 3.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.729 . . . . 74.34 112.48 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.97 144.45 6.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 72.03 110.838 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -144.24 -179.81 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 71.14 110.887 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.4 135.76 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 73.44 111.115 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -137.03 148.54 46.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 75.13 110.896 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -148.54 165.01 32.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 72.24 110.912 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -143.14 142.4 31.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 63.45 111.123 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -159.32 159.38 33.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 72.11 110.884 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -127.22 170.35 12.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 74.23 111.14 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.09 167.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 74.42 111.139 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.39 -43.23 4.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 64.45 110.884 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.43 162.74 31.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 65.44 110.904 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.26 116.09 19.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 70.54 110.91 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.78 141.06 31.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 64.42 111.145 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -97.34 107.17 19.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 75.12 111.134 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.22 147.01 47.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 73.04 111.095 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 p -110.9 110.84 33.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.25 111.176 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.5 140.25 49.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.23 111.115 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.499 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 4.7 p -130.75 166.47 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.888 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.58 152.57 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 71.3 111.129 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.01 177.23 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 63.54 110.813 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 74.43 112.482 -179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 CA--C 1.526 0.047 0 CA-C-O 120.815 0.34 . . . . 70.31 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.22 125.92 49.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 74.04 111.112 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.08 151.54 22.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 64.24 110.842 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 tt -116.09 127.8 55.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.917 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -138.43 143.11 39.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 65.44 110.904 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 tt -149.21 135.96 19.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 73.21 110.918 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -143.64 138.25 28.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 72.23 110.897 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.52 101.02 11.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 63.01 111.126 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.05 -92.39 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.742 . . . . 44.43 112.476 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.9 p -87.5 131.4 34.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 74.15 110.851 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.68 134.8 6.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.589 0.709 . . . . 75.31 110.877 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 143.75 51.66 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.69 2.26 . . . . 75.4 112.311 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.18 177.5 5.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.436 . . . . 70.04 111.123 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 p -63.62 -15.92 59.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.138 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -119.63 -25.44 5.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 73.34 110.898 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.94 125.14 48.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 74.23 110.832 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.86 153.54 34.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 74.52 110.937 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -108.61 -29.12 8.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 74.01 110.825 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.5 m -136.32 123.73 22.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.13 110.882 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -175.04 132.52 0.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.626 0.727 . . . . 74.32 110.891 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.251 . . . . 65.31 112.315 -179.949 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.867 0.365 . . . . 64.15 110.856 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.3 t30 63.8 15.88 9.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.884 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -120.41 96.15 5.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.892 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.499 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -134.52 170.53 15.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 75.03 110.875 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -120.35 153.29 36.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 73.2 110.888 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -129.2 108.5 10.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 74.13 110.833 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.2 t -150.44 149.83 14.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 74.22 111.119 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.1 p -75.68 102.4 5.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 63.54 110.896 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.49 143.81 30.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 72.05 111.111 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.15 142.91 26.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 74.54 111.107 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 141.09 44.24 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 70.43 112.337 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.67 -13.14 7.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.688 -0.767 . . . . 63.53 112.481 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -125.27 130.4 51.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 73.45 111.158 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 m -73.19 137.8 45.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 51.43 111.13 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -108.72 136.16 48.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 73.51 110.926 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -107.56 160.45 15.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.21 110.862 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.95 138.55 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 65.51 111.088 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.73 125.08 19.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 71.11 110.885 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.2 mm -114.79 130.28 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.32 111.141 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -111.49 149.85 30.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 73.41 110.899 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.19 152.27 16.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.721 -0.752 . . . . 64.4 112.544 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -120.39 -17.79 8.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 72.32 110.938 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -174.73 136.11 0.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 60.15 110.829 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 90' ' ' SER . 17.5 t-20 -35.06 103.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 74.23 110.889 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -155.38 100.18 2.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 74.23 110.906 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.6 p -109.47 151.85 26.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.071 -0.513 . . . . 71.41 110.82 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.08 24.16 1.34 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 73.12 112.476 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.63 142.63 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 62.24 111.121 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.43 117.07 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 75.0 111.152 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.1 tp -106.01 140.06 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 72.2 110.923 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -144.51 165.19 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 73.24 110.864 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.3 137.68 32.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.93 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.59 113.12 24.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 65.11 110.892 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.4 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 73.22 110.89 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.6 m120 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.871 0.367 . . . . 64.22 110.894 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.3 m -117.63 108.55 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.43 111.121 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.94 150.23 52.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 74.54 110.907 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 14.8 tptt -167.19 -35.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 73.34 110.922 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -101.39 155.61 17.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 75.24 110.891 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 24.4 t30 83.99 -69.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 73.32 110.891 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -123.08 121.3 27.19 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.569 0.7 . . . . 74.45 111.113 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 153.51 68.84 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.267 . . . . 74.2 112.317 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.23 114.84 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 75.31 111.15 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -85.56 160.74 19.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.836 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 p30 40.2 62.17 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 75.12 110.89 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.03 -169.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.903 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 p -146.57 139.32 25.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 71.52 111.156 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.12 57.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.754 . . . . 33.25 112.486 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.94 152.95 36.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 72.14 110.914 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.24 -42.76 66.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 73.31 110.871 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.82 -48.69 1.07 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.778 -0.725 . . . . 63.34 112.508 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.28 134.1 54.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 64.03 110.799 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -134.65 172.6 12.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 74.24 110.874 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.41 139.23 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 70.11 111.12 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -136.78 151.23 48.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 74.22 110.871 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -145.14 165.97 26.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 74.05 110.933 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 8.7 m -141.69 138.13 32.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.075 -0.511 . . . . 65.42 111.157 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -160.61 158.19 28.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.887 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.7 p -128.07 171.22 12.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 73.02 111.093 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.35 147.7 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 75.44 111.135 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -91.03 -49.83 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.884 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.14 161.39 26.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.878 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -81.06 114.12 19.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 73.22 110.858 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.99 138.96 28.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 73.35 111.078 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -94.37 106.7 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 74.14 111.139 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.26 146.23 46.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 64.13 111.066 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.9 t -109.39 111.88 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.11 111.148 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.7 t -127.02 139.27 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 72.34 111.136 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.455 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 42.6 p -134.03 166.48 22.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 60.4 110.877 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.96 149.49 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 63.42 111.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.66 177.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 54.12 110.864 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.728 . . . . 65.23 112.511 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.833 0.349 . . . . 74.52 110.894 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.1 106.64 12.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.42 111.119 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.64 152.35 37.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 74.53 110.864 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.27 127.27 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.862 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -133.93 139.63 46.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 64.41 110.931 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -143.4 134.13 25.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.906 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -142.4 122.66 13.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 75.13 110.883 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.47 48.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 73.11 111.112 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.15 -81.9 1.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.719 -0.753 . . . . 71.24 112.501 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -93.67 177.48 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.907 0.384 . . . . 75.03 110.844 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.12 138.22 30.86 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.569 0.699 . . . . 75.43 110.895 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.15 49.93 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 75.43 112.332 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -103.34 178.99 4.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 61.31 111.194 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.7 p -65.47 -14.24 60.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 74.52 111.124 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.4 m -121.35 -26.25 5.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 75.15 110.858 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.13 126.47 49.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 64.45 110.878 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.28 153.7 35.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 65.44 110.944 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -111.69 -27.63 8.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 74.43 110.897 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.1 m -140.52 123.78 16.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.916 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -179.51 115.78 0.22 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.589 0.709 . . . . 74.44 110.87 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HD2' ' HG2' ' A' ' 70' ' ' GLU . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.161 0 C-N-CA 122.664 2.243 . . . . 61.42 112.364 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.833 0.349 . . . . 74.31 110.902 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.7 t30 68.01 18.27 9.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 71.01 110.891 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 14.1 tt0 -122.19 88.82 3.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 72.54 110.831 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.455 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.4 m -134.63 169.03 17.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 70.1 110.854 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.22 152.34 38.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 71.02 110.879 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -127.03 109.29 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.43 110.881 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.5 m -150.96 152.74 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 73.21 111.112 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.5 p -80.1 101.89 9.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 71.23 110.884 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.87 151.18 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 71.31 111.078 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.87 144.13 32.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.547 0.689 . . . . 74.41 111.104 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 124.67 11.32 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.713 2.275 . . . . 75.11 112.306 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.03 -15.99 1.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 55.22 112.485 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.9 m -126.16 131.33 52.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.37 . . . . 75.02 111.134 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.9 m -72.66 138.15 46.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.44 111.153 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -108.57 139.58 43.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 75.23 110.926 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -107.25 160.19 15.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 73.42 110.831 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 t -137.8 126.14 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 75.15 111.148 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.04 123.06 27.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 74.5 110.845 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.1 mm -111.2 124.32 67.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 75.12 111.112 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 145.25 32.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.865 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -117.14 140.61 15.99 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 62.25 112.49 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -101.76 -24.3 14.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.923 0.392 . . . . 75.43 110.953 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 91' ' ' ASN . 72.2 p -174.52 139.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 64.41 110.835 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 90' ' ' SER . 5.1 p-10 -31.56 106.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 65.22 110.913 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -163.09 110.6 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 65.54 110.93 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 p -117.25 158.83 23.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 73.44 110.868 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.34 25.45 2.0 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 72.14 112.529 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.36 146.83 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.865 0.364 . . . . 55.24 111.162 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.71 113.72 27.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 71.43 111.171 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tp -99.88 141.08 33.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 72.24 110.921 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -151.58 169.92 20.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.936 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.411 ' HA ' ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -89.42 144.8 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 74.04 110.903 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.39 101.79 11.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 70.12 110.888 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.931 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.869 0.366 . . . . 72.02 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -117.83 108.84 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.44 111.13 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.07 149.74 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 72.22 110.875 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.421 ' HD3' HG22 ' A' ' 84' ' ' VAL . 18.4 tptm -162.7 -70.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.31 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.579 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -71.65 155.4 40.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 74.05 110.888 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 18.4 t30 89.03 -67.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.45 110.875 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 m -124.19 120.66 26.24 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.614 0.721 . . . . 75.25 111.171 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 154.14 68.3 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.7 2.267 . . . . 71.42 112.384 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.9 t -87.48 113.78 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 61.34 111.131 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 p -91.31 175.14 7.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.858 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 p30 40.62 48.91 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 74.32 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.38 -176.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.952 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 p -143.86 139.61 29.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 73.24 111.146 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.75 64.54 0.56 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.794 -0.717 . . . . 74.45 112.497 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -73.93 160.5 31.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.941 0.4 . . . . 74.44 110.858 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 90' ' ' SER . 0.9 OUTLIER -45.22 -64.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.905 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.9 -48.14 1.81 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 73.12 112.501 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.57 157.81 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.839 0.352 . . . . 70.2 110.881 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.65 -179.32 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 71.22 110.893 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.66 146.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.21 111.141 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -137.55 145.72 43.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 70.43 110.88 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -144.88 165.9 26.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 74.44 110.913 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 8.2 m -140.79 140.02 34.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 51.33 111.089 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -159.68 160.69 34.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 71.54 110.858 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.5 p -130.1 170.22 14.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.484 . . . . 73.32 111.125 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.11 170.76 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.42 111.121 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -99.46 -67.99 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.887 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -125.31 148.68 48.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 75.25 110.869 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -50.53 117.49 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 73.43 110.84 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.97 144.42 33.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 74.04 111.079 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 t -103.05 107.13 17.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.436 . . . . 72.41 111.167 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.56 147.13 46.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 75.22 111.138 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -107.57 111.69 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 72.52 111.129 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 t -127.64 139.67 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.31 111.15 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.456 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 9.5 p -135.15 165.27 25.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 71.13 110.858 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.4 150.93 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 73.2 111.111 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 177.5 172.93 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 73.54 110.831 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 72.31 112.443 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.8 0.333 . . . . 73.43 110.864 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.67 116.36 26.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 73.13 111.108 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -78.21 147.2 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 62.23 110.844 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 tt -108.4 126.93 53.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 71.12 110.909 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -142.66 139.37 31.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 75.22 110.901 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.09 133.64 19.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 73.34 110.908 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 133.86 24.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.466 . . . . 74.33 110.918 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.27 132.53 38.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 52.35 111.123 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.82 -80.63 1.81 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 44.34 112.509 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -92.92 175.95 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 70.0 110.842 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.15 137.75 31.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 72.42 110.895 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 142.65 48.38 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.691 2.26 . . . . 65.43 112.334 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.67 178.68 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 74.32 111.155 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 p -66.81 -13.38 61.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.54 111.113 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 m -123.01 -25.96 4.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 61.41 110.85 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.83 125.99 49.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 70.5 110.839 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.11 153.67 34.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 74.03 110.964 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -102.02 -32.19 10.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 64.45 110.85 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.2 m -138.03 123.57 19.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 63.24 110.856 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -177.29 127.16 0.3 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.568 0.699 . . . . 74.22 110.893 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 C--O 1.231 0.164 0 C-N-CA 122.726 2.284 . . . . 73.23 112.38 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.854 0.359 . . . . 71.31 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.8 25.57 11.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 70.44 110.906 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.32 96.13 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 71.12 110.865 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -133.85 170.95 14.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 53.2 110.862 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.46 149.56 41.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 65.54 110.951 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 p -126.72 109.27 11.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.44 110.864 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.2 t -150.91 152.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 52.11 111.139 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 p -81.41 102.14 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 70.02 110.85 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.55 149.96 26.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 54.41 111.13 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.58 144.23 28.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.595 0.712 . . . . 74.15 111.094 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.25 7.04 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.684 2.256 . . . . 74.33 112.314 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.68 -4.97 80.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.728 . . . . 62.01 112.494 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.9 m -126.22 125.48 42.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 73.1 111.125 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 m -71.24 137.78 48.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 74.1 111.127 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -111.66 137.98 48.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 75.53 110.936 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -105.98 162.41 13.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 72.52 110.841 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG22 ' HD3' ' A' ' 5' ' ' LYS . 2.7 t -135.89 138.57 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.31 111.147 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.8 tpp -140.3 121.77 15.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 75.23 110.83 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.4 mm -118.86 113.16 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.21 111.144 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -100.11 155.79 17.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 74.11 110.915 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.03 153.24 17.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 73.12 112.478 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.87 -21.98 8.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.895 0.379 . . . . 63.02 110.927 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.479 ' O ' ' C ' ' A' ' 91' ' ' ASN . 1.6 p -175.04 134.44 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 70.21 110.905 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 90' ' ' SER . 39.2 t30 -32.02 106.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 65.22 110.905 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -163.95 116.52 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.926 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.6 p -121.84 151.62 40.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 72.35 110.856 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.16 29.38 1.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 74.35 112.488 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.56 145.73 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.929 0.395 . . . . 72.23 111.127 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -101.15 118.56 37.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 71.22 111.165 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.422 ' CD1' ' C ' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -111.45 127.81 55.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 73.42 110.917 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -135.15 167.92 20.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.908 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.18 141.2 28.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 74.22 110.923 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.08 110.99 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 75.04 110.927 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.928 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.847 0.356 . . . . 75.0 110.9 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 m -106.39 108.45 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 72.32 111.097 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.14 149.93 52.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 62.34 110.904 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -166.71 -67.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.907 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -76.09 153.93 35.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 74.04 110.918 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.1 t-20 87.32 -69.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.887 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.1 m -120.88 121.55 28.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.57 0.7 . . . . 61.52 111.105 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 154.38 67.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.692 2.262 . . . . 74.2 112.363 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.13 116.22 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 62.51 111.137 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 p -87.96 159.71 18.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 64.1 110.834 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 p30 40.08 69.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 73.11 110.855 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.81 -174.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 65.24 110.889 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -140.49 138.0 34.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 74.1 111.146 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.52 64.05 0.58 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.693 -0.765 . . . . 63.53 112.454 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -75.59 148.18 39.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.357 . . . . 72.32 110.905 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.36 -57.02 7.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 75.21 110.881 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.63 -64.21 1.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 42.13 112.491 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.92 144.61 8.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 72.4 110.865 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -139.67 179.33 6.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 61.14 110.892 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.13 138.0 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 74.54 111.127 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -135.41 139.58 44.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 71.34 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -137.44 163.8 30.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 75.44 110.926 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 p -142.17 146.91 35.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 72.22 111.136 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.39 163.28 35.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 64.21 110.822 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 p -125.58 169.74 12.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 54.03 111.183 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.2 t -108.33 145.09 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.13 111.089 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -86.21 -44.29 12.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.832 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -142.78 154.72 44.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 75.1 110.86 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -72.04 116.62 12.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 72.21 110.938 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.75 141.3 31.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 63.31 111.116 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -94.81 105.66 17.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 74.14 111.114 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.11 148.62 45.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 71.34 111.136 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -107.93 111.12 34.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 72.53 111.12 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.41 139.9 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 71.22 111.09 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.481 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 24.3 p -135.89 166.21 23.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 73.04 110.855 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -111.4 150.66 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 72.13 111.152 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.3 173.58 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 64.34 110.884 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 64.31 112.495 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.866 0.365 . . . . 72.03 110.861 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.93 127.12 54.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 74.52 111.073 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 1.7 m-20 -88.91 152.36 21.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 70.14 110.867 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.6 tt -118.75 142.24 47.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 72.44 110.891 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -153.36 142.92 21.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 73.02 110.945 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.66 134.08 29.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 74.35 110.922 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -149.16 129.64 13.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 74.44 110.906 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.3 98.98 8.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 64.1 111.091 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.07 -90.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 71.55 112.463 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.0 m -90.46 128.48 36.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.957 0.408 . . . . 63.44 110.849 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.26 133.93 3.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.574 0.702 . . . . 72.42 110.87 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 143.02 49.54 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.677 2.251 . . . . 73.32 112.336 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 p -107.63 178.73 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 74.42 111.164 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.8 p -63.28 -15.18 56.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 74.11 111.164 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 m -118.96 -26.33 6.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 74.51 110.858 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.73 125.49 49.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.852 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.97 153.4 34.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.909 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -108.18 -34.58 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 71.41 110.912 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 70.5 m -144.64 123.1 12.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.86 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -177.37 129.14 0.32 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.606 0.717 . . . . 74.45 110.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HG2' ' CG ' ' A' ' 70' ' ' GLU . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.237 . . . . 64.03 112.399 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.836 0.351 . . . . 73.32 110.897 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.3 t30 65.63 12.19 8.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.878 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.417 ' CG ' ' HG2' ' A' ' 63' ' ' PRO . 4.3 tt0 -116.68 87.5 2.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.876 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.481 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -133.28 169.26 17.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 72.42 110.846 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.74 156.73 31.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 71.32 110.865 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.68 107.22 9.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 52.04 110.832 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -150.65 153.12 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.43 111.168 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -70.21 104.72 2.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.22 110.863 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.93 131.5 35.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 70.23 111.127 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.99 139.94 20.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.589 0.709 . . . . 55.33 111.078 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 170.45 16.55 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.683 2.255 . . . . 75.23 112.349 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.16 -39.24 2.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 45.01 112.474 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.6 m -97.04 128.93 44.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 71.34 111.155 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.1 m -71.43 133.24 45.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 72.31 111.141 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -104.03 136.02 44.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 72.05 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -106.97 159.14 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 64.32 110.834 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.93 139.39 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 73.13 111.108 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.82 123.65 25.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 74.0 110.892 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.1 mm -118.81 113.61 42.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 74.13 111.099 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 10.3 mmmm -98.29 165.32 11.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 74.42 110.927 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.88 135.08 8.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.713 -0.756 . . . . 73.22 112.449 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -96.61 -31.54 12.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 75.21 110.943 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 91' ' ' ASN . 78.1 p -167.62 136.92 2.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 65.42 110.859 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 90' ' ' SER . 13.5 t-20 -34.62 105.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 75.01 110.898 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -164.37 119.25 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 74.04 110.953 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 p -121.56 155.76 34.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 70.53 110.891 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.65 23.29 1.52 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 72.32 112.468 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.15 143.12 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.911 0.386 . . . . 73.31 111.123 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.08 132.26 45.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.3 111.158 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 13.8 tp -118.99 149.71 41.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.928 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -157.87 164.27 37.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 74.51 110.919 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.96 138.95 31.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.25 -0.432 . . . . 70.44 110.907 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -98.09 112.0 24.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 63.33 110.941 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 p90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 73.12 110.926 -179.833 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.893 0.378 . . . . 74.12 110.831 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.56 109.25 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 75.45 111.103 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.47 148.95 52.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 75.32 110.936 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -166.66 -68.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 73.4 110.883 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -75.01 154.98 37.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.54 110.877 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.0 t-20 88.38 -65.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 71.31 110.906 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 m -129.35 121.67 20.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.551 0.691 . . . . 71.05 111.098 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 154.07 67.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.653 2.236 . . . . 73.05 112.359 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.3 t -84.83 115.09 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 61.14 111.134 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.2 146.12 28.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 74.02 110.853 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.66 81.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 75.14 110.942 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.58 -172.69 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 71.21 110.924 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -136.98 138.72 40.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 75.12 111.139 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.77 71.87 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.746 -0.74 . . . . 74.32 112.505 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -76.98 134.54 38.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 61.21 110.89 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -24.57 8.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.901 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.13 -40.64 1.37 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 61.44 112.439 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.27 -173.12 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.356 . . . . 72.23 110.871 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.12 -178.01 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 75.1 110.918 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.0 145.76 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 74.41 111.168 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -137.21 143.4 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.51 110.849 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -140.15 165.25 27.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 73.33 110.926 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 m -147.11 142.32 27.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 74.21 111.137 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.36 162.51 35.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 74.25 110.868 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 p -130.34 169.94 14.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 72.42 111.115 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 m -108.68 169.89 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.197 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -108.73 -45.16 3.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.895 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -133.38 158.82 42.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 75.1 110.881 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.7 116.27 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 55.21 110.896 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.38 139.19 31.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 65.23 111.127 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.3 m -96.21 106.77 19.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 71.41 111.154 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.59 147.29 46.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 70.31 111.117 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -107.5 111.29 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 52.31 111.132 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -127.45 140.22 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 75.01 111.115 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.489 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 5.4 p -133.53 166.25 23.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.891 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.91 152.44 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 74.22 111.169 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.79 173.9 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.886 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 54.22 112.496 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.812 0.339 . . . . 53.02 110.826 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.64 120.55 39.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.55 111.159 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.55 161.99 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 75.52 110.887 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 tt -118.78 129.82 55.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 75.12 110.959 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -133.85 146.54 50.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.913 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.52 133.47 13.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 75.33 110.922 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.87 121.58 11.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.854 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.49 89.46 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 74.33 111.109 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.89 -83.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 75.44 112.456 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -106.41 133.96 50.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.925 0.393 . . . . 70.04 110.862 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.66 127.34 2.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 75.44 110.932 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 142.87 49.23 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.708 2.272 . . . . 63.33 112.305 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.48 178.32 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 74.02 111.152 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.3 p -60.63 -17.04 44.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 75.51 111.152 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.6 m -117.04 -25.45 7.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.833 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.46 124.87 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 74.13 110.847 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.87 153.41 33.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.91 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -115.51 -34.91 4.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 75.4 110.886 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.9 m -140.37 122.68 15.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 74.13 110.873 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.32 140.69 0.4 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.582 0.706 . . . . 70.42 110.907 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 122.69 2.26 . . . . 73.02 112.313 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 CA--C 1.526 0.034 0 CA-C-O 120.856 0.36 . . . . 74.31 110.865 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.9 t30 66.86 16.55 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.15 110.905 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.92 96.98 4.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 63.4 110.899 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.489 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 2.4 m -134.32 171.2 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.901 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.29 152.96 35.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 74.53 110.882 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -128.64 109.26 11.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.24 110.854 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.6 m -150.89 152.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 62.42 111.135 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.6 p -73.2 106.97 5.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 64.01 110.8 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.71 132.55 35.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 74.11 111.066 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.63 139.23 19.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.525 0.678 . . . . 74.15 111.101 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 142.11 46.88 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.629 2.219 . . . . 72.22 112.325 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.97 -12.77 8.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.774 -0.727 . . . . 73.11 112.461 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.1 m -126.41 129.23 48.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 70.01 111.165 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -70.98 138.07 49.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 74.35 111.159 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -108.6 135.86 49.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 73.2 110.946 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -107.24 158.91 16.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 61.41 110.879 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 t -138.3 138.57 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 75.4 111.14 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.97 123.05 17.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.43 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.44 112.96 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 64.43 111.169 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -110.38 134.31 52.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 74.45 110.874 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.74 144.67 17.66 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.753 . . . . 31.11 112.456 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.77 -22.27 20.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.902 0.382 . . . . 75.14 110.962 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 91' ' ' ASN . 2.7 p -163.85 139.76 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 72.54 110.891 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 90' ' ' SER . 13.3 t-20 -35.07 106.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 64.35 110.882 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -155.47 115.59 3.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 71.54 110.946 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.1 p -122.17 151.5 40.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 71.04 110.849 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.46 23.65 2.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 74.22 112.469 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.74 143.94 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 72.01 111.096 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.94 124.19 46.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 72.43 111.124 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.5 tp -112.32 148.38 34.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 64.45 110.951 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -153.79 164.7 37.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 72.43 110.878 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.43 136.91 32.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.236 -0.438 . . . . 74.4 110.922 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.38 112.18 24.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.01 110.931 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 75.45 110.871 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 m120 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.856 0.36 . . . . 71.22 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.5 m -117.9 108.27 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 73.32 111.146 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.54 150.66 52.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 70.43 110.95 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -166.09 -73.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 74.41 110.883 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 9.8 t-20 -63.39 157.75 22.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 73.01 110.919 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.3 t30 88.52 -60.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.868 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.4 m -133.59 121.62 16.32 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 72.45 111.161 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 152.28 69.54 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 2.243 . . . . 63.33 112.353 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -79.37 115.02 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 74.35 111.175 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.49 146.31 31.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 72.25 110.844 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.59 81.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 73.3 110.841 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -168.72 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 73.52 110.911 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 p -139.61 138.34 36.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 73.3 111.137 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.63 58.82 0.65 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.721 -0.752 . . . . 75.31 112.517 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -76.56 139.17 40.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.874 0.368 . . . . 73.25 110.848 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -26.11 9.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 71.42 110.942 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.98 -56.33 0.4 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.735 -0.745 . . . . 73.1 112.503 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.13 158.73 6.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.854 0.359 . . . . 75.4 110.868 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -152.6 167.58 28.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 73.35 110.922 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.61 136.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 64.25 111.102 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -137.42 147.15 45.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 73.23 110.825 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -146.22 166.11 27.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 70.44 110.968 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.416 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 27.6 m -140.04 140.7 36.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 73.1 111.108 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -160.74 155.06 23.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.925 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 p -128.07 170.49 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.04 111.178 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -108.5 170.21 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 74.34 111.11 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.05 -52.83 3.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 62.41 110.873 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.43 172.67 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.25 110.873 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -75.93 117.13 17.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 75.13 110.845 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.81 133.5 25.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 65.2 111.143 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.6 m -95.18 107.98 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 74.45 111.118 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.2 148.33 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 73.54 111.067 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 p -106.92 111.03 33.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 74.53 111.099 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.16 139.34 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 60.15 111.115 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.484 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 17.0 p -135.48 170.23 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 75.35 110.889 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 pt -108.01 157.49 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 73.23 111.112 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 174.12 171.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 75.53 110.838 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.679 -0.772 . . . . 71.34 112.429 -179.968 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.818 0.342 . . . . 65.12 110.89 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.76 120.92 36.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 73.23 111.1 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.64 172.64 11.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.891 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 tt -124.63 141.82 51.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 73.04 110.914 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -150.37 146.62 26.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.949 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.87 146.23 23.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 71.14 110.934 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 7.1 tttt -149.62 123.12 9.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 72.42 110.923 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.54 84.28 6.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 72.34 111.109 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.89 -64.22 0.4 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 72.55 112.527 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -139.99 137.7 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.949 0.404 . . . . 75.35 110.833 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -32.52 127.2 0.36 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.522 0.677 . . . . 75.55 110.929 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 143.45 50.76 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.668 2.245 . . . . 71.13 112.329 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -103.35 178.35 4.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 55.14 111.106 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.5 p -62.69 -15.71 53.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 74.31 111.172 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.3 m -117.21 -26.23 6.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 71.11 110.858 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.94 123.52 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 73.14 110.838 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.39 153.55 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 73.21 110.903 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 49' ' ' LYS . 35.6 m-20 -112.27 -45.67 3.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 55.2 110.847 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 36.9 m -121.9 123.57 42.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 74.13 110.869 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -175.77 127.61 0.37 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 74.51 110.848 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.183 0 C-N-CA 122.694 2.263 . . . . 63.03 112.344 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 p30 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.81 0.338 . . . . 74.32 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.3 t30 61.09 24.2 14.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.31 110.876 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -128.98 90.23 3.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 75.33 110.908 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.484 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 2.6 m -133.04 169.97 16.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 71.2 110.86 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.57 154.76 34.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 75.2 110.869 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.6 p -128.29 109.67 11.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.846 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.1 t -150.33 153.02 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 72.34 111.123 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -75.41 105.38 6.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.3 110.857 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.13 138.41 34.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.41 111.064 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.29 146.52 32.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.711 . . . . 73.22 111.13 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 164.55 34.09 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 73.21 112.374 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.0 -21.18 38.3 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.713 -0.756 . . . . 71.35 112.482 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.0 m -108.75 124.01 49.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 64.43 111.111 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.0 m -72.89 134.06 44.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 63.12 111.127 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -109.13 136.91 47.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.885 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -118.55 139.56 51.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 73.42 110.851 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.03 126.83 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 74.21 111.091 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 tpt -123.51 128.82 50.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 62.24 110.846 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.6 mm -113.97 126.43 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 74.42 111.109 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.19 146.3 30.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 73.35 110.9 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.39 150.13 18.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 71.52 112.472 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.15 -37.9 5.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.35 . . . . 74.41 110.868 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 91' ' ' ASN . 7.6 p -161.74 137.64 7.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 73.03 110.908 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.482 ' C ' ' O ' ' A' ' 90' ' ' SER . 4.8 p-10 -31.65 108.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.877 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.63 121.66 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 75.13 110.919 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.5 p -121.59 168.23 11.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 74.3 110.82 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.39 22.66 2.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 71.12 112.478 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -113.38 140.75 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 74.13 111.123 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.54 120.04 39.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 74.2 111.185 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.4 tp -106.22 149.99 26.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.912 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -156.92 162.91 39.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 75.35 110.866 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.27 140.34 29.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 75.34 110.909 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -103.5 112.42 25.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 74.15 110.916 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.8 p90 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.52 110.903 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.3 m120 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.82 0.343 . . . . 74.4 110.921 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -121.9 108.26 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.54 111.103 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.03 149.34 52.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 75.01 110.927 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 1.4 tppm? -163.55 -75.34 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.928 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.578 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -62.27 155.11 25.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 71.43 110.903 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.7 t-20 89.03 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.03 110.834 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.2 m -121.67 121.01 28.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 74.1 111.144 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 153.57 68.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.266 . . . . 72.42 112.326 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.4 t -84.48 114.49 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 75.3 111.152 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 p -86.69 167.89 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 63.4 110.862 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 39.75 55.76 2.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 61.43 110.855 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mt -58.9 -175.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 75.14 110.884 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.9 p -141.76 138.33 32.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.101 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.96 55.17 0.7 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 73.21 112.477 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -75.84 140.44 42.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 70.11 110.86 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -26.9 5.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 70.22 110.884 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.23 -61.43 0.48 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 71.44 112.455 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -58.16 144.42 40.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 71.25 110.893 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -138.99 170.7 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 70.2 110.845 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.61 135.55 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 73.33 111.118 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -138.23 154.16 49.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.02 110.886 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -148.0 166.77 26.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.948 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 58.3 m -137.44 140.45 41.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 72.12 111.132 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -159.95 158.13 30.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 75.14 110.847 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.4 p -127.39 170.51 12.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 72.42 111.141 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.45 171.02 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 72.41 111.134 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.75 -66.57 0.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 70.13 110.898 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -127.08 149.73 49.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.879 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -51.02 117.04 2.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 65.22 110.837 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.95 145.12 34.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 63.14 111.095 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -104.77 106.67 17.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 73.11 111.181 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.29 147.23 47.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 73.25 111.111 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 p -107.51 112.32 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 75.42 111.179 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.8 t -127.5 139.77 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 63.33 111.152 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.462 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 9.9 p -134.68 166.41 22.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 70.43 110.866 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.04 146.41 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 72.33 111.115 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.3 t 177.9 161.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.894 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 73.41 112.485 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.853 0.358 . . . . 73.54 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.32 120.12 35.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 74.43 111.067 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.74 143.75 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 72.12 110.849 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 tt -103.48 131.34 50.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 64.23 110.905 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -130.65 154.45 47.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 72.32 110.949 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.6 133.63 12.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 61.13 110.863 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -148.95 124.48 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.882 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.58 82.9 7.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 62.3 111.083 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.72 -82.51 0.19 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 54.11 112.508 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 m -109.08 136.92 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 73.35 110.83 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.64 126.01 2.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 74.13 110.919 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 142.58 48.25 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.723 2.282 . . . . 73.22 112.299 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.84 177.98 4.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 64.41 111.151 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.9 p -62.71 -16.78 58.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 74.33 111.094 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m -116.78 -26.24 7.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 72.01 110.823 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.94 124.11 47.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 72.24 110.845 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.61 153.38 33.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 73.45 110.907 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -107.85 -44.99 4.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.03 110.852 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.5 m -145.17 122.21 11.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 64.53 110.879 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -177.38 153.94 1.05 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.604 0.716 . . . . 75.24 110.885 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.147 0 C-N-CA 122.705 2.27 . . . . 70.21 112.313 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.792 0.329 . . . . 74.14 110.928 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 63.94 16.76 10.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 71.23 110.923 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -127.25 100.09 5.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 74.32 110.872 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.462 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 4.9 m -136.77 173.13 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 74.52 110.894 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.71 150.53 38.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 74.41 110.904 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.4 p -126.09 109.86 12.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 74.21 110.878 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -150.75 148.73 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.54 111.134 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.27 102.37 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 73.23 110.848 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.7 151.42 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 72.31 111.056 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.69 145.72 31.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 71.23 111.088 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 162.78 40.7 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 65.42 112.347 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.07 -18.5 51.85 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.77 -0.728 . . . . 72.22 112.487 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.9 m -116.87 125.97 52.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 63.24 111.13 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -71.25 137.57 48.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 73.52 111.17 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -112.46 152.71 28.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 71.25 110.921 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -131.36 159.0 39.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 75.33 110.872 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.44 125.46 53.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 72.22 111.151 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.23 124.19 46.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 72.03 110.867 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mm -110.54 113.17 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.54 111.122 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.97 133.21 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 73.24 110.921 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.22 160.29 16.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 71.22 112.475 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -117.46 -29.79 5.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 73.21 110.953 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 91' ' ' ASN . 97.5 p -168.21 143.54 3.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 70.55 110.783 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' SER . 39.1 t30 -33.04 109.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.505 . . . . 74.35 110.893 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.6 111.69 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 65.55 110.893 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 p -121.67 159.68 26.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 74.45 110.876 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 120.4 22.24 3.17 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.699 -0.762 . . . . 74.45 112.476 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.13 146.22 18.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.921 0.391 . . . . 71.21 111.113 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.26 132.54 46.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 73.01 111.131 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.8 tp -121.45 148.79 43.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.899 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -155.07 170.04 22.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.853 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.407 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -90.65 140.85 29.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.03 110.896 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -103.1 108.64 19.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.53 110.889 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 73.45 110.932 -179.864 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.802 0.334 . . . . 71.5 110.931 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.1 m -117.7 108.39 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 74.33 111.093 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.98 148.89 52.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.939 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 17.8 tptt -164.0 -74.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.893 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 12.2 t-20 -65.87 156.66 32.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.31 110.937 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.5 t30 85.61 -69.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 73.24 110.913 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -119.34 120.84 30.6 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.565 0.697 . . . . 75.44 111.137 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 153.54 68.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.656 2.238 . . . . 72.5 112.372 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.4 t -84.05 115.34 26.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.158 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.05 162.07 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.876 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 40.52 65.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 75.35 110.838 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.13 -173.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 75.44 110.915 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 p -143.2 139.15 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 73.21 111.146 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.77 64.89 0.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.792 -0.718 . . . . 75.24 112.522 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.5 160.49 30.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 72.31 110.876 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 90' ' ' SER . 31.0 mmtp -44.87 -70.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.453 . . . . 65.25 110.909 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.6 -45.59 2.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.68 -0.771 . . . . 73.2 112.496 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.89 151.88 13.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.342 . . . . 75.21 110.849 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.53 -179.4 8.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 74.34 110.896 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.56 144.76 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 64.12 111.119 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -137.43 145.27 42.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.44 110.852 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -144.09 166.09 25.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 74.04 110.942 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 2.5 m -141.96 138.58 32.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 75.15 111.128 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 2.0 t80 -160.53 162.98 33.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 74.55 110.882 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -131.7 171.09 13.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 74.23 111.142 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.2 170.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 73.43 111.159 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -111.98 -39.31 4.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 53.23 110.848 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.95 157.87 45.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.43 110.886 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -79.93 116.45 20.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 72.13 110.891 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.98 142.86 32.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 71.4 111.122 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 t -99.17 107.84 20.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 72.22 111.105 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.08 147.23 45.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 74.51 111.098 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 p -107.87 111.37 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 71.23 111.165 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.8 t -127.83 140.33 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.35 111.13 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.493 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 2.0 p -132.36 167.16 20.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.854 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.402 HG23 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -110.38 142.66 22.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 74.53 111.121 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 p -179.32 -169.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.84 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 74.11 112.518 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.755 0.312 . . . . 74.44 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.56 108.38 14.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.04 111.069 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.0 144.58 54.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.853 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 tt -112.46 126.94 55.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.945 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -136.41 148.84 47.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 73.4 110.907 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.95 133.81 13.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 71.24 110.938 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -141.96 140.04 32.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.33 110.899 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.74 -48.45 13.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 72.23 111.148 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.61 -96.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 73.11 112.503 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -106.79 162.38 13.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.917 0.389 . . . . 71.24 110.828 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.12 128.35 5.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.575 0.702 . . . . 75.44 110.906 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 142.35 47.22 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.654 2.236 . . . . 73.43 112.305 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -113.42 179.77 3.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 70.21 111.15 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.5 p -60.96 -16.75 46.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 71.25 111.14 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -117.11 -26.03 6.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 74.04 110.848 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 124.94 49.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 73.32 110.862 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.34 152.97 31.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.92 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -114.76 -31.5 6.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 74.33 110.86 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.8 m -141.89 121.89 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.872 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.58 122.7 0.13 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.625 0.726 . . . . 72.13 110.855 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.437 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.202 0 C-N-CA 122.649 2.233 . . . . 61.02 112.325 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.871 0.367 . . . . 62.44 110.876 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.7 t30 64.13 14.61 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 61.41 110.914 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -126.88 98.1 5.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 75.32 110.876 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.493 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 3.5 m -135.81 171.43 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 71.44 110.862 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.83 150.86 38.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 72.45 110.907 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 p -128.47 108.48 10.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 73.3 110.873 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -151.08 148.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 75.54 111.163 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.28 106.37 6.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 71.21 110.876 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.33 145.25 29.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 70.3 111.03 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.19 139.38 21.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 50.24 111.087 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 133.56 25.9 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.708 2.272 . . . . 73.22 112.326 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.88 -20.06 2.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 75.22 112.462 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.2 m -126.51 134.95 50.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.371 . . . . 63.44 111.15 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.6 m -71.07 137.6 49.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 73.3 111.156 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -104.77 139.6 39.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 73.55 110.948 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -107.18 161.24 14.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 60.25 110.823 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.91 138.17 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 75.51 111.15 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.7 tpt -142.98 123.27 13.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 70.41 110.923 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 mm -118.95 112.15 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 71.22 111.094 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -95.77 157.18 16.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 75.41 110.924 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.34 145.95 16.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 75.14 112.467 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -112.16 -21.71 11.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 73.22 110.868 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 91' ' ' ASN . 7.1 p -165.74 127.97 2.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 73.3 110.877 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 90' ' ' SER . 9.1 t-20 -35.38 106.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 71.02 110.894 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.42 115.63 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.932 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 p -115.87 151.85 34.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 72.4 110.86 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.47 28.26 0.92 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 52.01 112.519 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.33 147.38 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 72.12 111.088 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.03 114.14 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 74.4 111.107 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 37' ' ' ILE . 1.7 tm? -104.25 132.78 50.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 75.45 110.935 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -144.18 163.72 32.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 71.23 110.832 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.405 ' HA ' ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -91.69 140.67 29.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 64.54 110.9 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.81 113.04 24.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.25 110.925 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.0 p90 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 74.32 110.953 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.855 0.36 . . . . 74.43 110.923 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 24' ' ' THR . 3.1 m -120.32 108.85 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.31 111.125 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.45 148.72 52.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.13 110.893 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.46 -69.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 64.11 110.859 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.574 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 8.6 t-20 -77.68 158.73 29.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 65.32 110.904 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.574 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.4 t30 88.38 -68.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.13 110.918 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.7 m -123.4 113.73 29.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.552 0.691 . . . . 75.2 111.129 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 53.4 Cg_endo -69.76 150.28 68.0 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 74.41 112.34 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.5 t -77.99 113.8 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 75.34 111.091 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.21 140.02 41.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 71.54 110.854 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.35 84.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 74.12 110.89 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -167.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 74.01 110.886 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 p -139.05 138.56 37.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.24 111.135 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.69 60.3 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 74.12 112.474 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -76.02 158.4 31.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 64.04 110.857 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -61.23 2.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.857 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.72 -50.63 1.94 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 75.41 112.503 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.74 140.63 14.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 73.41 110.88 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -141.19 170.46 15.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 71.54 110.859 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.29 137.06 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 64.44 111.161 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.25 152.27 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 64.41 110.899 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -143.34 165.56 27.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 73.32 110.934 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 3.2 m -135.24 139.07 44.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 75.14 111.125 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.01 162.58 34.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 71.54 110.863 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.4 p -136.72 171.04 15.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 73.33 111.154 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.407 ' HB ' ' CZ ' ' A' ' 101' ' ' TYR . 22.3 m -108.38 172.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.54 111.123 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.6 -57.61 2.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 64.05 110.865 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.19 140.43 51.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 74.11 110.859 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -48.78 118.87 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 65.15 110.906 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.39 131.15 27.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 72.25 111.125 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 t -94.68 106.58 18.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 75.02 111.146 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.09 147.77 40.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.03 111.052 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -113.9 109.24 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.13 111.157 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 t -130.95 141.19 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 74.15 111.153 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.487 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 29.1 p -129.12 167.68 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 75.23 110.873 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.96 147.18 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 72.22 111.132 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.22 163.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.41 110.914 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.796 -0.716 . . . . 73.44 112.517 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.817 0.341 . . . . 72.2 110.905 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.12 128.59 46.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 62.41 111.104 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -102.45 124.49 48.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 75.01 110.905 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.11 130.1 37.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.257 -0.429 . . . . 63.4 110.865 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -132.58 148.89 52.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.899 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.34 142.79 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 72.22 110.858 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.91 117.72 5.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.926 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.52 123.92 20.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 64.4 111.115 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 -82.83 0.8 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 73.45 112.49 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.9 m -93.67 -179.19 4.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.952 0.406 . . . . 63.14 110.858 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 134.72 28.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 71.03 110.862 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 141.51 45.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 70.52 112.325 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -102.5 179.03 4.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 65.23 111.131 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.1 p -65.63 -13.7 59.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 73.41 111.145 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 m -121.36 -26.46 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.861 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.83 126.22 49.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 75.1 110.852 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.37 153.47 34.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 74.1 110.892 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -108.89 -29.11 8.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 75.53 110.844 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.9 m -136.93 124.0 21.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.88 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HG3' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -174.74 126.57 0.4 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.611 0.72 . . . . 73.54 110.904 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HD2' ' HG3' ' A' ' 62' ' ' ARG . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.158 0 C-N-CA 122.647 2.231 . . . . 71.14 112.363 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.803 0.335 . . . . 72.31 110.873 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.2 t30 63.94 19.63 11.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 73.41 110.862 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -123.16 88.74 2.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 75.02 110.907 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.487 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -132.23 170.16 15.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 74.01 110.852 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.24 154.01 34.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 55.23 110.899 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.7 p -128.25 104.19 7.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 74.04 110.834 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -152.22 152.73 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 72.52 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.1 p -84.32 104.39 14.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 75.03 110.884 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.68 154.72 25.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 74.41 111.066 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.39 139.71 20.42 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.629 0.728 . . . . 74.21 111.086 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 140.03 41.62 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 75.44 112.328 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.26 -6.18 9.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.751 . . . . 73.25 112.51 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.5 m -126.41 129.6 49.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 73.21 111.127 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.2 m -72.46 136.86 46.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 62.33 111.139 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -111.88 134.44 53.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.936 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -106.07 162.76 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 62.41 110.863 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.79 140.0 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 60.23 111.129 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.13 121.07 14.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.894 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.8 mm -111.16 113.13 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 74.42 111.131 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 135.62 41.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 72.14 110.914 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.38 157.24 15.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.757 . . . . 61.05 112.486 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -117.12 -28.04 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.946 0.403 . . . . 73.21 110.904 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 91' ' ' ASN . 73.2 p -166.88 136.06 2.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 75.5 110.882 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 90' ' ' SER . 3.1 m120 -31.75 105.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 64.25 110.866 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -162.78 113.07 1.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 73.54 110.942 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.7 p -121.51 159.83 25.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 74.14 110.851 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.03 19.46 2.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.747 . . . . 74.21 112.532 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.42 141.45 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 72.4 111.169 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.7 m -99.32 122.84 43.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 73.04 111.141 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.2 tp -102.04 142.7 32.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.877 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -151.22 153.0 34.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 75.24 110.946 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.493 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -88.52 140.85 29.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.32 110.895 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -93.9 113.66 25.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 74.05 110.889 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.407 ' CZ ' ' HB ' ' A' ' 27' ' ' VAL . 4.9 t80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 71.33 110.959 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.836 0.351 . . . . 64.31 110.93 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.1 m -117.47 109.42 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 73.21 111.113 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.48 148.48 52.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 73.22 110.95 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 15.4 tptm -164.74 -65.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 71.42 110.914 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 8.4 t-20 -77.92 155.74 30.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 74.04 110.869 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 10.3 t-20 87.2 -68.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 74.35 110.867 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.5 m -121.5 120.89 28.64 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.594 0.712 . . . . 74.53 111.138 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB3' ' HD3' ' A' ' 98' ' ' LYS . 53.7 Cg_endo -69.83 153.82 68.17 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.695 2.263 . . . . 73.43 112.327 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.6 t -83.21 115.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 73.25 111.076 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.07 142.25 31.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 75.32 110.864 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.28 86.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 74.21 110.906 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.88 -171.97 3.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 73.43 110.884 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 p -139.41 139.47 37.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 74.31 111.162 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.45 69.99 0.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 73.21 112.507 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -76.42 153.55 35.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 74.55 110.865 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.4 -34.29 23.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.879 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.66 -52.72 0.25 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 53.14 112.477 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 t -52.56 168.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 72.31 110.817 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.84 175.6 3.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 74.24 110.893 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.31 144.67 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 74.44 111.096 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -136.91 128.14 28.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 73.11 110.87 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -127.45 164.64 21.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 75.12 110.895 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.406 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 2.4 m -141.06 143.42 34.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 72.21 111.14 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -160.27 163.33 33.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 74.21 110.878 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 p -132.5 170.31 15.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 65.03 111.117 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.6 m -109.2 167.47 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 72.42 111.12 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -97.43 -48.59 5.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.51 110.852 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 165.31 27.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 73.53 110.873 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -56.7 117.91 4.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.868 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.54 120.91 12.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 75.04 111.09 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 t -98.33 105.55 17.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 73.54 111.108 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.38 147.5 45.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 74.5 111.099 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -108.49 110.6 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 62.15 111.137 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.3 141.11 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 64.01 111.12 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.472 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.62 166.49 17.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 74.54 110.851 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.44 147.33 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 74.43 111.168 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.93 172.09 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 71.11 110.85 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.764 -0.732 . . . . 75.15 112.512 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.833 0.349 . . . . 63.44 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.06 124.9 45.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.14 111.046 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.7 152.02 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 61.53 110.887 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tt -106.93 127.02 53.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 64.34 110.894 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -136.49 142.61 43.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.934 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -154.12 135.7 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 72.41 110.914 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -140.81 121.56 14.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.939 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.35 77.54 9.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.23 111.082 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.72 -59.98 0.3 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 62.31 112.454 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -142.21 141.78 32.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 55.4 110.834 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.73 120.15 1.4 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.574 0.702 . . . . 74.34 110.899 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 143.4 51.19 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.68 2.254 . . . . 60.2 112.38 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.35 178.31 4.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 72.32 111.138 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.0 p -61.48 -17.32 54.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 72.42 111.135 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 t -114.14 -26.86 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.844 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.86 123.49 47.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 72.25 110.891 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.23 153.58 32.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 74.53 110.945 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -110.71 -33.51 6.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.886 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.2 m -134.12 123.23 24.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 53.11 110.893 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -179.58 126.16 0.24 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 73.45 110.887 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.172 0 C-N-CA 122.74 2.293 . . . . 65.5 112.352 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.865 0.364 . . . . 74.35 110.872 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 67.11 13.59 9.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 74.32 110.836 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.05 101.97 6.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 73.55 110.844 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.472 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 10.6 m -133.75 175.02 9.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 73.24 110.876 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.66 158.76 24.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 65.42 110.916 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.64 113.89 16.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.863 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 t -146.38 158.37 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 73.21 111.143 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.9 p -78.33 129.63 35.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 63.33 110.845 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 101' ' ' TYR . . . -78.9 151.54 31.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 73.13 111.051 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.05 121.57 18.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.556 0.693 . . . . 63.2 111.117 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 115.78 4.25 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.694 2.262 . . . . 74.54 112.331 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.96 -11.62 3.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 74.24 112.475 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.3 m -126.18 127.31 45.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.885 0.374 . . . . 73.25 111.092 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.9 m -70.71 137.52 49.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 75.44 111.168 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -106.02 133.41 50.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 71.23 110.953 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -104.74 161.18 14.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 71.13 110.813 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.414 HG21 ' HD3' ' A' ' 5' ' ' LYS . 2.8 t -137.9 138.05 44.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 70.2 111.131 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -138.29 122.21 17.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 64.45 110.851 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.8 mm -114.1 112.28 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 72.33 111.088 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.64 140.29 40.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 75.12 110.896 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -114.85 156.06 15.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.753 . . . . 72.24 112.464 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -114.34 -21.54 10.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.897 0.38 . . . . 71.13 110.921 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -161.35 128.2 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 64.13 110.874 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 90' ' ' SER . 15.2 t-20 -31.61 106.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 75.54 110.912 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -157.65 112.81 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 75.31 110.883 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 p -121.37 154.58 36.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.509 . . . . 63.11 110.835 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.46 20.88 2.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.716 -0.754 . . . . 75.24 112.492 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.26 147.23 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 74.12 111.177 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m -97.61 121.97 40.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 70.33 111.138 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.72 125.16 53.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 71.22 110.946 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.422 ' HD3' ' HB3' ' A' ' 9' ' ' PRO . 8.5 ttpt -133.94 167.03 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 75.21 110.86 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.99 137.16 32.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.908 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.455 ' O ' ' CG ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -100.19 108.66 20.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 72.03 110.942 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' A' ' 100' ' ' GLN . 6.4 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.24 110.912 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.843 0.354 . . . . 75.15 110.918 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.7 m -116.52 108.2 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 74.33 111.142 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.65 149.14 52.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.31 110.907 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 19.8 tptm -164.05 -71.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 74.43 110.846 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 10.1 t-20 -68.32 157.8 34.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 74.04 110.912 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.3 t30 86.72 -68.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 70.14 110.943 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.5 m -125.15 119.68 25.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.537 0.685 . . . . 75.35 111.161 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HB3' ' HD3' ' A' ' 98' ' ' LYS . 54.3 Cg_endo -69.75 150.64 68.52 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.679 2.252 . . . . 74.45 112.372 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.99 115.77 20.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 71.41 111.119 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.59 143.9 31.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 64.44 110.835 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.23 80.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.13 110.879 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.55 -172.77 1.93 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.477 . . . . 74.5 110.938 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 p -132.74 138.39 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.1 111.102 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.33 53.71 0.75 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.775 -0.726 . . . . 75.24 112.502 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -76.27 140.97 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 73.33 110.9 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -28.38 6.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.917 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.82 -64.61 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 63.31 112.443 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -52.22 134.14 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 65.45 110.844 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -131.21 172.58 11.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 74.52 110.894 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.22 138.53 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 75.23 111.109 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -136.66 147.08 46.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 73.31 110.894 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -143.59 164.82 29.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.926 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.431 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -138.28 139.77 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.18 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -159.53 162.8 35.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.855 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -133.1 171.11 14.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 75.03 111.131 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -108.3 169.28 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.43 111.181 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -98.37 -48.86 4.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.898 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.67 173.34 11.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 74.44 110.841 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -80.0 117.2 20.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 74.13 110.913 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.11 144.59 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 72.05 111.086 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.3 t -104.59 106.4 16.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.425 . . . . 65.34 111.18 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.93 147.79 46.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.15 111.095 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.11 111.81 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 73.45 111.113 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.75 140.83 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 71.22 111.097 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.477 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 10.7 p -133.31 166.5 22.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 72.44 110.849 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.81 144.58 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 75.11 111.161 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.98 -174.99 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 72.32 110.901 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.75 -0.738 . . . . 62.23 112.523 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.847 0.356 . . . . 64.34 110.861 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.48 114.75 26.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 63.44 111.115 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.11 135.67 36.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 71.32 110.891 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.6 tt -102.34 126.84 49.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 74.32 110.893 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -134.61 149.0 50.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 75.24 110.91 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.14 133.32 11.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 71.32 110.954 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -144.86 123.42 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.4 110.851 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.36 71.59 7.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.1 111.116 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.46 -83.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 75.1 112.481 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -110.54 141.57 43.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.365 . . . . 74.0 110.917 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.19 121.85 3.15 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.609 0.719 . . . . 74.25 110.864 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 142.49 48.1 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.712 2.275 . . . . 74.5 112.335 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -109.66 178.74 4.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 65.42 111.142 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.1 p -60.07 -17.7 41.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.159 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 t -114.8 -26.3 7.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.32 110.85 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.86 124.19 47.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 64.24 110.847 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.99 153.22 32.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.105 -0.498 . . . . 75.24 110.909 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -115.67 -35.33 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 72.42 110.856 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.8 m -143.76 125.12 14.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 73.04 110.854 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 179.65 157.08 0.72 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.658 0.742 . . . . 75.24 110.824 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.204 0 C-N-CA 122.661 2.24 . . . . 70.51 112.321 -179.999 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.862 0.363 . . . . 75.44 110.851 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.77 14.14 9.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.959 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.88 105.67 7.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 73.3 110.909 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.477 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 13.0 m -136.59 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 62.51 110.831 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.03 153.75 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.41 110.846 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -128.24 110.28 12.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.901 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 t -149.31 153.11 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 73.35 111.119 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.4 p -73.3 110.85 7.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 72.25 110.854 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.4 130.79 35.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 75.12 111.103 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.33 139.23 20.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.59 0.709 . . . . 62.1 111.126 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 160.21 50.57 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.701 2.267 . . . . 75.25 112.328 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.5 -18.95 56.01 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.776 -0.726 . . . . 61.24 112.51 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 m -111.94 122.84 48.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.87 0.367 . . . . 72.22 111.163 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.4 m -71.24 136.27 47.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 72.41 111.152 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -103.76 141.68 35.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.928 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -107.36 160.75 15.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 75.32 110.837 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.19 138.36 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 73.34 111.108 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.89 122.98 13.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 71.42 110.88 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.0 mm -118.04 112.6 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.24 111.139 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -104.48 130.44 52.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.906 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.37 161.03 21.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 72.22 112.452 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.25 -28.59 5.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 72.5 110.923 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.51 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -166.56 132.64 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 73.42 110.817 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 90' ' ' SER . 1.5 p-10 -28.35 115.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 72.55 110.878 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.4 113.85 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.41 110.94 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 p -121.55 156.59 32.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 72.42 110.847 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.02 23.12 1.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 75.43 112.489 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.04 145.98 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.962 0.41 . . . . 75.31 111.098 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.7 m -99.29 114.73 27.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 72.34 111.137 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.69 125.58 50.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 75.41 110.931 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.408 ' HD3' ' HB3' ' A' ' 9' ' ' PRO . 5.1 ttpt -133.41 165.09 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 74.54 110.934 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 138.5 31.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.41 110.92 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -98.87 112.84 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 75.54 110.93 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.9 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 60.53 110.929 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.856 0.36 . . . . 73.31 110.912 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.9 m -118.46 108.57 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 75.55 111.15 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.58 147.84 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 72.43 110.978 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 17.9 tptt -158.49 -39.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 75.2 110.871 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.593 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -108.24 158.1 17.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 72.41 110.95 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 5.9 t30 90.04 -68.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.34 110.883 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.4 m -126.34 113.83 23.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.576 0.703 . . . . 73.04 111.135 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.42 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.7 Cg_endo -69.78 153.51 68.76 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.658 2.239 . . . . 73.13 112.372 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.25 113.18 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 75.22 111.124 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.11 149.4 28.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 72.44 110.864 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.4 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.3 OUTLIER 47.33 66.59 0.97 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 74.51 110.86 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.05 -174.16 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 74.12 110.902 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 p -131.14 138.24 49.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 73.34 111.188 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.64 57.19 0.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 74.21 112.489 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -75.65 139.35 41.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 64.1 110.921 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -27.6 7.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.87 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.12 -60.63 0.5 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 73.4 112.479 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.84 140.68 51.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 63.13 110.872 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -135.85 170.26 16.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.915 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.46 139.11 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 75.24 111.111 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -137.01 145.17 43.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 74.51 110.886 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -142.09 165.84 26.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.923 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 51.9 m -146.12 142.12 28.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 72.23 111.148 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 6' ' ' ASN . 4.1 t80 -160.49 162.56 33.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 71.43 110.917 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.1 p -128.88 170.44 13.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 71.32 111.164 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.403 ' HB ' ' CZ ' ' A' ' 101' ' ' TYR . 15.9 m -108.12 173.26 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 74.3 111.146 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -110.44 -59.32 1.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.845 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.64 140.9 51.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 65.03 110.855 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -50.15 119.91 4.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 74.22 110.844 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.36 129.86 25.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.53 111.074 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.2 m -94.28 106.17 18.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 64.02 111.156 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.87 150.97 43.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.51 111.155 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.75 112.04 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 73.43 111.143 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 100' ' ' GLN . 5.3 t -127.17 141.79 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 71.34 111.1 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 8.0 p -142.09 171.45 14.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 75.4 110.87 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 pt -107.04 158.69 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 74.3 111.128 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.56 165.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 75.33 110.88 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 64.44 112.524 -179.98 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.804 0.335 . . . . 71.11 110.868 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.68 111.58 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 65.5 111.11 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -80.26 164.55 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 55.23 110.819 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 tt -124.18 138.43 54.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 73.01 110.879 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -152.63 133.58 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 75.44 110.932 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp -139.26 153.02 47.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 75.53 110.904 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -156.36 145.99 20.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 75.24 110.912 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.66 101.56 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 61.2 111.086 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.84 -92.98 0.75 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 41.14 112.517 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 m -82.83 129.26 34.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.994 0.426 . . . . 71.44 110.837 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.44 137.12 5.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.554 0.692 . . . . 74.24 110.912 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.73 51.74 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.672 2.248 . . . . 73.51 112.33 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -101.38 178.54 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 74.22 111.155 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 p -64.94 -14.39 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 75.4 111.16 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.5 t -120.31 -26.14 5.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 75.13 110.899 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.75 125.48 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 74.43 110.876 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.64 153.59 34.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.925 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -110.71 -23.17 11.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 64.41 110.821 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.0 m -143.64 122.71 12.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 64.21 110.867 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 177.9 117.26 0.18 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 74.11 110.903 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.174 0 C-N-CA 122.671 2.247 . . . . 73.31 112.36 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.809 0.338 . . . . 65.53 110.899 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.6 t30 53.79 27.9 7.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 70.33 110.923 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -131.15 81.27 1.98 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 64.25 110.876 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -132.51 170.75 14.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.877 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -119.28 156.91 29.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 74.01 110.898 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.0 p -128.94 106.77 9.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.13 110.87 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -151.75 153.25 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 75.12 111.12 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.8 p -84.93 107.68 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.888 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.09 154.9 25.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 74.01 111.077 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.17 138.57 19.56 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.549 0.69 . . . . 72.21 111.134 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 134.23 27.56 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.694 2.262 . . . . 71.15 112.388 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.9 -21.98 4.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 51.31 112.505 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -114.3 131.68 56.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 72.13 111.142 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.8 m -71.95 137.38 47.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 73.33 111.186 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -112.05 133.0 54.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 75.51 110.921 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -107.08 161.19 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 65.03 110.892 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -137.08 138.35 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 74.45 111.148 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 tpt -134.82 122.84 22.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.876 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.3 mm -112.5 116.01 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 74.31 111.134 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 145.54 29.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 71.32 110.864 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.45 151.74 18.23 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 71.42 112.457 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -107.33 -28.13 10.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 72.24 110.878 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.466 ' O ' ' C ' ' A' ' 91' ' ' ASN . 88.5 p -175.37 144.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 74.22 110.877 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 90' ' ' SER . 3.0 p30 -32.64 105.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.492 . . . . 63.41 110.942 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -166.77 118.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.31 110.897 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.9 p -122.01 160.82 24.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 61.33 110.852 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 12' ' ' ASN . . . 121.36 23.44 2.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 73.05 112.475 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.81 146.58 18.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.887 0.375 . . . . 72.54 111.156 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -106.86 135.06 49.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 72.34 111.146 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.438 ' CD1' ' C ' ' A' ' 97' ' ' LEU . 2.5 tm? -118.58 128.03 54.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 64.43 110.866 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -138.12 154.65 49.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 75.43 110.929 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.433 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -87.3 145.1 26.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 73.32 110.904 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.487 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -94.86 112.98 24.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 72.44 110.978 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.403 ' CZ ' ' HB ' ' A' ' 27' ' ' VAL . 2.3 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.926 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.3 m120 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.834 0.349 . . . . 73.44 110.894 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m -121.77 109.16 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 70.42 111.135 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.27 149.01 52.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 72.42 110.916 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 99' ' ' LEU . 2.2 tppm? -155.73 -73.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.907 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.8 t-20 -64.22 158.66 22.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.874 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.6 t30 91.21 -68.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 73.55 110.886 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 m -132.71 121.79 17.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.576 0.703 . . . . 64.44 111.155 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 154.85 67.1 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 71.51 112.341 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.44 115.36 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 73.33 111.136 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.49 166.39 13.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 70.0 110.872 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 39.97 52.05 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 74.14 110.876 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 mt -57.84 -178.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 71.31 110.944 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 p -137.19 138.15 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 61.22 111.078 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.66 56.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.751 . . . . 35.25 112.493 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -74.79 150.96 39.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 74.54 110.902 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.71 -33.49 10.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.872 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.59 -57.84 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 75.42 112.496 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.77 139.04 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 72.11 110.863 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -139.01 175.01 9.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 75.04 110.907 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.97 135.65 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.34 111.158 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -138.87 149.81 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.2 110.902 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -145.96 166.36 26.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 74.54 110.929 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.5 m -138.75 138.91 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 65.51 111.142 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -160.94 153.17 20.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 74.44 110.915 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.9 p -127.92 170.44 12.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.15 111.14 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 101' ' ' TYR . 13.9 m -113.02 170.83 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 75.35 111.109 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.15 11.45 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 65.53 110.84 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.58 137.79 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 75.53 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -72.85 118.85 16.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.3 110.871 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.31 145.57 37.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 74.43 111.094 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -107.92 104.95 14.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 74.15 111.1 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 101' ' ' TYR . . . -139.57 149.1 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.35 111.117 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -113.63 111.85 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.113 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.01 140.86 47.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 70.55 111.078 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.497 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 6.0 p -124.86 166.74 15.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 60.04 110.826 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.21 151.07 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 74.04 111.136 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.53 168.0 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 72.42 110.866 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 63.12 112.499 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.847 0.356 . . . . 63.55 110.867 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.65 117.16 29.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 74.31 111.109 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -85.23 163.83 18.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 73.44 110.889 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tt -120.31 127.56 52.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.01 110.924 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -137.63 153.23 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 63.55 110.889 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tt -154.34 140.46 18.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 75.31 110.923 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.17 141.55 25.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 75.21 110.923 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.35 126.97 35.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 74.31 111.11 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.85 -61.02 0.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 65.21 112.527 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.75 -173.03 2.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.955 0.407 . . . . 73.13 110.837 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 134.13 30.56 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.566 0.698 . . . . 73.25 110.925 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 143.38 50.82 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.708 2.272 . . . . 74.12 112.32 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 p -104.49 178.71 4.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 74.14 111.123 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.9 p -64.03 -15.14 58.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 70.25 111.168 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.0 m -119.84 -26.06 5.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.864 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.11 126.08 48.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 72.11 110.843 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.99 154.03 36.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 75.13 110.888 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -115.88 -34.52 4.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 72.05 110.864 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.2 m -145.39 124.42 12.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 72.42 110.886 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.16 150.18 1.23 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 74.45 110.921 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.231 0.159 0 C-N-CA 122.714 2.276 . . . . 74.43 112.318 -179.977 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.813 0.339 . . . . 61.43 110.918 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.99 16.06 9.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 65.31 110.873 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -127.44 96.88 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 72.13 110.87 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.497 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.4 m -134.78 170.73 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 70.45 110.91 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.79 162.62 19.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 71.35 110.863 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.37 111.62 12.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 75.21 110.886 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.7 t -149.11 153.65 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 72.01 111.171 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.3 p -94.28 105.74 17.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 65.44 110.913 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.39 152.19 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 75.54 111.08 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.21 142.73 26.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.572 0.701 . . . . 71.02 111.119 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 120.57 7.33 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 73.52 112.308 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.6 -19.94 0.9 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 44.1 112.465 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 m -122.76 136.57 54.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.372 . . . . 73.54 111.11 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.5 m -71.77 138.02 48.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 72.44 111.109 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.435 ' CD2' ' OH ' ' A' ' 101' ' ' TYR . 76.8 m-85 -118.3 142.84 47.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.927 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -121.94 160.76 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 74.21 110.88 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 t -133.45 125.31 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.54 111.173 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.65 128.98 55.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 71.32 110.886 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.0 mm -118.41 114.01 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 73.03 111.128 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.15 150.17 21.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 75.4 110.897 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -112.16 160.75 13.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 74.43 112.481 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -119.0 -24.56 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.918 0.389 . . . . 73.25 110.955 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 91' ' ' ASN . 52.1 p -176.77 144.13 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 72.53 110.87 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 90' ' ' SER . 42.4 t30 -32.69 106.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 74.31 110.893 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -166.54 115.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 74.32 110.903 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.1 p -121.76 155.35 35.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 63.45 110.838 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.05 26.74 1.82 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 71.44 112.508 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.91 139.62 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 74.33 111.122 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.58 114.89 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 61.42 111.153 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.412 ' CD1' ' C ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -105.13 128.64 53.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 73.02 110.909 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -133.34 171.2 14.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 73.12 110.91 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.534 ' HG ' ' CD1' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -88.14 137.47 32.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 71.45 110.952 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.467 ' C ' ' HD1' ' A' ' 101' ' ' TYR . 1.8 pp0? -108.76 112.58 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 70.4 110.908 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.534 ' CD1' ' HG ' ' A' ' 99' ' ' LEU . 5.1 m-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 74.55 110.946 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.842 0.353 . . . . 74.41 110.883 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 m -118.15 109.49 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.14 111.128 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.32 147.61 52.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.932 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -158.78 -69.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 74.23 110.895 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 17.0 t-20 -76.08 158.23 32.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.91 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.0 t-20 88.58 -68.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 72.52 110.902 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 m -125.28 115.02 25.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.599 0.714 . . . . 73.23 111.143 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.416 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.5 Cg_endo -69.76 150.24 67.97 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.663 2.242 . . . . 74.34 112.331 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.6 113.51 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 74.54 111.095 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.7 147.8 30.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 64.53 110.859 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.66 64.36 1.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 72.51 110.932 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 tp -58.95 -175.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 72.01 110.897 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 p -136.09 139.29 42.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 75.34 111.128 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.83 60.48 0.58 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 74.41 112.458 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -76.48 138.71 40.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.896 0.379 . . . . 62.32 110.925 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -29.1 8.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 75.03 110.902 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.13 -62.08 0.46 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 65.13 112.49 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.6 m -60.67 151.44 29.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.887 0.375 . . . . 75.42 110.807 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.31 179.4 8.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 71.51 110.904 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.71 149.18 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 64.42 111.109 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -136.78 134.85 37.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 73.35 110.853 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.9 165.48 25.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 73.54 110.931 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.3 m -147.92 141.72 25.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.497 . . . . 74.04 111.154 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -159.34 163.28 35.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.89 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 p -131.41 170.98 13.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 70.32 111.186 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.91 169.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 74.34 111.131 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -108.42 -47.1 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 64.12 110.855 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -129.73 155.47 45.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.897 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -77.42 115.7 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 74.23 110.859 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.45 145.89 34.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 73.34 111.108 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 t -99.25 107.31 19.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.32 111.121 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.06 148.8 47.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 71.22 111.099 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.9 p -105.78 111.07 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 75.11 111.169 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.9 t -127.06 140.4 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 75.2 111.15 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 0.1 OUTLIER -139.6 169.02 18.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 72.15 110.873 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 pt -110.14 159.36 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 72.33 111.165 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 171.17 167.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.889 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 75.24 112.49 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.825 0.345 . . . . 72.54 110.838 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.494 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -90.44 123.88 34.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 72.21 111.119 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -80.35 147.31 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.879 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.49 127.08 55.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 70.42 110.932 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.73 148.56 44.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 75.44 110.932 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.15 132.93 12.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 74.31 110.882 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -144.71 131.12 19.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 74.15 110.894 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.53 -66.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 72.51 111.128 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -45.36 -90.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 71.44 112.49 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.18 -168.59 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 74.23 110.895 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 132.88 87.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 74.2 110.887 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.495 ' HB3' ' HG3' ' A' ' 49' ' ' LYS . 53.6 Cg_endo -69.75 140.71 43.39 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 70.43 112.351 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.18 178.75 4.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 71.22 111.146 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -66.41 -13.1 60.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 75.21 111.173 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -124.08 -25.97 4.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.87 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.52 124.37 47.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 74.21 110.868 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.73 153.87 33.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.489 . . . . 74.11 110.896 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -102.02 -31.75 10.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 72.14 110.885 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.8 m -140.24 122.67 16.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 74.05 110.876 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -176.11 134.44 0.44 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 71.4 110.854 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--O 1.231 0.159 0 C-N-CA 122.634 2.223 . . . . 73.15 112.341 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.494 ' ND2' ' H ' ' A' ' 44' ' ' ALA . 41.6 m-80 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.857 0.36 . . . . 71.34 110.896 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 61.5 28.03 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.915 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.65 89.92 2.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 75.05 110.877 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -129.05 172.6 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 60.31 110.883 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.19 162.07 18.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.119 -0.491 . . . . 74.42 110.881 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 p -128.51 109.14 11.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 55.02 110.847 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.98 152.99 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 74.34 111.114 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.8 p -80.53 113.82 18.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.839 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.29 131.04 35.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 63.13 111.091 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.74 136.49 22.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.594 0.711 . . . . 74.31 111.077 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 124.92 11.55 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 73.11 112.355 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.73 -18.55 2.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 73.31 112.516 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.7 m -125.6 131.51 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 71.13 111.149 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.8 m -72.44 137.63 46.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 73.54 111.149 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -107.81 131.65 54.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 70.11 110.957 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -107.14 158.96 16.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 71.4 110.867 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.8 t -137.71 138.17 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 74.45 111.157 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.3 tpt -129.03 121.54 28.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 72.22 110.847 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.3 mm -109.63 114.41 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.33 111.158 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 87' ' ' LYS . 9.5 mmmm -109.12 139.86 43.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 73.31 110.915 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.88 150.05 16.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 75.13 112.46 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -117.81 -17.07 9.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.878 0.37 . . . . 75.33 110.946 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -177.89 129.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 72.11 110.867 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 90' ' ' SER . 54.5 t-20 -29.62 109.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 74.11 110.844 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -166.5 112.72 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 74.03 110.925 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.1 p -120.71 166.42 13.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 54.55 110.844 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.9 23.07 4.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.747 -0.739 . . . . 60.33 112.471 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.6 t -113.29 148.34 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 74.01 111.107 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.3 m -106.68 126.17 51.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 71.32 111.161 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 tp -108.4 135.13 50.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.896 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -144.79 154.63 42.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.884 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.457 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -88.7 144.65 26.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 71.53 110.906 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.481 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -94.13 112.85 24.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 73.53 110.88 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.0 p90 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 70.23 110.947 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.895 0.379 . . . . 74.55 110.884 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.94 107.96 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 74.03 111.138 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.34 149.0 51.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.31 110.905 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 13.4 tptt -174.65 -74.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 62.01 110.921 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.419 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -70.13 153.17 43.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 72.24 110.858 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.2 t30 78.07 -58.88 0.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 64.31 110.906 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.5 m -122.75 119.32 28.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.615 0.722 . . . . 74.25 111.125 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 137.93 36.7 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.701 2.267 . . . . 72.44 112.357 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.4 t -77.27 114.93 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 75.24 111.17 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 p -87.62 163.2 16.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 63.14 110.859 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 40.18 64.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 74.35 110.888 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -164.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 72.3 110.911 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 p -147.4 136.73 22.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 71.44 111.145 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.4 67.17 0.47 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 75.3 112.452 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -76.05 135.49 39.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 72.24 110.912 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -30.64 23.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 72.45 110.944 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.34 -46.71 0.98 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 74.41 112.491 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.15 160.83 27.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 74.02 110.872 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -143.95 169.02 18.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 70.01 110.893 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.14 150.53 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.24 111.089 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -138.85 151.34 46.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.52 110.893 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -148.95 166.65 27.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 74.41 110.906 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.7 m -148.59 140.67 23.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 52.41 111.106 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -160.74 162.71 32.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 73.12 110.854 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.1 p -131.09 170.66 14.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 75.43 111.127 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.27 170.01 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 75.43 111.122 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.46 -50.8 3.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 71.32 110.849 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 167.12 21.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.925 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -80.19 115.52 19.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 70.04 110.911 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.2 141.91 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 70.31 111.12 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.9 t -94.7 106.28 18.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 74.32 111.149 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.26 149.21 45.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.24 111.127 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.49 112.56 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 73.41 111.145 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.9 t -123.72 140.52 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 74.32 111.078 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.501 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 11.6 p -139.97 165.48 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 64.34 110.868 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -111.77 154.64 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 73.22 111.124 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -167.51 153.11 7.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.4 110.827 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 95' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 74.21 112.529 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.825 0.345 . . . . 53.21 110.861 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.42 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . . . -89.54 131.53 35.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 71.11 111.119 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.52 133.33 35.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 72.44 110.906 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tt -92.93 138.14 31.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 75.54 110.87 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -152.42 143.04 22.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.947 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.68 146.68 26.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 72.5 110.929 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.05 112.12 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 75.11 110.904 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.35 119.35 7.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 75.35 111.121 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.21 -81.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.734 . . . . 73.22 112.485 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.6 p -99.14 -174.28 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.965 0.412 . . . . 74.35 110.83 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.58 133.76 27.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.692 . . . . 73.44 110.892 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 141.69 45.72 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.711 2.274 . . . . 61.25 112.293 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 p -102.29 178.96 4.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 74.53 111.124 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 p -65.24 -14.39 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 75.11 111.163 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.2 m -120.03 -26.68 5.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 72.2 110.879 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.07 126.38 50.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 73.43 110.832 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.15 154.02 36.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 74.35 110.939 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.43 -31.86 6.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.423 . . . . 73.22 110.819 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.7 m -142.06 123.14 14.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 73.11 110.853 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 176.44 134.48 0.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.562 0.696 . . . . 75.54 110.904 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.268 . . . . 73.2 112.346 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.858 0.361 . . . . 61.44 110.893 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 66.33 10.63 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.902 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.47 91.33 3.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 70.41 110.912 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.501 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -133.8 171.66 13.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 73.35 110.853 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.45 157.94 27.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 64.41 110.877 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 p -128.41 109.57 11.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 73.35 110.867 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.8 t -150.13 152.82 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 73.12 111.133 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 85.6 p -74.1 104.57 4.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 75.2 110.826 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.27 131.41 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 71.33 111.105 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.92 142.25 24.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.561 0.696 . . . . 62.42 111.139 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 162.06 43.52 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.741 2.294 . . . . 73.22 112.343 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.14 -21.69 42.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.792 -0.718 . . . . 74.23 112.488 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -106.77 123.63 48.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 65.22 111.146 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 m -71.49 135.0 46.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 73.51 111.134 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -108.68 133.69 52.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.905 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -109.17 147.79 31.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 73.33 110.855 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -123.54 138.81 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 73.45 111.136 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.81 122.41 25.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.858 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.5 mm -114.83 111.65 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 74.24 111.115 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 -65.11 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.907 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 44' ' ' ALA . . . 114.39 -146.84 18.76 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 73.33 112.482 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -175.78 -57.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.898 0.38 . . . . 75.24 110.932 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' ASN . 3.0 p -144.85 128.0 16.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 73.44 110.865 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 90' ' ' SER . 34.6 t30 -33.86 104.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 74.44 110.919 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.15 139.46 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.905 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.4 p -122.52 157.22 32.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 74.23 110.85 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 135.95 25.31 0.49 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.761 -0.733 . . . . 63.11 112.504 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.47 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.3 t -113.64 147.35 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.925 0.393 . . . . 72.22 111.098 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.428 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 1.3 m -106.17 112.81 26.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 73.04 111.181 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.2 tp -102.91 142.56 33.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 72.24 110.936 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -153.74 161.99 41.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 73.15 110.865 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.41 143.81 26.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.23 110.929 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.496 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.31 110.88 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 71.23 110.883 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.9 p90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 74.55 110.963 -179.897 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.4 m120 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.861 0.363 . . . . 75.14 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 24' ' ' THR . 1.8 m -115.12 109.19 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.14 111.115 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.14 148.34 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 74.54 110.923 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 1.7 tppm? -165.19 -74.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.919 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -63.96 155.18 31.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 73.14 110.893 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.2 t-20 88.23 -61.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 70.35 110.886 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 m -130.09 120.38 19.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 73.1 111.185 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 153.38 68.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 51.24 112.341 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -85.22 114.23 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 75.34 111.188 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 p -88.69 167.45 13.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 63.31 110.856 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 p30 40.5 53.23 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 72.41 110.87 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.75 178.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 73.31 110.905 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -135.37 138.08 42.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.35 111.112 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.47 68.91 0.53 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.759 . . . . 75.22 112.477 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -76.42 138.43 40.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 73.0 110.897 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -17.11 38.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 72.12 110.874 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.15 -41.44 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.805 -0.712 . . . . 64.14 112.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 m -90.68 168.66 11.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 73.55 110.929 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.0 -176.37 5.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 71.35 110.933 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.87 144.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.072 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -138.5 149.63 45.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 74.4 110.875 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -147.9 166.52 27.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 74.5 110.941 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 63.4 m -143.76 139.46 29.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 74.44 111.16 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -159.27 160.55 35.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 73.31 110.895 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.9 p -129.88 171.76 12.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 74.35 111.114 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.2 m -106.61 170.63 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 73.23 111.094 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -113.03 -41.58 3.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 74.22 110.888 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 158.6 39.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 73.54 110.851 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -80.53 115.2 19.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 75.54 110.842 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.19 140.3 30.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 53.35 111.119 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 t -95.71 105.93 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 74.33 111.127 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.97 148.58 45.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 75.21 111.143 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 p -106.63 111.47 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 74.11 111.116 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.91 140.14 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 75.45 111.138 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.502 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 92.9 p -142.72 167.72 21.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 61.05 110.831 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -108.87 144.14 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 71.45 111.114 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p -178.01 166.77 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 74.45 110.871 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.761 -0.733 . . . . 74.11 112.484 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.859 0.361 . . . . 55.23 110.883 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.81 110.65 21.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 65.44 111.106 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -72.44 155.55 39.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 71.22 110.886 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.55 138.28 52.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 74.54 110.938 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -146.7 146.14 30.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.919 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.26 152.68 47.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 75.1 110.903 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -153.35 115.71 4.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 75.13 110.874 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.27 120.97 13.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 63.21 111.075 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.82 -76.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 75.43 112.452 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 t -107.82 -179.53 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 73.34 110.853 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.02 133.68 40.61 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.553 0.692 . . . . 74.22 110.917 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 143.92 52.15 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 71.41 112.339 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.19 179.03 4.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 72.34 111.148 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -67.79 -12.46 60.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 74.4 111.184 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 m -120.96 -28.28 4.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 70.34 110.885 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.19 124.01 48.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 73.15 110.817 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -152.86 153.99 34.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 72.43 110.941 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -107.15 -35.29 6.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 70.41 110.888 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.5 m -127.9 123.92 36.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 52.25 110.853 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -175.22 120.39 0.33 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.658 0.742 . . . . 74.14 110.877 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.26 . . . . 75.55 112.357 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.6 m120 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.812 0.339 . . . . 75.05 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 72.01 16.28 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.42 110.888 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.42 103.75 5.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 64.11 110.86 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.502 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 2.3 m -134.32 174.68 10.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 74.42 110.855 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.67 152.54 32.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 73.4 110.893 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 p -127.73 111.51 13.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 63.1 110.851 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 t -149.28 152.29 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 75.22 111.141 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.9 p -71.71 106.9 4.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 75.42 110.908 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.3 131.48 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 74.32 111.093 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.32 142.58 24.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.594 0.712 . . . . 75.44 111.07 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 126.37 13.24 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.747 2.298 . . . . 75.03 112.345 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.57 -27.13 3.41 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.711 -0.757 . . . . 72.41 112.467 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.4 m -106.53 124.64 49.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 71.21 111.135 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.2 m -71.55 138.06 48.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 74.15 111.108 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -112.15 150.5 30.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 71.23 110.901 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -131.56 145.16 51.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 73.03 110.873 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 t -121.96 133.59 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 73.11 111.092 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.8 133.54 50.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.41 110.832 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.31 134.53 62.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 75.11 111.133 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB3' ' OH ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -140.23 113.47 8.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 74.13 110.883 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.09 161.2 25.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 75.44 112.517 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.75 -29.18 13.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.889 0.376 . . . . 72.51 110.908 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.494 ' O ' ' C ' ' A' ' 91' ' ' ASN . 54.6 p -156.12 137.37 13.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 73.23 110.819 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 90' ' ' SER . 70.4 m-20 -30.32 109.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 71.42 110.907 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -160.42 118.8 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 63.3 110.911 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.8 p -122.71 156.43 34.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.853 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.08 23.76 2.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 53.22 112.525 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.99 147.08 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.901 0.381 . . . . 75.02 111.148 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.421 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -105.23 124.75 50.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 71.51 111.115 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 0.7 OUTLIER -116.07 143.03 46.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 72.1 110.958 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -149.27 168.69 22.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.23 110.867 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.423 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -91.03 142.69 27.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.951 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.502 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.51 111.52 23.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 74.21 110.912 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 25.9 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 71.04 110.913 -179.873 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 m120 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.821 0.343 . . . . 72.45 110.939 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 24' ' ' THR . 3.5 m -123.57 109.02 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.43 111.138 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.18 150.18 52.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 75.24 110.903 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.46 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -155.56 -77.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.863 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.9 t-20 -66.22 159.2 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 62.23 110.865 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.5 t-20 89.59 -70.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 65.02 110.859 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -133.35 118.32 14.86 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.556 0.694 . . . . 72.34 111.143 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.448 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 54.1 Cg_endo -69.81 155.86 64.71 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.688 2.259 . . . . 74.31 112.324 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.8 t -75.56 112.43 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 74.05 111.099 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -82.08 163.63 21.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 74.21 110.883 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 39.82 57.14 2.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 75.03 110.922 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 tp -57.93 -173.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 71.51 110.931 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 p -145.55 139.19 26.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 73.34 111.171 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.97 65.16 0.5 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.683 -0.77 . . . . 54.24 112.485 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -75.9 155.29 35.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 61.23 110.927 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.02 -31.0 16.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.11 110.879 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.88 -55.66 0.27 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 73.04 112.49 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.75 136.58 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.338 . . . . 71.24 110.858 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.79 170.07 16.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 73.01 110.899 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.39 140.67 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 64.51 111.104 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -137.75 151.0 47.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 72.31 110.905 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -146.24 164.95 30.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 73.4 110.94 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 31.7 m -140.06 138.79 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 65.22 111.14 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -160.2 163.15 33.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.34 110.887 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -130.74 170.7 13.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.52 111.163 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 m -107.55 169.3 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 74.24 111.163 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -104.54 -52.92 2.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 62.14 110.868 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -128.94 157.24 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.878 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -73.64 116.16 13.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 72.41 110.871 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.37 144.86 33.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 65.5 111.1 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 t -100.96 106.79 18.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 70.03 111.15 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.45 148.93 46.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 73.54 111.088 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.05 111.72 36.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 73.43 111.155 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 98' ' ' LYS . 7.5 t -126.77 139.99 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 75.41 111.138 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.492 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 34.5 p -136.56 167.06 22.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 62.32 110.863 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.403 HG23 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -110.01 142.75 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.42 111.119 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 p -169.57 172.57 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 72.32 110.85 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 64.04 112.487 -179.968 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.813 0.34 . . . . 70.3 110.851 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.43 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -91.54 109.43 20.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 64.35 111.084 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.94 146.7 54.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 54.33 110.882 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 tt -110.86 127.08 55.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 64.44 110.92 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -131.28 154.19 48.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 73.21 110.906 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -154.03 133.11 12.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 75.31 110.948 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.03 125.72 17.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.853 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.4 126.17 28.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 73.2 111.119 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.41 -71.17 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 71.11 112.475 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 m -112.58 -175.47 2.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 64.01 110.86 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.31 136.04 32.21 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.57 0.7 . . . . 73.43 110.937 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 143.85 52.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.7 2.267 . . . . 72.54 112.35 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -100.79 178.08 4.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.22 111.153 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.6 p -64.86 -15.2 61.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 70.12 111.126 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.7 m -119.44 -25.8 5.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 71.54 110.827 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.95 126.39 50.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.32 110.803 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.5 154.07 36.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 72.45 110.935 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -112.45 -27.95 8.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 71.15 110.866 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.2 m -145.72 124.57 12.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.912 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -173.17 124.99 0.45 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 63.11 110.878 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.686 2.257 . . . . 65.43 112.351 -179.962 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.43 ' ND2' ' H ' ' A' ' 44' ' ' ALA . 62.3 m-20 . . . . . 0 CA--C 1.526 0.045 0 CA-C-O 120.856 0.36 . . . . 72.14 110.88 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 74.41 5.99 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 72.12 110.884 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 3.7 pt-20 -127.3 115.49 19.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 73.52 110.908 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.492 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 10.1 m -140.77 174.3 10.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.21 110.869 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.94 153.79 33.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 65.31 110.89 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.85 109.37 11.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 75.32 110.847 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -150.21 152.33 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 75.22 111.155 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.5 p -79.52 102.34 8.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 64.21 110.88 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.52 143.14 31.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 64.33 111.107 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.59 142.92 25.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.561 0.696 . . . . 70.01 111.102 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 143.81 52.08 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.657 2.238 . . . . 73.41 112.342 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.23 -22.81 6.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.704 -0.76 . . . . 63.5 112.459 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.6 m -117.27 131.52 56.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 74.34 111.15 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 m -74.23 136.5 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 73.41 111.113 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.35 154.78 20.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 74.14 110.883 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -134.34 160.93 36.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 75.11 110.84 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.423 HG21 ' HD2' ' A' ' 5' ' ' LYS . 10.6 t -136.17 137.68 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 71.02 111.117 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.27 122.36 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 65.02 110.865 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.98 112.83 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 75.11 111.116 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.79 104.08 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 74.03 110.939 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.51 160.16 37.54 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 71.11 112.511 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -115.79 -18.4 10.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 71.44 110.906 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 91' ' ' ASN . 60.7 p -166.24 136.23 3.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 64.31 110.888 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 90' ' ' SER . 57.7 t30 -33.84 108.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 72.54 110.92 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -160.84 112.68 1.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 75.41 110.923 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.0 p -119.44 163.87 16.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 72.33 110.875 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.86 26.36 4.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.743 . . . . 42.13 112.491 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 t -113.75 147.49 17.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 73.54 111.156 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.1 m -103.59 117.12 33.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.34 111.169 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.403 HD21 HG23 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -99.58 121.48 41.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 74.33 110.914 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HE3' ' CA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -131.12 154.8 47.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 73.43 110.861 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.46 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -84.54 140.9 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 71.3 110.922 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.44 113.36 25.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.897 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 p90 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.467 . . . . 73.24 110.942 -179.892 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.913 0.387 . . . . 74.11 110.874 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.5 m -117.75 108.86 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 73.23 111.112 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.65 149.82 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 72.51 110.913 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.425 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -156.42 -73.37 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 74.15 110.951 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 16.9 t30 -67.98 158.09 33.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 74.41 110.945 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.8 t-20 88.95 -69.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 72.23 110.885 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -133.18 118.06 14.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.578 0.704 . . . . 72.41 111.108 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.432 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . 53.6 Cg_endo -69.79 157.2 61.14 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 73.03 112.341 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.93 113.9 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 72.54 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.04 144.25 30.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.12 110.85 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.409 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.8 OUTLIER 48.07 74.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 65.4 110.857 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 tp -65.02 -166.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.179 -0.464 . . . . 75.24 110.928 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -143.37 140.72 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 72.0 111.151 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.88 60.2 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 50.11 112.46 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 90' ' ' SER . 1.7 t-20 -78.47 139.14 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 75.11 110.897 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER -52.28 -48.16 65.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 65.32 110.904 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.04 -46.53 2.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 64.43 112.538 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.03 128.39 35.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 74.13 110.883 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.21 160.57 31.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 73.3 110.868 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.25 139.01 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 64.25 111.126 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -136.93 146.83 45.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.931 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -144.08 165.02 28.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 75.15 110.856 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 26.0 m -143.81 138.74 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.513 . . . . 62.54 111.151 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -160.09 162.97 34.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 54.2 110.859 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -129.86 170.78 13.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 73.23 111.138 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 m -107.35 168.06 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 73.54 111.149 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -106.91 -49.93 3.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.857 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -126.13 156.76 39.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 75.43 110.843 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -78.85 114.84 18.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 74.22 110.925 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.71 145.5 33.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 55.13 111.086 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 m -97.96 107.54 20.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 74.14 111.133 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.97 148.91 47.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 73.23 111.034 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 p -106.55 113.0 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 62.21 111.148 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.4 t -126.12 139.97 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.22 111.125 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.539 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -138.86 166.72 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 71.21 110.888 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.41 147.51 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.35 111.153 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -178.41 170.73 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 70.31 110.831 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 73.23 112.524 -179.983 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.83 0.348 . . . . 74.33 110.838 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.07 115.56 28.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 64.41 111.129 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.68 157.31 17.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 75.45 110.874 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 tp -124.74 129.81 51.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 74.32 110.916 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -136.94 131.66 33.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.35 110.924 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.28 142.56 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 72.42 110.913 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -143.73 117.67 9.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.951 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.97 124.37 20.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 73.41 111.119 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 -81.04 0.72 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 75.33 112.516 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.1 p -96.17 -169.7 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 75.42 110.9 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.33 135.02 21.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.631 0.729 . . . . 74.54 110.869 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 141.25 44.74 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.664 2.243 . . . . 74.35 112.364 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 p -105.36 178.93 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.135 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.4 p -63.1 -15.05 55.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 73.21 111.092 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -118.41 -26.72 6.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 73.45 110.886 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.87 126.44 50.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 75.51 110.837 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.28 153.73 35.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 74.23 110.929 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -117.72 -42.89 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.866 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.1 m -117.39 120.82 39.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.44 110.868 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -179.59 127.6 0.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 75.12 110.856 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.642 2.228 . . . . 73.22 112.352 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.805 0.336 . . . . 73.22 110.886 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.75 15.75 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.881 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -121.4 82.95 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 71.32 110.853 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.539 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -133.23 170.2 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 70.44 110.874 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.06 152.42 37.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 72.23 110.861 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.7 p -128.38 108.98 11.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 75.32 110.858 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.1 t -150.46 152.76 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.11 111.122 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -77.6 103.64 7.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.22 110.88 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.19 134.33 35.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 73.44 111.085 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.5 139.27 23.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 73.34 111.127 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 121.02 7.72 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.724 2.283 . . . . 74.33 112.348 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.58 -19.09 1.85 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 65.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.8 m -116.9 133.78 55.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.39 . . . . 73.04 111.109 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.07 131.41 41.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 51.4 111.13 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -107.89 138.05 44.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 73.32 110.926 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -117.86 159.15 23.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 74.14 110.871 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.425 ' HB ' ' HE2' ' A' ' 5' ' ' LYS . 20.9 t -137.6 137.16 45.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 70.41 111.187 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 tpt -129.99 122.27 28.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 75.33 110.938 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.5 mm -104.2 112.7 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 75.25 111.144 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 124.55 49.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.937 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.8 162.88 30.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 71.14 112.441 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -95.16 -34.13 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 71.25 110.886 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.449 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 4.6 t -167.83 -62.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 75.43 110.829 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -171.81 86.68 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.871 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.63 119.9 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 74.2 110.948 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 p -122.88 153.4 39.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 75.01 110.817 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 12' ' ' ASN . . . 123.71 25.76 1.69 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 74.45 112.514 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.88 146.99 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.904 0.383 . . . . 71.12 111.128 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 m -101.34 115.52 30.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 61.31 111.095 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -100.94 130.89 47.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 62.33 110.927 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 9' ' ' PRO . 6.6 ttpt -143.79 163.81 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 75.04 110.885 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.416 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -91.73 143.3 26.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 74.24 110.902 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.492 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -94.7 113.91 25.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 75.4 110.95 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 12.9 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 74.42 110.954 -179.84 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.886 0.374 . . . . 74.35 110.886 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.9 m -119.88 109.07 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 73.24 111.143 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.74 151.3 52.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.9 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -164.51 -39.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 74.33 110.864 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.0 t-20 -103.98 155.37 18.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 74.4 110.882 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.6 t-20 87.43 -67.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 64.04 110.873 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.1 m -127.77 119.52 21.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 74.31 111.136 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 152.7 69.37 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.706 2.271 . . . . 74.14 112.296 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.44 115.45 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.23 111.126 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.8 142.11 32.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.832 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.59 80.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 74.45 110.878 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.28 -167.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 75.43 110.96 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 p -145.67 139.0 26.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.45 111.131 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.37 61.68 0.51 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.743 -0.741 . . . . 72.31 112.487 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -76.09 150.13 37.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.947 0.403 . . . . 74.33 110.862 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -35.89 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.51 110.917 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.82 -63.08 0.52 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 74.51 112.5 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.77 140.08 20.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 73.52 110.84 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -135.08 171.91 13.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 73.43 110.858 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.05 136.26 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 75.22 111.165 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -136.77 141.53 42.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.51 110.91 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -130.56 165.03 23.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.928 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.421 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 9.4 m -141.19 138.8 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 74.53 111.13 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.48 160.34 34.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 72.11 110.906 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.8 p -126.62 171.59 10.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 73.14 111.139 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 t -108.18 141.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 75.22 111.148 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -92.24 -42.59 9.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 73.53 110.86 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -132.15 148.39 52.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 73.04 110.864 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -72.89 114.27 10.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 74.23 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.34 140.76 29.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 55.35 111.134 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 t -98.98 107.08 19.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 72.0 111.11 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.72 148.02 48.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 70.03 111.104 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.1 p -106.72 111.19 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 71.01 111.119 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.71 139.82 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 74.54 111.157 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.456 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -134.51 166.33 23.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.43 110.861 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.11 142.23 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 74.3 111.162 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t 178.82 159.67 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.852 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.7 -0.762 . . . . 63.41 112.471 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.8 0.333 . . . . 74.31 110.843 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.527 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -92.54 113.93 26.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 74.42 111.108 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.32 166.16 24.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 75.23 110.856 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 tt -123.86 145.67 48.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.912 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -152.85 148.89 27.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 75.04 110.924 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 tt -152.73 140.13 19.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.899 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -147.57 130.41 16.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 75.33 110.882 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.71 86.53 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 72.32 111.139 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.94 -86.01 0.22 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.739 . . . . 73.32 112.501 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.03 134.04 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.953 0.406 . . . . 72.14 110.855 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.64 128.09 3.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.624 0.726 . . . . 62.11 110.895 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 142.84 49.11 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 63.32 112.376 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -110.08 179.31 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 75.33 111.183 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.8 p -60.92 -16.62 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 72.43 111.158 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 t -117.43 -25.78 6.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 73.12 110.83 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 124.76 48.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 72.0 110.871 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.73 153.18 32.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 73.21 110.929 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -114.24 -48.59 2.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 74.12 110.852 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.6 m -123.24 122.51 38.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.871 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.47 137.27 0.35 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.63 0.728 . . . . 72.43 110.866 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 65.15 112.308 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 44' ' ' ALA . 52.2 m-80 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.855 0.36 . . . . 64.35 110.907 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.9 t30 64.54 14.18 8.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 75.15 110.906 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.7 103.62 7.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 73.3 110.873 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 5.5 m -135.03 173.63 11.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 75.15 110.845 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.94 151.6 36.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 60.21 110.89 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.5 p -129.72 109.01 10.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 63.4 110.854 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.1 m -151.02 153.48 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 72.14 111.173 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -72.25 100.18 2.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.12 110.864 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.32 151.31 25.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 63.53 111.146 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.82 145.99 46.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.606 0.717 . . . . 71.32 111.086 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 173.37 11.06 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.669 2.246 . . . . 75.42 112.294 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.78 -46.86 1.72 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.742 . . . . 72.1 112.452 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.9 m -94.61 128.82 41.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 71.5 111.142 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.5 m -70.7 137.75 50.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 72.55 111.138 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -109.52 137.84 46.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 72.45 110.874 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -106.46 157.91 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 63.55 110.874 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.96 137.98 44.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 73.51 111.169 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.5 tpt -136.09 123.87 22.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 72.2 110.913 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.5 mm -111.94 111.91 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 72.02 111.111 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.84 149.76 23.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 71.12 110.864 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.8 157.81 16.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 50.33 112.539 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -114.18 -21.68 10.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 75.13 110.88 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 91' ' ' ASN . 72.3 p -169.99 134.97 1.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 64.03 110.863 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 90' ' ' SER . 1.7 p30 -33.83 107.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.1 110.88 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -164.12 114.03 1.24 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 72.11 110.938 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 p -121.08 162.56 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 73.14 110.878 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.35 19.38 3.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.718 -0.754 . . . . 72.23 112.515 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.8 t -112.43 147.93 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 75.32 111.135 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -100.21 129.76 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 73.22 111.176 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.2 tp -113.11 148.31 35.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 65.1 110.913 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -157.4 166.39 33.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.859 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.88 147.31 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 74.05 110.905 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.495 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -106.06 104.48 14.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 74.32 110.91 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 61.25 110.898 -179.84 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.502 -0.239 . . . . 74.4 112.502 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -110.8 -177.95 3.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 62.42 110.917 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -116.09 108.61 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 74.11 111.096 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.4 147.79 52.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.947 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 7.2 tptp -169.92 -37.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 75.41 110.926 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 12.6 t-20 -99.14 155.9 17.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 75.12 110.867 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 5.8 t30 81.54 -68.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 73.25 110.886 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.1 m -116.33 121.11 33.94 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 70.22 111.113 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 153.14 69.13 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.715 2.277 . . . . 74.25 112.348 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.24 114.4 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.45 111.119 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -81.85 158.26 24.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 64.33 110.83 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER 37.15 66.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 72.23 110.908 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.58 -169.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 74.11 110.935 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 p -145.8 139.39 26.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 73.13 111.136 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.68 65.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 64.5 112.485 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -76.57 139.89 40.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 74.24 110.924 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.28 -28.7 12.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 75.12 110.933 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.92 -49.7 0.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.749 . . . . 74.2 112.487 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -76.45 149.4 36.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 74.34 110.861 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -141.85 170.55 15.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 71.42 110.886 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.07 138.24 55.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 75.13 111.157 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -137.07 150.66 48.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 74.15 110.91 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -148.58 166.1 29.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 71.24 110.922 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 9.8 m -137.75 138.15 39.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 72.53 111.16 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.427 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -160.4 162.95 33.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 72.23 110.868 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.9 p -136.24 171.41 14.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 73.45 111.145 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.1 m -106.84 167.58 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 75.52 111.14 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -109.1 -48.23 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 72.53 110.834 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -125.56 156.93 38.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 73.03 110.874 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -80.06 115.22 19.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 71.21 110.845 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.47 144.61 34.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 75.05 111.139 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 t -98.8 107.24 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 74.43 111.148 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.95 148.27 45.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 64.14 111.071 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.74 110.67 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 72.22 111.144 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.51 140.86 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 74.54 111.15 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 24.2 p -140.63 167.72 21.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.55 110.844 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.71 149.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 75.43 111.194 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -179.85 -175.5 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 64.43 110.824 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.27 -18.81 0.92 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.774 -0.727 . . . . 62.31 112.484 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.45 -104.25 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 74.41 112.464 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.2 m -129.23 161.55 29.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 71.24 110.863 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.26 96.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 70.03 112.519 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 -38.21 1.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.829 0.347 . . . . 65.45 110.912 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.13 121.55 44.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 73.43 111.102 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -87.68 159.35 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 75.32 110.843 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.93 130.56 53.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.41 110.928 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -125.82 147.75 49.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 74.03 110.901 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 tt -143.76 134.99 25.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 74.03 110.917 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -144.04 116.02 8.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 73.31 110.896 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.41 120.68 10.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 64.5 111.085 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.49 -80.89 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 62.03 112.469 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 m -98.14 -178.06 3.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.389 . . . . 75.02 110.862 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 134.68 31.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.534 0.683 . . . . 74.52 110.927 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 143.3 50.35 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.655 2.237 . . . . 74.44 112.319 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -104.45 178.72 4.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 72.23 111.137 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.8 p -65.15 -14.43 60.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.436 . . . . 75.44 111.152 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -119.99 -26.75 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 72.0 110.851 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.07 125.95 50.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 64.15 110.868 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.23 153.62 35.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 74.35 110.929 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -111.83 -24.49 9.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 74.13 110.877 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.3 m -143.75 123.78 13.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.864 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -176.88 118.74 0.27 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.606 0.717 . . . . 70.33 110.893 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 53.6 Cg_endo -69.78 -6.07 17.73 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.684 2.256 . . . . 74.43 112.352 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 67.91 59.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 72.25 110.893 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.73 -172.38 2.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.866 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -100.14 108.39 20.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 74.12 110.922 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.63 -129.12 29.6 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.736 -0.745 . . . . 75.53 112.485 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -50.91 170.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 75.11 110.902 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 t30 64.47 18.87 11.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.23 110.887 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.414 ' HG3' ' HG2' ' A' ' 63' ' ' PRO . 19.9 tt0 -119.61 85.82 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 62.14 110.921 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.464 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.9 m -133.11 169.68 16.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.24 110.857 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.24 155.22 33.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 54.1 110.875 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.23 106.55 8.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 70.22 110.864 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.1 t -151.17 149.81 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 74.13 111.134 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.8 p -73.55 102.5 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 74.32 110.86 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.51 137.42 34.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.113 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.47 141.37 22.57 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 74.53 111.09 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 132.2 22.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.71 2.273 . . . . 75.33 112.358 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.78 -18.93 4.01 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.741 . . . . 71.51 112.509 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.5 m -115.55 129.71 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 75.35 111.14 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.4 m -72.19 137.06 46.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 73.42 111.135 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -109.86 138.21 46.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 75.43 110.918 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -108.16 161.98 14.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 75.33 110.836 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.9 t -132.31 139.05 50.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 73.42 111.124 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.7 121.18 11.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 75.45 110.853 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 mm -115.64 116.17 51.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 75.05 111.113 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.7 128.99 56.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 73.11 110.896 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.43 159.5 13.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 75.11 112.499 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -98.83 -21.36 16.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.868 0.366 . . . . 74.34 110.899 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 91' ' ' ASN . 23.3 p -167.07 141.65 3.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 74.21 110.897 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 90' ' ' SER . 55.2 t-20 -35.64 107.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 75.2 110.889 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -160.11 116.85 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 61.42 110.921 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.1 p -119.62 161.25 20.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 73.12 110.892 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.45 22.85 2.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 73.15 112.49 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.49 147.03 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.909 0.385 . . . . 74.41 111.11 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.63 114.35 28.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.21 111.147 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.5 tp -99.44 144.01 29.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 72.04 110.91 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -153.16 164.92 37.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.32 110.892 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.54 140.58 29.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 72.12 110.881 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -100.43 111.17 23.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 73.32 110.885 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.7 p90 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.464 . . . . 71.43 110.922 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.519 -0.233 . . . . 71.04 112.519 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -102.63 178.33 4.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 73.51 110.865 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 m -108.03 108.15 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 75.31 111.14 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.61 149.69 52.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 75.21 110.897 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 13.2 tptm -169.29 -38.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.876 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 8.8 t-20 -97.91 155.32 17.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 64.12 110.851 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 26.1 t30 82.0 -68.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 72.34 110.88 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 m -124.99 119.76 25.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.598 0.713 . . . . 74.45 111.163 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 154.73 67.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.682 2.255 . . . . 45.42 112.355 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 t -76.47 114.01 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.03 111.131 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.64 144.98 29.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 74.55 110.83 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.09 77.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 75.21 110.896 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.36 -172.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 72.1 110.902 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 p -136.55 137.95 40.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 75.51 111.15 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.18 60.73 0.55 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 75.42 112.529 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -77.07 163.04 27.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.373 . . . . 74.32 110.895 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -45.4 -69.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 75.43 110.913 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.67 -50.72 3.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.729 . . . . 74.34 112.48 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.97 144.45 6.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 72.03 110.838 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -144.24 -179.81 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 71.14 110.887 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.4 135.76 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 73.44 111.115 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -137.03 148.54 46.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 75.13 110.896 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -148.54 165.01 32.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 72.24 110.912 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -143.14 142.4 31.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 63.45 111.123 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -159.32 159.38 33.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 72.11 110.884 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -127.22 170.35 12.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 74.23 111.14 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.09 167.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 74.42 111.139 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.39 -43.23 4.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 64.45 110.884 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.43 162.74 31.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 65.44 110.904 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.26 116.09 19.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 70.54 110.91 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.78 141.06 31.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 64.42 111.145 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -97.34 107.17 19.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 75.12 111.134 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.22 147.01 47.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 73.04 111.095 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 p -110.9 110.84 33.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.25 111.176 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.5 140.25 49.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.23 111.115 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.499 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 4.7 p -130.75 166.47 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.888 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.58 152.57 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 71.3 111.129 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.01 177.23 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 63.54 110.813 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.82 -23.39 0.22 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 74.43 112.482 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.21 -116.04 0.52 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 72.53 112.482 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.8 p -120.16 162.49 19.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 73.01 110.866 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -47.78 120.89 6.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.783 -0.723 . . . . 71.42 112.47 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -165.81 -37.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.815 0.34 . . . . 70.31 110.856 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.22 125.92 49.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 74.04 111.112 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.08 151.54 22.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 64.24 110.842 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 tt -116.09 127.8 55.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.917 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -138.43 143.11 39.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 65.44 110.904 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 tt -149.21 135.96 19.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 73.21 110.918 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -143.64 138.25 28.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 72.23 110.897 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.52 101.02 11.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 63.01 111.126 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.05 -92.39 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.742 . . . . 44.43 112.476 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.9 p -87.5 131.4 34.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 74.15 110.851 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.68 134.8 6.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.589 0.709 . . . . 75.31 110.877 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 143.75 51.66 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.69 2.26 . . . . 75.4 112.311 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.18 177.5 5.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.436 . . . . 70.04 111.123 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 p -63.62 -15.92 59.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.138 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -119.63 -25.44 5.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 73.34 110.898 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.94 125.14 48.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 74.23 110.832 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.86 153.54 34.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 74.52 110.937 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -108.61 -29.12 8.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 74.01 110.825 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.5 m -136.32 123.73 22.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.13 110.882 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -175.04 132.52 0.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.626 0.727 . . . . 74.32 110.891 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -1.33 8.3 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.251 . . . . 65.31 112.315 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 70.47 77.87 0.19 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 74.43 110.925 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.4 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -174.79 -169.54 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 75.1 110.85 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -134.96 140.22 45.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 73.51 110.951 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.94 172.45 39.03 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.711 -0.757 . . . . 61.21 112.513 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -175.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 64.15 110.856 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.3 t30 63.8 15.88 9.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.884 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.4 ' HG3' ' HB3' ' A' ' 65' ' ' ARG . 35.2 mm-40 -120.41 96.15 5.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.892 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.499 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -134.52 170.53 15.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 75.03 110.875 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -120.35 153.29 36.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 73.2 110.888 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -129.2 108.5 10.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 74.13 110.833 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.2 t -150.44 149.83 14.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 74.22 111.119 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.1 p -75.68 102.4 5.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 63.54 110.896 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.49 143.81 30.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 72.05 111.111 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.15 142.91 26.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 74.54 111.107 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 141.09 44.24 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 70.43 112.337 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.67 -13.14 7.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.688 -0.767 . . . . 63.53 112.481 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -125.27 130.4 51.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 73.45 111.158 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 m -73.19 137.8 45.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 51.43 111.13 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -108.72 136.16 48.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 73.51 110.926 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -107.56 160.45 15.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.21 110.862 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.95 138.55 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 65.51 111.088 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.73 125.08 19.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 71.11 110.885 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.2 mm -114.79 130.28 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.32 111.141 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -111.49 149.85 30.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 73.41 110.899 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.19 152.27 16.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.721 -0.752 . . . . 64.4 112.544 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -120.39 -17.79 8.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 72.32 110.938 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -174.73 136.11 0.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 60.15 110.829 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 90' ' ' SER . 17.5 t-20 -35.06 103.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 74.23 110.889 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -155.38 100.18 2.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 74.23 110.906 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.6 p -109.47 151.85 26.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.071 -0.513 . . . . 71.41 110.82 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.08 24.16 1.34 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 73.12 112.476 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.63 142.63 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 62.24 111.121 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.43 117.07 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 75.0 111.152 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.1 tp -106.01 140.06 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 72.2 110.923 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -144.51 165.19 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 73.24 110.864 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.3 137.68 32.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.93 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.59 113.12 24.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 65.11 110.892 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.4 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 73.22 110.89 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.454 -0.258 . . . . 73.32 112.454 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -122.93 179.37 4.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 64.22 110.894 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.3 m -117.63 108.55 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.43 111.121 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.94 150.23 52.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 74.54 110.907 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 14.8 tptt -167.19 -35.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 73.34 110.922 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -101.39 155.61 17.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 75.24 110.891 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 24.4 t30 83.99 -69.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 73.32 110.891 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -123.08 121.3 27.19 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.569 0.7 . . . . 74.45 111.113 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 153.51 68.84 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.267 . . . . 74.2 112.317 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.23 114.84 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 75.31 111.15 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -85.56 160.74 19.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.836 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 p30 40.2 62.17 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 75.12 110.89 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.03 -169.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.903 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 p -146.57 139.32 25.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 71.52 111.156 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.12 57.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.754 . . . . 33.25 112.486 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.94 152.95 36.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 72.14 110.914 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.24 -42.76 66.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 73.31 110.871 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.82 -48.69 1.07 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.778 -0.725 . . . . 63.34 112.508 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.28 134.1 54.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 64.03 110.799 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -134.65 172.6 12.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 74.24 110.874 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.41 139.23 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 70.11 111.12 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -136.78 151.23 48.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 74.22 110.871 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -145.14 165.97 26.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 74.05 110.933 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 8.7 m -141.69 138.13 32.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.075 -0.511 . . . . 65.42 111.157 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -160.61 158.19 28.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.887 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.7 p -128.07 171.22 12.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 73.02 111.093 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.35 147.7 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 75.44 111.135 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -91.03 -49.83 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.884 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.14 161.39 26.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.878 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -81.06 114.12 19.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 73.22 110.858 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.99 138.96 28.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 73.35 111.078 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -94.37 106.7 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 74.14 111.139 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.26 146.23 46.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 64.13 111.066 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.9 t -109.39 111.88 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.11 111.148 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.7 t -127.02 139.27 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 72.34 111.136 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.455 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 42.6 p -134.03 166.48 22.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 60.4 110.877 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.96 149.49 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 63.42 111.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.66 177.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 54.12 110.864 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.77 -45.32 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.728 . . . . 65.23 112.511 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.02 -106.22 0.62 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.721 -0.752 . . . . 55.21 112.47 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.6 p -103.95 158.51 16.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.942 0.401 . . . . 74.45 110.82 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.27 90.78 0.82 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 54.21 112.474 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -135.4 2.31 2.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 74.52 110.894 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.1 106.64 12.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.42 111.119 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.64 152.35 37.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 74.53 110.864 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.27 127.27 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.862 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -133.93 139.63 46.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 64.41 110.931 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tt -143.4 134.13 25.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.906 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -142.4 122.66 13.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 75.13 110.883 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.47 48.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 73.11 111.112 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.15 -81.9 1.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.719 -0.753 . . . . 71.24 112.501 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -93.67 177.48 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.907 0.384 . . . . 75.03 110.844 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.12 138.22 30.86 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.569 0.699 . . . . 75.43 110.895 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.15 49.93 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 75.43 112.332 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -103.34 178.99 4.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 61.31 111.194 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.7 p -65.47 -14.24 60.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 74.52 111.124 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.4 m -121.35 -26.25 5.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 75.15 110.858 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.13 126.47 49.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 64.45 110.878 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.28 153.7 35.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 65.44 110.944 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -111.69 -27.63 8.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 74.43 110.897 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.1 m -140.52 123.78 16.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.916 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -179.51 115.78 0.22 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.589 0.709 . . . . 74.44 110.87 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HD2' ' HG2' ' A' ' 70' ' ' GLU . 53.9 Cg_endo -69.74 -7.95 22.36 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.664 2.243 . . . . 61.42 112.364 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 67.34 74.57 0.31 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 74.25 110.877 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.65 -167.84 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.21 110.889 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -101.99 105.37 16.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.895 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 49.8 -130.78 27.36 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 73.32 112.528 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -48.12 167.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 74.31 110.902 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.7 t30 68.01 18.27 9.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 71.01 110.891 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 14.1 tt0 -122.19 88.82 3.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 72.54 110.831 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.455 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.4 m -134.63 169.03 17.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 70.1 110.854 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.22 152.34 38.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 71.02 110.879 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -127.03 109.29 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.43 110.881 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.5 m -150.96 152.74 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 73.21 111.112 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.5 p -80.1 101.89 9.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 71.23 110.884 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.87 151.18 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 71.31 111.078 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.87 144.13 32.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.547 0.689 . . . . 74.41 111.104 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 124.67 11.32 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.713 2.275 . . . . 75.11 112.306 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.03 -15.99 1.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 55.22 112.485 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.9 m -126.16 131.33 52.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.37 . . . . 75.02 111.134 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.9 m -72.66 138.15 46.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.44 111.153 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -108.57 139.58 43.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 75.23 110.926 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -107.25 160.19 15.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 73.42 110.831 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 t -137.8 126.14 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 75.15 111.148 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.04 123.06 27.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 74.5 110.845 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.1 mm -111.2 124.32 67.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 75.12 111.112 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 145.25 32.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.865 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -117.14 140.61 15.99 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 62.25 112.49 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -101.76 -24.3 14.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.923 0.392 . . . . 75.43 110.953 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 91' ' ' ASN . 72.2 p -174.52 139.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 64.41 110.835 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 90' ' ' SER . 5.1 p-10 -31.56 106.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 65.22 110.913 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -163.09 110.6 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 65.54 110.93 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 p -117.25 158.83 23.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 73.44 110.868 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.34 25.45 2.0 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 72.14 112.529 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.36 146.83 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.865 0.364 . . . . 55.24 111.162 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.71 113.72 27.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 71.43 111.171 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tp -99.88 141.08 33.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 72.24 110.921 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -151.58 169.92 20.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.936 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.411 ' HA ' ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -89.42 144.8 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 74.04 110.903 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.39 101.79 11.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 70.12 110.888 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.931 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.498 -0.241 . . . . 42.12 112.498 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -103.9 -175.29 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 72.02 110.891 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -117.83 108.84 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.44 111.13 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.07 149.74 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 72.22 110.875 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.421 ' HD3' HG22 ' A' ' 84' ' ' VAL . 18.4 tptm -162.7 -70.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.31 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.579 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -71.65 155.4 40.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 74.05 110.888 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 18.4 t30 89.03 -67.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.45 110.875 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 m -124.19 120.66 26.24 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.614 0.721 . . . . 75.25 111.171 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 154.14 68.3 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.7 2.267 . . . . 71.42 112.384 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.9 t -87.48 113.78 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 61.34 111.131 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 p -91.31 175.14 7.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.858 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 p30 40.62 48.91 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 74.32 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.38 -176.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.952 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 p -143.86 139.61 29.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 73.24 111.146 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.75 64.54 0.56 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.794 -0.717 . . . . 74.45 112.497 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -73.93 160.5 31.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.941 0.4 . . . . 74.44 110.858 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 90' ' ' SER . 0.9 OUTLIER -45.22 -64.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.905 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.9 -48.14 1.81 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 73.12 112.501 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.57 157.81 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.839 0.352 . . . . 70.2 110.881 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.65 -179.32 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 71.22 110.893 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.66 146.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.21 111.141 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -137.55 145.72 43.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 70.43 110.88 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -144.88 165.9 26.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 74.44 110.913 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 8.2 m -140.79 140.02 34.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 51.33 111.089 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -159.68 160.69 34.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 71.54 110.858 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.5 p -130.1 170.22 14.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.484 . . . . 73.32 111.125 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.11 170.76 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.42 111.121 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -99.46 -67.99 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.887 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -125.31 148.68 48.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 75.25 110.869 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -50.53 117.49 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 73.43 110.84 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.97 144.42 33.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 74.04 111.079 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 t -103.05 107.13 17.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.436 . . . . 72.41 111.167 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.56 147.13 46.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 75.22 111.138 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -107.57 111.69 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 72.52 111.129 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 t -127.64 139.67 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.31 111.15 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.456 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 9.5 p -135.15 165.27 25.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 71.13 110.858 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.4 150.93 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 73.2 111.111 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 177.5 172.93 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 73.54 110.831 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.46 -23.6 0.23 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 72.31 112.443 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.27 -115.37 0.44 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 73.45 112.487 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 m -112.43 160.57 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 74.13 110.891 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.56 106.45 0.59 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 72.14 112.479 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -144.09 -45.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 73.43 110.864 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.67 116.36 26.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 73.13 111.108 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -78.21 147.2 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 62.23 110.844 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 tt -108.4 126.93 53.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 71.12 110.909 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -142.66 139.37 31.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 75.22 110.901 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.09 133.64 19.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 73.34 110.908 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 133.86 24.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.466 . . . . 74.33 110.918 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.27 132.53 38.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 52.35 111.123 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.82 -80.63 1.81 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 44.34 112.509 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -92.92 175.95 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 70.0 110.842 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.15 137.75 31.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 72.42 110.895 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 142.65 48.38 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.691 2.26 . . . . 65.43 112.334 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.67 178.68 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 74.32 111.155 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 p -66.81 -13.38 61.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.54 111.113 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 m -123.01 -25.96 4.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 61.41 110.85 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.83 125.99 49.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 70.5 110.839 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.11 153.67 34.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 74.03 110.964 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -102.02 -32.19 10.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 64.45 110.85 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.2 m -138.03 123.57 19.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 63.24 110.856 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -177.29 127.16 0.3 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.568 0.699 . . . . 74.22 110.893 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -12.02 32.08 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.726 2.284 . . . . 73.23 112.38 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.1 t80 65.45 83.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 73.11 110.88 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 178.98 -166.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 75.42 110.886 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -46.52 160.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 74.1 110.948 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.24 -93.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.75 . . . . 74.41 112.499 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.34 161.26 2.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 71.31 110.892 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.8 25.57 11.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 70.44 110.906 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.32 96.13 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 71.12 110.865 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -133.85 170.95 14.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 53.2 110.862 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.46 149.56 41.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 65.54 110.951 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 p -126.72 109.27 11.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.44 110.864 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.2 t -150.91 152.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 52.11 111.139 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 p -81.41 102.14 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 70.02 110.85 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.55 149.96 26.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 54.41 111.13 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.58 144.23 28.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.595 0.712 . . . . 74.15 111.094 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.25 7.04 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.684 2.256 . . . . 74.33 112.314 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.68 -4.97 80.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.728 . . . . 62.01 112.494 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.9 m -126.22 125.48 42.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 73.1 111.125 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 m -71.24 137.78 48.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 74.1 111.127 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -111.66 137.98 48.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 75.53 110.936 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -105.98 162.41 13.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 72.52 110.841 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG22 ' HD3' ' A' ' 5' ' ' LYS . 2.7 t -135.89 138.57 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.31 111.147 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.8 tpp -140.3 121.77 15.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 75.23 110.83 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.4 mm -118.86 113.16 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.21 111.144 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -100.11 155.79 17.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 74.11 110.915 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.03 153.24 17.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 73.12 112.478 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.87 -21.98 8.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.895 0.379 . . . . 63.02 110.927 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.479 ' O ' ' C ' ' A' ' 91' ' ' ASN . 1.6 p -175.04 134.44 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 70.21 110.905 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 90' ' ' SER . 39.2 t30 -32.02 106.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 65.22 110.905 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -163.95 116.52 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.926 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.6 p -121.84 151.62 40.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 72.35 110.856 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.16 29.38 1.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 74.35 112.488 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.56 145.73 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.929 0.395 . . . . 72.23 111.127 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -101.15 118.56 37.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 71.22 111.165 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.422 ' CD1' ' C ' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -111.45 127.81 55.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 73.42 110.917 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -135.15 167.92 20.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.908 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.18 141.2 28.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 74.22 110.923 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.08 110.99 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 75.04 110.927 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.928 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.488 -0.245 . . . . 72.04 112.488 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -95.06 -177.32 4.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.847 0.356 . . . . 75.0 110.9 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 m -106.39 108.45 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 72.32 111.097 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.14 149.93 52.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 62.34 110.904 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -166.71 -67.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.907 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -76.09 153.93 35.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 74.04 110.918 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.1 t-20 87.32 -69.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.887 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.1 m -120.88 121.55 28.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.57 0.7 . . . . 61.52 111.105 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 154.38 67.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.692 2.262 . . . . 74.2 112.363 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.13 116.22 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 62.51 111.137 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 p -87.96 159.71 18.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 64.1 110.834 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 p30 40.08 69.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 73.11 110.855 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.81 -174.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 65.24 110.889 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -140.49 138.0 34.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 74.1 111.146 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.52 64.05 0.58 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.693 -0.765 . . . . 63.53 112.454 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -75.59 148.18 39.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.357 . . . . 72.32 110.905 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.36 -57.02 7.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 75.21 110.881 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.63 -64.21 1.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 42.13 112.491 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.92 144.61 8.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 72.4 110.865 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -139.67 179.33 6.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 61.14 110.892 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.13 138.0 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 74.54 111.127 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -135.41 139.58 44.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 71.34 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -137.44 163.8 30.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 75.44 110.926 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 p -142.17 146.91 35.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 72.22 111.136 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.39 163.28 35.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 64.21 110.822 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 p -125.58 169.74 12.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 54.03 111.183 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.2 t -108.33 145.09 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.13 111.089 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -86.21 -44.29 12.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.832 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -142.78 154.72 44.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 75.1 110.86 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -72.04 116.62 12.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 72.21 110.938 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.75 141.3 31.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 63.31 111.116 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -94.81 105.66 17.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 74.14 111.114 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.11 148.62 45.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 71.34 111.136 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -107.93 111.12 34.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 72.53 111.12 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.41 139.9 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 71.22 111.09 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.481 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 24.3 p -135.89 166.21 23.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 73.04 110.855 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -111.4 150.66 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 72.13 111.152 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.3 173.58 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 64.34 110.884 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.0 -27.31 0.13 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 64.31 112.495 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.62 -114.97 0.34 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.711 -0.757 . . . . 74.45 112.508 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.1 p -111.97 162.18 15.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 74.12 110.871 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.85 134.67 21.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.732 -0.747 . . . . 61.13 112.462 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -174.39 -35.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 72.03 110.861 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.93 127.12 54.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 74.52 111.073 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 1.7 m-20 -88.91 152.36 21.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 70.14 110.867 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.6 tt -118.75 142.24 47.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 72.44 110.891 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -153.36 142.92 21.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 73.02 110.945 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.66 134.08 29.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 74.35 110.922 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -149.16 129.64 13.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 74.44 110.906 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.3 98.98 8.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 64.1 111.091 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.07 -90.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 71.55 112.463 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.0 m -90.46 128.48 36.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.957 0.408 . . . . 63.44 110.849 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.26 133.93 3.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.574 0.702 . . . . 72.42 110.87 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 143.02 49.54 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.677 2.251 . . . . 73.32 112.336 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 p -107.63 178.73 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 74.42 111.164 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.8 p -63.28 -15.18 56.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 74.11 111.164 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 m -118.96 -26.33 6.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 74.51 110.858 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.73 125.49 49.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.852 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.97 153.4 34.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.909 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -108.18 -34.58 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 71.41 110.912 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 70.5 m -144.64 123.1 12.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.86 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -177.37 129.14 0.32 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.606 0.717 . . . . 74.45 110.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HG2' ' CG ' ' A' ' 70' ' ' GLU . 53.8 Cg_endo -69.76 -4.78 14.72 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.237 . . . . 64.03 112.399 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 6.5 t80 69.1 101.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 75.44 110.913 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.68 -169.49 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 74.45 110.86 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -87.41 -77.1 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.966 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 68' ' ' ASN . . . -150.98 145.35 13.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 75.51 112.46 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER 58.93 150.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 73.32 110.897 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.3 t30 65.63 12.19 8.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.878 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.417 ' CG ' ' HG2' ' A' ' 63' ' ' PRO . 4.3 tt0 -116.68 87.5 2.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.876 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.481 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -133.28 169.26 17.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 72.42 110.846 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.74 156.73 31.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 71.32 110.865 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.68 107.22 9.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 52.04 110.832 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -150.65 153.12 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.43 111.168 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -70.21 104.72 2.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.22 110.863 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.93 131.5 35.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 70.23 111.127 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.99 139.94 20.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.589 0.709 . . . . 55.33 111.078 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 170.45 16.55 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.683 2.255 . . . . 75.23 112.349 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.16 -39.24 2.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 45.01 112.474 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.6 m -97.04 128.93 44.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 71.34 111.155 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.1 m -71.43 133.24 45.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 72.31 111.141 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -104.03 136.02 44.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 72.05 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -106.97 159.14 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 64.32 110.834 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.93 139.39 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 73.13 111.108 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.82 123.65 25.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 74.0 110.892 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.1 mm -118.81 113.61 42.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 74.13 111.099 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 10.3 mmmm -98.29 165.32 11.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 74.42 110.927 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.88 135.08 8.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.713 -0.756 . . . . 73.22 112.449 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -96.61 -31.54 12.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 75.21 110.943 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 91' ' ' ASN . 78.1 p -167.62 136.92 2.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 65.42 110.859 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 90' ' ' SER . 13.5 t-20 -34.62 105.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 75.01 110.898 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -164.37 119.25 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 74.04 110.953 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 p -121.56 155.76 34.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 70.53 110.891 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.65 23.29 1.52 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 72.32 112.468 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.15 143.12 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.911 0.386 . . . . 73.31 111.123 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.08 132.26 45.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.3 111.158 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 13.8 tp -118.99 149.71 41.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.928 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -157.87 164.27 37.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 74.51 110.919 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.96 138.95 31.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.25 -0.432 . . . . 70.44 110.907 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -98.09 112.0 24.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 63.33 110.941 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 p90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 73.12 110.926 -179.833 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.512 -0.235 . . . . 70.3 112.512 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -102.57 -176.95 3.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.893 0.378 . . . . 74.12 110.831 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.56 109.25 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 75.45 111.103 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.47 148.95 52.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 75.32 110.936 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -166.66 -68.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 73.4 110.883 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -75.01 154.98 37.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.54 110.877 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.0 t-20 88.38 -65.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 71.31 110.906 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 m -129.35 121.67 20.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.551 0.691 . . . . 71.05 111.098 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 154.07 67.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.653 2.236 . . . . 73.05 112.359 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.3 t -84.83 115.09 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 61.14 111.134 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.2 146.12 28.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 74.02 110.853 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.66 81.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 75.14 110.942 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.58 -172.69 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 71.21 110.924 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -136.98 138.72 40.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 75.12 111.139 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.77 71.87 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.746 -0.74 . . . . 74.32 112.505 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -76.98 134.54 38.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 61.21 110.89 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -24.57 8.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.901 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.13 -40.64 1.37 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 61.44 112.439 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.27 -173.12 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.356 . . . . 72.23 110.871 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.12 -178.01 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 75.1 110.918 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.0 145.76 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 74.41 111.168 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -137.21 143.4 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.51 110.849 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -140.15 165.25 27.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 73.33 110.926 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 m -147.11 142.32 27.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 74.21 111.137 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.36 162.51 35.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 74.25 110.868 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 p -130.34 169.94 14.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 72.42 111.115 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 m -108.68 169.89 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.197 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -108.73 -45.16 3.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.895 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -133.38 158.82 42.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 75.1 110.881 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.7 116.27 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 55.21 110.896 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.38 139.19 31.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 65.23 111.127 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.3 m -96.21 106.77 19.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 71.41 111.154 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.59 147.29 46.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 70.31 111.117 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -107.5 111.29 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 52.31 111.132 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -127.45 140.22 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 75.01 111.115 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.489 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 5.4 p -133.53 166.25 23.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.891 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.91 152.44 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 74.22 111.169 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.79 173.9 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.886 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 165.58 -25.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 54.22 112.496 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.2 -110.05 0.32 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 71.4 112.485 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 m -114.86 160.57 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 72.32 110.862 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.03 96.86 0.11 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.694 -0.765 . . . . 71.14 112.488 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -133.41 -39.69 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 53.02 110.826 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.64 120.55 39.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.55 111.159 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.55 161.99 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 75.52 110.887 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 tt -118.78 129.82 55.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 75.12 110.959 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -133.85 146.54 50.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.913 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.52 133.47 13.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 75.33 110.922 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.87 121.58 11.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.854 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.49 89.46 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 74.33 111.109 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.89 -83.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 75.44 112.456 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -106.41 133.96 50.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.925 0.393 . . . . 70.04 110.862 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.66 127.34 2.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 75.44 110.932 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 142.87 49.23 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.708 2.272 . . . . 63.33 112.305 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.48 178.32 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 74.02 111.152 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.3 p -60.63 -17.04 44.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 75.51 111.152 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.6 m -117.04 -25.45 7.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.833 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.46 124.87 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 74.13 110.847 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.87 153.41 33.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.91 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -115.51 -34.91 4.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 75.4 110.886 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.9 m -140.37 122.68 15.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 74.13 110.873 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.513 ' C ' ' H ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -178.32 140.69 0.4 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.582 0.706 . . . . 70.42 110.907 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 64' ' ' TYR . 53.6 Cg_endo -69.77 32.97 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.69 2.26 . . . . 73.02 112.313 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER 36.69 68.98 0.22 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 74.45 110.88 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -170.63 -175.31 1.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 72.52 110.822 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -135.53 149.94 49.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 75.32 110.896 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.86 161.54 34.42 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.755 -0.736 . . . . 73.05 112.485 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -53.76 177.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 74.31 110.865 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.9 t30 66.86 16.55 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.15 110.905 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.92 96.98 4.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 63.4 110.899 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.489 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 2.4 m -134.32 171.2 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.901 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.29 152.96 35.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 74.53 110.882 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -128.64 109.26 11.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.24 110.854 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.6 m -150.89 152.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 62.42 111.135 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.6 p -73.2 106.97 5.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 64.01 110.8 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.71 132.55 35.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 74.11 111.066 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.63 139.23 19.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.525 0.678 . . . . 74.15 111.101 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 142.11 46.88 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.629 2.219 . . . . 72.22 112.325 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.97 -12.77 8.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.774 -0.727 . . . . 73.11 112.461 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.1 m -126.41 129.23 48.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 70.01 111.165 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -70.98 138.07 49.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 74.35 111.159 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -108.6 135.86 49.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 73.2 110.946 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -107.24 158.91 16.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 61.41 110.879 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 t -138.3 138.57 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 75.4 111.14 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.97 123.05 17.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.43 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.44 112.96 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 64.43 111.169 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -110.38 134.31 52.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 74.45 110.874 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.74 144.67 17.66 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.753 . . . . 31.11 112.456 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.77 -22.27 20.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.902 0.382 . . . . 75.14 110.962 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 91' ' ' ASN . 2.7 p -163.85 139.76 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 72.54 110.891 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 90' ' ' SER . 13.3 t-20 -35.07 106.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 64.35 110.882 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -155.47 115.59 3.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 71.54 110.946 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.1 p -122.17 151.5 40.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 71.04 110.849 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.46 23.65 2.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 74.22 112.469 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.74 143.94 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 72.01 111.096 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.94 124.19 46.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 72.43 111.124 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.5 tp -112.32 148.38 34.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 64.45 110.951 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -153.79 164.7 37.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 72.43 110.878 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.43 136.91 32.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.236 -0.438 . . . . 74.4 110.922 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.38 112.18 24.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.01 110.931 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 75.45 110.871 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.456 -0.258 . . . . 53.03 112.456 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -155.43 -175.86 5.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 71.22 110.885 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.5 m -117.9 108.27 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 73.32 111.146 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.54 150.66 52.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 70.43 110.95 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -166.09 -73.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 74.41 110.883 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 9.8 t-20 -63.39 157.75 22.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 73.01 110.919 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.3 t30 88.52 -60.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.868 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.4 m -133.59 121.62 16.32 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 72.45 111.161 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 152.28 69.54 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 2.243 . . . . 63.33 112.353 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -79.37 115.02 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 74.35 111.175 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.49 146.31 31.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 72.25 110.844 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.59 81.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 73.3 110.841 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -168.72 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 73.52 110.911 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 p -139.61 138.34 36.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 73.3 111.137 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.63 58.82 0.65 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.721 -0.752 . . . . 75.31 112.517 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -76.56 139.17 40.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.874 0.368 . . . . 73.25 110.848 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -26.11 9.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 71.42 110.942 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.98 -56.33 0.4 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.735 -0.745 . . . . 73.1 112.503 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.13 158.73 6.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.854 0.359 . . . . 75.4 110.868 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -152.6 167.58 28.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 73.35 110.922 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.61 136.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 64.25 111.102 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -137.42 147.15 45.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 73.23 110.825 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -146.22 166.11 27.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 70.44 110.968 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.416 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 27.6 m -140.04 140.7 36.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 73.1 111.108 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -160.74 155.06 23.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.925 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 p -128.07 170.49 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.04 111.178 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -108.5 170.21 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 74.34 111.11 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.05 -52.83 3.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 62.41 110.873 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.43 172.67 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.25 110.873 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -75.93 117.13 17.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 75.13 110.845 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.81 133.5 25.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 65.2 111.143 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.6 m -95.18 107.98 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 74.45 111.118 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.2 148.33 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 73.54 111.067 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 p -106.92 111.03 33.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 74.53 111.099 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.16 139.34 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 60.15 111.115 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.484 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 17.0 p -135.48 170.23 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 75.35 110.889 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 pt -108.01 157.49 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 73.23 111.112 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 174.12 171.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 75.53 110.838 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 164.62 -25.68 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.679 -0.772 . . . . 71.34 112.429 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.49 -91.24 0.18 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.79 -0.719 . . . . 72.55 112.473 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.1 m -130.13 145.82 51.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.937 0.399 . . . . 71.32 110.82 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.09 -30.4 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 72.54 112.51 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.08 33.76 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.818 0.342 . . . . 65.12 110.89 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.76 120.92 36.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 73.23 111.1 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.64 172.64 11.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.891 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 tt -124.63 141.82 51.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 73.04 110.914 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -150.37 146.62 26.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.949 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.87 146.23 23.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 71.14 110.934 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 7.1 tttt -149.62 123.12 9.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 72.42 110.923 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.54 84.28 6.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 72.34 111.109 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.89 -64.22 0.4 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 72.55 112.527 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -139.99 137.7 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.949 0.404 . . . . 75.35 110.833 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -32.52 127.2 0.36 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.522 0.677 . . . . 75.55 110.929 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 143.45 50.76 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.668 2.245 . . . . 71.13 112.329 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -103.35 178.35 4.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 55.14 111.106 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.5 p -62.69 -15.71 53.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 74.31 111.172 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.3 m -117.21 -26.23 6.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 71.11 110.858 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.94 123.52 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 73.14 110.838 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.39 153.55 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 73.21 110.903 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 49' ' ' LYS . 35.6 m-20 -112.27 -45.67 3.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 55.2 110.847 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 36.9 m -121.9 123.57 42.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 74.13 110.869 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 64' ' ' TYR . 26.7 ttp180 -175.77 127.61 0.37 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 74.51 110.848 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -3.29 11.73 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.694 2.263 . . . . 63.03 112.344 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.409 ' H ' ' HG2' ' A' ' 62' ' ' ARG . 10.3 m-85 68.21 84.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 72.22 110.91 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.53 -173.36 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 75.14 110.893 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -121.96 175.83 6.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 74.11 110.963 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.85 170.79 0.47 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.699 -0.763 . . . . 65.35 112.507 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -60.39 -167.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 74.32 110.921 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.3 t30 61.09 24.2 14.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.31 110.876 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -128.98 90.23 3.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 75.33 110.908 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.484 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 2.6 m -133.04 169.97 16.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 71.2 110.86 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.57 154.76 34.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 75.2 110.869 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.6 p -128.29 109.67 11.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.846 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.1 t -150.33 153.02 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 72.34 111.123 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -75.41 105.38 6.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.3 110.857 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.13 138.41 34.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.41 111.064 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.29 146.52 32.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.711 . . . . 73.22 111.13 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 164.55 34.09 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 73.21 112.374 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.0 -21.18 38.3 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.713 -0.756 . . . . 71.35 112.482 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.0 m -108.75 124.01 49.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 64.43 111.111 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.0 m -72.89 134.06 44.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 63.12 111.127 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -109.13 136.91 47.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.885 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -118.55 139.56 51.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 73.42 110.851 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.03 126.83 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 74.21 111.091 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 tpt -123.51 128.82 50.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 62.24 110.846 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.6 mm -113.97 126.43 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 74.42 111.109 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.19 146.3 30.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 73.35 110.9 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.39 150.13 18.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 71.52 112.472 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.15 -37.9 5.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.35 . . . . 74.41 110.868 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 91' ' ' ASN . 7.6 p -161.74 137.64 7.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 73.03 110.908 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.482 ' C ' ' O ' ' A' ' 90' ' ' SER . 4.8 p-10 -31.65 108.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.877 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.63 121.66 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 75.13 110.919 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.5 p -121.59 168.23 11.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 74.3 110.82 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.39 22.66 2.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 71.12 112.478 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -113.38 140.75 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 74.13 111.123 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.54 120.04 39.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 74.2 111.185 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.4 tp -106.22 149.99 26.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.912 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -156.92 162.91 39.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 75.35 110.866 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.27 140.34 29.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 75.34 110.909 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -103.5 112.42 25.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 74.15 110.916 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.8 p90 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.52 110.903 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.536 -0.226 . . . . 74.31 112.536 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -121.61 -176.4 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 74.4 110.921 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -121.9 108.26 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.54 111.103 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.03 149.34 52.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 75.01 110.927 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 1.4 tppm? -163.55 -75.34 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.928 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.578 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -62.27 155.11 25.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 71.43 110.903 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.7 t-20 89.03 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.03 110.834 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.2 m -121.67 121.01 28.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 74.1 111.144 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 153.57 68.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.266 . . . . 72.42 112.326 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.4 t -84.48 114.49 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 75.3 111.152 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 p -86.69 167.89 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 63.4 110.862 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 39.75 55.76 2.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 61.43 110.855 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mt -58.9 -175.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 75.14 110.884 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.9 p -141.76 138.33 32.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.101 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.96 55.17 0.7 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 73.21 112.477 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -75.84 140.44 42.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 70.11 110.86 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -26.9 5.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 70.22 110.884 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.23 -61.43 0.48 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 71.44 112.455 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -58.16 144.42 40.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 71.25 110.893 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -138.99 170.7 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 70.2 110.845 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.61 135.55 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 73.33 111.118 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -138.23 154.16 49.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.02 110.886 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -148.0 166.77 26.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.948 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 58.3 m -137.44 140.45 41.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 72.12 111.132 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -159.95 158.13 30.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 75.14 110.847 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.4 p -127.39 170.51 12.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 72.42 111.141 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.45 171.02 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 72.41 111.134 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.75 -66.57 0.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 70.13 110.898 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -127.08 149.73 49.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.879 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -51.02 117.04 2.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 65.22 110.837 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.95 145.12 34.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 63.14 111.095 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -104.77 106.67 17.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 73.11 111.181 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.29 147.23 47.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 73.25 111.111 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 p -107.51 112.32 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 75.42 111.179 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.8 t -127.5 139.77 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 63.33 111.152 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.462 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 9.9 p -134.68 166.41 22.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 70.43 110.866 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.04 146.41 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 72.33 111.115 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.3 t 177.9 161.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.894 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 165.42 -58.54 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 73.41 112.485 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.49 -120.57 4.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 54.14 112.479 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 m -103.99 161.85 13.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.378 . . . . 72.2 110.861 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.3 84.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.787 -0.72 . . . . 74.55 112.462 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.79 8.75 2.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.358 . . . . 73.54 110.859 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.32 120.12 35.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 74.43 111.067 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.74 143.75 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 72.12 110.849 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 tt -103.48 131.34 50.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 64.23 110.905 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -130.65 154.45 47.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 72.32 110.949 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.6 133.63 12.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 61.13 110.863 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -148.95 124.48 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.882 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.58 82.9 7.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 62.3 111.083 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.72 -82.51 0.19 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 54.11 112.508 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 m -109.08 136.92 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 73.35 110.83 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.64 126.01 2.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 74.13 110.919 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 142.58 48.25 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.723 2.282 . . . . 73.22 112.299 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.84 177.98 4.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 64.41 111.151 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.9 p -62.71 -16.78 58.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 74.33 111.094 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m -116.78 -26.24 7.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 72.01 110.823 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.94 124.11 47.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 72.24 110.845 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.61 153.38 33.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 73.45 110.907 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -107.85 -44.99 4.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.03 110.852 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.5 m -145.17 122.21 11.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 64.53 110.879 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -177.38 153.94 1.05 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.604 0.716 . . . . 75.24 110.885 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -163.67 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.705 2.27 . . . . 70.21 112.313 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -152.1 73.79 1.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 74.43 110.898 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -148.21 -163.23 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 73.24 110.843 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -47.5 -77.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 70.04 110.919 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.15 -89.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 60.21 112.49 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.14 160.91 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 74.14 110.928 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 63.94 16.76 10.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 71.23 110.923 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -127.25 100.09 5.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 74.32 110.872 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.462 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 4.9 m -136.77 173.13 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 74.52 110.894 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.71 150.53 38.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 74.41 110.904 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.4 p -126.09 109.86 12.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 74.21 110.878 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -150.75 148.73 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.54 111.134 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.27 102.37 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 73.23 110.848 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.7 151.42 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 72.31 111.056 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.69 145.72 31.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 71.23 111.088 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 162.78 40.7 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 65.42 112.347 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.07 -18.5 51.85 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.77 -0.728 . . . . 72.22 112.487 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.9 m -116.87 125.97 52.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 63.24 111.13 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -71.25 137.57 48.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 73.52 111.17 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -112.46 152.71 28.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 71.25 110.921 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -131.36 159.0 39.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 75.33 110.872 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.44 125.46 53.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 72.22 111.151 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.23 124.19 46.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 72.03 110.867 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mm -110.54 113.17 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.54 111.122 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.97 133.21 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 73.24 110.921 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.22 160.29 16.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 71.22 112.475 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -117.46 -29.79 5.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 73.21 110.953 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 91' ' ' ASN . 97.5 p -168.21 143.54 3.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 70.55 110.783 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' SER . 39.1 t30 -33.04 109.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.505 . . . . 74.35 110.893 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.6 111.69 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 65.55 110.893 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 p -121.67 159.68 26.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 74.45 110.876 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 120.4 22.24 3.17 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.699 -0.762 . . . . 74.45 112.476 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.13 146.22 18.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.921 0.391 . . . . 71.21 111.113 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.26 132.54 46.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 73.01 111.131 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.8 tp -121.45 148.79 43.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.899 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -155.07 170.04 22.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.853 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.407 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -90.65 140.85 29.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.03 110.896 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -103.1 108.64 19.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.53 110.889 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 73.45 110.932 -179.864 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.519 -0.232 . . . . 63.22 112.519 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -129.4 -176.98 4.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 71.5 110.931 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.1 m -117.7 108.39 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 74.33 111.093 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.98 148.89 52.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.939 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 17.8 tptt -164.0 -74.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.893 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 12.2 t-20 -65.87 156.66 32.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.31 110.937 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.5 t30 85.61 -69.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 73.24 110.913 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -119.34 120.84 30.6 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.565 0.697 . . . . 75.44 111.137 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 153.54 68.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.656 2.238 . . . . 72.5 112.372 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.4 t -84.05 115.34 26.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.158 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.05 162.07 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.876 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 40.52 65.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 75.35 110.838 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.13 -173.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 75.44 110.915 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 p -143.2 139.15 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 73.21 111.146 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.77 64.89 0.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.792 -0.718 . . . . 75.24 112.522 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.5 160.49 30.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 72.31 110.876 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 90' ' ' SER . 31.0 mmtp -44.87 -70.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.453 . . . . 65.25 110.909 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.6 -45.59 2.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.68 -0.771 . . . . 73.2 112.496 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.89 151.88 13.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.342 . . . . 75.21 110.849 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.53 -179.4 8.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 74.34 110.896 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.56 144.76 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 64.12 111.119 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -137.43 145.27 42.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.44 110.852 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -144.09 166.09 25.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 74.04 110.942 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 2.5 m -141.96 138.58 32.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 75.15 111.128 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 2.0 t80 -160.53 162.98 33.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 74.55 110.882 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -131.7 171.09 13.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 74.23 111.142 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.2 170.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 73.43 111.159 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -111.98 -39.31 4.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 53.23 110.848 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.95 157.87 45.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.43 110.886 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -79.93 116.45 20.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 72.13 110.891 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.98 142.86 32.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 71.4 111.122 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 t -99.17 107.84 20.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 72.22 111.105 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.08 147.23 45.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 74.51 111.098 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 p -107.87 111.37 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 71.23 111.165 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.8 t -127.83 140.33 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.35 111.13 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.493 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 2.0 p -132.36 167.16 20.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.854 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.402 HG23 HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -110.38 142.66 22.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 74.53 111.121 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 p -179.32 -169.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.84 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.13 -147.92 19.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 74.11 112.518 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.44 -48.12 31.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.704 -0.76 . . . . 72.04 112.496 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 m -107.05 163.96 12.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.368 . . . . 72.32 110.837 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.45 -130.5 2.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 55.21 112.455 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 60.04 30.21 19.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 74.44 110.863 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.56 108.38 14.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.04 111.069 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.0 144.58 54.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.853 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 tt -112.46 126.94 55.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.945 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -136.41 148.84 47.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 73.4 110.907 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.95 133.81 13.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 71.24 110.938 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -141.96 140.04 32.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.33 110.899 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.74 -48.45 13.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 72.23 111.148 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.61 -96.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 73.11 112.503 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -106.79 162.38 13.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.917 0.389 . . . . 71.24 110.828 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.12 128.35 5.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.575 0.702 . . . . 75.44 110.906 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 142.35 47.22 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.654 2.236 . . . . 73.43 112.305 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -113.42 179.77 3.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 70.21 111.15 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.5 p -60.96 -16.75 46.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 71.25 111.14 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -117.11 -26.03 6.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 74.04 110.848 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 124.94 49.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 73.32 110.862 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.34 152.97 31.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.92 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -114.76 -31.5 6.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 74.33 110.86 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.8 m -141.89 121.89 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.872 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.58 122.7 0.13 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.625 0.726 . . . . 72.13 110.855 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.437 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 53.6 Cg_endo -69.79 4.76 2.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.649 2.233 . . . . 61.02 112.325 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.409 ' CG ' ' C ' ' A' ' 63' ' ' PRO . 5.6 p90 38.73 72.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 73.32 110.945 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.49 -65.28 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 73.31 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.19 -166.39 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 75.3 110.911 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.14 -103.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 63.43 112.459 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -68.36 167.73 13.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 62.44 110.876 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.7 t30 64.13 14.61 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 61.41 110.914 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -126.88 98.1 5.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 75.32 110.876 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.493 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 3.5 m -135.81 171.43 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 71.44 110.862 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.83 150.86 38.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 72.45 110.907 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 p -128.47 108.48 10.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 73.3 110.873 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -151.08 148.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 75.54 111.163 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.28 106.37 6.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 71.21 110.876 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.33 145.25 29.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 70.3 111.03 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.19 139.38 21.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 50.24 111.087 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 133.56 25.9 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.708 2.272 . . . . 73.22 112.326 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.88 -20.06 2.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 75.22 112.462 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.2 m -126.51 134.95 50.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.371 . . . . 63.44 111.15 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.6 m -71.07 137.6 49.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 73.3 111.156 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -104.77 139.6 39.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 73.55 110.948 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -107.18 161.24 14.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 60.25 110.823 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.91 138.17 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 75.51 111.15 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.7 tpt -142.98 123.27 13.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 70.41 110.923 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 mm -118.95 112.15 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 71.22 111.094 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -95.77 157.18 16.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 75.41 110.924 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.34 145.95 16.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 75.14 112.467 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -112.16 -21.71 11.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 73.22 110.868 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 91' ' ' ASN . 7.1 p -165.74 127.97 2.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 73.3 110.877 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 90' ' ' SER . 9.1 t-20 -35.38 106.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 71.02 110.894 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.42 115.63 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.932 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 p -115.87 151.85 34.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 72.4 110.86 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.47 28.26 0.92 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 52.01 112.519 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.33 147.38 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 72.12 111.088 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.03 114.14 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 74.4 111.107 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 37' ' ' ILE . 1.7 tm? -104.25 132.78 50.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 75.45 110.935 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -144.18 163.72 32.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 71.23 110.832 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.405 ' HA ' ' HE3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -91.69 140.67 29.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 64.54 110.9 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.81 113.04 24.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.25 110.925 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.0 p90 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 74.32 110.953 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.481 -0.248 . . . . 60.32 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -90.88 -174.72 4.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 74.43 110.923 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 24' ' ' THR . 3.1 m -120.32 108.85 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.31 111.125 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.45 148.72 52.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.13 110.893 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.46 -69.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 64.11 110.859 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.574 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 8.6 t-20 -77.68 158.73 29.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 65.32 110.904 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.574 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.4 t30 88.38 -68.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.13 110.918 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.7 m -123.4 113.73 29.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.552 0.691 . . . . 75.2 111.129 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 53.4 Cg_endo -69.76 150.28 68.0 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 74.41 112.34 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.5 t -77.99 113.8 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 75.34 111.091 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.21 140.02 41.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 71.54 110.854 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.35 84.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 74.12 110.89 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -167.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 74.01 110.886 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 p -139.05 138.56 37.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.24 111.135 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.69 60.3 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 74.12 112.474 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -76.02 158.4 31.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 64.04 110.857 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -61.23 2.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.857 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.72 -50.63 1.94 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 75.41 112.503 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.74 140.63 14.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 73.41 110.88 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -141.19 170.46 15.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 71.54 110.859 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.29 137.06 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 64.44 111.161 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.25 152.27 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 64.41 110.899 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -143.34 165.56 27.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 73.32 110.934 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 3.2 m -135.24 139.07 44.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 75.14 111.125 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.01 162.58 34.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 71.54 110.863 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.4 p -136.72 171.04 15.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 73.33 111.154 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.407 ' HB ' ' CZ ' ' A' ' 101' ' ' TYR . 22.3 m -108.38 172.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.54 111.123 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.6 -57.61 2.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 64.05 110.865 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.19 140.43 51.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 74.11 110.859 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -48.78 118.87 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 65.15 110.906 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.39 131.15 27.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 72.25 111.125 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 t -94.68 106.58 18.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 75.02 111.146 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.09 147.77 40.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.03 111.052 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -113.9 109.24 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.13 111.157 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 t -130.95 141.19 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 74.15 111.153 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.487 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 29.1 p -129.12 167.68 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 75.23 110.873 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.96 147.18 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 72.22 111.132 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.22 163.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.41 110.914 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 176.08 -30.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.796 -0.716 . . . . 73.44 112.517 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.11 -117.2 1.1 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 65.42 112.496 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -113.93 161.3 17.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 63.22 110.858 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.04 126.08 29.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.503 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -170.81 -37.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.341 . . . . 72.2 110.905 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.12 128.59 46.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 62.41 111.104 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -102.45 124.49 48.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 75.01 110.905 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.11 130.1 37.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.257 -0.429 . . . . 63.4 110.865 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -132.58 148.89 52.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.899 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.34 142.79 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 72.22 110.858 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.91 117.72 5.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.926 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.52 123.92 20.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 64.4 111.115 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 -82.83 0.8 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 73.45 112.49 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.9 m -93.67 -179.19 4.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.952 0.406 . . . . 63.14 110.858 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 134.72 28.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 71.03 110.862 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 141.51 45.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 70.52 112.325 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -102.5 179.03 4.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 65.23 111.131 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.1 p -65.63 -13.7 59.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 73.41 111.145 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 m -121.36 -26.46 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.861 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.83 126.22 49.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 75.1 110.852 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.37 153.47 34.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 74.1 110.892 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -108.89 -29.11 8.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 75.53 110.844 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.9 m -136.93 124.0 21.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.88 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HG3' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -174.74 126.57 0.4 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.611 0.72 . . . . 73.54 110.904 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HD2' ' HG3' ' A' ' 62' ' ' ARG . 54.2 Cg_endo -69.77 -2.94 11.03 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.647 2.231 . . . . 71.14 112.363 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 70.15 92.18 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 75.12 110.916 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.94 -168.92 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 65.14 110.865 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.57 128.1 36.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.15 110.925 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.95 -178.75 36.34 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 74.41 112.488 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -172.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.803 0.335 . . . . 72.31 110.873 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.2 t30 63.94 19.63 11.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 73.41 110.862 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -123.16 88.74 2.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 75.02 110.907 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.487 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -132.23 170.16 15.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 74.01 110.852 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.24 154.01 34.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 55.23 110.899 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.7 p -128.25 104.19 7.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 74.04 110.834 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -152.22 152.73 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 72.52 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.1 p -84.32 104.39 14.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 75.03 110.884 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.68 154.72 25.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 74.41 111.066 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.39 139.71 20.42 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.629 0.728 . . . . 74.21 111.086 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 140.03 41.62 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 75.44 112.328 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.26 -6.18 9.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.751 . . . . 73.25 112.51 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.5 m -126.41 129.6 49.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 73.21 111.127 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.2 m -72.46 136.86 46.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 62.33 111.139 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -111.88 134.44 53.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.936 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -106.07 162.76 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 62.41 110.863 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.79 140.0 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 60.23 111.129 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.13 121.07 14.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.894 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.8 mm -111.16 113.13 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 74.42 111.131 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 135.62 41.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 72.14 110.914 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.38 157.24 15.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.757 . . . . 61.05 112.486 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -117.12 -28.04 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.946 0.403 . . . . 73.21 110.904 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 91' ' ' ASN . 73.2 p -166.88 136.06 2.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 75.5 110.882 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 90' ' ' SER . 3.1 m120 -31.75 105.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 64.25 110.866 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -162.78 113.07 1.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 73.54 110.942 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.7 p -121.51 159.83 25.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 74.14 110.851 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.03 19.46 2.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.747 . . . . 74.21 112.532 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.42 141.45 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 72.4 111.169 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.7 m -99.32 122.84 43.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 73.04 111.141 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.2 tp -102.04 142.7 32.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.877 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -151.22 153.0 34.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 75.24 110.946 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.493 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -88.52 140.85 29.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.32 110.895 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -93.9 113.66 25.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 74.05 110.889 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.407 ' CZ ' ' HB ' ' A' ' 27' ' ' VAL . 4.9 t80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 71.33 110.959 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.503 -0.239 . . . . 63.24 112.503 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -104.72 -176.34 3.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 64.31 110.93 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.1 m -117.47 109.42 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 73.21 111.113 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.48 148.48 52.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 73.22 110.95 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 15.4 tptm -164.74 -65.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 71.42 110.914 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 8.4 t-20 -77.92 155.74 30.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 74.04 110.869 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 10.3 t-20 87.2 -68.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 74.35 110.867 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.5 m -121.5 120.89 28.64 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.594 0.712 . . . . 74.53 111.138 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB3' ' HD3' ' A' ' 98' ' ' LYS . 53.7 Cg_endo -69.83 153.82 68.17 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.695 2.263 . . . . 73.43 112.327 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.6 t -83.21 115.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 73.25 111.076 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.07 142.25 31.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 75.32 110.864 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.28 86.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 74.21 110.906 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.88 -171.97 3.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 73.43 110.884 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 p -139.41 139.47 37.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 74.31 111.162 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.45 69.99 0.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 73.21 112.507 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -76.42 153.55 35.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 74.55 110.865 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.4 -34.29 23.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.879 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.66 -52.72 0.25 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 53.14 112.477 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 t -52.56 168.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 72.31 110.817 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.84 175.6 3.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 74.24 110.893 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.31 144.67 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 74.44 111.096 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -136.91 128.14 28.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 73.11 110.87 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -127.45 164.64 21.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 75.12 110.895 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.406 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 2.4 m -141.06 143.42 34.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 72.21 111.14 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -160.27 163.33 33.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 74.21 110.878 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 p -132.5 170.31 15.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 65.03 111.117 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.6 m -109.2 167.47 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 72.42 111.12 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -97.43 -48.59 5.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.51 110.852 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 165.31 27.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 73.53 110.873 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -56.7 117.91 4.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.868 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.54 120.91 12.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 75.04 111.09 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 t -98.33 105.55 17.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 73.54 111.108 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.38 147.5 45.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 74.5 111.099 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -108.49 110.6 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 62.15 111.137 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.3 141.11 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 64.01 111.12 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.472 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.62 166.49 17.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 74.54 110.851 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.44 147.33 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 74.43 111.168 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.93 172.09 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 71.11 110.85 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.38 -22.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.764 -0.732 . . . . 75.15 112.512 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.53 -104.01 0.23 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 52.1 112.485 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.3 m -130.17 155.1 46.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.953 0.406 . . . . 75.4 110.896 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -50.88 122.18 13.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 64.22 112.464 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -161.28 -38.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.833 0.349 . . . . 63.44 110.885 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.06 124.9 45.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.14 111.046 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.7 152.02 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 61.53 110.887 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tt -106.93 127.02 53.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 64.34 110.894 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -136.49 142.61 43.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.934 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -154.12 135.7 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 72.41 110.914 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -140.81 121.56 14.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.939 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.35 77.54 9.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.23 111.082 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.72 -59.98 0.3 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 62.31 112.454 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -142.21 141.78 32.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 55.4 110.834 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.73 120.15 1.4 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.574 0.702 . . . . 74.34 110.899 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 143.4 51.19 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.68 2.254 . . . . 60.2 112.38 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.35 178.31 4.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 72.32 111.138 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.0 p -61.48 -17.32 54.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 72.42 111.135 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 t -114.14 -26.86 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.844 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.86 123.49 47.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 72.25 110.891 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.23 153.58 32.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 74.53 110.945 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -110.71 -33.51 6.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.886 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.2 m -134.12 123.23 24.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 53.11 110.893 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -179.58 126.16 0.24 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 73.45 110.887 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 64' ' ' TYR . 53.8 Cg_endo -69.73 -5.9 17.29 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.74 2.293 . . . . 65.5 112.352 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' PRO . 19.7 p90 38.08 42.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 75.15 110.903 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.89 -34.32 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 75.55 110.895 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 178.38 -177.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 64.23 110.962 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.66 -106.42 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 70.3 112.497 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.42 160.67 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 74.35 110.872 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 67.11 13.59 9.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 74.32 110.836 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.05 101.97 6.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 73.55 110.844 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.472 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 10.6 m -133.75 175.02 9.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 73.24 110.876 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.66 158.76 24.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 65.42 110.916 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.64 113.89 16.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.863 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 t -146.38 158.37 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 73.21 111.143 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.9 p -78.33 129.63 35.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 63.33 110.845 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 101' ' ' TYR . . . -78.9 151.54 31.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 73.13 111.051 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.05 121.57 18.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.556 0.693 . . . . 63.2 111.117 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 115.78 4.25 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.694 2.262 . . . . 74.54 112.331 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.96 -11.62 3.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 74.24 112.475 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.3 m -126.18 127.31 45.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.885 0.374 . . . . 73.25 111.092 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.9 m -70.71 137.52 49.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 75.44 111.168 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -106.02 133.41 50.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 71.23 110.953 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -104.74 161.18 14.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 71.13 110.813 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.414 HG21 ' HD3' ' A' ' 5' ' ' LYS . 2.8 t -137.9 138.05 44.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 70.2 111.131 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -138.29 122.21 17.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 64.45 110.851 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.8 mm -114.1 112.28 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 72.33 111.088 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.64 140.29 40.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 75.12 110.896 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -114.85 156.06 15.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.753 . . . . 72.24 112.464 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -114.34 -21.54 10.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.897 0.38 . . . . 71.13 110.921 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -161.35 128.2 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 64.13 110.874 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 90' ' ' SER . 15.2 t-20 -31.61 106.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 75.54 110.912 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -157.65 112.81 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 75.31 110.883 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 p -121.37 154.58 36.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.509 . . . . 63.11 110.835 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.46 20.88 2.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.716 -0.754 . . . . 75.24 112.492 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.26 147.23 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 74.12 111.177 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m -97.61 121.97 40.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 70.33 111.138 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.72 125.16 53.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 71.22 110.946 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.422 ' HD3' ' HB3' ' A' ' 9' ' ' PRO . 8.5 ttpt -133.94 167.03 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 75.21 110.86 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.99 137.16 32.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.908 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.455 ' O ' ' CG ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -100.19 108.66 20.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 72.03 110.942 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' A' ' 100' ' ' GLN . 6.4 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.24 110.912 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.496 -0.241 . . . . 74.1 112.496 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -104.76 -175.82 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 75.15 110.918 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.7 m -116.52 108.2 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 74.33 111.142 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.65 149.14 52.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.31 110.907 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 19.8 tptm -164.05 -71.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 74.43 110.846 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 10.1 t-20 -68.32 157.8 34.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 74.04 110.912 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.3 t30 86.72 -68.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 70.14 110.943 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.5 m -125.15 119.68 25.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.537 0.685 . . . . 75.35 111.161 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HB3' ' HD3' ' A' ' 98' ' ' LYS . 54.3 Cg_endo -69.75 150.64 68.52 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.679 2.252 . . . . 74.45 112.372 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.99 115.77 20.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 71.41 111.119 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.59 143.9 31.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 64.44 110.835 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.23 80.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.13 110.879 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.55 -172.77 1.93 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.477 . . . . 74.5 110.938 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 p -132.74 138.39 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.1 111.102 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.33 53.71 0.75 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.775 -0.726 . . . . 75.24 112.502 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -76.27 140.97 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 73.33 110.9 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -28.38 6.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.917 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.82 -64.61 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 63.31 112.443 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -52.22 134.14 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 65.45 110.844 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -131.21 172.58 11.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 74.52 110.894 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.22 138.53 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 75.23 111.109 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -136.66 147.08 46.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 73.31 110.894 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -143.59 164.82 29.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.926 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.431 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -138.28 139.77 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.18 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -159.53 162.8 35.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.855 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -133.1 171.11 14.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 75.03 111.131 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -108.3 169.28 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.43 111.181 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -98.37 -48.86 4.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.898 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.67 173.34 11.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 74.44 110.841 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -80.0 117.2 20.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 74.13 110.913 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.11 144.59 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 72.05 111.086 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.3 t -104.59 106.4 16.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.425 . . . . 65.34 111.18 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.93 147.79 46.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.15 111.095 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.11 111.81 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 73.45 111.113 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.75 140.83 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 71.22 111.097 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.477 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 10.7 p -133.31 166.5 22.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 72.44 110.849 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.81 144.58 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 75.11 111.161 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.98 -174.99 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 72.32 110.901 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.21 -127.17 1.83 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.75 -0.738 . . . . 62.23 112.523 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.09 -23.84 9.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 70.4 112.487 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.1 p -130.66 163.93 26.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 72.43 110.849 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.02 -135.33 4.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.729 . . . . 72.11 112.532 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 69.5 22.74 6.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.847 0.356 . . . . 64.34 110.861 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.48 114.75 26.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 63.44 111.115 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.11 135.67 36.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 71.32 110.891 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.6 tt -102.34 126.84 49.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 74.32 110.893 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -134.61 149.0 50.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 75.24 110.91 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.14 133.32 11.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 71.32 110.954 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -144.86 123.42 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.4 110.851 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.36 71.59 7.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.1 111.116 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.46 -83.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 75.1 112.481 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -110.54 141.57 43.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.365 . . . . 74.0 110.917 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.19 121.85 3.15 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.609 0.719 . . . . 74.25 110.864 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 142.49 48.1 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.712 2.275 . . . . 74.5 112.335 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -109.66 178.74 4.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 65.42 111.142 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.1 p -60.07 -17.7 41.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.159 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 t -114.8 -26.3 7.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.32 110.85 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.86 124.19 47.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 64.24 110.847 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.99 153.22 32.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.105 -0.498 . . . . 75.24 110.909 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -115.67 -35.33 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 72.42 110.856 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.8 m -143.76 125.12 14.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 73.04 110.854 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' C ' ' H ' ' A' ' 64' ' ' TYR . 1.4 ptt-85 179.65 157.08 0.72 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.658 0.742 . . . . 75.24 110.824 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 33.17 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.661 2.24 . . . . 70.51 112.321 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 62' ' ' ARG . 0.1 OUTLIER 41.3 40.5 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.919 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.68 -176.2 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.932 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -128.74 153.57 47.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.931 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.19 140.93 6.2 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 60.4 112.496 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -51.12 169.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 75.44 110.851 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.77 14.14 9.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.959 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.88 105.67 7.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 73.3 110.909 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.477 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 13.0 m -136.59 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 62.51 110.831 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.03 153.75 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.41 110.846 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -128.24 110.28 12.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.901 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 t -149.31 153.11 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 73.35 111.119 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.4 p -73.3 110.85 7.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 72.25 110.854 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.4 130.79 35.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 75.12 111.103 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.33 139.23 20.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.59 0.709 . . . . 62.1 111.126 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 160.21 50.57 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.701 2.267 . . . . 75.25 112.328 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.5 -18.95 56.01 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.776 -0.726 . . . . 61.24 112.51 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 m -111.94 122.84 48.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.87 0.367 . . . . 72.22 111.163 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.4 m -71.24 136.27 47.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 72.41 111.152 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -103.76 141.68 35.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.928 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -107.36 160.75 15.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 75.32 110.837 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.19 138.36 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 73.34 111.108 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.89 122.98 13.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 71.42 110.88 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.0 mm -118.04 112.6 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.24 111.139 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -104.48 130.44 52.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.906 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.37 161.03 21.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 72.22 112.452 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.25 -28.59 5.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 72.5 110.923 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.51 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -166.56 132.64 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 73.42 110.817 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 90' ' ' SER . 1.5 p-10 -28.35 115.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 72.55 110.878 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.4 113.85 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.41 110.94 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 p -121.55 156.59 32.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 72.42 110.847 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.02 23.12 1.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 75.43 112.489 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.04 145.98 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.962 0.41 . . . . 75.31 111.098 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.7 m -99.29 114.73 27.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 72.34 111.137 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.69 125.58 50.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 75.41 110.931 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.408 ' HD3' ' HB3' ' A' ' 9' ' ' PRO . 5.1 ttpt -133.41 165.09 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 74.54 110.934 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 138.5 31.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.41 110.92 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -98.87 112.84 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 75.54 110.93 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.9 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 60.53 110.929 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.494 -0.242 . . . . 72.23 112.494 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -133.09 -175.89 3.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 73.31 110.912 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.9 m -118.46 108.57 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 75.55 111.15 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.58 147.84 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 72.43 110.978 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 17.9 tptt -158.49 -39.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 75.2 110.871 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.593 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -108.24 158.1 17.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 72.41 110.95 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 5.9 t30 90.04 -68.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.34 110.883 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.4 m -126.34 113.83 23.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.576 0.703 . . . . 73.04 111.135 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.7 Cg_endo -69.78 153.51 68.76 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.658 2.239 . . . . 73.13 112.372 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.25 113.18 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 75.22 111.124 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.11 149.4 28.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 72.44 110.864 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.4 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.3 OUTLIER 47.33 66.59 0.97 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 74.51 110.86 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.05 -174.16 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 74.12 110.902 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 p -131.14 138.24 49.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 73.34 111.188 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.64 57.19 0.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 74.21 112.489 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -75.65 139.35 41.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 64.1 110.921 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -27.6 7.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.87 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.12 -60.63 0.5 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 73.4 112.479 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.84 140.68 51.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 63.13 110.872 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -135.85 170.26 16.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.915 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.46 139.11 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 75.24 111.111 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -137.01 145.17 43.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 74.51 110.886 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -142.09 165.84 26.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.923 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 51.9 m -146.12 142.12 28.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 72.23 111.148 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 6' ' ' ASN . 4.1 t80 -160.49 162.56 33.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 71.43 110.917 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.1 p -128.88 170.44 13.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 71.32 111.164 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.403 ' HB ' ' CZ ' ' A' ' 101' ' ' TYR . 15.9 m -108.12 173.26 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 74.3 111.146 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -110.44 -59.32 1.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.845 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.64 140.9 51.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 65.03 110.855 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -50.15 119.91 4.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 74.22 110.844 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.36 129.86 25.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.53 111.074 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.2 m -94.28 106.17 18.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 64.02 111.156 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.87 150.97 43.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.51 111.155 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.75 112.04 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 73.43 111.143 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 100' ' ' GLN . 5.3 t -127.17 141.79 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 71.34 111.1 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 8.0 p -142.09 171.45 14.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 75.4 110.87 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 pt -107.04 158.69 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 74.3 111.128 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.56 165.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 75.33 110.88 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.39 -87.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 64.44 112.524 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.86 -116.51 4.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.725 -0.75 . . . . 74.14 112.505 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 m -104.99 161.23 14.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 72.21 110.889 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.39 133.17 51.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 71.01 112.486 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.35 -38.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.804 0.335 . . . . 71.11 110.868 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.68 111.58 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 65.5 111.11 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -80.26 164.55 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 55.23 110.819 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 tt -124.18 138.43 54.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 73.01 110.879 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -152.63 133.58 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 75.44 110.932 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp -139.26 153.02 47.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 75.53 110.904 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -156.36 145.99 20.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 75.24 110.912 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.66 101.56 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 61.2 111.086 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.84 -92.98 0.75 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 41.14 112.517 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 m -82.83 129.26 34.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.994 0.426 . . . . 71.44 110.837 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.44 137.12 5.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.554 0.692 . . . . 74.24 110.912 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.73 51.74 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.672 2.248 . . . . 73.51 112.33 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -101.38 178.54 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 74.22 111.155 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 p -64.94 -14.39 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 75.4 111.16 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.5 t -120.31 -26.14 5.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 75.13 110.899 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.75 125.48 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 74.43 110.876 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.64 153.59 34.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.925 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -110.71 -23.17 11.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 64.41 110.821 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.0 m -143.64 122.71 12.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 64.21 110.867 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 177.9 117.26 0.18 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 74.11 110.903 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -18.07 37.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.671 2.247 . . . . 73.31 112.36 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.7 t80 62.62 87.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 73.04 110.916 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -132.41 -80.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 74.4 110.908 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.5 t80 177.38 107.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 74.13 110.948 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 49.69 -128.29 24.46 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 73.2 112.471 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.28 179.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 65.53 110.899 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.6 t30 53.79 27.9 7.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 70.33 110.923 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -131.15 81.27 1.98 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 64.25 110.876 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -132.51 170.75 14.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.877 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -119.28 156.91 29.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 74.01 110.898 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.0 p -128.94 106.77 9.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.13 110.87 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -151.75 153.25 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 75.12 111.12 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.8 p -84.93 107.68 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.888 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.09 154.9 25.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 74.01 111.077 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.17 138.57 19.56 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.549 0.69 . . . . 72.21 111.134 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 134.23 27.56 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.694 2.262 . . . . 71.15 112.388 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.9 -21.98 4.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 51.31 112.505 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -114.3 131.68 56.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 72.13 111.142 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.8 m -71.95 137.38 47.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 73.33 111.186 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -112.05 133.0 54.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 75.51 110.921 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -107.08 161.19 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 65.03 110.892 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -137.08 138.35 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 74.45 111.148 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 tpt -134.82 122.84 22.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.876 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.3 mm -112.5 116.01 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 74.31 111.134 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 145.54 29.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 71.32 110.864 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.45 151.74 18.23 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 71.42 112.457 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -107.33 -28.13 10.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 72.24 110.878 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.466 ' O ' ' C ' ' A' ' 91' ' ' ASN . 88.5 p -175.37 144.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 74.22 110.877 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 90' ' ' SER . 3.0 p30 -32.64 105.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.492 . . . . 63.41 110.942 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -166.77 118.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.31 110.897 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.9 p -122.01 160.82 24.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 61.33 110.852 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 12' ' ' ASN . . . 121.36 23.44 2.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 73.05 112.475 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.81 146.58 18.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.887 0.375 . . . . 72.54 111.156 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -106.86 135.06 49.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 72.34 111.146 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.438 ' CD1' ' C ' ' A' ' 97' ' ' LEU . 2.5 tm? -118.58 128.03 54.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 64.43 110.866 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -138.12 154.65 49.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 75.43 110.929 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.433 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -87.3 145.1 26.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 73.32 110.904 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.487 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -94.86 112.98 24.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 72.44 110.978 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.403 ' CZ ' ' HB ' ' A' ' 27' ' ' VAL . 2.3 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.926 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.491 -0.244 . . . . 74.23 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -152.16 -173.34 4.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.834 0.349 . . . . 73.44 110.894 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m -121.77 109.16 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 70.42 111.135 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.27 149.01 52.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 72.42 110.916 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 99' ' ' LEU . 2.2 tppm? -155.73 -73.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.907 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.8 t-20 -64.22 158.66 22.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.874 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.6 t30 91.21 -68.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 73.55 110.886 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 m -132.71 121.79 17.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.576 0.703 . . . . 64.44 111.155 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 154.85 67.1 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 71.51 112.341 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.44 115.36 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 73.33 111.136 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.49 166.39 13.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 70.0 110.872 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 39.97 52.05 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 74.14 110.876 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 mt -57.84 -178.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 71.31 110.944 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 p -137.19 138.15 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 61.22 111.078 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.66 56.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.751 . . . . 35.25 112.493 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -74.79 150.96 39.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 74.54 110.902 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.71 -33.49 10.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.872 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.59 -57.84 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 75.42 112.496 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.77 139.04 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 72.11 110.863 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -139.01 175.01 9.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 75.04 110.907 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.97 135.65 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.34 111.158 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -138.87 149.81 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.2 110.902 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -145.96 166.36 26.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 74.54 110.929 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.5 m -138.75 138.91 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 65.51 111.142 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -160.94 153.17 20.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 74.44 110.915 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.9 p -127.92 170.44 12.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.15 111.14 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 101' ' ' TYR . 13.9 m -113.02 170.83 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 75.35 111.109 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.15 11.45 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 65.53 110.84 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.58 137.79 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 75.53 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -72.85 118.85 16.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.3 110.871 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.31 145.57 37.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 74.43 111.094 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -107.92 104.95 14.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 74.15 111.1 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 101' ' ' TYR . . . -139.57 149.1 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.35 111.117 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -113.63 111.85 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.113 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.01 140.86 47.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 70.55 111.078 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.497 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 6.0 p -124.86 166.74 15.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 60.04 110.826 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.21 151.07 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 74.04 111.136 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.53 168.0 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 72.42 110.866 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.77 -24.15 0.23 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 63.12 112.499 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.67 -120.01 1.28 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 62.02 112.457 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 m -119.41 162.46 18.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 54.13 110.85 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -50.29 103.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 63.42 112.515 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.01 -40.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 63.55 110.867 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.65 117.16 29.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 74.31 111.109 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -85.23 163.83 18.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 73.44 110.889 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tt -120.31 127.56 52.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.01 110.924 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -137.63 153.23 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 63.55 110.889 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 tt -154.34 140.46 18.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 75.31 110.923 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.17 141.55 25.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 75.21 110.923 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.35 126.97 35.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 74.31 111.11 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.85 -61.02 0.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 65.21 112.527 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.75 -173.03 2.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.955 0.407 . . . . 73.13 110.837 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 134.13 30.56 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.566 0.698 . . . . 73.25 110.925 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 143.38 50.82 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.708 2.272 . . . . 74.12 112.32 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 p -104.49 178.71 4.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 74.14 111.123 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.9 p -64.03 -15.14 58.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 70.25 111.168 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.0 m -119.84 -26.06 5.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.864 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.11 126.08 48.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 72.11 110.843 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.99 154.03 36.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 75.13 110.888 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -115.88 -34.52 4.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 72.05 110.864 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.2 m -145.39 124.42 12.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 72.42 110.886 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.16 150.18 1.23 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 74.45 110.921 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 -5.72 16.87 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.714 2.276 . . . . 74.43 112.318 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 69.62 68.32 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.926 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -172.96 -173.92 1.02 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 65.01 110.861 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -135.36 137.65 42.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.44 110.924 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.65 162.66 21.43 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.742 -0.742 . . . . 73.55 112.432 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.1 179.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.339 . . . . 61.43 110.918 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.99 16.06 9.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 65.31 110.873 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -127.44 96.88 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 72.13 110.87 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.497 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.4 m -134.78 170.73 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 70.45 110.91 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.79 162.62 19.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 71.35 110.863 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.37 111.62 12.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 75.21 110.886 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.7 t -149.11 153.65 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 72.01 111.171 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.3 p -94.28 105.74 17.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 65.44 110.913 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.39 152.19 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 75.54 111.08 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.21 142.73 26.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.572 0.701 . . . . 71.02 111.119 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 120.57 7.33 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 73.52 112.308 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.6 -19.94 0.9 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 44.1 112.465 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 m -122.76 136.57 54.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.372 . . . . 73.54 111.11 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.5 m -71.77 138.02 48.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 72.44 111.109 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.435 ' CD2' ' OH ' ' A' ' 101' ' ' TYR . 76.8 m-85 -118.3 142.84 47.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.927 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -121.94 160.76 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 74.21 110.88 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 t -133.45 125.31 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.54 111.173 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.65 128.98 55.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 71.32 110.886 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.0 mm -118.41 114.01 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 73.03 111.128 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.15 150.17 21.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 75.4 110.897 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -112.16 160.75 13.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 74.43 112.481 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -119.0 -24.56 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.918 0.389 . . . . 73.25 110.955 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 91' ' ' ASN . 52.1 p -176.77 144.13 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 72.53 110.87 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 90' ' ' SER . 42.4 t30 -32.69 106.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 74.31 110.893 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -166.54 115.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 74.32 110.903 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.1 p -121.76 155.35 35.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 63.45 110.838 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.05 26.74 1.82 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 71.44 112.508 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.91 139.62 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 74.33 111.122 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.58 114.89 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 61.42 111.153 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.412 ' CD1' ' C ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -105.13 128.64 53.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 73.02 110.909 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -133.34 171.2 14.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 73.12 110.91 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.534 ' HG ' ' CD1' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -88.14 137.47 32.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 71.45 110.952 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.467 ' C ' ' HD1' ' A' ' 101' ' ' TYR . 1.8 pp0? -108.76 112.58 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 70.4 110.908 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.534 ' CD1' ' HG ' ' A' ' 99' ' ' LEU . 5.1 m-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 74.55 110.946 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.444 -0.262 . . . . 71.34 112.444 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -134.47 -177.49 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 74.41 110.883 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 m -118.15 109.49 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.14 111.128 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.32 147.61 52.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.932 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -158.78 -69.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 74.23 110.895 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 17.0 t-20 -76.08 158.23 32.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.91 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.0 t-20 88.58 -68.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 72.52 110.902 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 m -125.28 115.02 25.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.599 0.714 . . . . 73.23 111.143 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.5 Cg_endo -69.76 150.24 67.97 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.663 2.242 . . . . 74.34 112.331 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.6 113.51 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 74.54 111.095 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.7 147.8 30.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 64.53 110.859 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.66 64.36 1.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 72.51 110.932 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 tp -58.95 -175.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 72.01 110.897 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 p -136.09 139.29 42.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 75.34 111.128 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.83 60.48 0.58 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 74.41 112.458 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -76.48 138.71 40.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.896 0.379 . . . . 62.32 110.925 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -29.1 8.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 75.03 110.902 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.13 -62.08 0.46 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 65.13 112.49 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.6 m -60.67 151.44 29.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.887 0.375 . . . . 75.42 110.807 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.31 179.4 8.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 71.51 110.904 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.71 149.18 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 64.42 111.109 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -136.78 134.85 37.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 73.35 110.853 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.9 165.48 25.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 73.54 110.931 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.3 m -147.92 141.72 25.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.497 . . . . 74.04 111.154 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -159.34 163.28 35.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.89 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 p -131.41 170.98 13.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 70.32 111.186 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.91 169.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 74.34 111.131 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -108.42 -47.1 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 64.12 110.855 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -129.73 155.47 45.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.897 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -77.42 115.7 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 74.23 110.859 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.45 145.89 34.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 73.34 111.108 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 t -99.25 107.31 19.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.32 111.121 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.06 148.8 47.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 71.22 111.099 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.9 p -105.78 111.07 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 75.11 111.169 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.9 t -127.06 140.4 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 75.2 111.15 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 0.1 OUTLIER -139.6 169.02 18.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 72.15 110.873 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 pt -110.14 159.36 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 72.33 111.165 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 171.17 167.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.889 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.49 -31.68 0.43 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 75.24 112.49 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -150.1 -117.97 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 74.22 112.496 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.82 160.82 15.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 73.51 110.865 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.47 99.38 0.58 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.736 . . . . 54.42 112.49 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -132.92 -38.96 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.825 0.345 . . . . 72.54 110.838 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.494 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -90.44 123.88 34.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 72.21 111.119 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -80.35 147.31 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.879 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.49 127.08 55.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 70.42 110.932 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.73 148.56 44.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 75.44 110.932 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.15 132.93 12.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 74.31 110.882 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -144.71 131.12 19.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 74.15 110.894 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.53 -66.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 72.51 111.128 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -45.36 -90.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 71.44 112.49 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.18 -168.59 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 74.23 110.895 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 132.88 87.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 74.2 110.887 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.495 ' HB3' ' HG3' ' A' ' 49' ' ' LYS . 53.6 Cg_endo -69.75 140.71 43.39 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 70.43 112.351 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.18 178.75 4.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 71.22 111.146 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -66.41 -13.1 60.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 75.21 111.173 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -124.08 -25.97 4.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.87 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.52 124.37 47.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 74.21 110.868 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.73 153.87 33.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.489 . . . . 74.11 110.896 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -102.02 -31.75 10.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 72.14 110.885 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.8 m -140.24 122.67 16.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 74.05 110.876 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -176.11 134.44 0.44 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 71.4 110.854 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -9.12 25.32 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.634 2.223 . . . . 73.15 112.341 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 63.84 100.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.921 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -178.94 -31.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 75.52 110.856 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.5 t80 72.2 125.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 75.32 110.888 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.74 158.07 18.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 72.51 112.523 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.494 ' ND2' ' H ' ' A' ' 44' ' ' ALA . 41.6 m-80 -53.83 176.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.36 . . . . 71.34 110.896 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 61.5 28.03 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.915 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.65 89.92 2.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 75.05 110.877 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -129.05 172.6 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 60.31 110.883 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.19 162.07 18.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.119 -0.491 . . . . 74.42 110.881 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 p -128.51 109.14 11.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 55.02 110.847 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.98 152.99 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 74.34 111.114 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.8 p -80.53 113.82 18.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.839 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.29 131.04 35.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 63.13 111.091 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.74 136.49 22.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.594 0.711 . . . . 74.31 111.077 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 124.92 11.55 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 73.11 112.355 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.73 -18.55 2.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 73.31 112.516 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.7 m -125.6 131.51 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 71.13 111.149 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.8 m -72.44 137.63 46.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 73.54 111.149 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -107.81 131.65 54.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 70.11 110.957 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -107.14 158.96 16.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 71.4 110.867 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.8 t -137.71 138.17 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 74.45 111.157 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.3 tpt -129.03 121.54 28.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 72.22 110.847 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.3 mm -109.63 114.41 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.33 111.158 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 87' ' ' LYS . 9.5 mmmm -109.12 139.86 43.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 73.31 110.915 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.88 150.05 16.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 75.13 112.46 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -117.81 -17.07 9.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.878 0.37 . . . . 75.33 110.946 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -177.89 129.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 72.11 110.867 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 90' ' ' SER . 54.5 t-20 -29.62 109.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 74.11 110.844 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -166.5 112.72 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 74.03 110.925 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.1 p -120.71 166.42 13.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 54.55 110.844 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.9 23.07 4.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.747 -0.739 . . . . 60.33 112.471 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.6 t -113.29 148.34 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 74.01 111.107 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.3 m -106.68 126.17 51.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 71.32 111.161 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 tp -108.4 135.13 50.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.896 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -144.79 154.63 42.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.884 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.457 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -88.7 144.65 26.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 71.53 110.906 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.481 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -94.13 112.85 24.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 73.53 110.88 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.0 p90 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 70.23 110.947 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.48 -0.248 . . . . 74.21 112.48 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -111.95 -178.6 3.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.895 0.379 . . . . 74.55 110.884 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.94 107.96 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 74.03 111.138 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.34 149.0 51.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.31 110.905 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 13.4 tptt -174.65 -74.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 62.01 110.921 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.419 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -70.13 153.17 43.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 72.24 110.858 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.2 t30 78.07 -58.88 0.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 64.31 110.906 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.5 m -122.75 119.32 28.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.615 0.722 . . . . 74.25 111.125 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 137.93 36.7 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.701 2.267 . . . . 72.44 112.357 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.4 t -77.27 114.93 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 75.24 111.17 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 p -87.62 163.2 16.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 63.14 110.859 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 40.18 64.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 74.35 110.888 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -164.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 72.3 110.911 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 p -147.4 136.73 22.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 71.44 111.145 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.4 67.17 0.47 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 75.3 112.452 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -76.05 135.49 39.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 72.24 110.912 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -30.64 23.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 72.45 110.944 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.34 -46.71 0.98 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 74.41 112.491 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.15 160.83 27.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 74.02 110.872 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -143.95 169.02 18.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 70.01 110.893 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.14 150.53 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.24 111.089 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -138.85 151.34 46.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.52 110.893 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -148.95 166.65 27.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 74.41 110.906 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.7 m -148.59 140.67 23.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 52.41 111.106 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -160.74 162.71 32.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 73.12 110.854 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.1 p -131.09 170.66 14.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 75.43 111.127 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.27 170.01 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 75.43 111.122 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.46 -50.8 3.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 71.32 110.849 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 167.12 21.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.925 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -80.19 115.52 19.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 70.04 110.911 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.2 141.91 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 70.31 111.12 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.9 t -94.7 106.28 18.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 74.32 111.149 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.26 149.21 45.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.24 111.127 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.49 112.56 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 73.41 111.145 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.9 t -123.72 140.52 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 74.32 111.078 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.501 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 11.6 p -139.97 165.48 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 64.34 110.868 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -111.77 154.64 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 73.22 111.124 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -167.51 153.11 7.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.4 110.827 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 95' ' ' VAL . . . -155.98 -154.37 6.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 74.21 112.529 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -122.42 -53.38 0.21 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 60.11 112.495 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 p -103.86 154.76 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.382 . . . . 74.32 110.893 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 58.42 172.79 0.38 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 63.25 112.48 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.77 110.98 7.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 53.21 110.861 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.42 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . . . -89.54 131.53 35.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 71.11 111.119 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.52 133.33 35.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 72.44 110.906 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tt -92.93 138.14 31.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 75.54 110.87 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -152.42 143.04 22.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.947 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.68 146.68 26.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 72.5 110.929 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.05 112.12 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 75.11 110.904 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.35 119.35 7.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 75.35 111.121 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.21 -81.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.734 . . . . 73.22 112.485 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.6 p -99.14 -174.28 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.965 0.412 . . . . 74.35 110.83 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.58 133.76 27.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.692 . . . . 73.44 110.892 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 141.69 45.72 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.711 2.274 . . . . 61.25 112.293 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 p -102.29 178.96 4.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 74.53 111.124 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 p -65.24 -14.39 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 75.11 111.163 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.2 m -120.03 -26.68 5.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 72.2 110.879 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.07 126.38 50.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 73.43 110.832 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.15 154.02 36.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 74.35 110.939 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.43 -31.86 6.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.423 . . . . 73.22 110.819 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.7 m -142.06 123.14 14.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 73.11 110.853 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 64' ' ' TYR . 1.2 ttt-85 176.44 134.48 0.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.562 0.696 . . . . 75.54 110.904 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 23.69 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.268 . . . . 73.2 112.346 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.522 ' H ' ' C ' ' A' ' 62' ' ' ARG . 0.2 OUTLIER 50.84 72.91 0.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 75.44 110.921 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.66 -171.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 75.41 110.905 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.09 -175.94 3.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 74.11 110.935 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.1 160.3 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 73.2 112.52 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -57.01 -176.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 61.44 110.893 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 66.33 10.63 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.902 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.47 91.33 3.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 70.41 110.912 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.501 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -133.8 171.66 13.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 73.35 110.853 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.45 157.94 27.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 64.41 110.877 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 p -128.41 109.57 11.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 73.35 110.867 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.8 t -150.13 152.82 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 73.12 111.133 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 85.6 p -74.1 104.57 4.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 75.2 110.826 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.27 131.41 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 71.33 111.105 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.92 142.25 24.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.561 0.696 . . . . 62.42 111.139 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 162.06 43.52 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.741 2.294 . . . . 73.22 112.343 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.14 -21.69 42.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.792 -0.718 . . . . 74.23 112.488 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -106.77 123.63 48.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 65.22 111.146 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 m -71.49 135.0 46.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 73.51 111.134 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -108.68 133.69 52.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.905 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -109.17 147.79 31.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 73.33 110.855 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -123.54 138.81 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 73.45 111.136 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.81 122.41 25.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.858 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.5 mm -114.83 111.65 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 74.24 111.115 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 -65.11 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.907 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 44' ' ' ALA . . . 114.39 -146.84 18.76 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 73.33 112.482 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -175.78 -57.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.898 0.38 . . . . 75.24 110.932 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' ASN . 3.0 p -144.85 128.0 16.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 73.44 110.865 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 90' ' ' SER . 34.6 t30 -33.86 104.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 74.44 110.919 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.15 139.46 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.905 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.4 p -122.52 157.22 32.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 74.23 110.85 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 135.95 25.31 0.49 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.761 -0.733 . . . . 63.11 112.504 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.47 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.3 t -113.64 147.35 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.925 0.393 . . . . 72.22 111.098 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.428 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 1.3 m -106.17 112.81 26.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 73.04 111.181 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.2 tp -102.91 142.56 33.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 72.24 110.936 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -153.74 161.99 41.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 73.15 110.865 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.41 143.81 26.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.23 110.929 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.496 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.31 110.88 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 71.23 110.883 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.9 p90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 74.55 110.963 -179.897 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.508 -0.237 . . . . 64.25 112.508 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.51 -174.21 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 75.14 110.88 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 24' ' ' THR . 1.8 m -115.12 109.19 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.14 111.115 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.14 148.34 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 74.54 110.923 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 1.7 tppm? -165.19 -74.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.919 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -63.96 155.18 31.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 73.14 110.893 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.2 t-20 88.23 -61.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 70.35 110.886 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 m -130.09 120.38 19.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 73.1 111.185 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 153.38 68.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 51.24 112.341 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -85.22 114.23 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 75.34 111.188 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 p -88.69 167.45 13.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 63.31 110.856 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 p30 40.5 53.23 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 72.41 110.87 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.75 178.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 73.31 110.905 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -135.37 138.08 42.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.35 111.112 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.47 68.91 0.53 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.759 . . . . 75.22 112.477 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -76.42 138.43 40.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 73.0 110.897 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -17.11 38.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 72.12 110.874 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.15 -41.44 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.805 -0.712 . . . . 64.14 112.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 m -90.68 168.66 11.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 73.55 110.929 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.0 -176.37 5.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 71.35 110.933 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.87 144.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.072 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -138.5 149.63 45.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 74.4 110.875 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -147.9 166.52 27.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 74.5 110.941 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 63.4 m -143.76 139.46 29.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 74.44 111.16 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -159.27 160.55 35.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 73.31 110.895 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.9 p -129.88 171.76 12.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 74.35 111.114 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.2 m -106.61 170.63 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 73.23 111.094 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -113.03 -41.58 3.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 74.22 110.888 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 158.6 39.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 73.54 110.851 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -80.53 115.2 19.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 75.54 110.842 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.19 140.3 30.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 53.35 111.119 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 t -95.71 105.93 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 74.33 111.127 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.97 148.58 45.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 75.21 111.143 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 p -106.63 111.47 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 74.11 111.116 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.91 140.14 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 75.45 111.138 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.502 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 92.9 p -142.72 167.72 21.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 61.05 110.831 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -108.87 144.14 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 71.45 111.114 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p -178.01 166.77 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 74.45 110.871 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.55 -23.28 0.22 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.761 -0.733 . . . . 74.11 112.484 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.08 -107.46 0.58 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.705 -0.759 . . . . 73.34 112.447 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -120.65 143.58 48.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 72.54 110.927 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.59 92.41 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.766 -0.73 . . . . 74.2 112.472 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -127.82 -37.58 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 55.23 110.883 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.81 110.65 21.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 65.44 111.106 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -72.44 155.55 39.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 71.22 110.886 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.55 138.28 52.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 74.54 110.938 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -146.7 146.14 30.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.919 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.26 152.68 47.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 75.1 110.903 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -153.35 115.71 4.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 75.13 110.874 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.27 120.97 13.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 63.21 111.075 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.82 -76.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 75.43 112.452 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 t -107.82 -179.53 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 73.34 110.853 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.02 133.68 40.61 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.553 0.692 . . . . 74.22 110.917 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 143.92 52.15 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 71.41 112.339 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.19 179.03 4.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 72.34 111.148 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -67.79 -12.46 60.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 74.4 111.184 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 m -120.96 -28.28 4.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 70.34 110.885 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.19 124.01 48.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 73.15 110.817 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -152.86 153.99 34.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 72.43 110.941 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -107.15 -35.29 6.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 70.41 110.888 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.5 m -127.9 123.92 36.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 52.25 110.853 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -175.22 120.39 0.33 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.658 0.742 . . . . 74.14 110.877 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' C ' ' CG ' ' A' ' 64' ' ' TYR . 53.2 Cg_endo -69.83 1.53 4.4 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.26 . . . . 75.55 112.357 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' CG ' ' C ' ' A' ' 63' ' ' PRO . 4.5 p90 38.52 85.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 75.54 110.923 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.06 -69.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 71.42 110.856 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -157.04 -172.56 4.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 75.52 110.909 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.44 -124.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 64.04 112.509 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -49.8 164.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 75.05 110.889 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 72.01 16.28 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.42 110.888 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.42 103.75 5.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 64.11 110.86 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.502 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 2.3 m -134.32 174.68 10.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 74.42 110.855 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.67 152.54 32.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 73.4 110.893 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 p -127.73 111.51 13.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 63.1 110.851 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 t -149.28 152.29 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 75.22 111.141 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.9 p -71.71 106.9 4.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 75.42 110.908 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.3 131.48 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 74.32 111.093 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.32 142.58 24.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.594 0.712 . . . . 75.44 111.07 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 126.37 13.24 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.747 2.298 . . . . 75.03 112.345 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.57 -27.13 3.41 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.711 -0.757 . . . . 72.41 112.467 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.4 m -106.53 124.64 49.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 71.21 111.135 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.2 m -71.55 138.06 48.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 74.15 111.108 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -112.15 150.5 30.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 71.23 110.901 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -131.56 145.16 51.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 73.03 110.873 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 t -121.96 133.59 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 73.11 111.092 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.8 133.54 50.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.41 110.832 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.31 134.53 62.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 75.11 111.133 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB3' ' OH ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -140.23 113.47 8.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 74.13 110.883 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.09 161.2 25.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 75.44 112.517 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.75 -29.18 13.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.889 0.376 . . . . 72.51 110.908 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.494 ' O ' ' C ' ' A' ' 91' ' ' ASN . 54.6 p -156.12 137.37 13.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 73.23 110.819 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 90' ' ' SER . 70.4 m-20 -30.32 109.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 71.42 110.907 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -160.42 118.8 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 63.3 110.911 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.8 p -122.71 156.43 34.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.853 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.08 23.76 2.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 53.22 112.525 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.99 147.08 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.901 0.381 . . . . 75.02 111.148 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.421 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -105.23 124.75 50.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 71.51 111.115 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . 0.7 OUTLIER -116.07 143.03 46.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 72.1 110.958 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -149.27 168.69 22.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.23 110.867 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.423 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -91.03 142.69 27.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.951 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.502 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.51 111.52 23.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 74.21 110.912 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 25.9 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 71.04 110.913 -179.873 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.455 -0.258 . . . . 73.13 112.455 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -156.45 -176.21 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 72.45 110.939 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 24' ' ' THR . 3.5 m -123.57 109.02 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.43 111.138 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.18 150.18 52.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 75.24 110.903 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.46 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -155.56 -77.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.863 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.9 t-20 -66.22 159.2 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 62.23 110.865 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.5 t-20 89.59 -70.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 65.02 110.859 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -133.35 118.32 14.86 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.556 0.694 . . . . 72.34 111.143 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 54.1 Cg_endo -69.81 155.86 64.71 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.688 2.259 . . . . 74.31 112.324 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.8 t -75.56 112.43 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 74.05 111.099 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -82.08 163.63 21.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 74.21 110.883 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 39.82 57.14 2.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 75.03 110.922 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 tp -57.93 -173.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 71.51 110.931 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 p -145.55 139.19 26.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 73.34 111.171 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.97 65.16 0.5 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.683 -0.77 . . . . 54.24 112.485 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -75.9 155.29 35.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 61.23 110.927 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.02 -31.0 16.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.11 110.879 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.88 -55.66 0.27 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 73.04 112.49 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.75 136.58 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.338 . . . . 71.24 110.858 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.79 170.07 16.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 73.01 110.899 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.39 140.67 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 64.51 111.104 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -137.75 151.0 47.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 72.31 110.905 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -146.24 164.95 30.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 73.4 110.94 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 31.7 m -140.06 138.79 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 65.22 111.14 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -160.2 163.15 33.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.34 110.887 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -130.74 170.7 13.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.52 111.163 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 m -107.55 169.3 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 74.24 111.163 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -104.54 -52.92 2.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 62.14 110.868 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -128.94 157.24 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.878 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -73.64 116.16 13.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 72.41 110.871 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.37 144.86 33.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 65.5 111.1 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 t -100.96 106.79 18.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 70.03 111.15 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.45 148.93 46.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 73.54 111.088 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.05 111.72 36.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 73.43 111.155 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 98' ' ' LYS . 7.5 t -126.77 139.99 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 75.41 111.138 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.492 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 34.5 p -136.56 167.06 22.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 62.32 110.863 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.403 HG23 HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -110.01 142.75 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.42 111.119 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 p -169.57 172.57 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 72.32 110.85 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 157.31 -20.48 0.41 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 64.04 112.487 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -157.46 -96.72 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 51.32 112.493 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 m -130.54 148.79 52.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 70.22 110.878 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.61 91.42 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 74.01 112.499 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -35.03 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 70.3 110.851 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.43 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -91.54 109.43 20.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 64.35 111.084 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.94 146.7 54.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 54.33 110.882 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 tt -110.86 127.08 55.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 64.44 110.92 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -131.28 154.19 48.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 73.21 110.906 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -154.03 133.11 12.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 75.31 110.948 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.03 125.72 17.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.853 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.4 126.17 28.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 73.2 111.119 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.41 -71.17 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 71.11 112.475 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 m -112.58 -175.47 2.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 64.01 110.86 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.31 136.04 32.21 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.57 0.7 . . . . 73.43 110.937 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 143.85 52.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.7 2.267 . . . . 72.54 112.35 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -100.79 178.08 4.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.22 111.153 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.6 p -64.86 -15.2 61.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 70.12 111.126 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.7 m -119.44 -25.8 5.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 71.54 110.827 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.95 126.39 50.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.32 110.803 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.5 154.07 36.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 72.45 110.935 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -112.45 -27.95 8.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 71.15 110.866 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.2 m -145.72 124.57 12.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.912 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -173.17 124.99 0.45 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 63.11 110.878 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -6.62 19.07 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.686 2.257 . . . . 65.43 112.351 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.9 t80 67.62 80.49 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 70.34 110.889 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.38 -176.1 4.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 73.04 110.837 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.92 -75.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 73.03 110.946 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.98 -125.38 1.79 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.746 . . . . 71.24 112.438 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.43 ' ND2' ' H ' ' A' ' 44' ' ' ALA . 62.3 m-20 -49.62 168.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.856 0.36 . . . . 72.14 110.88 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 74.41 5.99 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 72.12 110.884 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 3.7 pt-20 -127.3 115.49 19.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 73.52 110.908 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.492 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 10.1 m -140.77 174.3 10.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.21 110.869 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.94 153.79 33.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 65.31 110.89 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.85 109.37 11.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 75.32 110.847 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -150.21 152.33 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 75.22 111.155 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.5 p -79.52 102.34 8.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 64.21 110.88 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.52 143.14 31.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 64.33 111.107 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.59 142.92 25.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.561 0.696 . . . . 70.01 111.102 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 143.81 52.08 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.657 2.238 . . . . 73.41 112.342 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.23 -22.81 6.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.704 -0.76 . . . . 63.5 112.459 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.6 m -117.27 131.52 56.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 74.34 111.15 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 m -74.23 136.5 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 73.41 111.113 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.35 154.78 20.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 74.14 110.883 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -134.34 160.93 36.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 75.11 110.84 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.423 HG21 ' HD2' ' A' ' 5' ' ' LYS . 10.6 t -136.17 137.68 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 71.02 111.117 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.27 122.36 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 65.02 110.865 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.98 112.83 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 75.11 111.116 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.79 104.08 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 74.03 110.939 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.51 160.16 37.54 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 71.11 112.511 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -115.79 -18.4 10.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 71.44 110.906 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 91' ' ' ASN . 60.7 p -166.24 136.23 3.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 64.31 110.888 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 90' ' ' SER . 57.7 t30 -33.84 108.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 72.54 110.92 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -160.84 112.68 1.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 75.41 110.923 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.0 p -119.44 163.87 16.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 72.33 110.875 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.86 26.36 4.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.743 . . . . 42.13 112.491 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 t -113.75 147.49 17.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 73.54 111.156 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.1 m -103.59 117.12 33.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.34 111.169 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.403 HD21 HG23 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -99.58 121.48 41.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 74.33 110.914 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HE3' ' CA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -131.12 154.8 47.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 73.43 110.861 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.46 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -84.54 140.9 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 71.3 110.922 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.44 113.36 25.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.897 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 p90 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.467 . . . . 73.24 110.942 -179.892 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.501 -0.24 . . . . 73.24 112.501 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -113.12 -179.14 3.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.913 0.387 . . . . 74.11 110.874 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.5 m -117.75 108.86 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 73.23 111.112 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.65 149.82 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 72.51 110.913 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.425 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -156.42 -73.37 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 74.15 110.951 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 16.9 t30 -67.98 158.09 33.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 74.41 110.945 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.8 t-20 88.95 -69.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 72.23 110.885 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -133.18 118.06 14.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.578 0.704 . . . . 72.41 111.108 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.432 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . 53.6 Cg_endo -69.79 157.2 61.14 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 73.03 112.341 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.93 113.9 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 72.54 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.04 144.25 30.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.12 110.85 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.409 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.8 OUTLIER 48.07 74.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 65.4 110.857 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 tp -65.02 -166.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.179 -0.464 . . . . 75.24 110.928 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -143.37 140.72 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 72.0 111.151 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.88 60.2 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 50.11 112.46 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 90' ' ' SER . 1.7 t-20 -78.47 139.14 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 75.11 110.897 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER -52.28 -48.16 65.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 65.32 110.904 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.04 -46.53 2.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 64.43 112.538 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.03 128.39 35.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 74.13 110.883 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.21 160.57 31.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 73.3 110.868 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.25 139.01 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 64.25 111.126 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -136.93 146.83 45.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.931 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -144.08 165.02 28.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 75.15 110.856 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 26.0 m -143.81 138.74 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.513 . . . . 62.54 111.151 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -160.09 162.97 34.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 54.2 110.859 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -129.86 170.78 13.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 73.23 111.138 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 m -107.35 168.06 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 73.54 111.149 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -106.91 -49.93 3.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.857 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -126.13 156.76 39.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 75.43 110.843 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -78.85 114.84 18.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 74.22 110.925 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.71 145.5 33.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 55.13 111.086 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 m -97.96 107.54 20.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 74.14 111.133 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.97 148.91 47.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 73.23 111.034 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 p -106.55 113.0 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 62.21 111.148 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.4 t -126.12 139.97 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.22 111.125 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.539 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -138.86 166.72 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 71.21 110.888 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.41 147.51 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.35 111.153 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -178.41 170.73 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 70.31 110.831 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.7 -25.32 0.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 73.23 112.524 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.04 -119.76 1.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 61.31 112.5 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 m -109.29 161.95 14.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 73.23 110.853 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.16 94.57 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 64.04 112.52 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.85 -37.9 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 74.33 110.838 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.07 115.56 28.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 64.41 111.129 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.68 157.31 17.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 75.45 110.874 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 tp -124.74 129.81 51.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 74.32 110.916 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -136.94 131.66 33.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.35 110.924 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.28 142.56 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 72.42 110.913 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -143.73 117.67 9.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.951 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.97 124.37 20.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 73.41 111.119 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 -81.04 0.72 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 75.33 112.516 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.1 p -96.17 -169.7 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 75.42 110.9 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.33 135.02 21.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.631 0.729 . . . . 74.54 110.869 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 141.25 44.74 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.664 2.243 . . . . 74.35 112.364 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 p -105.36 178.93 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.135 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.4 p -63.1 -15.05 55.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 73.21 111.092 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -118.41 -26.72 6.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 73.45 110.886 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.87 126.44 50.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 75.51 110.837 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.28 153.73 35.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 74.23 110.929 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -117.72 -42.89 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.866 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.1 m -117.39 120.82 39.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.44 110.868 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -179.59 127.6 0.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 75.12 110.856 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 0.91 4.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.642 2.228 . . . . 73.22 112.352 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 72.06 62.41 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 71.31 110.902 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -168.89 2.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 74.51 110.9 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -136.79 127.62 27.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 73.54 110.888 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.04 -171.43 48.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.75 -0.738 . . . . 63.53 112.479 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -52.08 175.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 73.22 110.886 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.75 15.75 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.881 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -121.4 82.95 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 71.32 110.853 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.539 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -133.23 170.2 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 70.44 110.874 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.06 152.42 37.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 72.23 110.861 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.7 p -128.38 108.98 11.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 75.32 110.858 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.1 t -150.46 152.76 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.11 111.122 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -77.6 103.64 7.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.22 110.88 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.19 134.33 35.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 73.44 111.085 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.5 139.27 23.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 73.34 111.127 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 121.02 7.72 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.724 2.283 . . . . 74.33 112.348 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.58 -19.09 1.85 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 65.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.8 m -116.9 133.78 55.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.39 . . . . 73.04 111.109 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.07 131.41 41.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 51.4 111.13 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -107.89 138.05 44.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 73.32 110.926 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -117.86 159.15 23.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 74.14 110.871 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.425 ' HB ' ' HE2' ' A' ' 5' ' ' LYS . 20.9 t -137.6 137.16 45.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 70.41 111.187 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 tpt -129.99 122.27 28.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 75.33 110.938 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.5 mm -104.2 112.7 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 75.25 111.144 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 124.55 49.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.937 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.8 162.88 30.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 71.14 112.441 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -95.16 -34.13 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 71.25 110.886 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.449 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 4.6 t -167.83 -62.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 75.43 110.829 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -171.81 86.68 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.871 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.63 119.9 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 74.2 110.948 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 p -122.88 153.4 39.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 75.01 110.817 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 12' ' ' ASN . . . 123.71 25.76 1.69 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 74.45 112.514 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.88 146.99 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.904 0.383 . . . . 71.12 111.128 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 m -101.34 115.52 30.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 61.31 111.095 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -100.94 130.89 47.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 62.33 110.927 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 9' ' ' PRO . 6.6 ttpt -143.79 163.81 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 75.04 110.885 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.416 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -91.73 143.3 26.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 74.24 110.902 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.492 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -94.7 113.91 25.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 75.4 110.95 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 12.9 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 74.42 110.954 -179.84 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.484 -0.246 . . . . 53.51 112.484 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -135.16 -177.46 4.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.886 0.374 . . . . 74.35 110.886 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.9 m -119.88 109.07 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 73.24 111.143 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.74 151.3 52.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.9 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -164.51 -39.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 74.33 110.864 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.0 t-20 -103.98 155.37 18.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 74.4 110.882 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.6 t-20 87.43 -67.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 64.04 110.873 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.1 m -127.77 119.52 21.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 74.31 111.136 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 152.7 69.37 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.706 2.271 . . . . 74.14 112.296 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.44 115.45 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.23 111.126 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.8 142.11 32.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.832 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.59 80.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 74.45 110.878 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.28 -167.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 75.43 110.96 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 p -145.67 139.0 26.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.45 111.131 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.37 61.68 0.51 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.743 -0.741 . . . . 72.31 112.487 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -76.09 150.13 37.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.947 0.403 . . . . 74.33 110.862 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -35.89 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.51 110.917 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.82 -63.08 0.52 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 74.51 112.5 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.77 140.08 20.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 73.52 110.84 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -135.08 171.91 13.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 73.43 110.858 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.05 136.26 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 75.22 111.165 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -136.77 141.53 42.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.51 110.91 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -130.56 165.03 23.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.928 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.421 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 9.4 m -141.19 138.8 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 74.53 111.13 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.48 160.34 34.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 72.11 110.906 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.8 p -126.62 171.59 10.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 73.14 111.139 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 t -108.18 141.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 75.22 111.148 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -92.24 -42.59 9.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 73.53 110.86 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -132.15 148.39 52.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 73.04 110.864 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -72.89 114.27 10.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 74.23 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.34 140.76 29.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 55.35 111.134 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 t -98.98 107.08 19.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 72.0 111.11 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.72 148.02 48.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 70.03 111.104 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.1 p -106.72 111.19 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 71.01 111.119 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.71 139.82 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 74.54 111.157 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.456 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -134.51 166.33 23.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.43 110.861 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.11 142.23 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 74.3 111.162 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t 178.82 159.67 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.852 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.67 -32.02 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.7 -0.762 . . . . 63.41 112.471 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.03 -82.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 71.03 112.519 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 m -129.67 160.49 33.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 75.4 110.882 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.44 92.78 1.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 74.43 112.471 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -127.3 -34.97 2.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 74.31 110.843 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.527 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -92.54 113.93 26.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 74.42 111.108 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.32 166.16 24.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 75.23 110.856 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 tt -123.86 145.67 48.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.912 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -152.85 148.89 27.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 75.04 110.924 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 tt -152.73 140.13 19.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.899 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -147.57 130.41 16.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 75.33 110.882 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.71 86.53 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 72.32 111.139 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.94 -86.01 0.22 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.739 . . . . 73.32 112.501 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.03 134.04 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.953 0.406 . . . . 72.14 110.855 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.64 128.09 3.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.624 0.726 . . . . 62.11 110.895 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 142.84 49.11 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 63.32 112.376 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -110.08 179.31 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 75.33 111.183 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.8 p -60.92 -16.62 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 72.43 111.158 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 t -117.43 -25.78 6.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 73.12 110.83 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 124.76 48.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 72.0 110.871 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.73 153.18 32.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 73.21 110.929 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -114.24 -48.59 2.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 74.12 110.852 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.6 m -123.24 122.51 38.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.871 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.47 137.27 0.35 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.63 0.728 . . . . 72.43 110.866 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -2.91 11.02 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 65.15 112.308 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 73.79 74.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 64.51 110.895 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -163.55 -169.94 2.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 74.41 110.888 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -139.79 160.04 40.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.51 110.913 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.03 165.85 9.57 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.671 -0.776 . . . . 45.43 112.491 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 44' ' ' ALA . 52.2 m-80 -56.62 -176.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 64.35 110.907 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.9 t30 64.54 14.18 8.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 75.15 110.906 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.7 103.62 7.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 73.3 110.873 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 5.5 m -135.03 173.63 11.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 75.15 110.845 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.94 151.6 36.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 60.21 110.89 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.5 p -129.72 109.01 10.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 63.4 110.854 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.1 m -151.02 153.48 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 72.14 111.173 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -72.25 100.18 2.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.12 110.864 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.32 151.31 25.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 63.53 111.146 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.82 145.99 46.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.606 0.717 . . . . 71.32 111.086 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 173.37 11.06 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.669 2.246 . . . . 75.42 112.294 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.78 -46.86 1.72 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.742 . . . . 72.1 112.452 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.9 m -94.61 128.82 41.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 71.5 111.142 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.5 m -70.7 137.75 50.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 72.55 111.138 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -109.52 137.84 46.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 72.45 110.874 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -106.46 157.91 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 63.55 110.874 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.96 137.98 44.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 73.51 111.169 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.5 tpt -136.09 123.87 22.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 72.2 110.913 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.5 mm -111.94 111.91 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 72.02 111.111 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.84 149.76 23.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 71.12 110.864 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.8 157.81 16.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 50.33 112.539 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -114.18 -21.68 10.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 75.13 110.88 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 91' ' ' ASN . 72.3 p -169.99 134.97 1.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 64.03 110.863 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 90' ' ' SER . 1.7 p30 -33.83 107.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.1 110.88 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -164.12 114.03 1.24 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 72.11 110.938 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 p -121.08 162.56 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 73.14 110.878 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.35 19.38 3.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.718 -0.754 . . . . 72.23 112.515 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.8 t -112.43 147.93 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 75.32 111.135 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -100.21 129.76 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 73.22 111.176 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.2 tp -113.11 148.31 35.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 65.1 110.913 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -157.4 166.39 33.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.859 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.88 147.31 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 74.05 110.905 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.495 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -106.06 104.48 14.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 74.32 110.91 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 61.25 110.898 -179.84 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.1 m120 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.866 0.365 . . . . 52.32 110.917 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -116.09 108.61 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 73.129999999999995 111.096 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.4 147.79 52.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 75.519999999999996 110.947 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.597 ' HE2' HD11 ' A' ' 97' ' ' LEU . 7.2 tptp -169.92 -37.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 110.926 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.656 ' OD1' HD22 ' A' ' 99' ' ' LEU . 12.6 t-20 -99.14 155.9 17.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 74.430000000000007 110.867 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 5.8 t30 81.54 -68.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 71.409999999999997 110.886 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.1 m -116.33 121.11 33.94 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 70.219999999999999 111.113 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.7 Cg_endo -69.79 153.14 69.13 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.715 2.277 . . . . 71.340000000000003 112.348 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.24 114.4 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.450000000000003 111.119 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -81.85 158.26 24.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 64.329999999999998 110.83 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER 37.15 66.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 72.230000000000004 110.908 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.58 -169.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 72.030000000000001 110.935 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 p -145.8 139.39 26.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 111.136 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.68 65.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 64.5 112.485 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -76.57 139.89 40.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 74.239999999999995 110.924 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.28 -28.7 12.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 75.120000000000005 110.933 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.92 -49.7 0.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.749 . . . . 74.200000000000003 112.487 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -76.45 149.4 36.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 72.109999999999999 110.861 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -141.85 170.55 15.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 71.420000000000002 110.886 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -129.07 138.24 55.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 75.129999999999995 111.157 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -137.07 150.66 48.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 62.539999999999999 110.91 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -148.58 166.1 29.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 110.922 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 9.8 m -137.75 138.15 39.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 72.530000000000001 111.16 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -160.4 162.95 33.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 72.230000000000004 110.868 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.608 HG22 ' HA ' ' A' ' 81' ' ' THR . 28.9 p -136.24 171.41 14.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 44.210000000000001 111.145 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 78' ' ' PRO . 28.1 m -106.84 167.58 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 111.14 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -109.1 -48.23 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 72.530000000000001 110.834 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -125.56 156.93 38.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 73.030000000000001 110.874 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -80.06 115.22 19.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 71.209999999999994 110.845 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.47 144.61 34.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 64.310000000000002 111.139 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 32' ' ' THR . 2.8 t -98.8 107.24 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 71.120000000000005 111.148 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.95 148.27 45.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 64.140000000000001 111.071 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.2 p -106.74 110.67 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 71.319999999999993 111.144 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.548 HG11 ' HG2' ' A' ' 98' ' ' LYS . 46.4 t -128.51 140.86 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 63.219999999999999 111.15 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.472 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 24.2 p -140.63 167.72 21.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 71.129999999999995 110.844 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.71 149.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 111.194 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -179.85 -175.5 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 64.430000000000007 110.824 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.774 -0.727 . . . . 62.310000000000002 112.484 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.829 0.347 . . . . 65.450000000000003 110.912 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.13 121.55 44.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 63.299999999999997 111.102 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -87.68 159.35 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.209999999999994 110.843 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 71' ' ' SER . 0.3 OUTLIER -121.93 130.56 53.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.409999999999997 110.928 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -125.82 147.75 49.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 72.540000000000006 110.901 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.654 HD12 ' NE2' ' A' ' 100' ' ' GLN . 1.4 tt -143.76 134.99 25.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 74.030000000000001 110.917 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.563 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.0 tttm -144.04 116.02 8.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 71.109999999999999 110.896 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.41 120.68 10.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 64.450000000000003 111.085 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.49 -80.89 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 51.109999999999999 112.469 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 m -98.14 -178.06 3.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.389 . . . . 65.049999999999997 110.862 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 134.68 31.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.534 0.683 . . . . 74.519999999999996 110.927 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 143.3 50.35 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.655 2.237 . . . . 64.049999999999997 112.319 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -104.45 178.72 4.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 72.230000000000004 111.137 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.8 p -65.15 -14.43 60.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.436 . . . . 75.439999999999998 111.152 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -119.99 -26.75 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 71.209999999999994 110.851 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.07 125.95 50.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 64.150000000000006 110.868 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.23 153.62 35.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 110.929 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -111.83 -24.49 9.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.877 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.3 m -143.75 123.78 13.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 73.340000000000003 110.864 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -176.88 118.74 0.27 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.606 0.717 . . . . 70.329999999999998 110.893 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.439 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 53.6 Cg_endo . . . . . 0 N--CA 1.465 -0.195 0 C-N-CA 122.684 2.256 . . . . 74.430000000000007 112.352 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.856 0.36 . . . . 75.109999999999999 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 t30 64.47 18.87 11.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 73.340000000000003 110.887 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 63' ' ' PRO . 19.9 tt0 -119.61 85.82 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 52.450000000000003 110.921 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.667 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.9 m -133.11 169.68 16.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.239999999999995 110.857 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.24 155.22 33.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 54.100000000000001 110.875 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -129.23 106.55 8.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 52.399999999999999 110.864 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.1 t -151.17 149.81 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 111.134 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.8 p -73.55 102.5 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 73.129999999999995 110.86 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.586 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.51 137.42 34.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 74.209999999999994 111.113 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.47 141.37 22.57 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 74.530000000000001 111.09 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.511 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.7 Cg_endo -69.77 132.2 22.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.71 2.273 . . . . 73.010000000000005 112.358 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.78 -18.93 4.01 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.741 . . . . 71.510000000000005 112.509 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.5 m -115.55 129.71 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 70.329999999999998 111.14 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.608 ' HA ' HG22 ' A' ' 26' ' ' THR . 17.4 m -72.19 137.06 46.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 62.119999999999997 111.135 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.586 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 34.1 m-85 -109.86 138.21 46.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 75.219999999999999 110.918 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -108.16 161.98 14.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 75.329999999999998 110.836 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG21 ' CG ' ' A' ' 5' ' ' LYS . 61.9 t -132.31 139.05 50.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 70.230000000000004 111.124 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.7 121.18 11.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 75.450000000000003 110.853 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.442 ' HB ' HG23 ' A' ' 21' ' ' VAL . 13.3 mm -115.64 116.17 51.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 71.109999999999999 111.113 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.7 128.99 56.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 70.340000000000003 110.896 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.43 159.5 13.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 75.109999999999999 112.499 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -98.83 -21.36 16.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.868 0.366 . . . . 73.329999999999998 110.899 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 91' ' ' ASN . 23.3 p -167.07 141.65 3.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 62.130000000000003 110.897 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 90' ' ' SER . 55.2 t-20 -35.64 107.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 75.200000000000003 110.889 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -160.11 116.85 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 61.420000000000002 110.921 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.1 p -119.62 161.25 20.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 73.120000000000005 110.892 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.45 22.85 2.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 70.099999999999994 112.49 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.49 147.03 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.909 0.385 . . . . 71.519999999999996 111.11 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.63 114.35 28.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 62.119999999999997 111.147 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.597 HD11 ' HE2' ' A' ' 5' ' ' LYS . 16.5 tp -99.44 144.01 29.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 65.349999999999994 110.91 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.548 ' HG2' HG11 ' A' ' 35' ' ' VAL . 3.6 ttpt -153.16 164.92 37.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 110.892 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.656 HD22 ' OD1' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -92.54 140.58 29.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 63.32 110.881 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.654 ' NE2' HD12 ' A' ' 48' ' ' LEU . 5.5 pm0 -100.43 111.17 23.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 64.349999999999994 110.885 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.7 p90 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.464 . . . . 64.239999999999995 110.922 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.865 0.364 . . . . 73.510000000000005 110.865 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 3' ' ' VAL . 14.5 m -108.03 108.15 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 75.310000000000002 111.14 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.61 149.69 52.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 63.310000000000002 110.897 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HE3' HD11 ' A' ' 97' ' ' LEU . 13.2 tptm -169.29 -38.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 60.140000000000001 110.876 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 60.3 t30 -97.91 155.32 17.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 63.240000000000002 110.851 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 26.1 t30 82.0 -68.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 72.340000000000003 110.88 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 m -124.99 119.76 25.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.598 0.713 . . . . 74.450000000000003 111.163 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.53 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.9 Cg_endo -69.73 154.73 67.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.682 2.255 . . . . 45.420000000000002 112.355 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 t -76.47 114.01 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.030000000000001 111.131 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.64 144.98 29.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 74.349999999999994 110.83 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.09 77.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 75.209999999999994 110.896 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.752 HD11 ' CB ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -73.36 -172.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 64.120000000000005 110.902 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 p -136.55 137.95 40.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 75.510000000000005 111.15 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.18 60.73 0.55 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 75.420000000000002 112.529 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -77.07 163.04 27.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.373 . . . . 74.319999999999993 110.895 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 90' ' ' SER . 3.0 mmmt -45.4 -69.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 75.430000000000007 110.913 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.67 -50.72 3.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.729 . . . . 74.340000000000003 112.48 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.97 144.45 6.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 65.109999999999999 110.838 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -144.24 -179.81 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 63.020000000000003 110.887 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.474 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -141.4 135.76 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 73.439999999999998 111.115 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -137.03 148.54 46.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 71.299999999999997 110.896 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -148.54 165.01 32.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 65.030000000000001 110.912 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.736 HG22 ' HA ' ' A' ' 83' ' ' HIS . 1.2 p -143.14 142.4 31.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 52.200000000000003 111.123 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -159.32 159.38 33.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 63.200000000000003 110.884 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.611 ' CG2' HG23 ' A' ' 81' ' ' THR . 17.4 p -127.22 170.35 12.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.109999999999999 111.14 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.09 167.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 70.409999999999997 111.139 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.39 -43.23 4.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 63.509999999999998 110.884 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.43 162.74 31.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 64.150000000000006 110.904 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.26 116.09 19.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 65.049999999999997 110.91 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.78 141.06 31.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 44.100000000000001 111.145 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.617 HG23 ' HB3' ' A' ' 75' ' ' SER . 1.1 m -97.34 107.17 19.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 73.120000000000005 111.134 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.22 147.01 47.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 61.340000000000003 111.095 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.565 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.4 p -110.9 110.84 33.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 111.176 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.5 140.25 49.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 61.119999999999997 111.115 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.507 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 4.7 p -130.75 166.47 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 110.888 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.521 HG21 HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -112.58 152.57 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 52.119999999999997 111.129 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.01 177.23 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 63.539999999999999 110.813 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 74.430000000000007 112.482 -179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 CA--C 1.526 0.047 0 CA-C-O 120.815 0.34 . . . . 64.120000000000005 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.22 125.92 49.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 74.040000000000006 111.112 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.08 151.54 22.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 64.239999999999995 110.842 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.521 HD12 HG21 ' A' ' 37' ' ' ILE . 10.0 tt -116.09 127.8 55.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.917 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -138.43 143.11 39.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 65.439999999999998 110.904 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.537 HD23 ' N ' ' A' ' 49' ' ' LYS . 1.3 tt -149.21 135.96 19.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 73.209999999999994 110.918 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.537 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.1 tttm -143.64 138.25 28.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 54.32 110.897 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.52 101.02 11.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 62.299999999999997 111.126 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.05 -92.39 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.742 . . . . 44.43 112.476 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.9 p -87.5 131.4 34.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 70.400000000000006 110.851 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.68 134.8 6.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.589 0.709 . . . . 75.310000000000002 110.877 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 143.75 51.66 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.69 2.26 . . . . 74.430000000000007 112.311 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.18 177.5 5.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.436 . . . . 62.450000000000003 111.123 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 p -63.62 -15.92 59.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 111.138 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -119.63 -25.44 5.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 73.340000000000003 110.898 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.94 125.14 48.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 64.200000000000003 110.832 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.86 153.54 34.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 72.430000000000007 110.937 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -108.61 -29.12 8.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 74.010000000000005 110.825 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.5 m -136.32 123.73 22.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.129999999999995 110.882 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -175.04 132.52 0.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.626 0.727 . . . . 74.099999999999994 110.891 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.251 . . . . 63.409999999999997 112.315 -179.949 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.867 0.365 . . . . 64.150000000000006 110.856 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.3 t30 63.8 15.88 9.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.430000000000007 110.884 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -120.41 96.15 5.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.892 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.507 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -134.52 170.53 15.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 75.030000000000001 110.875 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -120.35 153.29 36.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 73.140000000000001 110.888 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.565 ' HB3' HG23 ' A' ' 34' ' ' VAL . 6.0 p -129.2 108.5 10.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 74.129999999999995 110.833 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.2 t -150.44 149.83 14.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 61.420000000000002 111.119 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.617 ' HB3' HG23 ' A' ' 32' ' ' THR . 63.1 p -75.68 102.4 5.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 63.210000000000001 110.896 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.543 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.49 143.81 30.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 72.049999999999997 111.111 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.15 142.91 26.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 61.399999999999999 111.107 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 141.09 44.24 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 64.430000000000007 112.337 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.67 -13.14 7.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.688 -0.767 . . . . 63.409999999999997 112.481 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -125.27 130.4 51.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 73.420000000000002 111.158 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.611 HG23 ' CG2' ' A' ' 26' ' ' THR . 3.5 m -73.19 137.8 45.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 51.43 111.13 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.543 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 51.6 m-85 -108.72 136.16 48.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 73.510000000000005 110.926 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.736 ' HA ' HG22 ' A' ' 24' ' ' THR . 12.2 m-70 -107.56 160.45 15.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.209999999999994 110.862 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.469 HG11 ' HE3' ' A' ' 5' ' ' LYS . 2.6 t -137.95 138.55 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 65.510000000000005 111.088 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.73 125.08 19.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 71.109999999999999 110.885 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.514 HD11 HD22 ' A' ' 97' ' ' LEU . 21.2 mm -114.79 130.28 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 111.141 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -111.49 149.85 30.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.439999999999998 110.899 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.19 152.27 16.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.721 -0.752 . . . . 53.43 112.544 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -120.39 -17.79 8.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 72.319999999999993 110.938 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -174.73 136.11 0.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 60.149999999999999 110.829 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 90' ' ' SER . 17.5 t-20 -35.06 103.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 74.230000000000004 110.889 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -155.38 100.18 2.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 74.230000000000004 110.906 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.6 p -109.47 151.85 26.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.071 -0.513 . . . . 63.409999999999997 110.82 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.08 24.16 1.34 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 73.120000000000005 112.476 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.643 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -111.63 142.63 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 62.240000000000002 111.121 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -102.43 117.07 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 74.109999999999999 111.152 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.752 ' CB ' HD11 ' A' ' 13' ' ' LEU . 13.1 tp -106.01 140.06 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.219999999999999 110.923 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -144.51 165.19 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 73.239999999999995 110.864 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -92.3 137.68 32.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 72.340000000000003 110.93 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.59 113.12 24.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 63.009999999999998 110.892 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.4 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 73.219999999999999 110.89 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.6 m120 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.871 0.367 . . . . 52.329999999999998 110.894 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.429 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.3 m -117.63 108.55 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 111.121 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.94 150.23 52.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 74.540000000000006 110.907 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.727 ' HZ3' HD11 ' A' ' 97' ' ' LEU . 14.8 tptt -167.19 -35.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 73.340000000000003 110.922 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -101.39 155.61 17.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 64.349999999999994 110.891 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 24.4 t30 83.99 -69.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 65.310000000000002 110.891 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -123.08 121.3 27.19 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.569 0.7 . . . . 53.130000000000003 111.113 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.611 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.8 Cg_endo -69.76 153.51 68.84 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.267 . . . . 74.200000000000003 112.317 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.23 114.84 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 72.400000000000006 111.15 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -85.56 160.74 19.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 110.836 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 40.2 62.17 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 73.420000000000002 110.89 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.03 -169.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 64.329999999999998 110.903 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 p -146.57 139.32 25.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 51.25 111.156 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.12 57.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.754 . . . . 33.25 112.486 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.94 152.95 36.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 72.140000000000001 110.914 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.24 -42.76 66.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 73.310000000000002 110.871 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.82 -48.69 1.07 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.778 -0.725 . . . . 42.520000000000003 112.508 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.28 134.1 54.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 62.030000000000001 110.799 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -134.65 172.6 12.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 74.239999999999995 110.874 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.445 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.41 139.23 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 70.109999999999999 111.12 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -136.78 151.23 48.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 74.219999999999999 110.871 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -145.14 165.97 26.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 110.933 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.429 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 8.7 m -141.69 138.13 32.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.075 -0.511 . . . . 61.409999999999997 111.157 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -160.61 158.19 28.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 74.109999999999999 110.887 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 81' ' ' THR . 27.7 p -128.07 171.22 12.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 73.019999999999996 111.093 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.558 HG12 ' CZ ' ' A' ' 101' ' ' TYR . 34.4 m -107.35 147.7 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 75.439999999999998 111.135 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -91.03 -49.83 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 73.329999999999998 110.884 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.14 161.39 26.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 73.150000000000006 110.878 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -81.06 114.12 19.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 73.219999999999999 110.858 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.99 138.96 28.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 64.530000000000001 111.078 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 75' ' ' SER . 3.2 m -94.37 106.7 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 61.119999999999997 111.139 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -136.26 146.23 46.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 44.229999999999997 111.066 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 73' ' ' SER . 68.9 t -109.39 111.88 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 111.148 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.7 t -127.02 139.27 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 111.136 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 42.6 p -134.03 166.48 22.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 60.399999999999999 110.877 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.777 HG21 HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -110.96 149.49 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 63.420000000000002 111.136 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.66 177.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 54.119999999999997 110.864 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.728 . . . . 61.049999999999997 112.511 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.833 0.349 . . . . 74.519999999999996 110.894 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.1 106.64 12.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.420000000000002 111.119 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.64 152.35 37.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 74.530000000000001 110.864 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.27 127.27 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.219999999999999 110.862 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -133.93 139.63 46.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 64.239999999999995 110.931 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 49' ' ' LYS . 2.0 tt -143.4 134.13 25.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 74.329999999999998 110.906 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.589 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.3 tttt -142.4 122.66 13.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 72.109999999999999 110.883 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.47 48.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 73.109999999999999 111.112 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.15 -81.9 1.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.719 -0.753 . . . . 55.409999999999997 112.501 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -93.67 177.48 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.907 0.384 . . . . 75.030000000000001 110.844 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.12 138.22 30.86 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.569 0.699 . . . . 75.430000000000007 110.895 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.15 49.93 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 75.430000000000007 112.332 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -103.34 178.99 4.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 53.399999999999999 111.194 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.7 p -65.47 -14.24 60.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 74.519999999999996 111.124 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.4 m -121.35 -26.25 5.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 64.319999999999993 110.858 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.13 126.47 49.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 64.450000000000003 110.878 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.28 153.7 35.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 110.944 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -111.69 -27.63 8.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 74.430000000000007 110.897 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.1 m -140.52 123.78 16.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 71.340000000000003 110.916 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -179.51 115.78 0.22 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.589 0.709 . . . . 71.340000000000003 110.87 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.42 ' HD2' ' HG2' ' A' ' 70' ' ' GLU . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.161 0 C-N-CA 122.664 2.243 . . . . 61.420000000000002 112.364 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.833 0.349 . . . . 71.319999999999993 110.902 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.7 t30 68.01 18.27 9.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 51.520000000000003 110.891 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.42 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 14.1 tt0 -122.19 88.82 3.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 65.310000000000002 110.831 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.464 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.4 m -134.63 169.03 17.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 70.099999999999994 110.854 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.22 152.34 38.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 63.299999999999997 110.879 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.8 ' HB2' HG22 ' A' ' 34' ' ' VAL . 1.9 p -127.03 109.29 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.430000000000007 110.881 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.5 m -150.96 152.74 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 72.230000000000004 111.112 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.478 ' HB3' HG23 ' A' ' 32' ' ' THR . 77.5 p -80.1 101.89 9.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 71.230000000000004 110.884 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.506 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.87 151.18 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 71.120000000000005 111.078 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.87 144.13 32.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.547 0.689 . . . . 74.409999999999997 111.104 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.525 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.6 Cg_endo -69.73 124.67 11.32 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.713 2.275 . . . . 75.109999999999999 112.306 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.03 -15.99 1.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 55.219999999999999 112.485 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.9 m -126.16 131.33 52.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.37 . . . . 74.120000000000005 111.134 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.599 ' HA ' HG22 ' A' ' 26' ' ' THR . 26.9 m -72.66 138.15 46.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.439999999999998 111.153 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.506 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 47.5 m-85 -108.57 139.58 43.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 60.240000000000002 110.926 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -107.25 160.19 15.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 73.420000000000002 110.831 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 t -137.8 126.14 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 75.150000000000006 111.148 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.04 123.06 27.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 65.310000000000002 110.845 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.469 HD11 HD13 ' A' ' 97' ' ' LEU . 15.1 mm -111.2 124.32 67.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 74.129999999999995 111.112 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 145.25 32.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.865 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -117.14 140.61 15.99 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 62.25 112.49 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -101.76 -24.3 14.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.923 0.392 . . . . 75.430000000000007 110.953 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 91' ' ' ASN . 72.2 p -174.52 139.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 64.209999999999994 110.835 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 90' ' ' SER . 5.1 p-10 -31.56 106.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 54.229999999999997 110.913 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -163.09 110.6 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 65.540000000000006 110.93 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 p -117.25 158.83 23.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 61.210000000000001 110.868 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.34 25.45 2.0 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 64.099999999999994 112.529 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.36 146.83 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.865 0.364 . . . . 55.240000000000002 111.162 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.611 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.71 113.72 27.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 63.32 111.171 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.777 HD12 HG21 ' A' ' 37' ' ' ILE . 7.7 tp -99.88 141.08 33.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 72.239999999999995 110.921 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -151.58 169.92 20.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 74.420000000000002 110.936 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.657 HD21 ' HD2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -89.42 144.8 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 74.040000000000006 110.903 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.437 ' OE1' HD12 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -106.39 101.79 11.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 44.340000000000003 110.888 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.657 ' HD2' HD21 ' A' ' 99' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.931 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.869 0.366 . . . . 44.340000000000003 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -117.83 108.84 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.439999999999998 111.13 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.07 149.74 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 52.039999999999999 110.875 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.611 ' CE ' HD11 ' A' ' 97' ' ' LEU . 18.4 tptm -162.7 -70.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.109999999999999 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.579 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -71.65 155.4 40.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 71.099999999999994 110.888 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 18.4 t30 89.03 -67.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.450000000000003 110.875 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 m -124.19 120.66 26.24 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.614 0.721 . . . . 75.25 111.171 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HB2' HG22 ' A' ' 96' ' ' THR . 54.3 Cg_endo -69.71 154.14 68.3 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.7 2.267 . . . . 71.420000000000002 112.384 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.9 t -87.48 113.78 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 51.439999999999998 111.131 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 p -91.31 175.14 7.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 53.439999999999998 110.858 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 p30 40.62 48.91 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 62.299999999999997 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.808 HD11 ' HB2' ' A' ' 97' ' ' LEU . 4.2 mt -57.38 -176.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 72.510000000000005 110.952 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 p -143.86 139.61 29.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 51.520000000000003 111.146 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.75 64.54 0.56 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.794 -0.717 . . . . 74.450000000000003 112.497 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -73.93 160.5 31.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.941 0.4 . . . . 52.399999999999999 110.858 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 90' ' ' SER . 0.9 OUTLIER -45.22 -64.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.905 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.9 -48.14 1.81 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 73.120000000000005 112.501 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.57 157.81 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.839 0.352 . . . . 65.409999999999997 110.881 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.65 -179.32 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 52.100000000000001 110.893 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -133.66 146.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 111.141 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -137.55 145.72 43.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 60.329999999999998 110.88 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -144.88 165.9 26.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 73.200000000000003 110.913 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 8.2 m -140.79 140.02 34.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 43.340000000000003 111.089 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -159.68 160.69 34.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 60.119999999999997 110.858 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 81' ' ' THR . 24.5 p -130.1 170.22 14.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.484 . . . . 73.319999999999993 111.125 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.875 HG11 ' CE1' ' A' ' 101' ' ' TYR . 26.8 m -109.11 170.76 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.420000000000002 111.121 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -99.46 -67.99 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.887 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -125.31 148.68 48.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 75.25 110.869 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -50.53 117.49 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 73.430000000000007 110.84 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.65 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . . . -141.97 144.42 33.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 74.040000000000006 111.079 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 32' ' ' THR . 2.5 t -103.05 107.13 17.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.436 . . . . 64.450000000000003 111.167 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.56 147.13 46.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 75.219999999999999 111.138 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.2 p -107.57 111.69 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 71.209999999999994 111.129 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.437 HG11 ' HG2' ' A' ' 98' ' ' LYS . 11.5 t -127.64 139.67 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.049999999999997 111.15 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.465 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 9.5 p -135.15 165.27 25.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 45.439999999999998 110.858 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.494 HD13 ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -113.4 150.93 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 41.210000000000001 111.111 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 177.5 172.93 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 65.209999999999994 110.831 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 72.25 112.443 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.8 0.333 . . . . 73.430000000000007 110.864 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB1' ' CG2' ' A' ' 86' ' ' ILE . . . -88.67 116.36 26.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 62.030000000000001 111.108 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -78.21 147.2 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 62.229999999999997 110.844 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.719 HD11 HE22 ' A' ' 100' ' ' GLN . 5.9 tt -108.4 126.93 53.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 65.099999999999994 110.909 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -142.66 139.37 31.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 75.219999999999999 110.901 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.457 HD12 ' OE1' ' A' ' 100' ' ' GLN . 0.5 OUTLIER -147.09 133.64 19.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 73.340000000000003 110.908 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' H ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -143.35 133.86 24.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.466 . . . . 74.030000000000001 110.918 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.27 132.53 38.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 45.409999999999997 111.123 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.82 -80.63 1.81 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 33.530000000000001 112.509 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -92.92 175.95 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 64.510000000000005 110.842 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HD3' ' HE3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -88.15 137.75 31.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 72.420000000000002 110.895 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 142.65 48.38 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.691 2.26 . . . . 65.430000000000007 112.334 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.67 178.68 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 62.229999999999997 111.155 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 p -66.81 -13.38 61.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 111.113 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 m -123.01 -25.96 4.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 61.409999999999997 110.85 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.83 125.99 49.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 70.5 110.839 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.11 153.67 34.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 74.030000000000001 110.964 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -102.02 -32.19 10.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 64.450000000000003 110.85 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.2 m -138.03 123.57 19.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 63.240000000000002 110.856 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -177.29 127.16 0.3 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.568 0.699 . . . . 74.219999999999999 110.893 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 C--O 1.231 0.164 0 C-N-CA 122.726 2.284 . . . . 63.109999999999999 112.38 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.854 0.359 . . . . 54.149999999999999 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.8 25.57 11.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 70.439999999999998 110.906 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.32 96.13 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 63.240000000000002 110.865 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.591 ' HA ' HD13 ' A' ' 46' ' ' LEU . 1.7 m -133.85 170.95 14.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 42.299999999999997 110.862 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.46 149.56 41.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 65.540000000000006 110.951 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.487 ' HB3' HG23 ' A' ' 34' ' ' VAL . 13.6 p -126.72 109.27 11.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.864 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.2 t -150.91 152.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 52.109999999999999 111.139 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 p -81.41 102.14 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 70.019999999999996 110.85 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.787 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.55 149.96 26.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 43.549999999999997 111.13 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.58 144.23 28.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.595 0.712 . . . . 53.549999999999997 111.094 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.25 7.04 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.684 2.256 . . . . 74.329999999999998 112.314 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.68 -4.97 80.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.728 . . . . 62.009999999999998 112.494 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.9 m -126.22 125.48 42.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 73.099999999999994 111.125 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.48 ' HA ' HG22 ' A' ' 26' ' ' THR . 6.3 m -71.24 137.78 48.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 64.409999999999997 111.127 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.787 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 34.1 m-85 -111.66 137.98 48.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 75.530000000000001 110.936 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -105.98 162.41 13.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 71.349999999999994 110.841 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG21 ' HD3' ' A' ' 5' ' ' LYS . 2.7 t -135.89 138.57 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 54.409999999999997 111.147 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.412 ' HE3' ' HD3' ' A' ' 53' ' ' LYS . 6.8 tpp -140.3 121.77 15.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.83 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.416 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 20.4 mm -118.86 113.16 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 111.144 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -100.11 155.79 17.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 72.420000000000002 110.915 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.03 153.24 17.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 73.120000000000005 112.478 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.87 -21.98 8.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.895 0.379 . . . . 60.409999999999997 110.927 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.479 ' O ' ' C ' ' A' ' 91' ' ' ASN . 1.6 p -175.04 134.44 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 70.209999999999994 110.905 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 90' ' ' SER . 39.2 t30 -32.02 106.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 63.439999999999998 110.905 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -163.95 116.52 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.329999999999998 110.926 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.6 p -121.84 151.62 40.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 72.349999999999994 110.856 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.16 29.38 1.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 74.349999999999994 112.488 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.56 145.73 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.929 0.395 . . . . 72.209999999999994 111.127 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 9' ' ' PRO . 1.3 m -101.15 118.56 37.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 61.350000000000001 111.165 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.808 ' HB2' HD11 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -111.45 127.81 55.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 62.32 110.917 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.805 ' N ' HD22 ' A' ' 97' ' ' LEU . 3.9 ttpt -135.15 167.92 20.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 110.908 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -88.18 141.2 28.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 73.340000000000003 110.923 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.719 HE22 HD11 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -103.08 110.99 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 110.927 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.875 ' CE1' HG11 ' A' ' 27' ' ' VAL . 2.6 t80 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 110.928 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.847 0.356 . . . . 75.0 110.9 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.474 HG11 ' OG1' ' A' ' 24' ' ' THR . 11.1 m -106.39 108.45 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 72.109999999999999 111.097 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.14 149.93 52.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 61.020000000000003 110.904 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.636 ' HE3' HD11 ' A' ' 97' ' ' LEU . 13.7 tptm -166.71 -67.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.239999999999995 110.907 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.674 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.2 OUTLIER -76.09 153.93 35.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 74.040000000000006 110.918 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.1 t-20 87.32 -69.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.209999999999994 110.887 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.1 m -120.88 121.55 28.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.57 0.7 . . . . 61.520000000000003 111.105 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 154.38 67.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.692 2.262 . . . . 74.200000000000003 112.363 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.13 116.22 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 60.229999999999997 111.137 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 p -87.96 159.71 18.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 64.099999999999994 110.834 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 40.08 69.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 73.109999999999999 110.855 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.743 HD11 ' CB ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -69.81 -174.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 65.239999999999995 110.889 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -140.49 138.0 34.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 73.230000000000004 111.146 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.52 64.05 0.58 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.693 -0.765 . . . . 63.530000000000001 112.454 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -75.59 148.18 39.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.357 . . . . 54.240000000000002 110.905 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.36 -57.02 7.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 72.040000000000006 110.881 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.63 -64.21 1.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 42.130000000000003 112.491 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.92 144.61 8.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 72.400000000000006 110.865 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -139.67 179.33 6.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 61.140000000000001 110.892 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.584 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.13 138.0 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 74.540000000000006 111.127 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -135.41 139.58 44.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 71.340000000000003 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -137.44 163.8 30.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 110.926 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.724 HG22 ' HA ' ' A' ' 83' ' ' HIS . 1.9 p -142.17 146.91 35.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 72.219999999999999 111.136 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.39 163.28 35.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 64.209999999999994 110.822 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.622 HG22 HG23 ' A' ' 81' ' ' THR . 11.0 p -125.58 169.74 12.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 53.140000000000001 111.183 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.2 t -108.33 145.09 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 111.089 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -86.21 -44.29 12.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 74.209999999999994 110.832 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -142.78 154.72 44.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 75.099999999999994 110.86 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -72.04 116.62 12.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 72.209999999999994 110.938 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.75 141.3 31.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 63.310000000000002 111.116 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -94.81 105.66 17.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 111.114 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.11 148.62 45.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 71.340000000000003 111.136 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -107.93 111.12 34.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 72.530000000000001 111.12 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.496 HG11 ' HG2' ' A' ' 98' ' ' LYS . 41.2 t -127.41 139.9 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 71.219999999999999 111.09 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.488 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 24.3 p -135.89 166.21 23.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 73.040000000000006 110.855 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.461 HG21 HD12 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -111.4 150.66 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 52.409999999999997 111.152 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.3 173.58 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 64.340000000000003 110.884 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 64.310000000000002 112.495 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.866 0.365 . . . . 70.109999999999999 110.861 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.93 127.12 54.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 74.519999999999996 111.073 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 1.7 m-20 -88.91 152.36 21.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 70.140000000000001 110.867 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.413 HD22 ' O ' ' A' ' 70' ' ' GLU . 5.6 tt -118.75 142.24 47.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 72.439999999999998 110.891 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -153.36 142.92 21.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 72.209999999999994 110.945 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -140.66 134.08 29.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 74.25 110.922 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.477 ' N ' HD23 ' A' ' 48' ' ' LEU . 7.7 tttt -149.16 129.64 13.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 64.400000000000006 110.906 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.3 98.98 8.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 64.099999999999994 111.091 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.07 -90.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 43.420000000000002 112.463 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.0 m -90.46 128.48 36.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.957 0.408 . . . . 63.439999999999998 110.849 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.26 133.93 3.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.574 0.702 . . . . 72.420000000000002 110.87 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 143.02 49.54 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.677 2.251 . . . . 72.239999999999995 112.336 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 p -107.63 178.73 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 111.164 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.8 p -63.28 -15.18 56.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 64.420000000000002 111.164 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 m -118.96 -26.33 6.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 73.439999999999998 110.858 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.73 125.49 49.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.852 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.97 153.4 34.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.909 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -108.18 -34.58 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 71.409999999999997 110.912 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 70.5 m -144.64 123.1 12.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.86 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -177.37 129.14 0.32 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.606 0.717 . . . . 73.219999999999999 110.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HG2' ' CG ' ' A' ' 70' ' ' GLU . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.237 . . . . 64.030000000000001 112.399 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.836 0.351 . . . . 73.319999999999993 110.897 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.3 t30 65.63 12.19 8.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 54.219999999999999 110.878 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.43 ' CG ' ' HG2' ' A' ' 63' ' ' PRO . 4.3 tt0 -116.68 87.5 2.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.310000000000002 110.876 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.488 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -133.28 169.26 17.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 64.310000000000002 110.846 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.74 156.73 31.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 52.439999999999998 110.865 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.68 107.22 9.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 52.039999999999999 110.832 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -150.65 153.12 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.099999999999994 111.168 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -70.21 104.72 2.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.219999999999999 110.863 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.93 131.5 35.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 70.230000000000004 111.127 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.99 139.94 20.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.589 0.709 . . . . 43.439999999999998 111.078 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 170.45 16.55 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.683 2.255 . . . . 75.230000000000004 112.349 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.16 -39.24 2.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 45.009999999999998 112.474 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.6 m -97.04 128.93 44.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 71.340000000000003 111.155 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.622 HG23 HG22 ' A' ' 26' ' ' THR . 3.1 m -71.43 133.24 45.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 72.310000000000002 111.141 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -104.03 136.02 44.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 64.219999999999999 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.724 ' HA ' HG22 ' A' ' 24' ' ' THR . 17.9 m-70 -106.97 159.14 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 64.319999999999993 110.834 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.452 HG11 ' CE ' ' A' ' 5' ' ' LYS . 4.5 t -138.93 139.39 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 63.140000000000001 111.108 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.82 123.65 25.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 72.099999999999994 110.892 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.584 ' HB ' HG23 ' A' ' 21' ' ' VAL . 16.1 mm -118.81 113.61 42.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 72.439999999999998 111.099 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 10.3 mmmm -98.29 165.32 11.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 41.409999999999997 110.927 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.88 135.08 8.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.713 -0.756 . . . . 54.340000000000003 112.449 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -96.61 -31.54 12.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 75.209999999999994 110.943 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 91' ' ' ASN . 78.1 p -167.62 136.92 2.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 65.420000000000002 110.859 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 90' ' ' SER . 13.5 t-20 -34.62 105.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 55.009999999999998 110.898 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -164.37 119.25 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 74.040000000000006 110.953 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 p -121.56 155.76 34.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 70.530000000000001 110.891 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.65 23.29 1.52 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 63.100000000000001 112.468 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.659 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.7 t -114.15 143.12 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.911 0.386 . . . . 70.400000000000006 111.123 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.403 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 0.8 OUTLIER -100.08 132.26 45.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.299999999999997 111.158 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.743 ' CB ' HD11 ' A' ' 13' ' ' LEU . 13.8 tp -118.99 149.71 41.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 110.928 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HG2' HG11 ' A' ' 35' ' ' VAL . 3.4 ttpt -157.87 164.27 37.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 74.510000000000005 110.919 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.674 HD22 ' HB2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -90.96 138.95 31.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.25 -0.432 . . . . 70.439999999999998 110.907 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.09 112.0 24.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 54.439999999999998 110.941 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.422 ' HB3' HD21 ' A' ' 99' ' ' LEU . 29.6 p90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 70.450000000000003 110.926 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 2' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.893 0.378 . . . . 74.120000000000005 110.831 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.6 m -118.56 109.25 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 63.219999999999999 111.103 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.636 HD12 HG22 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -131.47 148.95 52.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 75.319999999999993 110.936 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.584 ' HE3' HD11 ' A' ' 97' ' ' LEU . 13.8 tptm -166.66 -68.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 65.439999999999998 110.883 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.651 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -75.01 154.98 37.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.540000000000006 110.877 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.0 t-20 88.38 -65.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 110.906 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 m -129.35 121.67 20.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.551 0.691 . . . . 64.329999999999998 111.098 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.41 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.7 Cg_endo -69.81 154.07 67.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.653 2.236 . . . . 73.049999999999997 112.359 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.636 HG22 HD12 ' A' ' 4' ' ' LEU . 37.3 t -84.83 115.09 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 61.140000000000001 111.134 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.2 146.12 28.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 74.019999999999996 110.853 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.66 81.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 75.140000000000001 110.942 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.73 HD11 ' CB ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -79.58 -172.69 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 52.329999999999998 110.924 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -136.98 138.72 40.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 75.120000000000005 111.139 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.77 71.87 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.746 -0.74 . . . . 52.0 112.505 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -76.98 134.54 38.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 61.210000000000001 110.89 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -24.57 8.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 55.109999999999999 110.901 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.13 -40.64 1.37 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 61.439999999999998 112.439 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.27 -173.12 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.356 . . . . 72.230000000000004 110.871 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.12 -178.01 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 73.540000000000006 110.918 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.0 145.76 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 72.299999999999997 111.168 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -137.21 143.4 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.510000000000005 110.849 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -140.15 165.25 27.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 71.120000000000005 110.926 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.43 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 7.8 m -147.11 142.32 27.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 64.099999999999994 111.137 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -159.36 162.51 35.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 74.25 110.868 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.491 HG22 HG23 ' A' ' 81' ' ' THR . 19.6 p -130.34 169.94 14.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 72.109999999999999 111.115 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 m -108.68 169.89 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.219999999999999 111.197 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -108.73 -45.16 3.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 54.409999999999997 110.895 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -133.38 158.82 42.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 75.099999999999994 110.881 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.7 116.27 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 55.210000000000001 110.896 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.38 139.19 31.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 65.230000000000004 111.127 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.3 m -96.21 106.77 19.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 63.329999999999998 111.154 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.59 147.29 46.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 70.310000000000002 111.117 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.2 p -107.5 111.29 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 52.210000000000001 111.132 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -127.45 140.22 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 75.010000000000005 111.115 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.497 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 5.4 p -133.53 166.25 23.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 61.149999999999999 110.891 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -111.91 152.44 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 64.310000000000002 111.169 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.79 173.9 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 71.329999999999998 110.886 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 54.219999999999999 112.496 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.812 0.339 . . . . 53.020000000000003 110.826 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.64 120.55 39.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.549999999999997 111.159 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.55 161.99 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 75.519999999999996 110.887 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.685 HD13 ' HA ' ' A' ' 71' ' ' SER . 9.4 tt -118.78 129.82 55.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 72.239999999999995 110.959 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -133.85 146.54 50.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 110.913 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -153.52 133.47 13.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 75.329999999999998 110.922 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.415 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -144.87 121.58 11.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 70.439999999999998 110.854 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.49 89.46 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 111.109 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.89 -83.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 61.119999999999997 112.456 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -106.41 133.96 50.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.925 0.393 . . . . 70.040000000000006 110.862 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.66 127.34 2.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 75.439999999999998 110.932 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 142.87 49.23 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.708 2.272 . . . . 60.100000000000001 112.305 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.48 178.32 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 74.019999999999996 111.152 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.3 p -60.63 -17.04 44.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 75.510000000000005 111.152 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.6 m -117.04 -25.45 7.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 110.833 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.46 124.87 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 110.847 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.87 153.41 33.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.91 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -115.51 -34.91 4.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 75.329999999999998 110.886 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.9 m -140.37 122.68 15.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 74.129999999999995 110.873 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.32 140.69 0.4 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.582 0.706 . . . . 70.420000000000002 110.907 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 122.69 2.26 . . . . 72.25 112.313 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 CA--C 1.526 0.034 0 CA-C-O 120.856 0.36 . . . . 74.310000000000002 110.865 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.9 t30 66.86 16.55 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.150000000000006 110.905 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.92 96.98 4.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 63.399999999999999 110.899 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.685 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.4 m -134.32 171.2 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 72.420000000000002 110.901 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.29 152.96 35.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.882 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 34' ' ' VAL . 1.3 p -128.64 109.26 11.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 63.210000000000001 110.854 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.6 m -150.89 152.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 62.420000000000002 111.135 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.6 p -73.2 106.97 5.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 64.010000000000005 110.8 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.71 132.55 35.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.109999999999999 111.066 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.63 139.23 19.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.525 0.678 . . . . 70.150000000000006 111.101 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 142.11 46.88 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.629 2.219 . . . . 72.219999999999999 112.325 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.97 -12.77 8.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.774 -0.727 . . . . 73.109999999999999 112.461 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.1 m -126.41 129.23 48.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 54.409999999999997 111.165 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.491 HG23 HG22 ' A' ' 26' ' ' THR . 5.2 m -70.98 138.07 49.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 74.349999999999994 111.159 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' O ' HG23 ' A' ' 24' ' ' THR . 42.4 m-85 -108.6 135.86 49.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 70.540000000000006 110.946 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -107.24 158.91 16.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 61.409999999999997 110.879 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.467 HG11 ' HE3' ' A' ' 5' ' ' LYS . 4.3 t -138.3 138.57 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 72.409999999999997 111.14 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.97 123.05 17.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' A' ' 21' ' ' VAL . 28.8 mm -113.44 112.96 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 60.240000000000002 111.169 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -110.38 134.31 52.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 74.450000000000003 110.874 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.74 144.67 17.66 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.753 . . . . 24.32 112.456 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.77 -22.27 20.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.902 0.382 . . . . 74.430000000000007 110.962 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 91' ' ' ASN . 2.7 p -163.85 139.76 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 72.540000000000006 110.891 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 90' ' ' SER . 13.3 t-20 -35.07 106.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 64.349999999999994 110.882 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -155.47 115.59 3.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 71.310000000000002 110.946 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.1 p -122.17 151.5 40.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 63.030000000000001 110.849 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.46 23.65 2.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 73.140000000000001 112.469 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.662 ' O ' HD12 ' A' ' 13' ' ' LEU . 1.4 t -111.74 143.94 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 72.010000000000005 111.096 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -100.94 124.19 46.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 62.340000000000003 111.124 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.73 ' CB ' HD11 ' A' ' 13' ' ' LEU . 15.5 tp -112.32 148.38 34.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 62.350000000000001 110.951 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -153.79 164.7 37.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 61.32 110.878 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.651 HD22 ' HB2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -91.43 136.91 32.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.236 -0.438 . . . . 72.530000000000001 110.922 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.416 HE22 HD11 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -97.38 112.18 24.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.010000000000005 110.931 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 75.450000000000003 110.871 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 m120 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.856 0.36 . . . . 71.219999999999999 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.5 m -117.9 108.27 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 71.239999999999995 111.146 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.54 150.66 52.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 61.009999999999998 110.95 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.722 ' HG2' HG21 ' A' ' 84' ' ' VAL . 2.2 tppm? -166.09 -73.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 110.883 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 59.7 t30 -63.39 157.75 22.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 73.010000000000005 110.919 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.3 t30 88.52 -60.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 73.219999999999999 110.868 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.4 m -133.59 121.62 16.32 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 42.109999999999999 111.161 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 152.28 69.54 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 2.243 . . . . 63.329999999999998 112.353 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.561 HG12 HD22 ' A' ' 13' ' ' LEU . 99.0 t -79.37 115.02 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 71.129999999999995 111.175 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.49 146.31 31.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 53.119999999999997 110.844 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.59 81.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 73.299999999999997 110.841 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.561 HD22 HG12 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -71.4 -168.72 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 62.140000000000001 110.911 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 p -139.61 138.34 36.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 73.299999999999997 111.137 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.63 58.82 0.65 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.721 -0.752 . . . . 43.149999999999999 112.517 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -76.56 139.17 40.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.874 0.368 . . . . 73.25 110.848 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -26.11 9.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 71.420000000000002 110.942 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.98 -56.33 0.4 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.735 -0.745 . . . . 73.099999999999994 112.503 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.13 158.73 6.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.854 0.359 . . . . 60.009999999999998 110.868 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -152.6 167.58 28.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 70.25 110.922 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -137.61 136.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 64.010000000000005 111.102 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -137.42 147.15 45.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 72.129999999999995 110.825 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -146.22 166.11 27.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 70.439999999999998 110.968 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 27.6 m -140.04 140.7 36.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 61.310000000000002 111.108 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -160.74 155.06 23.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 110.925 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.618 HG22 ' HA ' ' A' ' 81' ' ' THR . 19.1 p -128.07 170.49 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 64.219999999999999 111.178 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -108.5 170.21 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 61.130000000000003 111.11 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.05 -52.83 3.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 44.409999999999997 110.873 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.43 172.67 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.25 110.873 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -75.93 117.13 17.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 73.129999999999995 110.845 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.81 133.5 25.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 45.32 111.143 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.6 m -95.18 107.98 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 74.450000000000003 111.118 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.2 148.33 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 64.040000000000006 111.067 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -106.92 111.03 33.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 74.010000000000005 111.099 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.735 HG11 ' HG2' ' A' ' 98' ' ' LYS . 49.0 t -126.16 139.34 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 60.149999999999999 111.115 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.495 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 17.0 p -135.48 170.23 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 110.889 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.507 HD13 HD12 ' A' ' 46' ' ' LEU . 4.6 pt -108.01 157.49 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 73.230000000000004 111.112 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 174.12 171.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 75.530000000000001 110.838 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.679 -0.772 . . . . 71.340000000000003 112.429 -179.968 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.818 0.342 . . . . 65.120000000000005 110.89 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.76 120.92 36.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 111.1 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.64 172.64 11.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 74.230000000000004 110.891 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 71' ' ' SER . 8.5 tt -124.63 141.82 51.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 73.040000000000006 110.914 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -150.37 146.62 26.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 73.319999999999993 110.949 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.595 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -153.87 146.23 23.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 64.109999999999999 110.934 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.595 ' H ' HD23 ' A' ' 48' ' ' LEU . 7.1 tttt -149.62 123.12 9.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 60.409999999999997 110.923 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.54 84.28 6.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 72.340000000000003 111.109 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.89 -64.22 0.4 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 72.549999999999997 112.527 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -139.99 137.7 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.949 0.404 . . . . 75.349999999999994 110.833 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -32.52 127.2 0.36 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.522 0.677 . . . . 75.549999999999997 110.929 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 143.45 50.76 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.668 2.245 . . . . 71.129999999999995 112.329 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -103.35 178.35 4.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 55.140000000000001 111.106 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.5 p -62.69 -15.71 53.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 70.349999999999994 111.172 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.3 m -117.21 -26.23 6.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 71.109999999999999 110.858 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.94 123.52 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 52.350000000000001 110.838 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.39 153.55 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 73.209999999999994 110.903 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 49' ' ' LYS . 35.6 m-20 -112.27 -45.67 3.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 55.200000000000003 110.847 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 36.9 m -121.9 123.57 42.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 73.129999999999995 110.869 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -175.77 127.61 0.37 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 74.510000000000005 110.848 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.183 0 C-N-CA 122.694 2.263 . . . . 63.030000000000001 112.344 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 p30 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.81 0.338 . . . . 73.129999999999995 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.3 t30 61.09 24.2 14.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.310000000000002 110.876 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -128.98 90.23 3.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 74.150000000000006 110.908 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.709 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.6 m -133.04 169.97 16.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 62.509999999999998 110.86 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.57 154.76 34.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 75.200000000000003 110.869 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.458 ' HB3' HG23 ' A' ' 34' ' ' VAL . 60.6 p -128.29 109.67 11.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.420000000000002 110.846 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.1 t -150.33 153.02 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 64.109999999999999 111.123 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -75.41 105.38 6.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.299999999999997 110.857 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.13 138.41 34.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 111.064 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.29 146.52 32.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.711 . . . . 55.310000000000002 111.13 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 164.55 34.09 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 73.209999999999994 112.374 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.0 -21.18 38.3 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.713 -0.756 . . . . 71.129999999999995 112.482 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.0 m -108.75 124.01 49.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 53.530000000000001 111.111 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.618 ' HA ' HG22 ' A' ' 26' ' ' THR . 22.0 m -72.89 134.06 44.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 44.109999999999999 111.127 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.532 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 52.2 m-85 -109.13 136.91 47.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 73.430000000000007 110.885 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -118.55 139.56 51.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 73.420000000000002 110.851 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.722 HG21 ' HG2' ' A' ' 5' ' ' LYS . 13.7 t -116.03 126.83 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 111.091 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 tpt -123.51 128.82 50.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 51.409999999999997 110.846 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.558 HD11 ' CD2' ' A' ' 97' ' ' LEU . 30.6 mm -113.97 126.43 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 53.340000000000003 111.109 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.19 146.3 30.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 73.349999999999994 110.9 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.39 150.13 18.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 41.030000000000001 112.472 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.15 -37.9 5.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.35 . . . . 73.200000000000003 110.868 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 91' ' ' ASN . 7.6 p -161.74 137.64 7.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 73.030000000000001 110.908 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.482 ' C ' ' O ' ' A' ' 90' ' ' SER . 4.8 p-10 -31.65 108.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 73.200000000000003 110.877 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.63 121.66 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.5 110.919 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.5 p -121.59 168.23 11.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 64.109999999999999 110.82 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.39 22.66 2.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 70.430000000000007 112.478 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -113.38 140.75 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 74.129999999999995 111.123 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.54 120.04 39.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 71.319999999999993 111.185 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' CD2' HD11 ' A' ' 86' ' ' ILE . 19.4 tp -106.22 149.99 26.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.912 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.735 ' HG2' HG11 ' A' ' 35' ' ' VAL . 5.7 ttpt -156.92 162.91 39.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 74.420000000000002 110.866 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.27 140.34 29.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 54.329999999999998 110.909 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.469 ' OE1' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -103.5 112.42 25.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 74.109999999999999 110.916 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.8 p90 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.903 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.3 m120 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.82 0.343 . . . . 74.400000000000006 110.921 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.4 m -121.9 108.26 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.540000000000006 111.103 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.03 149.34 52.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 75.010000000000005 110.927 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.683 ' HE3' HG11 ' A' ' 84' ' ' VAL . 1.4 tppm? -163.55 -75.34 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 72.310000000000002 110.928 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.578 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -62.27 155.11 25.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 110.903 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.7 t-20 89.03 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.030000000000001 110.834 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.2 m -121.67 121.01 28.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 73.239999999999995 111.144 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.621 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.4 Cg_endo -69.76 153.57 68.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.266 . . . . 72.420000000000002 112.326 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.4 t -84.48 114.49 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 64.519999999999996 111.152 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 p -86.69 167.89 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 55.210000000000001 110.862 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 39.75 55.76 2.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 54.130000000000003 110.855 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.792 HD11 ' CB ' ' A' ' 97' ' ' LEU . 3.1 mt -58.9 -175.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 75.140000000000001 110.884 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.9 p -141.76 138.33 32.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 64.329999999999998 111.101 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.96 55.17 0.7 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 73.209999999999994 112.477 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -75.84 140.44 42.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 70.109999999999999 110.86 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -26.9 5.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 70.219999999999999 110.884 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.23 -61.43 0.48 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 64.219999999999999 112.455 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -58.16 144.42 40.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 62.329999999999998 110.893 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -138.99 170.7 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 70.200000000000003 110.845 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.503 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.61 135.55 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 43.509999999999998 111.118 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -138.23 154.16 49.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.019999999999996 110.886 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -148.0 166.77 26.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.319999999999993 110.948 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.421 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 58.3 m -137.44 140.45 41.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 54.130000000000003 111.132 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -159.95 158.13 30.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 75.140000000000001 110.847 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.615 HG22 HG23 ' A' ' 81' ' ' THR . 22.4 p -127.39 170.51 12.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 72.420000000000002 111.141 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.882 HG11 ' CE1' ' A' ' 101' ' ' TYR . 31.1 m -109.45 171.02 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 72.409999999999997 111.134 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.75 -66.57 0.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 70.129999999999995 110.898 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -127.08 149.73 49.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.430000000000007 110.879 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -51.02 117.04 2.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 63.420000000000002 110.837 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.656 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . . . -141.95 145.12 34.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 61.219999999999999 111.095 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -104.77 106.67 17.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 52.140000000000001 111.181 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.29 147.23 47.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 73.25 111.111 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.509 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -107.51 112.32 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 71.530000000000001 111.179 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG11 ' HG2' ' A' ' 98' ' ' LYS . 8.8 t -127.5 139.77 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 63.0 111.152 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.471 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 9.9 p -134.68 166.41 22.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 70.430000000000007 110.866 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.04 146.41 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 72.329999999999998 111.115 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.3 t 177.9 161.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 74.349999999999994 110.894 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 73.409999999999997 112.485 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.853 0.358 . . . . 72.310000000000002 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.32 120.12 35.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 111.067 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.74 143.75 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 72.120000000000005 110.849 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 71' ' ' SER . 4.7 tt -103.48 131.34 50.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 52.25 110.905 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -130.65 154.45 47.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 63.25 110.949 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.6 133.63 12.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 52.140000000000001 110.863 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -148.95 124.48 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.882 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.58 82.9 7.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 60.299999999999997 111.083 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.72 -82.51 0.19 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 51.109999999999999 112.508 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 m -109.08 136.92 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 73.129999999999995 110.83 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.64 126.01 2.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 64.329999999999998 110.919 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 142.58 48.25 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.723 2.282 . . . . 73.219999999999999 112.299 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.84 177.98 4.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 111.151 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 87' ' ' LYS . 58.9 p -62.71 -16.78 58.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 73.049999999999997 111.094 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m -116.78 -26.24 7.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 72.010000000000005 110.823 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.94 124.11 47.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 110.845 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.61 153.38 33.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 73.450000000000003 110.907 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -107.85 -44.99 4.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.030000000000001 110.852 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.5 m -145.17 122.21 11.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 54.109999999999999 110.879 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -177.38 153.94 1.05 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.604 0.716 . . . . 61.109999999999999 110.885 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.526 ' CD ' HD22 ' A' ' 46' ' ' LEU . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.147 0 C-N-CA 122.705 2.27 . . . . 70.209999999999994 112.313 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.792 0.329 . . . . 61.020000000000003 110.928 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 63.94 16.76 10.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 71.230000000000004 110.923 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -127.25 100.09 5.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 73.430000000000007 110.872 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.733 ' HA ' HD13 ' A' ' 46' ' ' LEU . 4.9 m -136.77 173.13 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 72.129999999999995 110.894 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.71 150.53 38.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 54.109999999999999 110.904 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.509 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.4 p -126.09 109.86 12.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 74.209999999999994 110.878 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -150.75 148.73 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 63.310000000000002 111.134 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.27 102.37 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 72.329999999999998 110.848 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.712 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.7 151.42 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 63.149999999999999 111.056 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.69 145.72 31.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 71.230000000000004 111.088 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 162.78 40.7 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 65.109999999999999 112.347 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.07 -18.5 51.85 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.77 -0.728 . . . . 72.219999999999999 112.487 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.9 m -116.87 125.97 52.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 62.130000000000003 111.13 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.615 HG23 HG22 ' A' ' 26' ' ' THR . 24.0 m -71.25 137.57 48.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 73.519999999999996 111.17 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.712 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 70.2 m-85 -112.46 152.71 28.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 71.25 110.921 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -131.36 159.0 39.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 75.329999999999998 110.872 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.683 HG11 ' HE3' ' A' ' 5' ' ' LYS . 22.0 t -132.44 125.46 53.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 72.140000000000001 111.151 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.23 124.19 46.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 62.329999999999998 110.867 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.526 ' CD1' HD22 ' A' ' 97' ' ' LEU . 24.7 mm -110.54 113.17 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.540000000000006 111.122 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HG3' HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -99.97 133.21 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 73.239999999999995 110.921 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.22 160.29 16.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 60.439999999999998 112.475 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -117.46 -29.79 5.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 73.209999999999994 110.953 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 91' ' ' ASN . 97.5 p -168.21 143.54 3.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 63.539999999999999 110.783 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' SER . 39.1 t30 -33.04 109.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.505 . . . . 74.140000000000001 110.893 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.6 111.69 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 65.549999999999997 110.893 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 p -121.67 159.68 26.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 74.450000000000003 110.876 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 120.4 22.24 3.17 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.699 -0.762 . . . . 74.450000000000003 112.476 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.13 146.22 18.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.921 0.391 . . . . 71.209999999999994 111.113 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -101.26 132.54 46.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.510000000000005 111.131 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.792 ' CB ' HD11 ' A' ' 13' ' ' LEU . 7.8 tp -121.45 148.79 43.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 55.210000000000001 110.899 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HG2' HG11 ' A' ' 35' ' ' VAL . 1.6 ttpt -155.07 170.04 22.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.140000000000001 110.853 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.65 140.85 29.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.030000000000001 110.896 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.584 ' OE1' HD11 ' A' ' 46' ' ' LEU . 1.7 pm0 -103.1 108.64 19.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.530000000000001 110.889 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.882 ' CE1' HG11 ' A' ' 27' ' ' VAL . 3.3 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 63.119999999999997 110.932 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.802 0.334 . . . . 63.100000000000001 110.931 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.423 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.1 m -117.7 108.39 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.400000000000006 111.093 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.98 148.89 52.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 71.329999999999998 110.939 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.595 ' NZ ' HD21 ' A' ' 97' ' ' LEU . 17.8 tptt -164.0 -74.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 73.209999999999994 110.893 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.659 ' CG ' HD22 ' A' ' 99' ' ' LEU . 12.2 t-20 -65.87 156.66 32.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.937 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.5 t30 85.61 -69.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 73.239999999999995 110.913 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -119.34 120.84 30.6 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.565 0.697 . . . . 73.040000000000006 111.137 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 153.54 68.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.656 2.238 . . . . 72.5 112.372 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.685 HG12 HD22 ' A' ' 13' ' ' LEU . 87.4 t -84.05 115.34 26.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 111.158 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.05 162.07 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 65.519999999999996 110.876 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 40.52 65.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 75.349999999999994 110.838 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.685 HD22 HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -62.13 -173.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 75.310000000000002 110.915 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 p -143.2 139.15 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 73.209999999999994 111.146 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.77 64.89 0.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.792 -0.718 . . . . 75.239999999999995 112.522 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.5 160.49 30.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 72.310000000000002 110.876 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 90' ' ' SER . 31.0 mmtp -44.87 -70.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.453 . . . . 62.240000000000002 110.909 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.6 -45.59 2.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.68 -0.771 . . . . 73.200000000000003 112.496 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.89 151.88 13.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.342 . . . . 75.209999999999994 110.849 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.53 -179.4 8.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 74.340000000000003 110.896 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -128.56 144.76 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 62.210000000000001 111.119 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -137.43 145.27 42.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 71.239999999999995 110.852 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -144.09 166.09 25.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 74.040000000000006 110.942 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.423 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 2.5 m -141.96 138.58 32.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 72.150000000000006 111.128 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 2.0 t80 -160.53 162.98 33.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 74.549999999999997 110.882 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.668 HG22 HG23 ' A' ' 81' ' ' THR . 17.3 p -131.7 171.09 13.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.030000000000001 111.142 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.2 170.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 60.219999999999999 111.159 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -111.98 -39.31 4.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 41.009999999999998 110.848 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.95 157.87 45.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 110.886 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -79.93 116.45 20.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 65.099999999999994 110.891 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.98 142.86 32.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 23.34 111.122 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 32' ' ' THR . 2.5 t -99.17 107.84 20.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 72.219999999999999 111.105 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.08 147.23 45.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 74.510000000000005 111.098 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.1 p -107.87 111.37 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 71.230000000000004 111.165 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.8 t -127.83 140.33 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.349999999999994 111.13 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.502 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 2.0 p -132.36 167.16 20.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.854 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.455 HD11 ' H ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -110.38 142.66 22.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 74.530000000000001 111.121 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 p -179.32 -169.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 53.200000000000003 110.84 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 74.109999999999999 112.518 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.755 0.312 . . . . 74.439999999999998 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.56 108.38 14.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.040000000000006 111.069 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.0 144.58 54.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 73.310000000000002 110.853 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 71' ' ' SER . 5.9 tt -112.46 126.94 55.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 73.140000000000001 110.945 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -136.41 148.84 47.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 71.230000000000004 110.907 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.95 133.81 13.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 71.239999999999995 110.938 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -141.96 140.04 32.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.040000000000006 110.899 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.74 -48.45 13.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 72.230000000000004 111.148 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.61 -96.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 73.109999999999999 112.503 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -106.79 162.38 13.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.917 0.389 . . . . 62.119999999999997 110.828 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HA ' ' CB ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -45.12 128.35 5.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.575 0.702 . . . . 52.350000000000001 110.906 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 142.35 47.22 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.654 2.236 . . . . 41.420000000000002 112.305 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -113.42 179.77 3.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 55.439999999999998 111.15 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.5 p -60.96 -16.75 46.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 71.25 111.14 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -117.11 -26.03 6.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 74.040000000000006 110.848 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 124.94 49.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 73.319999999999993 110.862 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.34 152.97 31.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.92 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -114.76 -31.5 6.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 70.25 110.86 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.8 m -141.89 121.89 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.872 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.58 122.7 0.13 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.625 0.726 . . . . 71.030000000000001 110.855 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.202 0 C-N-CA 122.649 2.233 . . . . 33.25 112.325 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.871 0.367 . . . . 62.439999999999998 110.876 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.7 t30 64.13 14.61 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 60.340000000000003 110.914 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -126.88 98.1 5.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 41.399999999999999 110.876 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.502 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 3.5 m -135.81 171.43 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 71.439999999999998 110.862 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.83 150.86 38.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 72.340000000000003 110.907 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 34' ' ' VAL . 1.2 p -128.47 108.48 10.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 65.040000000000006 110.873 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -151.08 148.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 75.540000000000006 111.163 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.28 106.37 6.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 35.119999999999997 110.876 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.645 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.33 145.25 29.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 70.299999999999997 111.03 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.19 139.38 21.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 50.240000000000002 111.087 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 133.56 25.9 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.708 2.272 . . . . 62.25 112.326 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.88 -20.06 2.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 72.310000000000002 112.462 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.2 m -126.51 134.95 50.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.371 . . . . 60.32 111.15 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.668 HG23 HG22 ' A' ' 26' ' ' THR . 23.6 m -71.07 137.6 49.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 64.420000000000002 111.156 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.645 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 32.5 m-85 -104.77 139.6 39.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 73.549999999999997 110.948 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.405 ' CB ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -107.18 161.24 14.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 60.25 110.823 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.91 138.17 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 75.510000000000005 111.15 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.7 tpt -142.98 123.27 13.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 70.409999999999997 110.923 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.405 ' HB ' HG23 ' A' ' 21' ' ' VAL . 19.9 mm -118.95 112.15 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 71.219999999999999 111.094 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -95.77 157.18 16.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 63.140000000000001 110.924 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.34 145.95 16.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 75.140000000000001 112.467 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -112.16 -21.71 11.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 72.310000000000002 110.868 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 91' ' ' ASN . 7.1 p -165.74 127.97 2.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 70.430000000000007 110.877 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 90' ' ' SER . 9.1 t-20 -35.38 106.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 54.310000000000002 110.894 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.42 115.63 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 74.209999999999994 110.932 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 p -115.87 151.85 34.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 51.210000000000001 110.86 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.47 28.26 0.92 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 50.32 112.519 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.33 147.38 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 61.5 111.088 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.03 114.14 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 74.400000000000006 111.107 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.67 ' HB3' HD21 ' A' ' 13' ' ' LEU . 1.7 tm? -104.25 132.78 50.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 55.119999999999997 110.935 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.651 ' N ' HD22 ' A' ' 97' ' ' LEU . 4.4 ttpt -144.18 163.72 32.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 71.230000000000004 110.832 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.659 HD22 ' CG ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -91.69 140.67 29.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 62.119999999999997 110.9 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.81 113.04 24.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.25 110.925 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.0 p90 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 110.953 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.855 0.36 . . . . 74.430000000000007 110.923 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 24' ' ' THR . 3.1 m -120.32 108.85 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 111.125 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.45 148.72 52.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.129999999999995 110.893 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.634 ' CD ' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -157.46 -69.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 55.0 110.859 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.574 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 54.1 t30 -77.68 158.73 29.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 41.140000000000001 110.904 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.574 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.4 t30 88.38 -68.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 110.918 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.7 m -123.4 113.73 29.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.552 0.691 . . . . 72.310000000000002 111.129 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.408 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.4 Cg_endo -69.76 150.28 68.0 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 74.409999999999997 112.34 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.563 HG12 HD22 ' A' ' 13' ' ' LEU . 76.5 t -77.99 113.8 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 73.030000000000001 111.091 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.21 140.02 41.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 71.540000000000006 110.854 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.35 84.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 74.120000000000005 110.89 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -72.35 -167.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 63.130000000000003 110.886 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 p -139.05 138.56 37.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 62.420000000000002 111.135 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.69 60.3 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 65.200000000000003 112.474 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -76.02 158.4 31.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 64.040000000000006 110.857 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -61.23 2.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.857 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.72 -50.63 1.94 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 75.409999999999997 112.503 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.74 140.63 14.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 73.409999999999997 110.88 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -141.19 170.46 15.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 43.539999999999999 110.859 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.29 137.06 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 64.439999999999998 111.161 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.25 152.27 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 54.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -143.34 165.56 27.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 63.530000000000001 110.934 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 3.2 m -135.24 139.07 44.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 75.140000000000001 111.125 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -160.01 162.58 34.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 71.540000000000006 110.863 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 81' ' ' THR . 20.4 p -136.72 171.04 15.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 73.329999999999998 111.154 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.732 HG11 ' CE1' ' A' ' 101' ' ' TYR . 22.3 m -108.38 172.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 70.200000000000003 111.123 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.6 -57.61 2.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 64.049999999999997 110.865 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.19 140.43 51.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 71.239999999999995 110.859 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -48.78 118.87 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 65.150000000000006 110.906 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.39 131.15 27.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 72.25 111.125 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 32' ' ' THR . 3.0 t -94.68 106.58 18.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 71.129999999999995 111.146 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.541 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -140.09 147.77 40.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.030000000000001 111.052 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.777 HG23 ' HB3' ' A' ' 73' ' ' SER . 2.8 p -113.9 109.24 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 111.157 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.82 HG11 ' HG2' ' A' ' 98' ' ' LYS . 3.7 t -130.95 141.19 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 73.340000000000003 111.153 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.495 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 29.1 p -129.12 167.68 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.409999999999997 110.873 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -109.96 147.18 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 64.120000000000005 111.132 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.22 163.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 62.439999999999998 110.914 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.796 -0.716 . . . . 73.439999999999998 112.517 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.817 0.341 . . . . 72.200000000000003 110.905 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.12 128.59 46.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 52.329999999999998 111.104 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -102.45 124.49 48.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 75.010000000000005 110.905 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 71' ' ' SER . 0.9 OUTLIER -92.11 130.1 37.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.257 -0.429 . . . . 54.530000000000001 110.865 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -132.58 148.89 52.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.899 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -146.34 142.79 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 63.310000000000002 110.858 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.572 ' H ' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -151.91 117.72 5.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 110.926 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.52 123.92 20.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 64.400000000000006 111.115 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 -82.83 0.8 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 12.24 112.49 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.9 m -93.67 -179.19 4.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.952 0.406 . . . . 63.140000000000001 110.858 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 134.72 28.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 71.030000000000001 110.862 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 141.51 45.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 70.519999999999996 112.325 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -102.5 179.03 4.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 65.230000000000004 111.131 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.1 p -65.63 -13.7 59.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 54.109999999999999 111.145 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 m -121.36 -26.46 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 44.210000000000001 110.861 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.83 126.22 49.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 60.130000000000003 110.852 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.37 153.47 34.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 74.099999999999994 110.892 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -108.89 -29.11 8.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 75.530000000000001 110.844 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.9 m -136.93 124.0 21.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 60.329999999999998 110.88 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HG3' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -174.74 126.57 0.4 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.611 0.72 . . . . 73.540000000000006 110.904 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HD2' ' HG3' ' A' ' 62' ' ' ARG . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.158 0 C-N-CA 122.647 2.231 . . . . 63.43 112.363 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.803 0.335 . . . . 65.400000000000006 110.873 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.2 t30 63.94 19.63 11.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 110.862 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -123.16 88.74 2.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 75.019999999999996 110.907 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.614 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.5 m -132.23 170.16 15.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.540000000000006 110.852 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.24 154.01 34.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 55.229999999999997 110.899 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.777 ' HB3' HG23 ' A' ' 34' ' ' VAL . 89.7 p -128.25 104.19 7.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 74.040000000000006 110.834 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -152.22 152.73 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 72.519999999999996 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.1 p -84.32 104.39 14.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 75.030000000000001 110.884 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.767 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -81.68 154.72 25.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 74.409999999999997 111.066 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.39 139.71 20.42 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.629 0.728 . . . . 73.099999999999994 111.086 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.495 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.9 Cg_endo -69.78 140.03 41.62 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 53.020000000000003 112.328 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.26 -6.18 9.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.751 . . . . 73.25 112.51 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.5 m -126.41 129.6 49.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 73.209999999999994 111.127 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.48 ' HA ' HG22 ' A' ' 26' ' ' THR . 6.2 m -72.46 136.86 46.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 55.020000000000003 111.139 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.767 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 39.8 m-85 -111.88 134.44 53.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 74.219999999999999 110.936 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -106.07 162.76 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 62.409999999999997 110.863 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.634 HG21 ' CD ' ' A' ' 5' ' ' LYS . 73.2 t -134.79 140.0 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 54.240000000000002 111.129 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.13 121.07 14.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.109999999999999 110.894 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.604 HD11 HD22 ' A' ' 97' ' ' LEU . 14.8 mm -111.16 113.13 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 74.420000000000002 111.131 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 135.62 41.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 70.200000000000003 110.914 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.38 157.24 15.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.757 . . . . 61.049999999999997 112.486 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -117.12 -28.04 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.946 0.403 . . . . 73.209999999999994 110.904 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 91' ' ' ASN . 73.2 p -166.88 136.06 2.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 70.219999999999999 110.882 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 90' ' ' SER . 3.1 m120 -31.75 105.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 64.209999999999994 110.866 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -162.78 113.07 1.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 70.209999999999994 110.942 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.7 p -121.51 159.83 25.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 63.5 110.851 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.03 19.46 2.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.747 . . . . 74.209999999999994 112.532 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.42 141.45 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 65.140000000000001 111.169 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.7 m -99.32 122.84 43.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 60.229999999999997 111.141 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 86' ' ' ILE . 19.2 tp -102.04 142.7 32.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 74.230000000000004 110.877 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.82 ' HG2' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -151.22 153.0 34.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 72.349999999999994 110.946 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -88.52 140.85 29.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 110.895 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -93.9 113.66 25.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 74.049999999999997 110.889 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.732 ' CE1' HG11 ' A' ' 27' ' ' VAL . 4.9 t80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 71.329999999999998 110.959 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.836 0.351 . . . . 64.310000000000002 110.93 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.1 m -117.47 109.42 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 65.239999999999995 111.113 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.48 148.48 52.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 65.430000000000007 110.95 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.602 ' CD ' HD11 ' A' ' 97' ' ' LEU . 15.4 tptm -164.74 -65.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 64.430000000000007 110.914 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.635 ' OD1' HD22 ' A' ' 99' ' ' LEU . 8.4 t-20 -77.92 155.74 30.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 62.299999999999997 110.869 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 10.3 t-20 87.2 -68.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.219999999999999 110.867 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.5 m -121.5 120.89 28.64 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.594 0.712 . . . . 74.530000000000001 111.138 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 153.82 68.17 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.695 2.263 . . . . 73.430000000000007 112.327 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.6 t -83.21 115.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 73.25 111.076 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.07 142.25 31.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 75.319999999999993 110.864 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.28 86.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 74.209999999999994 110.906 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -79.88 -171.97 3.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 62.439999999999998 110.884 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 p -139.41 139.47 37.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 54.229999999999997 111.162 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.45 69.99 0.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 73.209999999999994 112.507 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -76.42 153.55 35.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 74.549999999999997 110.865 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.4 -34.29 23.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 74.219999999999999 110.879 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.66 -52.72 0.25 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 53.140000000000001 112.477 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 t -52.56 168.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 53.0 110.817 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.84 175.6 3.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 74.239999999999995 110.893 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -132.31 144.67 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 74.209999999999994 111.096 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -136.91 128.14 28.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.87 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -127.45 164.64 21.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 72.540000000000006 110.895 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.414 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 2.4 m -141.06 143.42 34.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 72.209999999999994 111.14 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -160.27 163.33 33.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 74.209999999999994 110.878 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.537 HG22 HG23 ' A' ' 81' ' ' THR . 18.8 p -132.5 170.31 15.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 54.210000000000001 111.117 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.511 HG11 ' HB1' ' A' ' 76' ' ' ALA . 13.6 m -109.2 167.47 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 72.420000000000002 111.12 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -97.43 -48.59 5.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.510000000000005 110.852 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 165.31 27.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 110.873 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -56.7 117.91 4.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 70.0 110.868 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.54 120.91 12.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 75.040000000000006 111.09 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 32' ' ' THR . 2.5 t -98.33 105.55 17.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 73.540000000000006 111.108 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.605 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -137.38 147.5 45.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 74.5 111.099 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.695 HG22 ' CB ' ' A' ' 73' ' ' SER . 96.8 t -108.49 110.6 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 62.149999999999999 111.137 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.432 HG11 ' HE3' ' A' ' 98' ' ' LYS . 21.7 t -127.3 141.11 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 64.010000000000005 111.12 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.48 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.62 166.49 17.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.450000000000003 110.851 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.44 147.33 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 73.400000000000006 111.168 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.93 172.09 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 62.130000000000003 110.85 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.764 -0.732 . . . . 51.049999999999997 112.512 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.833 0.349 . . . . 54.539999999999999 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.06 124.9 45.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.140000000000001 111.046 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.7 152.02 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 60.420000000000002 110.887 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.643 HD13 ' HA ' ' A' ' 71' ' ' SER . 2.4 tt -106.93 127.02 53.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 64.340000000000003 110.894 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -136.49 142.61 43.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 73.420000000000002 110.934 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -154.12 135.7 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 54.340000000000003 110.914 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.481 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.2 tttm -140.81 121.56 14.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 74.310000000000002 110.939 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.35 77.54 9.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.230000000000004 111.082 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.72 -59.98 0.3 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 62.310000000000002 112.454 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -142.21 141.78 32.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 51.549999999999997 110.834 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.73 120.15 1.4 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.574 0.702 . . . . 72.010000000000005 110.899 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 143.4 51.19 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.68 2.254 . . . . 55.310000000000002 112.38 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.35 178.31 4.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 65.319999999999993 111.138 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.0 p -61.48 -17.32 54.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 72.420000000000002 111.135 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 t -114.14 -26.86 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 74.209999999999994 110.844 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.86 123.49 47.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 72.25 110.891 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.23 153.58 32.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 110.945 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -110.71 -33.51 6.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.886 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.2 m -134.12 123.23 24.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 44.43 110.893 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -179.58 126.16 0.24 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 72.010000000000005 110.887 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.172 0 C-N-CA 122.74 2.293 . . . . 63.119999999999997 112.352 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.865 0.364 . . . . 74.349999999999994 110.872 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 67.11 13.59 9.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 74.319999999999993 110.836 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.05 101.97 6.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 73.549999999999997 110.844 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.643 ' HA ' HD13 ' A' ' 46' ' ' LEU . 10.6 m -133.75 175.02 9.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 73.239999999999995 110.876 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.66 158.76 24.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 54.210000000000001 110.916 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.695 ' CB ' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -127.64 113.89 16.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 72.319999999999993 110.863 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 t -146.38 158.37 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 73.209999999999994 111.143 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.9 p -78.33 129.63 35.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 50.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.734 ' HB2' ' CG ' ' A' ' 101' ' ' TYR . . . -78.9 151.54 31.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 73.129999999999995 111.051 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.05 121.57 18.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.556 0.693 . . . . 63.109999999999999 111.117 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 115.78 4.25 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.694 2.262 . . . . 74.540000000000006 112.331 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.96 -11.62 3.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 74.239999999999995 112.475 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.3 m -126.18 127.31 45.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.885 0.374 . . . . 63.310000000000002 111.092 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.537 HG23 HG22 ' A' ' 26' ' ' THR . 6.9 m -70.71 137.52 49.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 64.25 111.168 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -106.02 133.41 50.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 70.219999999999999 110.953 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -104.74 161.18 14.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 71.129999999999995 110.813 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.418 HG11 ' HE3' ' A' ' 5' ' ' LYS . 2.8 t -137.9 138.05 44.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 62.100000000000001 111.131 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -138.29 122.21 17.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 64.450000000000003 110.851 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 21' ' ' VAL . 26.8 mm -114.1 112.28 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 72.329999999999998 111.088 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.64 140.29 40.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 75.120000000000005 110.896 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -114.85 156.06 15.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.753 . . . . 63.030000000000001 112.464 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -114.34 -21.54 10.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.897 0.38 . . . . 71.129999999999995 110.921 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -161.35 128.2 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 64.129999999999995 110.874 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 90' ' ' SER . 15.2 t-20 -31.61 106.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 75.439999999999998 110.912 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -157.65 112.81 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 71.400000000000006 110.883 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 p -121.37 154.58 36.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.509 . . . . 55.020000000000003 110.835 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.46 20.88 2.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.716 -0.754 . . . . 75.239999999999995 112.492 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.26 147.23 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 74.120000000000005 111.177 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m -97.61 121.97 40.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 70.329999999999998 111.138 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.768 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -111.72 125.16 53.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 71.150000000000006 110.946 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.768 ' N ' HD22 ' A' ' 97' ' ' LEU . 8.5 ttpt -133.94 167.03 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 71.340000000000003 110.86 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -85.99 137.16 32.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.908 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.575 ' NE2' HD11 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -100.19 108.66 20.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 72.030000000000001 110.942 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.734 ' CG ' ' HB2' ' A' ' 76' ' ' ALA . 6.4 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.219999999999999 110.912 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.843 0.354 . . . . 74.200000000000003 110.918 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.7 m -116.52 108.2 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 73.329999999999998 111.142 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.65 149.14 52.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 110.907 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.648 ' CE ' HD11 ' A' ' 97' ' ' LEU . 19.8 tptm -164.05 -71.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 74.430000000000007 110.846 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 10.1 t-20 -68.32 157.8 34.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 73.420000000000002 110.912 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.3 t30 86.72 -68.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 70.140000000000001 110.943 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.5 m -125.15 119.68 25.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.537 0.685 . . . . 75.349999999999994 111.161 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 150.64 68.52 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.679 2.252 . . . . 74.450000000000003 112.372 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.411 ' HB ' HD21 ' A' ' 13' ' ' LEU . 60.9 t -77.99 115.77 20.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 71.409999999999997 111.119 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.59 143.9 31.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 64.439999999999998 110.835 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.23 80.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 60.140000000000001 110.879 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.411 HD21 ' HB ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -75.55 -172.77 1.93 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.477 . . . . 73.120000000000005 110.938 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 p -132.74 138.39 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.099999999999994 111.102 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.33 53.71 0.75 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.775 -0.726 . . . . 54.219999999999999 112.502 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -76.27 140.97 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 73.329999999999998 110.9 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -28.38 6.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 73.109999999999999 110.917 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.82 -64.61 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 62.229999999999997 112.443 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -52.22 134.14 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 62.409999999999997 110.844 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -131.21 172.58 11.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 73.099999999999994 110.894 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.465 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.22 138.53 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 72.030000000000001 111.109 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -136.66 147.08 46.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 73.310000000000002 110.894 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -143.59 164.82 29.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 73.030000000000001 110.926 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.442 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -138.28 139.77 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 74.530000000000001 111.18 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -159.53 162.8 35.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 71.109999999999999 110.855 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.694 HG22 HG23 ' A' ' 81' ' ' THR . 15.0 p -133.1 171.11 14.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 54.200000000000003 111.131 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -108.3 169.28 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 111.181 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -98.37 -48.86 4.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 72.219999999999999 110.898 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.67 173.34 11.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.841 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -80.0 117.2 20.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 74.129999999999995 110.913 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.11 144.59 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 72.049999999999997 111.086 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 32' ' ' THR . 2.3 t -104.59 106.4 16.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.425 . . . . 65.340000000000003 111.18 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.93 147.79 46.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 65.329999999999998 111.095 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -108.11 111.81 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 70.540000000000006 111.113 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.401 HG11 ' HG2' ' A' ' 98' ' ' LYS . 84.6 t -126.75 140.83 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 65.430000000000007 111.097 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.484 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 10.7 p -133.31 166.5 22.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 33.219999999999999 110.849 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.81 144.58 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 71.540000000000006 111.161 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.98 -174.99 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 72.319999999999993 110.901 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.75 -0.738 . . . . 51.210000000000001 112.523 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.847 0.356 . . . . 43.43 110.861 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.48 114.75 26.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 63.439999999999998 111.115 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.11 135.67 36.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 71.319999999999993 110.891 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' A' ' 71' ' ' SER . 4.6 tt -102.34 126.84 49.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 71.519999999999996 110.893 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -134.61 149.0 50.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 74.140000000000001 110.91 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.429 HD12 ' NE2' ' A' ' 100' ' ' GLN . 0.4 OUTLIER -155.14 133.32 11.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 54.32 110.954 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HG2' ' HB2' ' A' ' 60' ' ' ASP . 11.5 tttt -144.86 123.42 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 110.851 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.36 71.59 7.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.099999999999994 111.116 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.46 -83.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 75.099999999999994 112.481 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -110.54 141.57 43.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.365 . . . . 73.430000000000007 110.917 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.19 121.85 3.15 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.609 0.719 . . . . 74.25 110.864 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 142.49 48.1 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.712 2.275 . . . . 71.510000000000005 112.335 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -109.66 178.74 4.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 65.420000000000002 111.142 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.1 p -60.07 -17.7 41.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 75.420000000000002 111.159 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 t -114.8 -26.3 7.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.319999999999993 110.85 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.86 124.19 47.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 54.109999999999999 110.847 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.99 153.22 32.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.105 -0.498 . . . . 75.239999999999995 110.909 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB2' ' HG2' ' A' ' 49' ' ' LYS . 8.1 t70 -115.67 -35.33 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 72.420000000000002 110.856 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.8 m -143.76 125.12 14.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.854 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 179.65 157.08 0.72 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.658 0.742 . . . . 73.209999999999994 110.824 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.204 0 C-N-CA 122.661 2.24 . . . . 64.450000000000003 112.321 -179.999 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.56 ' N ' HD21 ' A' ' 68' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.862 0.363 . . . . 65.450000000000003 110.851 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.77 14.14 9.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 74.420000000000002 110.959 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.88 105.67 7.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 73.299999999999997 110.909 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.51 ' HA ' HD13 ' A' ' 46' ' ' LEU . 13.0 m -136.59 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 53.119999999999997 110.831 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.03 153.75 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 64.519999999999996 110.846 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 34' ' ' VAL . 1.1 p -128.24 110.28 12.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 62.130000000000003 110.901 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 t -149.31 153.11 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 73.349999999999994 111.119 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.4 p -73.3 110.85 7.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 63.32 110.854 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.441 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.4 130.79 35.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 53.439999999999998 111.103 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.33 139.23 20.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.59 0.709 . . . . 62.100000000000001 111.126 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 160.21 50.57 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.701 2.267 . . . . 74.439999999999998 112.328 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.5 -18.95 56.01 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.776 -0.726 . . . . 45.219999999999999 112.51 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 m -111.94 122.84 48.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.87 0.367 . . . . 71.25 111.163 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.694 HG23 HG22 ' A' ' 26' ' ' THR . 10.4 m -71.24 136.27 47.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 72.140000000000001 111.152 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.441 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 60.4 m-85 -103.76 141.68 35.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.928 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -107.36 160.75 15.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 71.040000000000006 110.837 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG11 ' HD3' ' A' ' 5' ' ' LYS . 2.4 t -138.19 138.36 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 111.108 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.89 122.98 13.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 71.420000000000002 110.88 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.465 ' HB ' HG23 ' A' ' 21' ' ' VAL . 18.0 mm -118.04 112.6 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.239999999999995 111.139 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -104.48 130.44 52.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 72.319999999999993 110.906 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.37 161.03 21.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 53.210000000000001 112.452 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.25 -28.59 5.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 72.5 110.923 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.51 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -166.56 132.64 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 64.230000000000004 110.817 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 90' ' ' SER . 1.5 p-10 -28.35 115.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 72.549999999999997 110.878 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.4 113.85 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.409999999999997 110.94 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 p -121.55 156.59 32.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 72.420000000000002 110.847 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.02 23.12 1.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 75.430000000000007 112.489 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.04 145.98 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.962 0.41 . . . . 75.019999999999996 111.098 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.7 m -99.29 114.73 27.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 53.399999999999999 111.137 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.769 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -104.69 125.58 50.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 63.030000000000001 110.931 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.769 ' N ' HD22 ' A' ' 97' ' ' LEU . 5.1 ttpt -133.41 165.09 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.934 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.46 138.5 31.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.409999999999997 110.92 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.438 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 1.4 pm0 -98.87 112.84 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 110.93 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.9 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 60.530000000000001 110.929 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.856 0.36 . . . . 73.310000000000002 110.912 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.9 m -118.46 108.57 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 75.549999999999997 111.15 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.58 147.84 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 63.240000000000002 110.978 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.444 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 17.9 tptt -158.49 -39.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 75.150000000000006 110.871 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.638 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -108.24 158.1 17.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 72.409999999999997 110.95 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 5.9 t30 90.04 -68.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.340000000000003 110.883 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.4 m -126.34 113.83 23.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.576 0.703 . . . . 72.310000000000002 111.135 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.7 Cg_endo -69.78 153.51 68.76 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.658 2.239 . . . . 73.129999999999995 112.372 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.25 113.18 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 75.219999999999999 111.124 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.11 149.4 28.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 72.439999999999998 110.864 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 47.33 66.59 0.97 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 74.510000000000005 110.86 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -67.05 -174.16 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 74.120000000000005 110.902 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 p -131.14 138.24 49.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 73.340000000000003 111.188 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.64 57.19 0.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 74.209999999999994 112.489 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -75.65 139.35 41.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 34.130000000000003 110.921 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -27.6 7.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 110.87 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.12 -60.63 0.5 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 73.400000000000006 112.479 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.84 140.68 51.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 55.219999999999999 110.872 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -135.85 170.26 16.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 110.915 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.577 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.46 139.11 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 75.239999999999995 111.111 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -137.01 145.17 43.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 73.109999999999999 110.886 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -142.09 165.84 26.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 75.430000000000007 110.923 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.426 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 51.9 m -146.12 142.12 28.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 72.230000000000004 111.148 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 4.1 t80 -160.49 162.56 33.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 71.129999999999995 110.917 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.623 HG22 HG23 ' A' ' 81' ' ' THR . 18.1 p -128.88 170.44 13.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 71.319999999999993 111.164 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.754 HG11 ' CE1' ' A' ' 101' ' ' TYR . 15.9 m -108.12 173.26 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 63.43 111.146 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -110.44 -59.32 1.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 72.129999999999995 110.845 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.64 140.9 51.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 64.099999999999994 110.855 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.15 119.91 4.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.844 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.36 129.86 25.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.329999999999998 111.074 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 75' ' ' SER . 21.2 m -94.28 106.17 18.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 63.439999999999998 111.156 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.621 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -140.87 150.97 43.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.510000000000005 111.155 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.4 p -103.75 112.04 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 73.430000000000007 111.143 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.551 HG11 ' CG ' ' A' ' 98' ' ' LYS . 5.3 t -127.17 141.79 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 54.200000000000003 111.1 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 8.0 p -142.09 171.45 14.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 43.340000000000003 110.87 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.689 HD13 HD12 ' A' ' 46' ' ' LEU . 5.3 pt -107.04 158.69 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 74.239999999999995 111.128 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.56 165.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 73.239999999999995 110.88 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 64.439999999999998 112.524 -179.98 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.804 0.335 . . . . 71.109999999999999 110.868 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.68 111.58 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 44.310000000000002 111.11 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -80.26 164.55 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 55.229999999999997 110.819 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.689 HD12 HD13 ' A' ' 37' ' ' ILE . 8.5 tt -124.18 138.43 54.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 72.25 110.879 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.524 ' N ' HD23 ' A' ' 46' ' ' LEU . 94.9 m-85 -152.63 133.58 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.932 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp -139.26 153.02 47.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 62.329999999999998 110.904 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -156.36 145.99 20.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 75.239999999999995 110.912 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.66 101.56 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 61.200000000000003 111.086 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.84 -92.98 0.75 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 41.140000000000001 112.517 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 m -82.83 129.26 34.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.994 0.426 . . . . 61.100000000000001 110.837 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.44 137.12 5.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.554 0.692 . . . . 73.099999999999994 110.912 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.73 51.74 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.672 2.248 . . . . 73.409999999999997 112.33 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -101.38 178.54 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 74.219999999999999 111.155 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 p -64.94 -14.39 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 71.319999999999993 111.16 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.5 t -120.31 -26.14 5.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 60.200000000000003 110.899 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.75 125.48 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 74.430000000000007 110.876 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.64 153.59 34.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.925 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -110.71 -23.17 11.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 64.409999999999997 110.821 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.0 m -143.64 122.71 12.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 64.209999999999994 110.867 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 177.9 117.26 0.18 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 65.439999999999998 110.903 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HG2' ' CG ' ' A' ' 70' ' ' GLU . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.174 0 C-N-CA 122.671 2.247 . . . . 73.310000000000002 112.36 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.809 0.338 . . . . 65.530000000000001 110.899 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.6 t30 53.79 27.9 7.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 70.329999999999998 110.923 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.4 ' CG ' ' HG2' ' A' ' 63' ' ' PRO . 3.3 tt0 -131.15 81.27 1.98 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 64.25 110.876 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.654 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -132.51 170.75 14.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 72.230000000000004 110.877 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -119.28 156.91 29.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 35.210000000000001 110.898 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.455 ' HB3' HG23 ' A' ' 34' ' ' VAL . 81.0 p -128.94 106.77 9.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 73.030000000000001 110.87 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -151.75 153.25 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 62.219999999999999 111.12 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.446 ' HB3' HG23 ' A' ' 32' ' ' THR . 83.8 p -84.93 107.68 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.209999999999994 110.888 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.683 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.09 154.9 25.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 60.310000000000002 111.077 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.17 138.57 19.56 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.549 0.69 . . . . 72.209999999999994 111.134 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.525 ' HA ' HG23 ' A' ' 27' ' ' VAL . 54.0 Cg_endo -69.72 134.23 27.56 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.694 2.262 . . . . 71.040000000000006 112.388 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.9 -21.98 4.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 23.149999999999999 112.505 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -114.3 131.68 56.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 72.129999999999995 111.142 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.623 HG23 HG22 ' A' ' 26' ' ' THR . 4.8 m -71.95 137.38 47.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 111.186 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.683 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 62.6 m-85 -112.05 133.0 54.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 75.340000000000003 110.921 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -107.08 161.19 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 52.409999999999997 110.892 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.416 HG21 ' HB2' ' A' ' 5' ' ' LYS . 2.1 t -137.08 138.35 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 74.450000000000003 111.148 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 tpt -134.82 122.84 22.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.219999999999999 110.876 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 21' ' ' VAL . 25.3 mm -112.5 116.01 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 111.134 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 145.54 29.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 62.329999999999998 110.864 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.45 151.74 18.23 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 71.420000000000002 112.457 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -107.33 -28.13 10.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 72.209999999999994 110.878 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.466 ' O ' ' C ' ' A' ' 91' ' ' ASN . 88.5 p -175.37 144.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 52.420000000000002 110.877 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 90' ' ' SER . 3.0 p30 -32.64 105.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.492 . . . . 63.409999999999997 110.942 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -166.77 118.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.897 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.9 p -122.01 160.82 24.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 61.329999999999998 110.852 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.36 23.44 2.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 44.329999999999998 112.475 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.528 ' O ' HD12 ' A' ' 13' ' ' LEU . 3.1 t -113.81 146.58 18.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.887 0.375 . . . . 64.349999999999994 111.156 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -106.86 135.06 49.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 72.329999999999998 111.146 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.699 HD13 ' C ' ' A' ' 97' ' ' LEU . 2.5 tm? -118.58 128.03 54.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 64.430000000000007 110.866 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.551 ' CG ' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -138.12 154.65 49.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 62.229999999999997 110.929 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -87.3 145.1 26.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 62.229999999999997 110.904 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.487 ' O ' ' CD ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -94.86 112.98 24.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 72.439999999999998 110.978 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.754 ' CE1' HG11 ' A' ' 27' ' ' VAL . 2.3 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.319999999999993 110.926 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.3 m120 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.834 0.349 . . . . 64.519999999999996 110.894 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.413 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.4 m -121.77 109.16 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 70.420000000000002 111.135 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.27 149.01 52.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 72.420000000000002 110.916 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.628 ' HE3' HD11 ' A' ' 97' ' ' LEU . 2.2 tppm? -155.73 -73.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 65.0 110.907 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.8 t-20 -64.22 158.66 22.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.030000000000001 110.874 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.6 t30 91.21 -68.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 73.549999999999997 110.886 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 m -132.71 121.79 17.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.576 0.703 . . . . 51.530000000000001 111.155 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.658 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.7 Cg_endo -69.8 154.85 67.1 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 71.510000000000005 112.341 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.44 115.36 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 111.136 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.49 166.39 13.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 70.0 110.872 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 39.97 52.05 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 73.340000000000003 110.876 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.758 HD11 ' CB ' ' A' ' 97' ' ' LEU . 2.4 mt -57.84 -178.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 71.310000000000002 110.944 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 p -137.19 138.15 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 61.219999999999999 111.078 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.66 56.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.751 . . . . 35.25 112.493 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -74.79 150.96 39.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 74.540000000000006 110.902 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.71 -33.49 10.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 110.872 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.59 -57.84 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 75.420000000000002 112.496 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.77 139.04 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 72.109999999999999 110.863 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -139.01 175.01 9.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 62.130000000000003 110.907 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.573 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.97 135.65 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 62.229999999999997 111.158 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -138.87 149.81 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.200000000000003 110.902 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -145.96 166.36 26.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 74.329999999999998 110.929 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.499 HG23 ' CD2' ' A' ' 83' ' ' HIS . 58.5 m -138.75 138.91 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 64.129999999999995 111.142 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CB ' ' HB3' ' A' ' 5' ' ' LYS . 2.3 t80 -160.94 153.17 20.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 74.439999999999998 110.915 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 81' ' ' THR . 10.9 p -127.92 170.44 12.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 71.109999999999999 111.14 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' A' ' 101' ' ' TYR . 13.9 m -113.02 170.83 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 64.540000000000006 111.109 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.15 11.45 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 65.530000000000001 110.84 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.58 137.79 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 74.450000000000003 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -72.85 118.85 16.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 64.030000000000001 110.871 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.31 145.57 37.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 61.130000000000003 111.094 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 32' ' ' THR . 1.8 t -107.92 104.95 14.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 72.140000000000001 111.1 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 101' ' ' TYR . . . -139.57 149.1 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.349999999999994 111.117 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.624 HG22 ' CB ' ' A' ' 73' ' ' SER . 90.9 t -113.63 111.85 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 63.539999999999999 111.113 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.01 140.86 47.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 53.299999999999997 111.078 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.507 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 6.0 p -124.86 166.74 15.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 60.039999999999999 110.826 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -111.21 151.07 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 71.349999999999994 111.136 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.53 168.0 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 72.129999999999995 110.866 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 53.420000000000002 112.499 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.847 0.356 . . . . 63.549999999999997 110.867 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.65 117.16 29.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 74.310000000000002 111.109 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -85.23 163.83 18.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 73.439999999999998 110.889 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.68 HD13 ' HA ' ' A' ' 71' ' ' SER . 6.3 tt -120.31 127.56 52.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.010000000000005 110.924 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -137.63 153.23 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 62.219999999999999 110.889 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 49' ' ' LYS . 1.5 tt -154.34 140.46 18.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 75.310000000000002 110.923 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.591 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -148.17 141.55 25.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 75.209999999999994 110.923 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.35 126.97 35.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 44.420000000000002 111.11 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.85 -61.02 0.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 54.329999999999998 112.527 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.75 -173.03 2.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.955 0.407 . . . . 63.43 110.837 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 134.13 30.56 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.566 0.698 . . . . 53.119999999999997 110.925 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 143.38 50.82 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.708 2.272 . . . . 74.120000000000005 112.32 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 p -104.49 178.71 4.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 65.540000000000006 111.123 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.9 p -64.03 -15.14 58.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 70.25 111.168 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.0 m -119.84 -26.06 5.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.120000000000005 110.864 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.11 126.08 48.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 72.109999999999999 110.843 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.99 154.03 36.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 72.099999999999994 110.888 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -115.88 -34.52 4.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 72.049999999999997 110.864 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.2 m -145.39 124.42 12.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 65.219999999999999 110.886 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.16 150.18 1.23 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 74.450000000000003 110.921 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.231 0.159 0 C-N-CA 122.714 2.276 . . . . 41.32 112.318 -179.977 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.813 0.339 . . . . 61.039999999999999 110.918 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.99 16.06 9.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 65.310000000000002 110.873 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -127.44 96.88 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 71.150000000000006 110.87 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.68 ' HA ' HD13 ' A' ' 46' ' ' LEU . 1.4 m -134.78 170.73 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 54.020000000000003 110.91 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.79 162.62 19.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 71.349999999999994 110.863 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.624 ' CB ' HG22 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -131.37 111.62 12.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 75.120000000000005 110.886 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.7 t -149.11 153.65 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 72.010000000000005 111.171 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.3 p -94.28 105.74 17.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 65.439999999999998 110.913 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.785 ' HB3' ' CD2' ' A' ' 101' ' ' TYR . . . -86.39 152.19 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 75.540000000000006 111.08 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.21 142.73 26.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.572 0.701 . . . . 71.019999999999996 111.119 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.3 Cg_endo -69.78 120.57 7.33 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 73.519999999999996 112.308 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.6 -19.94 0.9 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 32.229999999999997 112.465 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 m -122.76 136.57 54.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.372 . . . . 64.040000000000006 111.11 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.54 ' HA ' HG22 ' A' ' 26' ' ' THR . 62.5 m -71.77 138.02 48.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 72.439999999999998 111.109 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -118.3 142.84 47.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 110.927 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.499 ' CD2' HG23 ' A' ' 24' ' ' THR . 13.9 m-70 -121.94 160.76 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 74.209999999999994 110.88 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.551 HG11 ' HE3' ' A' ' 5' ' ' LYS . 16.5 t -133.45 125.31 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.540000000000006 111.173 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.65 128.98 55.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 110.886 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.573 ' HB ' HG23 ' A' ' 21' ' ' VAL . 34.0 mm -118.41 114.01 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 73.030000000000001 111.128 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.15 150.17 21.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 70.349999999999994 110.897 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -112.16 160.75 13.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 74.430000000000007 112.481 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -119.0 -24.56 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.918 0.389 . . . . 63.25 110.955 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 91' ' ' ASN . 52.1 p -176.77 144.13 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 54.310000000000002 110.87 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 90' ' ' SER . 42.4 t30 -32.69 106.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 74.310000000000002 110.893 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -166.54 115.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 110.903 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.1 p -121.76 155.35 35.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 63.450000000000003 110.838 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.05 26.74 1.82 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 62.25 112.508 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.417 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.2 t -113.91 139.62 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 73.299999999999997 111.122 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.658 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -100.58 114.89 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 52.509999999999998 111.153 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.799 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -105.13 128.64 53.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.909 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.799 ' N ' HD22 ' A' ' 97' ' ' LEU . 1.5 ttpt -133.34 171.2 14.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 51.509999999999998 110.91 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.755 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -88.14 137.47 32.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 71.450000000000003 110.952 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.463 ' C ' ' HD1' ' A' ' 101' ' ' TYR . 1.8 pp0? -108.76 112.58 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 70.400000000000006 110.908 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 5.1 m-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 74.549999999999997 110.946 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.842 0.353 . . . . 73.310000000000002 110.883 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.42 ' HB ' ' H ' ' A' ' 24' ' ' THR . 1.9 m -118.15 109.49 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.140000000000001 111.128 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.32 147.61 52.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 72.340000000000003 110.932 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.658 ' HE3' HG11 ' A' ' 84' ' ' VAL . 8.8 tptp -158.78 -69.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 74.230000000000004 110.895 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.688 ' CG ' HD22 ' A' ' 99' ' ' LEU . 17.0 t-20 -76.08 158.23 32.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 73.129999999999995 110.91 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.0 t-20 88.58 -68.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 72.519999999999996 110.902 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 m -125.28 115.02 25.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.599 0.714 . . . . 73.230000000000004 111.143 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.5 Cg_endo -69.76 150.24 67.97 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.663 2.242 . . . . 72.230000000000004 112.331 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.411 ' HB ' HD13 ' A' ' 13' ' ' LEU . 21.2 t -77.6 113.51 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 111.095 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.7 147.8 30.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 64.530000000000001 110.859 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.66 64.36 1.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 72.510000000000005 110.932 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 13' ' ' LEU . 5.0 tp -58.95 -175.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 61.229999999999997 110.897 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 p -136.09 139.29 42.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 75.340000000000003 111.128 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.83 60.48 0.58 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 43.340000000000003 112.458 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -76.48 138.71 40.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.896 0.379 . . . . 62.32 110.925 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -29.1 8.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 75.030000000000001 110.902 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.13 -62.08 0.46 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 65.129999999999995 112.49 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.6 m -60.67 151.44 29.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.887 0.375 . . . . 75.420000000000002 110.807 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.31 179.4 8.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 63.530000000000001 110.904 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.437 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.71 149.18 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 61.539999999999999 111.109 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -136.78 134.85 37.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 73.349999999999994 110.853 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.9 165.48 25.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 73.540000000000006 110.931 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.42 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 55.3 m -147.92 141.72 25.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.497 . . . . 74.040000000000006 111.154 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 2.1 t80 -159.34 163.28 35.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 110.89 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.695 ' CG2' HG23 ' A' ' 81' ' ' THR . 14.2 p -131.41 170.98 13.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 52.240000000000002 111.186 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 76' ' ' ALA . 26.9 m -106.91 169.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 71.230000000000004 111.131 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -108.42 -47.1 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 62.25 110.855 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -129.73 155.47 45.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 71.420000000000002 110.897 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -77.42 115.7 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 62.32 110.859 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.45 145.89 34.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 64.219999999999999 111.108 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 32' ' ' THR . 2.7 t -99.25 107.31 19.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.319999999999993 111.121 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.594 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -137.06 148.8 47.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 51.130000000000003 111.099 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 73' ' ' SER . 2.9 p -105.78 111.07 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 75.109999999999999 111.169 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.609 HG11 ' HG2' ' A' ' 98' ' ' LYS . 9.9 t -127.06 140.4 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 51.409999999999997 111.15 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.534 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 0.1 OUTLIER -139.6 169.02 18.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 72.150000000000006 110.873 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.708 HG21 HD12 ' A' ' 97' ' ' LEU . 1.3 pt -110.14 159.36 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 72.329999999999998 111.165 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 171.17 167.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 72.030000000000001 110.889 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 55.229999999999997 112.49 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.825 0.345 . . . . 65.340000000000003 110.838 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.562 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -90.44 123.88 34.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 61.32 111.119 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -80.35 147.31 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 74.540000000000006 110.879 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.54 HD12 HD13 ' A' ' 37' ' ' ILE . 7.0 tt -113.49 127.08 55.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 61.219999999999999 110.932 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.73 148.56 44.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 75.439999999999998 110.932 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 82' ' ' TYR . 0.5 OUTLIER -154.15 132.93 12.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 74.310000000000002 110.882 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.486 ' HG3' ' HB3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -144.71 131.12 19.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 72.129999999999995 110.894 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HB1' HG21 ' A' ' 80' ' ' THR . . . -65.53 -66.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 72.510000000000005 111.128 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -45.36 -90.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 61.340000000000003 112.49 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.18 -168.59 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 74.230000000000004 110.895 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 132.88 87.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 63.340000000000003 110.887 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HB3' ' HG3' ' A' ' 49' ' ' LYS . 53.6 Cg_endo -69.75 140.71 43.39 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 60.32 112.351 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.18 178.75 4.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 62.409999999999997 111.146 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -66.41 -13.1 60.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 71.530000000000001 111.173 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -124.08 -25.97 4.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.140000000000001 110.87 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.52 124.37 47.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 74.209999999999994 110.868 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.73 153.87 33.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.489 . . . . 74.109999999999999 110.896 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -102.02 -31.75 10.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 72.140000000000001 110.885 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.8 m -140.24 122.67 16.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 74.049999999999997 110.876 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -176.11 134.44 0.44 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 65.150000000000006 110.854 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--O 1.231 0.159 0 C-N-CA 122.634 2.223 . . . . 72.109999999999999 112.341 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.836 ' ND2' HG11 ' A' ' 95' ' ' VAL . 11.8 m120 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.857 0.36 . . . . 71.340000000000003 110.896 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 t30 61.5 28.03 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 74.209999999999994 110.915 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.65 89.92 2.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 65.530000000000001 110.877 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.534 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -129.05 172.6 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 60.310000000000002 110.883 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.19 162.07 18.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.119 -0.491 . . . . 74.420000000000002 110.881 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.726 ' HB3' HG23 ' A' ' 34' ' ' VAL . 32.3 p -128.51 109.14 11.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 55.020000000000003 110.847 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.98 152.99 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 74.340000000000003 111.114 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.8 p -80.53 113.82 18.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 72.099999999999994 110.839 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.73 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.29 131.04 35.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 34.229999999999997 111.091 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.74 136.49 22.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.594 0.711 . . . . 73.150000000000006 111.077 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 124.92 11.55 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 73.109999999999999 112.355 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.73 -18.55 2.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 73.310000000000002 112.516 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.461 HG21 ' HB1' ' A' ' 50' ' ' ALA . 39.7 m -125.6 131.51 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 52.530000000000001 111.149 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.695 HG23 ' CG2' ' A' ' 26' ' ' THR . 10.8 m -72.44 137.63 46.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 54.119999999999997 111.149 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.73 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 52.9 m-85 -107.81 131.65 54.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 70.109999999999999 110.957 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -107.14 158.96 16.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 65.140000000000001 110.867 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.658 HG11 ' HE3' ' A' ' 5' ' ' LYS . 67.8 t -137.71 138.17 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 62.340000000000003 111.157 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.3 tpt -129.03 121.54 28.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 64.519999999999996 110.847 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.449 HG23 ' HB1' ' A' ' 44' ' ' ALA . 25.3 mm -109.63 114.41 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 65.319999999999993 111.158 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -109.12 139.86 43.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 73.239999999999995 110.915 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.88 150.05 16.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 75.129999999999995 112.46 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -117.81 -17.07 9.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.878 0.37 . . . . 71.340000000000003 110.946 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -177.89 129.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 72.109999999999999 110.867 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 90' ' ' SER . 54.5 t-20 -29.62 109.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 63.149999999999999 110.844 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -166.5 112.72 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 72.400000000000006 110.925 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.1 p -120.71 166.42 13.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 54.549999999999997 110.844 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.9 23.07 4.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.747 -0.739 . . . . 41.43 112.471 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.836 HG11 ' ND2' ' A' ' 68' ' ' ASN . 9.6 t -113.29 148.34 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 65.109999999999999 111.107 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.3 m -106.68 126.17 51.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 71.319999999999993 111.161 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 37' ' ' ILE . 3.4 tp -108.4 135.13 50.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 63.140000000000001 110.896 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.609 ' HG2' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -144.79 154.63 42.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 110.884 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.688 HD22 ' CG ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -88.7 144.65 26.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 71.530000000000001 110.906 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.481 ' O ' ' CD ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -94.13 112.85 24.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 61.409999999999997 110.88 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.594 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 15.0 p90 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 64.239999999999995 110.947 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.895 0.379 . . . . 74.549999999999997 110.884 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.428 ' HB ' ' H ' ' A' ' 24' ' ' THR . 1.9 m -117.94 107.96 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 74.030000000000001 111.138 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.975 HD12 HG22 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -133.34 149.0 51.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.0 110.905 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.679 ' HZ3' HD11 ' A' ' 97' ' ' LEU . 13.4 tptt -174.65 -74.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 62.009999999999998 110.921 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.613 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -70.13 153.17 43.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 72.239999999999995 110.858 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.2 t30 78.07 -58.88 0.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 64.310000000000002 110.906 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.5 m -122.75 119.32 28.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.615 0.722 . . . . 74.099999999999994 111.125 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 137.93 36.7 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.701 2.267 . . . . 71.099999999999994 112.357 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.975 HG22 HD12 ' A' ' 4' ' ' LEU . 46.4 t -77.27 114.93 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 72.209999999999994 111.17 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 p -87.62 163.2 16.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 41.539999999999999 110.859 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 40.18 64.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 74.349999999999994 110.888 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.552 HD22 HG12 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -64.35 -164.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 72.299999999999997 110.911 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.422 ' H ' HD12 ' A' ' 13' ' ' LEU . 3.5 p -147.4 136.73 22.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 63.130000000000003 111.145 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.4 67.17 0.47 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 75.299999999999997 112.452 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -76.05 135.49 39.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 63.420000000000002 110.912 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -30.64 23.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 61.399999999999999 110.944 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.34 -46.71 0.98 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 74.409999999999997 112.491 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.15 160.83 27.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 74.019999999999996 110.872 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -143.95 169.02 18.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 70.010000000000005 110.893 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.466 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -131.14 150.53 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.239999999999995 111.089 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -138.85 151.34 46.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.519999999999996 110.893 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -148.95 166.65 27.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 74.409999999999997 110.906 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.428 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 10.7 m -148.59 140.67 23.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 52.409999999999997 111.106 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' HD1' HD21 ' A' ' 6' ' ' ASN . 0.3 OUTLIER -160.74 162.71 32.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 72.099999999999994 110.854 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.436 ' CG2' HG23 ' A' ' 81' ' ' THR . 17.1 p -131.09 170.66 14.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 54.229999999999997 111.127 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 78' ' ' PRO . 17.5 m -108.27 170.01 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 75.430000000000007 111.122 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.46 -50.8 3.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 35.0 110.849 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 167.12 21.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 72.549999999999997 110.925 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -80.19 115.52 19.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 70.040000000000006 110.911 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.2 141.91 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 70.310000000000002 111.12 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 32' ' ' THR . 2.9 t -94.7 106.28 18.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.109999999999999 111.149 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.26 149.21 45.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.239999999999995 111.127 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.723 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.5 p -105.49 112.56 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 62.039999999999999 111.145 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.737 HG11 ' HG2' ' A' ' 98' ' ' LYS . 20.9 t -123.72 140.52 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 111.078 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.509 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 11.6 p -139.97 165.48 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 44.43 110.868 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.841 HG21 HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -111.77 154.64 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 73.219999999999999 111.124 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -167.51 153.11 7.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.400000000000006 110.827 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 95' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 60.329999999999998 112.529 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.825 0.345 . . . . 51.329999999999998 110.861 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.547 ' HB1' HG23 ' A' ' 86' ' ' ILE . . . -89.54 131.53 35.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 71.109999999999999 111.119 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.52 133.33 35.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 61.140000000000001 110.906 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 71' ' ' SER . 2.4 tt -92.93 138.14 31.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 61.420000000000002 110.87 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -152.42 143.04 22.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 70.329999999999998 110.947 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -150.68 146.68 26.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 63.109999999999999 110.929 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' H ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -156.05 112.12 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 72.439999999999998 110.904 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.35 119.35 7.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 75.349999999999994 111.121 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.21 -81.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.734 . . . . 73.219999999999999 112.485 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.6 p -99.14 -174.28 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.965 0.412 . . . . 74.349999999999994 110.83 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.58 133.76 27.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.692 . . . . 70.230000000000004 110.892 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 141.69 45.72 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.711 2.274 . . . . 61.25 112.293 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 p -102.29 178.96 4.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 111.124 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 p -65.24 -14.39 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 111.163 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.2 m -120.03 -26.68 5.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 63.530000000000001 110.879 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.07 126.38 50.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 70.319999999999993 110.832 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.15 154.02 36.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 74.25 110.939 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.43 -31.86 6.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.423 . . . . 73.219999999999999 110.819 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.7 m -142.06 123.14 14.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 53.32 110.853 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 176.44 134.48 0.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.562 0.696 . . . . 75.540000000000006 110.904 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.268 . . . . 73.200000000000003 112.346 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.596 ' HB3' HG11 ' A' ' 95' ' ' VAL . 7.7 p30 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.858 0.361 . . . . 60.409999999999997 110.893 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 66.33 10.63 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.902 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.461 ' H ' HD11 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -126.47 91.33 3.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 70.409999999999997 110.912 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.509 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -133.8 171.66 13.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 73.349999999999994 110.853 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.45 157.94 27.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 64.409999999999997 110.877 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.723 ' HB3' HG23 ' A' ' 34' ' ' VAL . 2.6 p -128.41 109.57 11.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 53.299999999999997 110.867 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.8 t -150.13 152.82 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 72.409999999999997 111.133 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 85.6 p -74.1 104.57 4.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 72.420000000000002 110.826 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.27 131.41 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 71.329999999999998 111.105 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.92 142.25 24.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.561 0.696 . . . . 53.32 111.139 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.473 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.5 Cg_endo -69.71 162.06 43.52 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.741 2.294 . . . . 33.420000000000002 112.343 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.14 -21.69 42.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.792 -0.718 . . . . 74.230000000000004 112.488 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -106.77 123.63 48.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 65.219999999999999 111.146 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.436 HG23 ' CG2' ' A' ' 26' ' ' THR . 2.4 m -71.49 135.0 46.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 73.510000000000005 111.134 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.46 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 50.9 m-85 -108.68 133.69 52.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.905 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -109.17 147.79 31.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 73.329999999999998 110.855 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG11 HD21 ' A' ' 97' ' ' LEU . 3.2 t -123.54 138.81 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 63.109999999999999 111.136 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.81 122.41 25.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.310000000000002 110.858 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.547 HG23 ' HB1' ' A' ' 44' ' ' ALA . 15.5 mm -114.83 111.65 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 72.340000000000003 111.115 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 -65.11 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.907 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 44' ' ' ALA . . . 114.39 -146.84 18.76 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 73.329999999999998 112.482 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -175.78 -57.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.898 0.38 . . . . 73.420000000000002 110.932 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' ASN . 3.0 p -144.85 128.0 16.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 73.430000000000007 110.865 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 90' ' ' SER . 34.6 t30 -33.86 104.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 74.439999999999998 110.919 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.15 139.46 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.905 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.4 p -122.52 157.22 32.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 72.409999999999997 110.85 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 135.95 25.31 0.49 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.761 -0.733 . . . . 63.109999999999999 112.504 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.596 HG11 ' HB3' ' A' ' 68' ' ' ASN . 1.3 t -113.64 147.35 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.925 0.393 . . . . 72.219999999999999 111.098 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 1.3 m -106.17 112.81 26.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 73.040000000000006 111.181 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.841 HD12 HG21 ' A' ' 37' ' ' ILE . 5.2 tp -102.91 142.56 33.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 72.219999999999999 110.936 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.737 ' HG2' HG11 ' A' ' 35' ' ' VAL . 6.4 ttpt -153.74 161.99 41.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 71.109999999999999 110.865 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.613 HD22 ' HB2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -91.41 143.81 26.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.230000000000004 110.929 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.496 ' O ' ' CD ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.31 110.88 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 71.230000000000004 110.883 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.557 ' HB3' HD21 ' A' ' 99' ' ' LEU . 35.9 p90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 74.549999999999997 110.963 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.4 m120 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.861 0.363 . . . . 75.140000000000001 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.428 ' HB ' ' H ' ' A' ' 24' ' ' THR . 1.8 m -115.12 109.19 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 72.519999999999996 111.115 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.14 148.34 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 74.540000000000006 110.923 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.68 ' HE3' HG11 ' A' ' 84' ' ' VAL . 1.7 tppm? -165.19 -74.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 70.049999999999997 110.919 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -63.96 155.18 31.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 73.140000000000001 110.893 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.2 t-20 88.23 -61.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 70.319999999999993 110.886 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 m -130.09 120.38 19.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 73.099999999999994 111.185 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.0 Cg_endo -69.79 153.38 68.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 41.450000000000003 112.341 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -85.22 114.23 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 75.340000000000003 111.188 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 p -88.69 167.45 13.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 61.520000000000003 110.856 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 40.5 53.23 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 70.129999999999995 110.87 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -54.75 178.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 55.219999999999999 110.905 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -135.37 138.08 42.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.349999999999994 111.112 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.47 68.91 0.53 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.759 . . . . 65.420000000000002 112.477 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -76.42 138.43 40.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 73.0 110.897 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -17.11 38.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 72.120000000000005 110.874 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.15 -41.44 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.805 -0.712 . . . . 64.140000000000001 112.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 m -90.68 168.66 11.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 73.549999999999997 110.929 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.0 -176.37 5.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 71.349999999999994 110.933 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.87 144.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 111.072 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -138.5 149.63 45.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 74.400000000000006 110.875 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -147.9 166.52 27.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 74.5 110.941 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.428 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 63.4 m -143.76 139.46 29.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 71.299999999999997 111.16 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -159.27 160.55 35.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 51.310000000000002 110.895 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.756 HG22 HG23 ' A' ' 81' ' ' THR . 10.9 p -129.88 171.76 12.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 71.140000000000001 111.114 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 78' ' ' PRO . 32.2 m -106.61 170.63 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 72.450000000000003 111.094 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -113.03 -41.58 3.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 74.219999999999999 110.888 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 158.6 39.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 65.040000000000006 110.851 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -80.53 115.2 19.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 74.109999999999999 110.842 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.19 140.3 30.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 53.350000000000001 111.119 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 32' ' ' THR . 2.8 t -95.71 105.93 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 72.25 111.127 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.97 148.58 45.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 63.530000000000001 111.143 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.696 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.1 p -106.63 111.47 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 71.340000000000003 111.116 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.91 140.14 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 75.109999999999999 111.138 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.51 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 92.9 p -142.72 167.72 21.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 54.329999999999998 110.831 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -108.87 144.14 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 44.210000000000001 111.114 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p -178.01 166.77 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 74.450000000000003 110.871 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.761 -0.733 . . . . 71.120000000000005 112.484 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.859 0.361 . . . . 55.229999999999997 110.883 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.52 ' HB1' ' CG2' ' A' ' 86' ' ' ILE . . . -91.81 110.65 21.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 51.439999999999998 111.106 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -72.44 155.55 39.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 71.219999999999999 110.886 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.74 HD22 ' HA ' ' A' ' 71' ' ' SER . 1.2 tt -127.55 138.28 52.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 110.938 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.547 ' CZ ' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -146.7 146.14 30.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 110.919 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.26 152.68 47.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 74.219999999999999 110.903 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -153.35 115.71 4.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 71.030000000000001 110.874 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 80' ' ' THR . . . -65.27 120.97 13.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 42.450000000000003 111.075 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.82 -76.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 75.430000000000007 112.452 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 t -107.82 -179.53 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 63.119999999999997 110.853 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.02 133.68 40.61 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.553 0.692 . . . . 72.349999999999994 110.917 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 143.92 52.15 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 71.409999999999997 112.339 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.19 179.03 4.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 71.239999999999995 111.148 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -67.79 -12.46 60.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 71.310000000000002 111.184 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 m -120.96 -28.28 4.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 51.229999999999997 110.885 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.19 124.01 48.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 73.150000000000006 110.817 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -152.86 153.99 34.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 72.430000000000007 110.941 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -107.15 -35.29 6.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 70.409999999999997 110.888 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.5 m -127.9 123.92 36.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 41.229999999999997 110.853 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -175.22 120.39 0.33 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.658 0.742 . . . . 71.150000000000006 110.877 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.26 . . . . 73.310000000000002 112.357 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.629 ' ND2' HG11 ' A' ' 95' ' ' VAL . 24.6 m120 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.812 0.339 . . . . 75.049999999999997 110.889 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 72.01 16.28 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 110.888 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.42 103.75 5.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 64.109999999999999 110.86 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.74 ' HA ' HD22 ' A' ' 46' ' ' LEU . 2.3 m -134.32 174.68 10.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 74.420000000000002 110.855 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.67 152.54 32.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 110.893 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.696 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.1 p -127.73 111.51 13.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 45.5 110.851 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 t -149.28 152.29 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 65.129999999999995 111.141 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.9 p -71.71 106.9 4.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 75.420000000000002 110.908 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.3 131.48 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.340000000000003 111.093 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.32 142.58 24.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.594 0.712 . . . . 75.439999999999998 111.07 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.515 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.7 Cg_endo -69.75 126.37 13.24 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.747 2.298 . . . . 75.030000000000001 112.345 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.57 -27.13 3.41 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.711 -0.757 . . . . 72.409999999999997 112.467 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.561 HG21 ' HB1' ' A' ' 50' ' ' ALA . 16.4 m -106.53 124.64 49.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 60.119999999999997 111.135 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.756 HG23 HG22 ' A' ' 26' ' ' THR . 9.2 m -71.55 138.06 48.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 74.150000000000006 111.108 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.523 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 40.6 m-85 -112.15 150.5 30.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 71.230000000000004 110.901 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -131.56 145.16 51.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 73.030000000000001 110.873 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.68 HG11 ' HE3' ' A' ' 5' ' ' LYS . 14.9 t -121.96 133.59 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 61.210000000000001 111.092 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.403 ' O ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -126.8 133.54 50.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.409999999999997 110.832 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.52 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 30.4 mm -119.31 134.53 62.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 64.120000000000005 111.133 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.499 ' HB3' ' OH ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -140.23 113.47 8.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 73.030000000000001 110.883 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.09 161.2 25.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 75.439999999999998 112.517 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.75 -29.18 13.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.889 0.376 . . . . 72.510000000000005 110.908 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.494 ' O ' ' C ' ' A' ' 91' ' ' ASN . 54.6 p -156.12 137.37 13.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 73.230000000000004 110.819 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 90' ' ' SER . 70.4 m-20 -30.32 109.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 45.450000000000003 110.907 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -160.42 118.8 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 63.299999999999997 110.911 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.8 p -122.71 156.43 34.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 75.109999999999999 110.853 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.08 23.76 2.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 53.219999999999999 112.525 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.629 HG11 ' ND2' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -112.99 147.08 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.901 0.381 . . . . 44.32 111.148 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -105.23 124.75 50.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 71.510000000000005 111.115 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HB3' HD11 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -116.07 143.03 46.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 72.099999999999994 110.958 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -149.27 168.69 22.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.230000000000004 110.867 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -91.03 142.69 27.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 110.951 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.502 ' O ' ' CD ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.51 111.52 23.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 65.430000000000007 110.912 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.536 ' HB3' HD21 ' A' ' 99' ' ' LEU . 25.9 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 71.040000000000006 110.913 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 m120 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.821 0.343 . . . . 72.450000000000003 110.939 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 24' ' ' THR . 3.5 m -123.57 109.02 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.430000000000007 111.138 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.18 150.18 52.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 75.239999999999995 110.903 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.484 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -155.56 -77.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 75.239999999999995 110.863 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 43.8 t30 -66.22 159.2 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 62.229999999999997 110.865 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.5 t-20 89.59 -70.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 65.019999999999996 110.859 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -133.35 118.32 14.86 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.556 0.694 . . . . 64.319999999999993 111.143 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.672 ' HB2' HG22 ' A' ' 96' ' ' THR . 54.1 Cg_endo -69.81 155.86 64.71 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.688 2.259 . . . . 51.119999999999997 112.324 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.8 t -75.56 112.43 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 73.109999999999999 111.099 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -82.08 163.63 21.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 53.240000000000002 110.883 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 39.82 57.14 2.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 75.030000000000001 110.922 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 13' ' ' LEU . 4.6 tp -57.93 -173.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 52.450000000000003 110.931 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 p -145.55 139.19 26.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 61.119999999999997 111.171 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.97 65.16 0.5 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.683 -0.77 . . . . 50.009999999999998 112.485 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -75.9 155.29 35.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 51.039999999999999 110.927 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.02 -31.0 16.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.879 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.88 -55.66 0.27 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 73.040000000000006 112.49 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.75 136.58 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.338 . . . . 71.239999999999995 110.858 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.79 170.07 16.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.899 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.39 140.67 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 54.219999999999999 111.104 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -137.75 151.0 47.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 53.310000000000002 110.905 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -146.24 164.95 30.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 62.43 110.94 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 31.7 m -140.06 138.79 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 55.32 111.14 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -160.2 163.15 33.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.340000000000003 110.887 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.702 HG22 HG23 ' A' ' 81' ' ' THR . 15.0 p -130.74 170.7 13.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.519999999999996 111.163 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 78' ' ' PRO . 16.8 m -107.55 169.3 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 74.239999999999995 111.163 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -104.54 -52.92 2.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 62.140000000000001 110.868 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -128.94 157.24 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 110.878 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -73.64 116.16 13.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 63.509999999999998 110.871 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.37 144.86 33.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 65.5 111.1 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 32' ' ' THR . 2.6 t -100.96 106.79 18.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 70.030000000000001 111.15 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.45 148.93 46.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 73.420000000000002 111.088 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 34' ' ' VAL . 3.2 p -106.05 111.72 36.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 62.340000000000003 111.155 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.636 HG11 ' HG2' ' A' ' 98' ' ' LYS . 7.5 t -126.77 139.99 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 54.329999999999998 111.138 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.5 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 34.5 p -136.56 167.06 22.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 62.32 110.863 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.409 HD11 ' H ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -110.01 142.75 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 64.310000000000002 111.119 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 p -169.57 172.57 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 72.319999999999993 110.85 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 64.040000000000006 112.487 -179.968 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.813 0.34 . . . . 70.299999999999997 110.851 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.578 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -91.54 109.43 20.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 64.299999999999997 111.084 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.94 146.7 54.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 42.350000000000001 110.882 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 tt -110.86 127.08 55.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 64.209999999999994 110.92 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -131.28 154.19 48.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.906 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -154.03 133.11 12.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 72.329999999999998 110.948 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.467 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -141.03 125.72 17.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 110.853 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.4 126.17 28.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 73.200000000000003 111.119 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.41 -71.17 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 71.109999999999999 112.475 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 m -112.58 -175.47 2.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 61.350000000000001 110.86 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.31 136.04 32.21 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.57 0.7 . . . . 72.420000000000002 110.937 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 143.85 52.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.7 2.267 . . . . 53.229999999999997 112.35 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -100.79 178.08 4.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.219999999999999 111.153 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.6 p -64.86 -15.2 61.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 70.120000000000005 111.126 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.7 m -119.44 -25.8 5.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 62.439999999999998 110.827 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.95 126.39 50.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.319999999999993 110.803 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.5 154.07 36.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 72.450000000000003 110.935 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -112.45 -27.95 8.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 71.150000000000006 110.866 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.2 m -145.72 124.57 12.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.439999999999998 110.912 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -173.17 124.99 0.45 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 63.109999999999999 110.878 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.686 2.257 . . . . 65.430000000000007 112.351 -179.962 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.884 ' ND2' HG11 ' A' ' 95' ' ' VAL . 19.5 m120 . . . . . 0 CA--C 1.526 0.045 0 CA-C-O 120.856 0.36 . . . . 64.010000000000005 110.88 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 74.41 5.99 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 72.120000000000005 110.884 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 70' ' ' GLU . 3.7 pt-20 -127.3 115.49 19.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 73.519999999999996 110.908 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.5 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 10.1 m -140.77 174.3 10.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.340000000000003 110.869 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.94 153.79 33.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 65.310000000000002 110.89 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -127.85 109.37 11.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 52.399999999999999 110.847 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -150.21 152.33 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 75.219999999999999 111.155 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.5 p -79.52 102.34 8.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 64.209999999999994 110.88 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.521 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.52 143.14 31.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 61.329999999999998 111.107 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.59 142.92 25.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.561 0.696 . . . . 70.010000000000005 111.102 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.483 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.7 Cg_endo -69.75 143.81 52.08 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.657 2.238 . . . . 73.409999999999997 112.342 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.23 -22.81 6.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.704 -0.76 . . . . 63.5 112.459 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.6 m -117.27 131.52 56.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 74.340000000000003 111.15 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.702 HG23 HG22 ' A' ' 26' ' ' THR . 14.3 m -74.23 136.5 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 73.409999999999997 111.113 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 56.8 m-85 -106.35 154.78 20.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 74.140000000000001 110.883 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -134.34 160.93 36.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 75.109999999999999 110.84 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG21 ' HD2' ' A' ' 5' ' ' LYS . 10.6 t -136.17 137.68 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 71.019999999999996 111.117 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.27 122.36 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 65.019999999999996 110.865 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.421 HG23 ' HB1' ' A' ' 44' ' ' ALA . 22.6 mm -104.98 112.83 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 74.530000000000001 111.116 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.79 104.08 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 72.439999999999998 110.939 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.51 160.16 37.54 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 33.409999999999997 112.511 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -115.79 -18.4 10.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 71.439999999999998 110.906 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 91' ' ' ASN . 60.7 p -166.24 136.23 3.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 63.229999999999997 110.888 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 90' ' ' SER . 57.7 t30 -33.84 108.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 72.540000000000006 110.92 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -160.84 112.68 1.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 74.519999999999996 110.923 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.0 p -119.44 163.87 16.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 72.030000000000001 110.875 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.86 26.36 4.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.743 . . . . 42.130000000000003 112.491 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.884 HG11 ' ND2' ' A' ' 68' ' ' ASN . 7.2 t -113.75 147.49 17.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 55.149999999999999 111.156 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.672 HG22 ' HB2' ' A' ' 9' ' ' PRO . 2.1 m -103.59 117.12 33.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.340000000000003 111.169 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.738 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -99.58 121.48 41.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 72.230000000000004 110.914 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.738 ' N ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -131.12 154.8 47.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 72.209999999999994 110.861 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -84.54 140.9 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 61.219999999999999 110.922 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.44 113.36 25.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 73.299999999999997 110.897 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 p90 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.467 . . . . 73.239999999999995 110.942 -179.892 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.913 0.387 . . . . 50.020000000000003 110.874 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.5 m -117.75 108.86 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 73.230000000000004 111.112 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.65 149.82 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 70.310000000000002 110.913 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.464 ' CD ' HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -156.42 -73.37 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 74.150000000000006 110.951 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 16.9 t30 -67.98 158.09 33.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 74.409999999999997 110.945 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.8 t-20 88.95 -69.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 53.240000000000002 110.885 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -133.18 118.06 14.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.578 0.704 . . . . 64.409999999999997 111.108 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . 53.6 Cg_endo -69.79 157.2 61.14 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 73.030000000000001 112.341 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.93 113.9 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 62.310000000000002 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.04 144.25 30.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.120000000000005 110.85 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.411 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.8 OUTLIER 48.07 74.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 65.400000000000006 110.857 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 tp -65.02 -166.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.179 -0.464 . . . . 74.450000000000003 110.928 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -143.37 140.72 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 72.0 111.151 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.88 60.2 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 43.100000000000001 112.46 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 90' ' ' SER . 1.7 t-20 -78.47 139.14 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 63.119999999999997 110.897 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER -52.28 -48.16 65.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 60.409999999999997 110.904 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.04 -46.53 2.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 64.430000000000007 112.538 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.03 128.39 35.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 71.310000000000002 110.883 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.21 160.57 31.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 73.299999999999997 110.868 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -121.25 139.01 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 64.25 111.126 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -136.93 146.83 45.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.239999999999995 110.931 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.414 ' HB2' ' CE ' ' A' ' 5' ' ' LYS . 17.7 m-85 -144.08 165.02 28.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.856 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 26.0 m -143.81 138.74 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.513 . . . . 62.539999999999999 111.151 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -160.09 162.97 34.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 54.119999999999997 110.859 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.469 ' CG2' HG23 ' A' ' 81' ' ' THR . 17.5 p -129.86 170.78 13.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 72.0 111.138 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 78' ' ' PRO . 18.9 m -107.35 168.06 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 111.149 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -106.91 -49.93 3.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 63.420000000000002 110.857 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -126.13 156.76 39.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 73.549999999999997 110.843 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -78.85 114.84 18.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 73.530000000000001 110.925 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.71 145.5 33.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 55.130000000000003 111.086 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 m -97.96 107.54 20.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 63.0 111.133 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.582 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -136.97 148.91 47.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 64.439999999999998 111.034 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.706 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -106.55 113.0 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 62.210000000000001 111.148 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.425 HG11 ' HG2' ' A' ' 98' ' ' LYS . 19.4 t -126.12 139.97 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.219999999999999 111.125 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.547 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -138.86 166.72 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 53.299999999999997 110.888 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.41 147.51 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 111.153 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -178.41 170.73 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 70.129999999999995 110.831 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 62.039999999999999 112.524 -179.983 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.83 0.348 . . . . 64.409999999999997 110.838 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.07 115.56 28.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 52.439999999999998 111.129 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.68 157.31 17.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 74.430000000000007 110.874 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.784 HD23 ' HA ' ' A' ' 71' ' ' SER . 1.8 tp -124.74 129.81 51.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 74.319999999999993 110.916 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.704 ' N ' HD12 ' A' ' 46' ' ' LEU . 30.1 m-85 -136.94 131.66 33.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 61.130000000000003 110.924 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -130.28 142.56 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 70.420000000000002 110.913 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.553 ' H ' HD23 ' A' ' 48' ' ' LEU . 1.3 tttm -143.73 117.67 9.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 73.150000000000006 110.951 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.97 124.37 20.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 73.409999999999997 111.119 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 -81.04 0.72 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 75.329999999999998 112.516 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.1 p -96.17 -169.7 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 74.409999999999997 110.9 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.33 135.02 21.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.631 0.729 . . . . 74.540000000000006 110.869 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 141.25 44.74 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.664 2.243 . . . . 74.349999999999994 112.364 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 p -105.36 178.93 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.135 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.4 p -63.1 -15.05 55.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.092 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -118.41 -26.72 6.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 73.450000000000003 110.886 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.87 126.44 50.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 55.130000000000003 110.837 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.28 153.73 35.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 74.230000000000004 110.929 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -117.72 -42.89 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 110.866 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.1 m -117.39 120.82 39.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.439999999999998 110.868 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -179.59 127.6 0.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 64.510000000000005 110.856 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HD2' ' HG2' ' A' ' 70' ' ' GLU . 53.2 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.642 2.228 . . . . 73.219999999999999 112.352 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.805 0.336 . . . . 73.219999999999999 110.886 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.75 15.75 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 110.881 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 16.3 tt0 -121.4 82.95 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 60.350000000000001 110.853 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.784 ' HA ' HD23 ' A' ' 46' ' ' LEU . 1.5 m -133.23 170.2 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 65.540000000000006 110.874 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.06 152.42 37.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 45.329999999999998 110.861 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.706 ' HB3' HG23 ' A' ' 34' ' ' VAL . 54.7 p -128.38 108.98 11.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 44.020000000000003 110.858 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.1 t -150.46 152.76 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 71.439999999999998 111.122 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -77.6 103.64 7.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.219999999999999 110.88 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.657 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.19 134.33 35.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 72.420000000000002 111.085 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.5 139.27 23.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 73.340000000000003 111.127 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.496 ' HA ' HG23 ' A' ' 27' ' ' VAL . 54.1 Cg_endo -69.76 121.02 7.72 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.724 2.283 . . . . 73.530000000000001 112.348 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.58 -19.09 1.85 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 65.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.8 m -116.9 133.78 55.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.39 . . . . 73.040000000000006 111.109 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.469 HG23 ' CG2' ' A' ' 26' ' ' THR . 0.7 OUTLIER -74.07 131.41 41.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 43.219999999999999 111.13 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.657 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 50.7 m-85 -107.89 138.05 44.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 73.319999999999993 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -117.86 159.15 23.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 74.140000000000001 110.871 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.436 ' HB ' ' HE2' ' A' ' 5' ' ' LYS . 20.9 t -137.6 137.16 45.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 70.409999999999997 111.187 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 tpt -129.99 122.27 28.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 110.938 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.477 ' HB ' HG23 ' A' ' 21' ' ' VAL . 25.5 mm -104.2 112.7 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 54.32 111.144 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 124.55 49.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 75.140000000000001 110.937 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.8 162.88 30.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 64.230000000000004 112.441 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -95.16 -34.13 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 64.299999999999997 110.886 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.448 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 4.6 t -167.83 -62.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 72.329999999999998 110.829 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -171.81 86.68 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.219999999999999 110.871 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.63 119.9 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 74.200000000000003 110.948 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 p -122.88 153.4 39.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 110.817 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 12' ' ' ASN . . . 123.71 25.76 1.69 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 60.240000000000002 112.514 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.88 146.99 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.904 0.383 . . . . 63.420000000000002 111.128 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 m -101.34 115.52 30.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 61.310000000000002 111.095 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.679 HD22 ' N ' ' A' ' 98' ' ' LYS . 1.6 tm? -100.94 130.89 47.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 62.240000000000002 110.927 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.679 ' N ' HD22 ' A' ' 97' ' ' LEU . 6.6 ttpt -143.79 163.81 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 63.340000000000003 110.885 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -91.73 143.3 26.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 64.150000000000006 110.902 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.492 ' O ' ' CD ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -94.7 113.91 25.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 75.319999999999993 110.95 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.582 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 12.9 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 110.954 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.886 0.374 . . . . 74.349999999999994 110.886 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.9 m -119.88 109.07 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 62.229999999999997 111.143 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.74 151.3 52.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 63.5 110.9 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.654 ' HD3' HG21 ' A' ' 84' ' ' VAL . 9.5 tptm -164.51 -39.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 74.209999999999994 110.864 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 5.8 t30 -103.98 155.37 18.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 72.120000000000005 110.882 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.6 t-20 87.43 -67.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 64.040000000000006 110.873 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.1 m -127.77 119.52 21.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 44.43 111.136 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 152.7 69.37 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.706 2.271 . . . . 74.140000000000001 112.296 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.44 115.45 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.230000000000004 111.126 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.8 142.11 32.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.832 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.59 80.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 74.209999999999994 110.878 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -70.28 -167.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 72.109999999999999 110.96 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 p -145.67 139.0 26.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.450000000000003 111.131 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.37 61.68 0.51 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.743 -0.741 . . . . 72.310000000000002 112.487 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -76.09 150.13 37.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.947 0.403 . . . . 62.420000000000002 110.862 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -35.89 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.420000000000002 110.917 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.82 -63.08 0.52 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 74.510000000000005 112.5 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.77 140.08 20.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 73.519999999999996 110.84 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -135.08 171.91 13.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 73.430000000000007 110.858 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.563 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.05 136.26 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 75.219999999999999 111.165 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -136.77 141.53 42.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.129999999999995 110.91 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -130.56 165.03 23.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.928 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.43 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 9.4 m -141.19 138.8 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 74.530000000000001 111.13 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.48 160.34 34.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 63.140000000000001 110.906 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.798 HG22 HG23 ' A' ' 81' ' ' THR . 17.8 p -126.62 171.59 10.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 73.140000000000001 111.139 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.585 HG13 ' CE1' ' A' ' 101' ' ' TYR . 12.1 t -108.18 141.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 75.219999999999999 111.148 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -92.24 -42.59 9.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 62.340000000000003 110.86 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -132.15 148.39 52.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 72.450000000000003 110.864 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -72.89 114.27 10.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 61.219999999999999 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.34 140.76 29.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 40.130000000000003 111.134 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 32' ' ' THR . 2.7 t -98.98 107.08 19.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 71.540000000000006 111.11 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -135.72 148.02 48.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 70.030000000000001 111.104 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.1 p -106.72 111.19 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 70.420000000000002 111.119 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.71 139.82 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 74.540000000000006 111.157 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -134.51 166.33 23.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 74.299999999999997 110.861 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.492 HG21 HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -111.11 142.23 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 64.140000000000001 111.162 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t 178.82 159.67 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 43.450000000000003 110.852 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.7 -0.762 . . . . 45.229999999999997 112.471 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.8 0.333 . . . . 74.310000000000002 110.843 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.601 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -92.54 113.93 26.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 111.108 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.32 166.16 24.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 75.230000000000004 110.856 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.665 HD13 ' HA ' ' A' ' 71' ' ' SER . 3.7 tt -123.86 145.67 48.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 64.519999999999996 110.912 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -152.85 148.89 27.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 75.040000000000006 110.924 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 49' ' ' LYS . 1.4 tt -152.73 140.13 19.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 71.140000000000001 110.899 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.551 ' N ' HD23 ' A' ' 48' ' ' LEU . 3.9 tttm -147.57 130.41 16.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 75.329999999999998 110.882 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.71 86.53 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 71.219999999999999 111.139 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.94 -86.01 0.22 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.739 . . . . 73.319999999999993 112.501 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.03 134.04 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.953 0.406 . . . . 72.140000000000001 110.855 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.64 128.09 3.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.624 0.726 . . . . 62.109999999999999 110.895 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 142.84 49.11 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 55.119999999999997 112.376 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -110.08 179.31 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 75.329999999999998 111.183 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.8 p -60.92 -16.62 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 65.209999999999994 111.158 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 t -117.43 -25.78 6.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 71.120000000000005 110.83 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 124.76 48.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 72.0 110.871 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.73 153.18 32.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 73.209999999999994 110.929 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -114.24 -48.59 2.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 74.120000000000005 110.852 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.6 m -123.24 122.51 38.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.209999999999994 110.871 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.47 137.27 0.35 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.63 0.728 . . . . 54.409999999999997 110.866 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 65.150000000000006 112.308 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.774 ' ND2' HG21 ' A' ' 95' ' ' VAL . 52.2 m-80 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.855 0.36 . . . . 60.009999999999998 110.907 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.9 t30 64.54 14.18 8.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 74.239999999999995 110.906 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.422 ' HG2' ' HG2' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -128.7 103.62 7.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 61.520000000000003 110.873 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.665 ' HA ' HD13 ' A' ' 46' ' ' LEU . 5.5 m -135.03 173.63 11.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 74.319999999999993 110.845 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.94 151.6 36.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 50.130000000000003 110.89 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.5 p -129.72 109.01 10.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 53.109999999999999 110.854 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.1 m -151.02 153.48 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 63.140000000000001 111.173 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -72.25 100.18 2.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 63.009999999999998 110.864 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.32 151.31 25.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 63.530000000000001 111.146 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.82 145.99 46.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.606 0.717 . . . . 64.219999999999999 111.086 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 173.37 11.06 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.669 2.246 . . . . 75.420000000000002 112.294 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.78 -46.86 1.72 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.742 . . . . 72.099999999999994 112.452 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.9 m -94.61 128.82 41.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 71.5 111.142 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.798 HG23 HG22 ' A' ' 26' ' ' THR . 10.5 m -70.7 137.75 50.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 52.450000000000003 111.138 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -109.52 137.84 46.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 70.519999999999996 110.874 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -106.46 157.91 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 63.549999999999997 110.874 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.654 HG21 ' HD3' ' A' ' 5' ' ' LYS . 21.3 t -137.96 137.98 44.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 65.340000000000003 111.169 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.5 tpt -136.09 123.87 22.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 72.200000000000003 110.913 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HB ' HG23 ' A' ' 21' ' ' VAL . 19.5 mm -111.94 111.91 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.111 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.84 149.76 23.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 64.450000000000003 110.864 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.8 157.81 16.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 50.329999999999998 112.539 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -114.18 -21.68 10.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 74.430000000000007 110.88 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 91' ' ' ASN . 72.3 p -169.99 134.97 1.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 53.350000000000001 110.863 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 90' ' ' SER . 0.4 OUTLIER -33.83 107.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.88 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -164.12 114.03 1.24 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 64.219999999999999 110.938 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 p -121.08 162.56 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 73.140000000000001 110.878 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.35 19.38 3.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.718 -0.754 . . . . 72.230000000000004 112.515 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.774 HG21 ' ND2' ' A' ' 68' ' ' ASN . 4.8 t -112.43 147.93 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 75.319999999999993 111.135 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -100.21 129.76 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 73.219999999999999 111.176 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.621 ' HB3' HD21 ' A' ' 13' ' ' LEU . 16.2 tp -113.11 148.31 35.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 62.43 110.913 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -157.4 166.39 33.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 72.439999999999998 110.859 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.793 HD21 ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -87.88 147.31 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 71.349999999999994 110.905 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.495 ' O ' ' CD ' ' A' ' 100' ' ' GLN . 3.9 pp0? -106.06 104.48 14.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 72.230000000000004 110.91 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.793 ' CE2' HD21 ' A' ' 99' ' ' LEU . 13.5 m-85 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 53.25 110.898 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.502 -0.239 . . . . 74.400000000000006 112.502 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -110.8 -177.95 3.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 52.32 110.917 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -116.09 108.61 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 73.129999999999995 111.096 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.4 147.79 52.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 75.519999999999996 110.947 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.597 ' HE2' HD11 ' A' ' 97' ' ' LEU . 7.2 tptp -169.92 -37.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 110.926 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.656 ' OD1' HD22 ' A' ' 99' ' ' LEU . 12.6 t-20 -99.14 155.9 17.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 74.430000000000007 110.867 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 5.8 t30 81.54 -68.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 71.409999999999997 110.886 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.1 m -116.33 121.11 33.94 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 70.219999999999999 111.113 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.7 Cg_endo -69.79 153.14 69.13 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.715 2.277 . . . . 71.340000000000003 112.348 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.24 114.4 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.450000000000003 111.119 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -81.85 158.26 24.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 64.329999999999998 110.83 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER 37.15 66.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 72.230000000000004 110.908 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.58 -169.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 72.030000000000001 110.935 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 p -145.8 139.39 26.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 111.136 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.68 65.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 64.5 112.485 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -76.57 139.89 40.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 74.239999999999995 110.924 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.28 -28.7 12.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 75.120000000000005 110.933 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.92 -49.7 0.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.749 . . . . 74.200000000000003 112.487 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -76.45 149.4 36.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 72.109999999999999 110.861 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -141.85 170.55 15.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 71.420000000000002 110.886 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -129.07 138.24 55.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 75.129999999999995 111.157 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -137.07 150.66 48.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 62.539999999999999 110.91 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -148.58 166.1 29.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 110.922 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 9.8 m -137.75 138.15 39.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 72.530000000000001 111.16 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -160.4 162.95 33.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 72.230000000000004 110.868 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.608 HG22 ' HA ' ' A' ' 81' ' ' THR . 28.9 p -136.24 171.41 14.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 44.210000000000001 111.145 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 78' ' ' PRO . 28.1 m -106.84 167.58 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 111.14 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -109.1 -48.23 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 72.530000000000001 110.834 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -125.56 156.93 38.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 73.030000000000001 110.874 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -80.06 115.22 19.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 71.209999999999994 110.845 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.47 144.61 34.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 64.310000000000002 111.139 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 32' ' ' THR . 2.8 t -98.8 107.24 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 71.120000000000005 111.148 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.95 148.27 45.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 64.140000000000001 111.071 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.2 p -106.74 110.67 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 71.319999999999993 111.144 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.548 HG11 ' HG2' ' A' ' 98' ' ' LYS . 46.4 t -128.51 140.86 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 63.219999999999999 111.15 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.472 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 24.2 p -140.63 167.72 21.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 71.129999999999995 110.844 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.71 149.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 111.194 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -179.85 -175.5 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 64.430000000000007 110.824 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.27 -18.81 0.92 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.774 -0.727 . . . . 62.310000000000002 112.484 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.45 -104.25 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 74.409999999999997 112.464 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.2 m -129.23 161.55 29.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 64.25 110.863 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.26 96.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 64.310000000000002 112.519 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 -38.21 1.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.829 0.347 . . . . 65.450000000000003 110.912 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.13 121.55 44.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 63.299999999999997 111.102 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -87.68 159.35 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.209999999999994 110.843 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 71' ' ' SER . 0.3 OUTLIER -121.93 130.56 53.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.409999999999997 110.928 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -125.82 147.75 49.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 72.540000000000006 110.901 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.654 HD12 ' NE2' ' A' ' 100' ' ' GLN . 1.4 tt -143.76 134.99 25.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 74.030000000000001 110.917 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.563 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.0 tttm -144.04 116.02 8.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 71.109999999999999 110.896 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.41 120.68 10.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 64.450000000000003 111.085 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.49 -80.89 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 51.109999999999999 112.469 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 m -98.14 -178.06 3.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.389 . . . . 65.049999999999997 110.862 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 134.68 31.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.534 0.683 . . . . 74.519999999999996 110.927 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 143.3 50.35 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.655 2.237 . . . . 64.049999999999997 112.319 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -104.45 178.72 4.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 72.230000000000004 111.137 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.8 p -65.15 -14.43 60.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.436 . . . . 75.439999999999998 111.152 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -119.99 -26.75 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 71.209999999999994 110.851 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.07 125.95 50.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 64.150000000000006 110.868 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.23 153.62 35.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 110.929 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -111.83 -24.49 9.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.877 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.3 m -143.75 123.78 13.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 73.340000000000003 110.864 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -176.88 118.74 0.27 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.606 0.717 . . . . 70.329999999999998 110.893 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.439 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 53.6 Cg_endo -69.78 -6.07 17.73 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.684 2.256 . . . . 74.430000000000007 112.352 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 67.91 59.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 71.310000000000002 110.893 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.73 -172.38 2.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.120000000000005 110.866 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -100.14 108.39 20.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 73.140000000000001 110.922 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.63 -129.12 29.6 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.736 -0.745 . . . . 54.240000000000002 112.485 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -50.91 170.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 75.109999999999999 110.902 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 t30 64.47 18.87 11.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 73.340000000000003 110.887 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 63' ' ' PRO . 19.9 tt0 -119.61 85.82 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 52.450000000000003 110.921 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.667 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.9 m -133.11 169.68 16.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.239999999999995 110.857 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.24 155.22 33.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 54.100000000000001 110.875 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -129.23 106.55 8.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 52.399999999999999 110.864 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.1 t -151.17 149.81 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 111.134 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.8 p -73.55 102.5 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 73.129999999999995 110.86 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.586 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.51 137.42 34.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 74.209999999999994 111.113 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.47 141.37 22.57 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 74.530000000000001 111.09 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.511 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.7 Cg_endo -69.77 132.2 22.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.71 2.273 . . . . 73.010000000000005 112.358 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.78 -18.93 4.01 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.741 . . . . 71.510000000000005 112.509 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.5 m -115.55 129.71 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 70.329999999999998 111.14 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.608 ' HA ' HG22 ' A' ' 26' ' ' THR . 17.4 m -72.19 137.06 46.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 62.119999999999997 111.135 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.586 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 34.1 m-85 -109.86 138.21 46.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 75.219999999999999 110.918 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -108.16 161.98 14.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 75.329999999999998 110.836 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG21 ' CG ' ' A' ' 5' ' ' LYS . 61.9 t -132.31 139.05 50.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 70.230000000000004 111.124 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.7 121.18 11.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 75.450000000000003 110.853 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.442 ' HB ' HG23 ' A' ' 21' ' ' VAL . 13.3 mm -115.64 116.17 51.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 71.109999999999999 111.113 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.7 128.99 56.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 70.340000000000003 110.896 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.43 159.5 13.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 75.109999999999999 112.499 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -98.83 -21.36 16.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.868 0.366 . . . . 73.329999999999998 110.899 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 91' ' ' ASN . 23.3 p -167.07 141.65 3.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 62.130000000000003 110.897 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 90' ' ' SER . 55.2 t-20 -35.64 107.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 75.200000000000003 110.889 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -160.11 116.85 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 61.420000000000002 110.921 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.1 p -119.62 161.25 20.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 73.120000000000005 110.892 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.45 22.85 2.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 70.099999999999994 112.49 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.49 147.03 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.909 0.385 . . . . 71.519999999999996 111.11 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.63 114.35 28.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 62.119999999999997 111.147 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.597 HD11 ' HE2' ' A' ' 5' ' ' LYS . 16.5 tp -99.44 144.01 29.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 65.349999999999994 110.91 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.548 ' HG2' HG11 ' A' ' 35' ' ' VAL . 3.6 ttpt -153.16 164.92 37.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 110.892 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.656 HD22 ' OD1' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -92.54 140.58 29.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 63.32 110.881 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.654 ' NE2' HD12 ' A' ' 48' ' ' LEU . 5.5 pm0 -100.43 111.17 23.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 64.349999999999994 110.885 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.7 p90 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.464 . . . . 64.239999999999995 110.922 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.519 -0.233 . . . . 65.299999999999997 112.519 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -102.63 178.33 4.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 73.510000000000005 110.865 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 3' ' ' VAL . 14.5 m -108.03 108.15 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 75.310000000000002 111.14 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.61 149.69 52.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 63.310000000000002 110.897 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HE3' HD11 ' A' ' 97' ' ' LEU . 13.2 tptm -169.29 -38.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 60.140000000000001 110.876 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 60.3 t30 -97.91 155.32 17.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 63.240000000000002 110.851 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 26.1 t30 82.0 -68.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 72.340000000000003 110.88 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 m -124.99 119.76 25.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.598 0.713 . . . . 74.450000000000003 111.163 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.53 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.9 Cg_endo -69.73 154.73 67.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.682 2.255 . . . . 45.420000000000002 112.355 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 t -76.47 114.01 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.030000000000001 111.131 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.64 144.98 29.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 74.349999999999994 110.83 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.09 77.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 75.209999999999994 110.896 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.752 HD11 ' CB ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -73.36 -172.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 64.120000000000005 110.902 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 p -136.55 137.95 40.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 75.510000000000005 111.15 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.18 60.73 0.55 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 75.420000000000002 112.529 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -77.07 163.04 27.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.373 . . . . 74.319999999999993 110.895 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 90' ' ' SER . 3.0 mmmt -45.4 -69.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 75.430000000000007 110.913 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.67 -50.72 3.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.729 . . . . 74.340000000000003 112.48 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.97 144.45 6.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 65.109999999999999 110.838 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -144.24 -179.81 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 63.020000000000003 110.887 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.474 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -141.4 135.76 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 73.439999999999998 111.115 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -137.03 148.54 46.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 71.299999999999997 110.896 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -148.54 165.01 32.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 65.030000000000001 110.912 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.736 HG22 ' HA ' ' A' ' 83' ' ' HIS . 1.2 p -143.14 142.4 31.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 52.200000000000003 111.123 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -159.32 159.38 33.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 63.200000000000003 110.884 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.611 ' CG2' HG23 ' A' ' 81' ' ' THR . 17.4 p -127.22 170.35 12.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.109999999999999 111.14 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.09 167.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 70.409999999999997 111.139 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.39 -43.23 4.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 63.509999999999998 110.884 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.43 162.74 31.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 64.150000000000006 110.904 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.26 116.09 19.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 65.049999999999997 110.91 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.78 141.06 31.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 44.100000000000001 111.145 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.617 HG23 ' HB3' ' A' ' 75' ' ' SER . 1.1 m -97.34 107.17 19.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 73.120000000000005 111.134 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.22 147.01 47.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 61.340000000000003 111.095 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.565 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.4 p -110.9 110.84 33.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 111.176 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.5 140.25 49.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 61.119999999999997 111.115 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.507 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 4.7 p -130.75 166.47 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 110.888 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.521 HG21 HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -112.58 152.57 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 52.119999999999997 111.129 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.01 177.23 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 63.539999999999999 110.813 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.82 -23.39 0.22 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 74.430000000000007 112.482 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.21 -116.04 0.52 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 61.530000000000001 112.482 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.8 p -120.16 162.49 19.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 61.439999999999998 110.866 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -47.78 120.89 6.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.783 -0.723 . . . . 71.420000000000002 112.47 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -165.81 -37.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.815 0.34 . . . . 64.120000000000005 110.856 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.22 125.92 49.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 74.040000000000006 111.112 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.08 151.54 22.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 64.239999999999995 110.842 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.521 HD12 HG21 ' A' ' 37' ' ' ILE . 10.0 tt -116.09 127.8 55.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.917 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -138.43 143.11 39.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 65.439999999999998 110.904 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.537 HD23 ' N ' ' A' ' 49' ' ' LYS . 1.3 tt -149.21 135.96 19.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 73.209999999999994 110.918 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.537 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.1 tttm -143.64 138.25 28.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 54.32 110.897 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.52 101.02 11.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 62.299999999999997 111.126 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.05 -92.39 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.742 . . . . 44.43 112.476 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.9 p -87.5 131.4 34.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 70.400000000000006 110.851 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.68 134.8 6.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.589 0.709 . . . . 75.310000000000002 110.877 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 143.75 51.66 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.69 2.26 . . . . 74.430000000000007 112.311 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.18 177.5 5.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.436 . . . . 62.450000000000003 111.123 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 p -63.62 -15.92 59.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 111.138 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -119.63 -25.44 5.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 73.340000000000003 110.898 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.94 125.14 48.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 64.200000000000003 110.832 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.86 153.54 34.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 72.430000000000007 110.937 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -108.61 -29.12 8.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 74.010000000000005 110.825 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.5 m -136.32 123.73 22.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.129999999999995 110.882 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' A' ' 64' ' ' TYR . 1.4 ttt-85 -175.04 132.52 0.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.626 0.727 . . . . 74.099999999999994 110.891 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -1.33 8.3 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.251 . . . . 63.409999999999997 112.315 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.414 ' H ' ' HG2' ' A' ' 62' ' ' ARG . 0.2 OUTLIER 70.47 77.87 0.19 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 73.219999999999999 110.925 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -174.79 -169.54 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 75.099999999999994 110.85 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -134.96 140.22 45.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 73.510000000000005 110.951 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.94 172.45 39.03 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.711 -0.757 . . . . 61.210000000000001 112.513 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -175.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 64.150000000000006 110.856 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.3 t30 63.8 15.88 9.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.430000000000007 110.884 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.43 ' HG3' ' HB3' ' A' ' 65' ' ' ARG . 35.2 mm-40 -120.41 96.15 5.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.892 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.507 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -134.52 170.53 15.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 75.030000000000001 110.875 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -120.35 153.29 36.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 73.140000000000001 110.888 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.565 ' HB3' HG23 ' A' ' 34' ' ' VAL . 6.0 p -129.2 108.5 10.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 74.129999999999995 110.833 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.2 t -150.44 149.83 14.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 61.420000000000002 111.119 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.617 ' HB3' HG23 ' A' ' 32' ' ' THR . 63.1 p -75.68 102.4 5.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 63.210000000000001 110.896 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.543 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.49 143.81 30.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 72.049999999999997 111.111 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.15 142.91 26.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 61.399999999999999 111.107 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 141.09 44.24 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 64.430000000000007 112.337 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.67 -13.14 7.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.688 -0.767 . . . . 63.409999999999997 112.481 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -125.27 130.4 51.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 73.420000000000002 111.158 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.611 HG23 ' CG2' ' A' ' 26' ' ' THR . 3.5 m -73.19 137.8 45.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 51.43 111.13 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.543 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 51.6 m-85 -108.72 136.16 48.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 73.510000000000005 110.926 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.736 ' HA ' HG22 ' A' ' 24' ' ' THR . 12.2 m-70 -107.56 160.45 15.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.209999999999994 110.862 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.469 HG11 ' HE3' ' A' ' 5' ' ' LYS . 2.6 t -137.95 138.55 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 65.510000000000005 111.088 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.73 125.08 19.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 71.109999999999999 110.885 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.514 HD11 HD22 ' A' ' 97' ' ' LEU . 21.2 mm -114.79 130.28 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 111.141 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -111.49 149.85 30.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.439999999999998 110.899 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.19 152.27 16.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.721 -0.752 . . . . 53.43 112.544 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -120.39 -17.79 8.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 72.319999999999993 110.938 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -174.73 136.11 0.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 60.149999999999999 110.829 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 90' ' ' SER . 17.5 t-20 -35.06 103.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 74.230000000000004 110.889 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -155.38 100.18 2.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 74.230000000000004 110.906 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.6 p -109.47 151.85 26.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.071 -0.513 . . . . 63.409999999999997 110.82 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.08 24.16 1.34 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 73.120000000000005 112.476 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.643 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -111.63 142.63 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 62.240000000000002 111.121 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -102.43 117.07 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 74.109999999999999 111.152 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.752 ' CB ' HD11 ' A' ' 13' ' ' LEU . 13.1 tp -106.01 140.06 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.219999999999999 110.923 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -144.51 165.19 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 73.239999999999995 110.864 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -92.3 137.68 32.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 72.340000000000003 110.93 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.59 113.12 24.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 63.009999999999998 110.892 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.4 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 73.219999999999999 110.89 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.454 -0.258 . . . . 73.319999999999993 112.454 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -122.93 179.37 4.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 52.329999999999998 110.894 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.429 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.3 m -117.63 108.55 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 111.121 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.94 150.23 52.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 74.540000000000006 110.907 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.727 ' HZ3' HD11 ' A' ' 97' ' ' LEU . 14.8 tptt -167.19 -35.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 73.340000000000003 110.922 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -101.39 155.61 17.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 64.349999999999994 110.891 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 24.4 t30 83.99 -69.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 65.310000000000002 110.891 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -123.08 121.3 27.19 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.569 0.7 . . . . 53.130000000000003 111.113 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.611 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.8 Cg_endo -69.76 153.51 68.84 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.267 . . . . 74.200000000000003 112.317 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.23 114.84 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 72.400000000000006 111.15 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -85.56 160.74 19.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 110.836 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 40.2 62.17 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 73.420000000000002 110.89 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.03 -169.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 64.329999999999998 110.903 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 p -146.57 139.32 25.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 51.25 111.156 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.12 57.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.754 . . . . 33.25 112.486 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.94 152.95 36.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 72.140000000000001 110.914 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.24 -42.76 66.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 73.310000000000002 110.871 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.82 -48.69 1.07 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.778 -0.725 . . . . 42.520000000000003 112.508 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.28 134.1 54.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 62.030000000000001 110.799 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -134.65 172.6 12.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 74.239999999999995 110.874 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.445 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.41 139.23 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 70.109999999999999 111.12 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -136.78 151.23 48.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 74.219999999999999 110.871 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -145.14 165.97 26.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 110.933 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.429 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 8.7 m -141.69 138.13 32.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.075 -0.511 . . . . 61.409999999999997 111.157 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -160.61 158.19 28.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 74.109999999999999 110.887 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 81' ' ' THR . 27.7 p -128.07 171.22 12.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 73.019999999999996 111.093 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.558 HG12 ' CZ ' ' A' ' 101' ' ' TYR . 34.4 m -107.35 147.7 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 75.439999999999998 111.135 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -91.03 -49.83 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 73.329999999999998 110.884 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.14 161.39 26.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 73.150000000000006 110.878 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -81.06 114.12 19.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 73.219999999999999 110.858 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.99 138.96 28.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 64.530000000000001 111.078 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 75' ' ' SER . 3.2 m -94.37 106.7 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 61.119999999999997 111.139 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -136.26 146.23 46.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 44.229999999999997 111.066 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 73' ' ' SER . 68.9 t -109.39 111.88 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.109999999999999 111.148 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.7 t -127.02 139.27 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 111.136 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 42.6 p -134.03 166.48 22.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 60.399999999999999 110.877 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.777 HG21 HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -110.96 149.49 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 63.420000000000002 111.136 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.66 177.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 54.119999999999997 110.864 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.77 -45.32 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.728 . . . . 61.049999999999997 112.511 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.02 -106.22 0.62 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.721 -0.752 . . . . 40.049999999999997 112.47 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.6 p -103.95 158.51 16.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.942 0.401 . . . . 74.450000000000003 110.82 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.27 90.78 0.82 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 54.210000000000001 112.474 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -135.4 2.31 2.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 74.519999999999996 110.894 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.1 106.64 12.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.420000000000002 111.119 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.64 152.35 37.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 74.530000000000001 110.864 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.27 127.27 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.219999999999999 110.862 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -133.93 139.63 46.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 64.239999999999995 110.931 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 49' ' ' LYS . 2.0 tt -143.4 134.13 25.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 74.329999999999998 110.906 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.589 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.3 tttt -142.4 122.66 13.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 72.109999999999999 110.883 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.47 48.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 73.109999999999999 111.112 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.15 -81.9 1.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.719 -0.753 . . . . 55.409999999999997 112.501 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -93.67 177.48 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.907 0.384 . . . . 75.030000000000001 110.844 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.12 138.22 30.86 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.569 0.699 . . . . 75.430000000000007 110.895 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.15 49.93 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 75.430000000000007 112.332 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -103.34 178.99 4.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 53.399999999999999 111.194 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.7 p -65.47 -14.24 60.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 74.519999999999996 111.124 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.4 m -121.35 -26.25 5.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 64.319999999999993 110.858 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.13 126.47 49.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 64.450000000000003 110.878 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.28 153.7 35.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 110.944 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -111.69 -27.63 8.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 74.430000000000007 110.897 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.1 m -140.52 123.78 16.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 71.340000000000003 110.916 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -179.51 115.78 0.22 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.589 0.709 . . . . 71.340000000000003 110.87 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.42 ' HD2' ' HG2' ' A' ' 70' ' ' GLU . 53.9 Cg_endo -69.74 -7.95 22.36 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.664 2.243 . . . . 61.420000000000002 112.364 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 67.34 74.57 0.31 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 74.25 110.877 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.65 -167.84 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.209999999999994 110.889 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -101.99 105.37 16.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 70.200000000000003 110.895 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 49.8 -130.78 27.36 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 70.420000000000002 112.528 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -48.12 167.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 71.319999999999993 110.902 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.7 t30 68.01 18.27 9.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 51.520000000000003 110.891 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.42 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 14.1 tt0 -122.19 88.82 3.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 65.310000000000002 110.831 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.464 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.4 m -134.63 169.03 17.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 70.099999999999994 110.854 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.22 152.34 38.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 63.299999999999997 110.879 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.8 ' HB2' HG22 ' A' ' 34' ' ' VAL . 1.9 p -127.03 109.29 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.430000000000007 110.881 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.5 m -150.96 152.74 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 72.230000000000004 111.112 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.478 ' HB3' HG23 ' A' ' 32' ' ' THR . 77.5 p -80.1 101.89 9.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 71.230000000000004 110.884 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.506 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.87 151.18 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 71.120000000000005 111.078 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.87 144.13 32.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.547 0.689 . . . . 74.409999999999997 111.104 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.525 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.6 Cg_endo -69.73 124.67 11.32 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.713 2.275 . . . . 75.109999999999999 112.306 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.03 -15.99 1.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 55.219999999999999 112.485 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.9 m -126.16 131.33 52.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.37 . . . . 74.120000000000005 111.134 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.599 ' HA ' HG22 ' A' ' 26' ' ' THR . 26.9 m -72.66 138.15 46.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.439999999999998 111.153 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.506 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 47.5 m-85 -108.57 139.58 43.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 60.240000000000002 110.926 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -107.25 160.19 15.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 73.420000000000002 110.831 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 t -137.8 126.14 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 75.150000000000006 111.148 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.04 123.06 27.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 65.310000000000002 110.845 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.469 HD11 HD13 ' A' ' 97' ' ' LEU . 15.1 mm -111.2 124.32 67.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 74.129999999999995 111.112 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 145.25 32.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.865 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -117.14 140.61 15.99 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 62.25 112.49 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -101.76 -24.3 14.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.923 0.392 . . . . 75.430000000000007 110.953 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 91' ' ' ASN . 72.2 p -174.52 139.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 64.209999999999994 110.835 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 90' ' ' SER . 5.1 p-10 -31.56 106.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 54.229999999999997 110.913 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -163.09 110.6 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 65.540000000000006 110.93 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 p -117.25 158.83 23.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 61.210000000000001 110.868 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.34 25.45 2.0 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 64.099999999999994 112.529 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.36 146.83 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.865 0.364 . . . . 55.240000000000002 111.162 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.611 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.71 113.72 27.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 63.32 111.171 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.777 HD12 HG21 ' A' ' 37' ' ' ILE . 7.7 tp -99.88 141.08 33.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 72.239999999999995 110.921 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -151.58 169.92 20.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 74.420000000000002 110.936 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.657 HD21 ' HD2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -89.42 144.8 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 74.040000000000006 110.903 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.437 ' OE1' HD12 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -106.39 101.79 11.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 44.340000000000003 110.888 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.657 ' HD2' HD21 ' A' ' 99' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.931 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.498 -0.241 . . . . 34.530000000000001 112.498 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -103.9 -175.29 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 44.340000000000003 110.891 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -117.83 108.84 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.439999999999998 111.13 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.07 149.74 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 52.039999999999999 110.875 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.611 ' CE ' HD11 ' A' ' 97' ' ' LEU . 18.4 tptm -162.7 -70.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.109999999999999 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.579 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -71.65 155.4 40.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 71.099999999999994 110.888 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 18.4 t30 89.03 -67.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.450000000000003 110.875 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 m -124.19 120.66 26.24 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.614 0.721 . . . . 75.25 111.171 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HB2' HG22 ' A' ' 96' ' ' THR . 54.3 Cg_endo -69.71 154.14 68.3 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.7 2.267 . . . . 71.420000000000002 112.384 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.9 t -87.48 113.78 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 51.439999999999998 111.131 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 p -91.31 175.14 7.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 53.439999999999998 110.858 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 p30 40.62 48.91 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 62.299999999999997 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.808 HD11 ' HB2' ' A' ' 97' ' ' LEU . 4.2 mt -57.38 -176.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 72.510000000000005 110.952 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 p -143.86 139.61 29.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 51.520000000000003 111.146 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.75 64.54 0.56 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.794 -0.717 . . . . 74.450000000000003 112.497 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -73.93 160.5 31.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.941 0.4 . . . . 52.399999999999999 110.858 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 90' ' ' SER . 0.9 OUTLIER -45.22 -64.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.905 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.9 -48.14 1.81 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 73.120000000000005 112.501 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.57 157.81 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.839 0.352 . . . . 65.409999999999997 110.881 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.65 -179.32 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 52.100000000000001 110.893 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -133.66 146.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 111.141 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -137.55 145.72 43.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 60.329999999999998 110.88 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -144.88 165.9 26.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 73.200000000000003 110.913 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 8.2 m -140.79 140.02 34.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 43.340000000000003 111.089 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -159.68 160.69 34.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 60.119999999999997 110.858 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 81' ' ' THR . 24.5 p -130.1 170.22 14.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.484 . . . . 73.319999999999993 111.125 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.875 HG11 ' CE1' ' A' ' 101' ' ' TYR . 26.8 m -109.11 170.76 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.420000000000002 111.121 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -99.46 -67.99 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.887 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -125.31 148.68 48.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 75.25 110.869 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -50.53 117.49 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 73.430000000000007 110.84 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.65 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . . . -141.97 144.42 33.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 74.040000000000006 111.079 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 32' ' ' THR . 2.5 t -103.05 107.13 17.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.436 . . . . 64.450000000000003 111.167 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.56 147.13 46.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 75.219999999999999 111.138 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.2 p -107.57 111.69 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 71.209999999999994 111.129 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.437 HG11 ' HG2' ' A' ' 98' ' ' LYS . 11.5 t -127.64 139.67 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.049999999999997 111.15 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.465 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 9.5 p -135.15 165.27 25.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 45.439999999999998 110.858 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.494 HD13 ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -113.4 150.93 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 41.210000000000001 111.111 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 177.5 172.93 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 65.209999999999994 110.831 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.46 -23.6 0.23 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 72.25 112.443 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.27 -115.37 0.44 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 73.450000000000003 112.487 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 m -112.43 160.57 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 52.509999999999998 110.891 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.56 106.45 0.59 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 72.140000000000001 112.479 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -144.09 -45.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 73.430000000000007 110.864 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB1' ' CG2' ' A' ' 86' ' ' ILE . . . -88.67 116.36 26.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 62.030000000000001 111.108 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -78.21 147.2 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 62.229999999999997 110.844 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.719 HD11 HE22 ' A' ' 100' ' ' GLN . 5.9 tt -108.4 126.93 53.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 65.099999999999994 110.909 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -142.66 139.37 31.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 75.219999999999999 110.901 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.457 HD12 ' OE1' ' A' ' 100' ' ' GLN . 0.5 OUTLIER -147.09 133.64 19.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 73.340000000000003 110.908 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' H ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -143.35 133.86 24.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.466 . . . . 74.030000000000001 110.918 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.27 132.53 38.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 45.409999999999997 111.123 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.82 -80.63 1.81 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 33.530000000000001 112.509 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -92.92 175.95 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 64.510000000000005 110.842 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HD3' ' HE3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -88.15 137.75 31.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 72.420000000000002 110.895 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 142.65 48.38 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.691 2.26 . . . . 65.430000000000007 112.334 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.67 178.68 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 62.229999999999997 111.155 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 p -66.81 -13.38 61.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 111.113 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 m -123.01 -25.96 4.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 61.409999999999997 110.85 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.83 125.99 49.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 70.5 110.839 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.11 153.67 34.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 74.030000000000001 110.964 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -102.02 -32.19 10.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 64.450000000000003 110.85 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.2 m -138.03 123.57 19.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 63.240000000000002 110.856 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -177.29 127.16 0.3 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.568 0.699 . . . . 74.219999999999999 110.893 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -12.02 32.08 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.726 2.284 . . . . 63.109999999999999 112.38 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.1 t80 65.45 83.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 72.219999999999999 110.88 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 178.98 -166.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 75.420000000000002 110.886 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -46.52 160.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 74.099999999999994 110.948 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.24 -93.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.75 . . . . 33.409999999999997 112.499 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.34 161.26 2.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 54.149999999999999 110.892 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.8 25.57 11.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 70.439999999999998 110.906 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.32 96.13 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 63.240000000000002 110.865 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.591 ' HA ' HD13 ' A' ' 46' ' ' LEU . 1.7 m -133.85 170.95 14.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 42.299999999999997 110.862 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.46 149.56 41.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 65.540000000000006 110.951 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.487 ' HB3' HG23 ' A' ' 34' ' ' VAL . 13.6 p -126.72 109.27 11.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.864 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.2 t -150.91 152.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 52.109999999999999 111.139 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 p -81.41 102.14 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 70.019999999999996 110.85 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.787 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.55 149.96 26.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 43.549999999999997 111.13 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.58 144.23 28.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.595 0.712 . . . . 53.549999999999997 111.094 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.25 7.04 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.684 2.256 . . . . 74.329999999999998 112.314 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.68 -4.97 80.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.728 . . . . 62.009999999999998 112.494 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.9 m -126.22 125.48 42.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 73.099999999999994 111.125 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.48 ' HA ' HG22 ' A' ' 26' ' ' THR . 6.3 m -71.24 137.78 48.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 64.409999999999997 111.127 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.787 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 34.1 m-85 -111.66 137.98 48.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 75.530000000000001 110.936 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -105.98 162.41 13.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 71.349999999999994 110.841 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG21 ' HD3' ' A' ' 5' ' ' LYS . 2.7 t -135.89 138.57 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 54.409999999999997 111.147 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.412 ' HE3' ' HD3' ' A' ' 53' ' ' LYS . 6.8 tpp -140.3 121.77 15.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.83 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.416 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 20.4 mm -118.86 113.16 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 111.144 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -100.11 155.79 17.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 72.420000000000002 110.915 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.03 153.24 17.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 73.120000000000005 112.478 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.87 -21.98 8.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.895 0.379 . . . . 60.409999999999997 110.927 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.479 ' O ' ' C ' ' A' ' 91' ' ' ASN . 1.6 p -175.04 134.44 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 70.209999999999994 110.905 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 90' ' ' SER . 39.2 t30 -32.02 106.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 63.439999999999998 110.905 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -163.95 116.52 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.329999999999998 110.926 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.6 p -121.84 151.62 40.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 72.349999999999994 110.856 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.16 29.38 1.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 74.349999999999994 112.488 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.56 145.73 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.929 0.395 . . . . 72.209999999999994 111.127 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 9' ' ' PRO . 1.3 m -101.15 118.56 37.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 61.350000000000001 111.165 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.808 ' HB2' HD11 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -111.45 127.81 55.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 62.32 110.917 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.805 ' N ' HD22 ' A' ' 97' ' ' LEU . 3.9 ttpt -135.15 167.92 20.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 110.908 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -88.18 141.2 28.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 73.340000000000003 110.923 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.719 HE22 HD11 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -103.08 110.99 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 110.927 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.875 ' CE1' HG11 ' A' ' 27' ' ' VAL . 2.6 t80 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 110.928 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.488 -0.245 . . . . 70.099999999999994 112.488 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -95.06 -177.32 4.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.847 0.356 . . . . 75.0 110.9 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.474 HG11 ' OG1' ' A' ' 24' ' ' THR . 11.1 m -106.39 108.45 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 72.109999999999999 111.097 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.14 149.93 52.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 61.020000000000003 110.904 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.636 ' HE3' HD11 ' A' ' 97' ' ' LEU . 13.7 tptm -166.71 -67.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.239999999999995 110.907 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.674 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.2 OUTLIER -76.09 153.93 35.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 74.040000000000006 110.918 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.1 t-20 87.32 -69.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.209999999999994 110.887 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.1 m -120.88 121.55 28.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.57 0.7 . . . . 61.520000000000003 111.105 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 154.38 67.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.692 2.262 . . . . 74.200000000000003 112.363 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.13 116.22 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 60.229999999999997 111.137 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 p -87.96 159.71 18.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 64.099999999999994 110.834 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 40.08 69.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 73.109999999999999 110.855 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.743 HD11 ' CB ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -69.81 -174.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 65.239999999999995 110.889 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -140.49 138.0 34.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 73.230000000000004 111.146 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.52 64.05 0.58 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.693 -0.765 . . . . 63.530000000000001 112.454 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -75.59 148.18 39.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.357 . . . . 54.240000000000002 110.905 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.36 -57.02 7.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 72.040000000000006 110.881 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.63 -64.21 1.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 42.130000000000003 112.491 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.92 144.61 8.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 72.400000000000006 110.865 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -139.67 179.33 6.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 61.140000000000001 110.892 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.584 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.13 138.0 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 74.540000000000006 111.127 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -135.41 139.58 44.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 71.340000000000003 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -137.44 163.8 30.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 110.926 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.724 HG22 ' HA ' ' A' ' 83' ' ' HIS . 1.9 p -142.17 146.91 35.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 72.219999999999999 111.136 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.39 163.28 35.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 64.209999999999994 110.822 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.622 HG22 HG23 ' A' ' 81' ' ' THR . 11.0 p -125.58 169.74 12.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 53.140000000000001 111.183 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.2 t -108.33 145.09 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 111.089 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -86.21 -44.29 12.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 74.209999999999994 110.832 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -142.78 154.72 44.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 75.099999999999994 110.86 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -72.04 116.62 12.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 72.209999999999994 110.938 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.75 141.3 31.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 63.310000000000002 111.116 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -94.81 105.66 17.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 111.114 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.11 148.62 45.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 71.340000000000003 111.136 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -107.93 111.12 34.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 72.530000000000001 111.12 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.496 HG11 ' HG2' ' A' ' 98' ' ' LYS . 41.2 t -127.41 139.9 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 71.219999999999999 111.09 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.488 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 24.3 p -135.89 166.21 23.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 73.040000000000006 110.855 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.461 HG21 HD12 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -111.4 150.66 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 52.409999999999997 111.152 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.3 173.58 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 64.340000000000003 110.884 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.0 -27.31 0.13 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 64.310000000000002 112.495 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.62 -114.97 0.34 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.711 -0.757 . . . . 74.450000000000003 112.508 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.1 p -111.97 162.18 15.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 72.450000000000003 110.871 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.85 134.67 21.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.732 -0.747 . . . . 54.100000000000001 112.462 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -174.39 -35.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 70.109999999999999 110.861 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.93 127.12 54.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 74.519999999999996 111.073 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 1.7 m-20 -88.91 152.36 21.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 70.140000000000001 110.867 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.413 HD22 ' O ' ' A' ' 70' ' ' GLU . 5.6 tt -118.75 142.24 47.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 72.439999999999998 110.891 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -153.36 142.92 21.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 72.209999999999994 110.945 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -140.66 134.08 29.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 74.25 110.922 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.477 ' N ' HD23 ' A' ' 48' ' ' LEU . 7.7 tttt -149.16 129.64 13.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 64.400000000000006 110.906 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.3 98.98 8.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 64.099999999999994 111.091 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.07 -90.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 43.420000000000002 112.463 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.0 m -90.46 128.48 36.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.957 0.408 . . . . 63.439999999999998 110.849 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.26 133.93 3.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.574 0.702 . . . . 72.420000000000002 110.87 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 143.02 49.54 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.677 2.251 . . . . 72.239999999999995 112.336 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 p -107.63 178.73 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 111.164 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.8 p -63.28 -15.18 56.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 64.420000000000002 111.164 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 m -118.96 -26.33 6.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 73.439999999999998 110.858 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.73 125.49 49.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.852 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.97 153.4 34.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.909 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -108.18 -34.58 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 71.409999999999997 110.912 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 70.5 m -144.64 123.1 12.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.86 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -177.37 129.14 0.32 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.606 0.717 . . . . 73.219999999999999 110.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HG2' ' CG ' ' A' ' 70' ' ' GLU . 53.8 Cg_endo -69.76 -4.78 14.72 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.237 . . . . 64.030000000000001 112.399 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 6.5 t80 69.1 101.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 72.439999999999998 110.913 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.68 -169.49 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 73.450000000000003 110.86 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -87.41 -77.1 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 65.329999999999998 110.966 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 68' ' ' ASN . . . -150.98 145.35 13.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 61.409999999999997 112.46 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER 58.93 150.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 73.319999999999993 110.897 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.3 t30 65.63 12.19 8.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 54.219999999999999 110.878 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.43 ' CG ' ' HG2' ' A' ' 63' ' ' PRO . 4.3 tt0 -116.68 87.5 2.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.310000000000002 110.876 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.488 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -133.28 169.26 17.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 64.310000000000002 110.846 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.74 156.73 31.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 52.439999999999998 110.865 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.68 107.22 9.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 52.039999999999999 110.832 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -150.65 153.12 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.099999999999994 111.168 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -70.21 104.72 2.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.219999999999999 110.863 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.93 131.5 35.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 70.230000000000004 111.127 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.99 139.94 20.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.589 0.709 . . . . 43.439999999999998 111.078 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 170.45 16.55 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.683 2.255 . . . . 75.230000000000004 112.349 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.16 -39.24 2.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 45.009999999999998 112.474 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.6 m -97.04 128.93 44.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 71.340000000000003 111.155 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.622 HG23 HG22 ' A' ' 26' ' ' THR . 3.1 m -71.43 133.24 45.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 72.310000000000002 111.141 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -104.03 136.02 44.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 64.219999999999999 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.724 ' HA ' HG22 ' A' ' 24' ' ' THR . 17.9 m-70 -106.97 159.14 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 64.319999999999993 110.834 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.452 HG11 ' CE ' ' A' ' 5' ' ' LYS . 4.5 t -138.93 139.39 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 63.140000000000001 111.108 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.82 123.65 25.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 72.099999999999994 110.892 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.584 ' HB ' HG23 ' A' ' 21' ' ' VAL . 16.1 mm -118.81 113.61 42.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 72.439999999999998 111.099 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 10.3 mmmm -98.29 165.32 11.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 41.409999999999997 110.927 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.88 135.08 8.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.713 -0.756 . . . . 54.340000000000003 112.449 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -96.61 -31.54 12.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 75.209999999999994 110.943 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 91' ' ' ASN . 78.1 p -167.62 136.92 2.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 65.420000000000002 110.859 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 90' ' ' SER . 13.5 t-20 -34.62 105.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 55.009999999999998 110.898 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -164.37 119.25 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 74.040000000000006 110.953 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 p -121.56 155.76 34.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 70.530000000000001 110.891 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.65 23.29 1.52 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 63.100000000000001 112.468 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.659 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.7 t -114.15 143.12 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.911 0.386 . . . . 70.400000000000006 111.123 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.403 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 0.8 OUTLIER -100.08 132.26 45.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.299999999999997 111.158 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.743 ' CB ' HD11 ' A' ' 13' ' ' LEU . 13.8 tp -118.99 149.71 41.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 110.928 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HG2' HG11 ' A' ' 35' ' ' VAL . 3.4 ttpt -157.87 164.27 37.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 74.510000000000005 110.919 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.674 HD22 ' HB2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -90.96 138.95 31.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.25 -0.432 . . . . 70.439999999999998 110.907 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.09 112.0 24.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 54.439999999999998 110.941 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.422 ' HB3' HD21 ' A' ' 99' ' ' LEU . 29.6 p90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 70.450000000000003 110.926 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.512 -0.235 . . . . 70.299999999999997 112.512 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -102.57 -176.95 3.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.893 0.378 . . . . 74.120000000000005 110.831 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.6 m -118.56 109.25 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 63.219999999999999 111.103 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.636 HD12 HG22 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -131.47 148.95 52.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 75.319999999999993 110.936 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.584 ' HE3' HD11 ' A' ' 97' ' ' LEU . 13.8 tptm -166.66 -68.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 65.439999999999998 110.883 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.651 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -75.01 154.98 37.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.540000000000006 110.877 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.0 t-20 88.38 -65.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 110.906 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 m -129.35 121.67 20.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.551 0.691 . . . . 64.329999999999998 111.098 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.41 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.7 Cg_endo -69.81 154.07 67.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.653 2.236 . . . . 73.049999999999997 112.359 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.636 HG22 HD12 ' A' ' 4' ' ' LEU . 37.3 t -84.83 115.09 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 61.140000000000001 111.134 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.2 146.12 28.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 74.019999999999996 110.853 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.66 81.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 75.140000000000001 110.942 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.73 HD11 ' CB ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -79.58 -172.69 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 52.329999999999998 110.924 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -136.98 138.72 40.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 75.120000000000005 111.139 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.77 71.87 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.746 -0.74 . . . . 52.0 112.505 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -76.98 134.54 38.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 61.210000000000001 110.89 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -24.57 8.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 55.109999999999999 110.901 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.13 -40.64 1.37 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 61.439999999999998 112.439 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.27 -173.12 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.356 . . . . 72.230000000000004 110.871 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.12 -178.01 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 73.540000000000006 110.918 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.0 145.76 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 72.299999999999997 111.168 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -137.21 143.4 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.510000000000005 110.849 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -140.15 165.25 27.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 71.120000000000005 110.926 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.43 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 7.8 m -147.11 142.32 27.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 64.099999999999994 111.137 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -159.36 162.51 35.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 74.25 110.868 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.491 HG22 HG23 ' A' ' 81' ' ' THR . 19.6 p -130.34 169.94 14.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 72.109999999999999 111.115 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 m -108.68 169.89 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.219999999999999 111.197 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -108.73 -45.16 3.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 54.409999999999997 110.895 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -133.38 158.82 42.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 75.099999999999994 110.881 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.7 116.27 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 55.210000000000001 110.896 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.38 139.19 31.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 65.230000000000004 111.127 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.3 m -96.21 106.77 19.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 63.329999999999998 111.154 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.59 147.29 46.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 70.310000000000002 111.117 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.2 p -107.5 111.29 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 52.210000000000001 111.132 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -127.45 140.22 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 75.010000000000005 111.115 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.497 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 5.4 p -133.53 166.25 23.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 61.149999999999999 110.891 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -111.91 152.44 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 64.310000000000002 111.169 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.79 173.9 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 71.329999999999998 110.886 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 165.58 -25.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 54.219999999999999 112.496 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.2 -110.05 0.32 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 71.400000000000006 112.485 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 m -114.86 160.57 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 51.310000000000002 110.862 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.03 96.86 0.11 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.694 -0.765 . . . . 71.140000000000001 112.488 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -133.41 -39.69 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 53.020000000000003 110.826 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.64 120.55 39.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.549999999999997 111.159 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.55 161.99 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 75.519999999999996 110.887 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.685 HD13 ' HA ' ' A' ' 71' ' ' SER . 9.4 tt -118.78 129.82 55.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 72.239999999999995 110.959 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -133.85 146.54 50.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 110.913 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -153.52 133.47 13.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 75.329999999999998 110.922 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.415 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -144.87 121.58 11.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 70.439999999999998 110.854 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.49 89.46 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 111.109 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.89 -83.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 61.119999999999997 112.456 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -106.41 133.96 50.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.925 0.393 . . . . 70.040000000000006 110.862 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.66 127.34 2.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 75.439999999999998 110.932 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 142.87 49.23 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.708 2.272 . . . . 60.100000000000001 112.305 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.48 178.32 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 74.019999999999996 111.152 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.3 p -60.63 -17.04 44.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 75.510000000000005 111.152 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.6 m -117.04 -25.45 7.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 110.833 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.46 124.87 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 110.847 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.87 153.41 33.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.91 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -115.51 -34.91 4.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 75.329999999999998 110.886 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.9 m -140.37 122.68 15.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 74.129999999999995 110.873 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.481 ' C ' ' H ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -178.32 140.69 0.4 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.582 0.706 . . . . 70.420000000000002 110.907 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 64' ' ' TYR . 53.6 Cg_endo -69.77 32.97 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.69 2.26 . . . . 72.25 112.313 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER 36.69 68.98 0.22 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 65.209999999999994 110.88 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.414 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -170.63 -175.31 1.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 51.149999999999999 110.822 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -135.53 149.94 49.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.129999999999995 110.896 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.86 161.54 34.42 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.755 -0.736 . . . . 73.049999999999997 112.485 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -53.76 177.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 74.310000000000002 110.865 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.9 t30 66.86 16.55 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.150000000000006 110.905 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -126.92 96.98 4.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 63.399999999999999 110.899 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.685 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.4 m -134.32 171.2 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 72.420000000000002 110.901 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.29 152.96 35.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.882 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 34' ' ' VAL . 1.3 p -128.64 109.26 11.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 63.210000000000001 110.854 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.6 m -150.89 152.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 62.420000000000002 111.135 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.6 p -73.2 106.97 5.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 64.010000000000005 110.8 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.71 132.55 35.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.109999999999999 111.066 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.63 139.23 19.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.525 0.678 . . . . 70.150000000000006 111.101 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 142.11 46.88 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.629 2.219 . . . . 72.219999999999999 112.325 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.97 -12.77 8.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.774 -0.727 . . . . 73.109999999999999 112.461 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.1 m -126.41 129.23 48.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 54.409999999999997 111.165 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.491 HG23 HG22 ' A' ' 26' ' ' THR . 5.2 m -70.98 138.07 49.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 74.349999999999994 111.159 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' O ' HG23 ' A' ' 24' ' ' THR . 42.4 m-85 -108.6 135.86 49.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 70.540000000000006 110.946 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -107.24 158.91 16.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 61.409999999999997 110.879 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.467 HG11 ' HE3' ' A' ' 5' ' ' LYS . 4.3 t -138.3 138.57 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 72.409999999999997 111.14 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.97 123.05 17.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' A' ' 21' ' ' VAL . 28.8 mm -113.44 112.96 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 60.240000000000002 111.169 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -110.38 134.31 52.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 74.450000000000003 110.874 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.74 144.67 17.66 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.753 . . . . 24.32 112.456 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.77 -22.27 20.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.902 0.382 . . . . 74.430000000000007 110.962 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 91' ' ' ASN . 2.7 p -163.85 139.76 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 72.540000000000006 110.891 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 90' ' ' SER . 13.3 t-20 -35.07 106.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 64.349999999999994 110.882 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -155.47 115.59 3.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 71.310000000000002 110.946 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.1 p -122.17 151.5 40.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 63.030000000000001 110.849 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.46 23.65 2.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 73.140000000000001 112.469 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.662 ' O ' HD12 ' A' ' 13' ' ' LEU . 1.4 t -111.74 143.94 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 72.010000000000005 111.096 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -100.94 124.19 46.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 62.340000000000003 111.124 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.73 ' CB ' HD11 ' A' ' 13' ' ' LEU . 15.5 tp -112.32 148.38 34.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 62.350000000000001 110.951 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -153.79 164.7 37.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 61.32 110.878 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.651 HD22 ' HB2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -91.43 136.91 32.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.236 -0.438 . . . . 72.530000000000001 110.922 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.416 HE22 HD11 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -97.38 112.18 24.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.010000000000005 110.931 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 75.450000000000003 110.871 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.456 -0.258 . . . . 53.030000000000001 112.456 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -155.43 -175.86 5.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 71.219999999999999 110.885 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.5 m -117.9 108.27 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 71.239999999999995 111.146 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.54 150.66 52.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 61.009999999999998 110.95 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.722 ' HG2' HG21 ' A' ' 84' ' ' VAL . 2.2 tppm? -166.09 -73.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 110.883 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 59.7 t30 -63.39 157.75 22.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 73.010000000000005 110.919 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.3 t30 88.52 -60.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 73.219999999999999 110.868 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.4 m -133.59 121.62 16.32 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 42.109999999999999 111.161 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 152.28 69.54 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 2.243 . . . . 63.329999999999998 112.353 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.561 HG12 HD22 ' A' ' 13' ' ' LEU . 99.0 t -79.37 115.02 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 71.129999999999995 111.175 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.49 146.31 31.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 53.119999999999997 110.844 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.59 81.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 73.299999999999997 110.841 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.561 HD22 HG12 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -71.4 -168.72 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 62.140000000000001 110.911 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 p -139.61 138.34 36.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 73.299999999999997 111.137 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.63 58.82 0.65 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.721 -0.752 . . . . 43.149999999999999 112.517 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -76.56 139.17 40.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.874 0.368 . . . . 73.25 110.848 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -26.11 9.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 71.420000000000002 110.942 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.98 -56.33 0.4 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.735 -0.745 . . . . 73.099999999999994 112.503 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.13 158.73 6.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.854 0.359 . . . . 60.009999999999998 110.868 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -152.6 167.58 28.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 70.25 110.922 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -137.61 136.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 64.010000000000005 111.102 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -137.42 147.15 45.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 72.129999999999995 110.825 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -146.22 166.11 27.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 70.439999999999998 110.968 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 27.6 m -140.04 140.7 36.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 61.310000000000002 111.108 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -160.74 155.06 23.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 110.925 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.618 HG22 ' HA ' ' A' ' 81' ' ' THR . 19.1 p -128.07 170.49 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 64.219999999999999 111.178 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -108.5 170.21 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 61.130000000000003 111.11 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.05 -52.83 3.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 44.409999999999997 110.873 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.43 172.67 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.25 110.873 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -75.93 117.13 17.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 73.129999999999995 110.845 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.81 133.5 25.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 45.32 111.143 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.6 m -95.18 107.98 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 74.450000000000003 111.118 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.2 148.33 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 64.040000000000006 111.067 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -106.92 111.03 33.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 74.010000000000005 111.099 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.735 HG11 ' HG2' ' A' ' 98' ' ' LYS . 49.0 t -126.16 139.34 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 60.149999999999999 111.115 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.495 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 17.0 p -135.48 170.23 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 110.889 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.507 HD13 HD12 ' A' ' 46' ' ' LEU . 4.6 pt -108.01 157.49 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 73.230000000000004 111.112 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 174.12 171.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 75.530000000000001 110.838 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 164.62 -25.68 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.679 -0.772 . . . . 71.340000000000003 112.429 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.49 -91.24 0.18 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.79 -0.719 . . . . 72.549999999999997 112.473 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.1 m -130.13 145.82 51.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.937 0.399 . . . . 65.340000000000003 110.82 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.5 ' HA3' HG23 ' A' ' 95' ' ' VAL . . . 177.09 -30.4 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 63.329999999999998 112.51 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.404 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 1.0 OUTLIER 68.08 33.76 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.818 0.342 . . . . 65.120000000000005 110.89 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.76 120.92 36.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 111.1 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.64 172.64 11.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 74.230000000000004 110.891 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 71' ' ' SER . 8.5 tt -124.63 141.82 51.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 73.040000000000006 110.914 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -150.37 146.62 26.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 73.319999999999993 110.949 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.595 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -153.87 146.23 23.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 64.109999999999999 110.934 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.595 ' H ' HD23 ' A' ' 48' ' ' LEU . 7.1 tttt -149.62 123.12 9.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 60.409999999999997 110.923 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.54 84.28 6.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 72.340000000000003 111.109 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.89 -64.22 0.4 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 72.549999999999997 112.527 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -139.99 137.7 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.949 0.404 . . . . 75.349999999999994 110.833 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -32.52 127.2 0.36 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.522 0.677 . . . . 75.549999999999997 110.929 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 143.45 50.76 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.668 2.245 . . . . 71.129999999999995 112.329 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -103.35 178.35 4.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 55.140000000000001 111.106 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.5 p -62.69 -15.71 53.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 70.349999999999994 111.172 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.3 m -117.21 -26.23 6.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 71.109999999999999 110.858 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.94 123.52 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 52.350000000000001 110.838 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.39 153.55 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 73.209999999999994 110.903 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 49' ' ' LYS . 35.6 m-20 -112.27 -45.67 3.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 55.200000000000003 110.847 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 36.9 m -121.9 123.57 42.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 73.129999999999995 110.869 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.479 ' HG2' ' H ' ' A' ' 64' ' ' TYR . 26.7 ttp180 -175.77 127.61 0.37 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 74.510000000000005 110.848 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -3.29 11.73 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.694 2.263 . . . . 63.030000000000001 112.344 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' H ' ' HG2' ' A' ' 62' ' ' ARG . 10.3 m-85 68.21 84.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 63.299999999999997 110.91 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.53 -173.36 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 62.399999999999999 110.893 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -121.96 175.83 6.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.963 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 43' ' ' ASP . . . 59.85 170.79 0.47 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.699 -0.763 . . . . 65.349999999999994 112.507 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -60.39 -167.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 73.129999999999995 110.921 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.3 t30 61.09 24.2 14.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.310000000000002 110.876 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -128.98 90.23 3.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 74.150000000000006 110.908 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.709 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.6 m -133.04 169.97 16.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 62.509999999999998 110.86 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.57 154.76 34.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 75.200000000000003 110.869 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.458 ' HB3' HG23 ' A' ' 34' ' ' VAL . 60.6 p -128.29 109.67 11.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.420000000000002 110.846 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.1 t -150.33 153.02 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 64.109999999999999 111.123 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -75.41 105.38 6.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.299999999999997 110.857 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.13 138.41 34.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 111.064 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.29 146.52 32.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.711 . . . . 55.310000000000002 111.13 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 164.55 34.09 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 73.209999999999994 112.374 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.0 -21.18 38.3 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.713 -0.756 . . . . 71.129999999999995 112.482 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.0 m -108.75 124.01 49.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 53.530000000000001 111.111 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.618 ' HA ' HG22 ' A' ' 26' ' ' THR . 22.0 m -72.89 134.06 44.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 44.109999999999999 111.127 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.532 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 52.2 m-85 -109.13 136.91 47.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 73.430000000000007 110.885 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -118.55 139.56 51.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 73.420000000000002 110.851 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.722 HG21 ' HG2' ' A' ' 5' ' ' LYS . 13.7 t -116.03 126.83 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 111.091 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 tpt -123.51 128.82 50.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 51.409999999999997 110.846 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.558 HD11 ' CD2' ' A' ' 97' ' ' LEU . 30.6 mm -113.97 126.43 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 53.340000000000003 111.109 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.19 146.3 30.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 73.349999999999994 110.9 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.39 150.13 18.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 41.030000000000001 112.472 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.15 -37.9 5.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.35 . . . . 73.200000000000003 110.868 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 91' ' ' ASN . 7.6 p -161.74 137.64 7.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 73.030000000000001 110.908 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.482 ' C ' ' O ' ' A' ' 90' ' ' SER . 4.8 p-10 -31.65 108.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 73.200000000000003 110.877 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.63 121.66 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.5 110.919 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.5 p -121.59 168.23 11.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 64.109999999999999 110.82 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.39 22.66 2.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 70.430000000000007 112.478 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.5 HG23 ' HA3' ' A' ' 42' ' ' GLY . 43.5 t -113.38 140.75 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 74.129999999999995 111.123 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.54 120.04 39.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 71.319999999999993 111.185 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' CD2' HD11 ' A' ' 86' ' ' ILE . 19.4 tp -106.22 149.99 26.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.912 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.735 ' HG2' HG11 ' A' ' 35' ' ' VAL . 5.7 ttpt -156.92 162.91 39.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 74.420000000000002 110.866 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.27 140.34 29.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 54.329999999999998 110.909 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.469 ' OE1' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -103.5 112.42 25.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 74.109999999999999 110.916 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.8 p90 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.903 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.536 -0.226 . . . . 55.020000000000003 112.536 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -121.61 -176.4 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 74.400000000000006 110.921 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.4 m -121.9 108.26 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.540000000000006 111.103 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.03 149.34 52.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 75.010000000000005 110.927 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.683 ' HE3' HG11 ' A' ' 84' ' ' VAL . 1.4 tppm? -163.55 -75.34 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 72.310000000000002 110.928 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.578 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -62.27 155.11 25.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 110.903 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.7 t-20 89.03 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.030000000000001 110.834 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.2 m -121.67 121.01 28.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 73.239999999999995 111.144 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.621 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.4 Cg_endo -69.76 153.57 68.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.266 . . . . 72.420000000000002 112.326 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.4 t -84.48 114.49 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 64.519999999999996 111.152 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 p -86.69 167.89 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 55.210000000000001 110.862 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 39.75 55.76 2.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 54.130000000000003 110.855 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.792 HD11 ' CB ' ' A' ' 97' ' ' LEU . 3.1 mt -58.9 -175.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 75.140000000000001 110.884 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.9 p -141.76 138.33 32.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 64.329999999999998 111.101 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.96 55.17 0.7 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 73.209999999999994 112.477 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -75.84 140.44 42.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 70.109999999999999 110.86 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -26.9 5.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 70.219999999999999 110.884 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.23 -61.43 0.48 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 64.219999999999999 112.455 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -58.16 144.42 40.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 62.329999999999998 110.893 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -138.99 170.7 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 70.200000000000003 110.845 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.503 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.61 135.55 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 43.509999999999998 111.118 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -138.23 154.16 49.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.019999999999996 110.886 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -148.0 166.77 26.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.319999999999993 110.948 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.421 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 58.3 m -137.44 140.45 41.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 54.130000000000003 111.132 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -159.95 158.13 30.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 75.140000000000001 110.847 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.615 HG22 HG23 ' A' ' 81' ' ' THR . 22.4 p -127.39 170.51 12.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 72.420000000000002 111.141 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.882 HG11 ' CE1' ' A' ' 101' ' ' TYR . 31.1 m -109.45 171.02 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 72.409999999999997 111.134 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.75 -66.57 0.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 70.129999999999995 110.898 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -127.08 149.73 49.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.430000000000007 110.879 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -51.02 117.04 2.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 63.420000000000002 110.837 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.656 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . . . -141.95 145.12 34.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 61.219999999999999 111.095 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -104.77 106.67 17.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 52.140000000000001 111.181 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.29 147.23 47.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 73.25 111.111 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.509 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -107.51 112.32 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 71.530000000000001 111.179 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.411 HG11 ' HG2' ' A' ' 98' ' ' LYS . 8.8 t -127.5 139.77 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 63.0 111.152 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.471 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 9.9 p -134.68 166.41 22.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 70.430000000000007 110.866 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.04 146.41 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 72.329999999999998 111.115 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.3 t 177.9 161.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 74.349999999999994 110.894 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 165.42 -58.54 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 73.409999999999997 112.485 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.49 -120.57 4.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 54.140000000000001 112.479 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 m -103.99 161.85 13.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.378 . . . . 52.32 110.861 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.3 84.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.787 -0.72 . . . . 74.549999999999997 112.462 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.79 8.75 2.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.358 . . . . 72.310000000000002 110.859 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.32 120.12 35.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 111.067 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.74 143.75 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 72.120000000000005 110.849 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 71' ' ' SER . 4.7 tt -103.48 131.34 50.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 52.25 110.905 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -130.65 154.45 47.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 63.25 110.949 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.6 133.63 12.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 52.140000000000001 110.863 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -148.95 124.48 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.882 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.58 82.9 7.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 60.299999999999997 111.083 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.72 -82.51 0.19 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 51.109999999999999 112.508 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 m -109.08 136.92 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 73.129999999999995 110.83 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.64 126.01 2.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 64.329999999999998 110.919 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 142.58 48.25 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.723 2.282 . . . . 73.219999999999999 112.299 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.84 177.98 4.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 111.151 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 87' ' ' LYS . 58.9 p -62.71 -16.78 58.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 73.049999999999997 111.094 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m -116.78 -26.24 7.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 72.010000000000005 110.823 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.94 124.11 47.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 110.845 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.61 153.38 33.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 73.450000000000003 110.907 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -107.85 -44.99 4.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.030000000000001 110.852 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.5 m -145.17 122.21 11.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 54.109999999999999 110.879 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -177.38 153.94 1.05 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.604 0.716 . . . . 61.109999999999999 110.885 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.526 ' CD ' HD22 ' A' ' 46' ' ' LEU . 54.2 Cg_endo -69.75 -163.67 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.705 2.27 . . . . 70.209999999999994 112.313 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -152.1 73.79 1.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 74.430000000000007 110.898 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -148.21 -163.23 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 73.239999999999995 110.843 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -47.5 -77.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 70.040000000000006 110.919 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.15 -89.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 51.420000000000002 112.49 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.14 160.91 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 61.020000000000003 110.928 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 63.94 16.76 10.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 71.230000000000004 110.923 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -127.25 100.09 5.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 73.430000000000007 110.872 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.733 ' HA ' HD13 ' A' ' 46' ' ' LEU . 4.9 m -136.77 173.13 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 72.129999999999995 110.894 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.71 150.53 38.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 54.109999999999999 110.904 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.509 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.4 p -126.09 109.86 12.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 74.209999999999994 110.878 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -150.75 148.73 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 63.310000000000002 111.134 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.27 102.37 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 72.329999999999998 110.848 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.712 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.7 151.42 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 63.149999999999999 111.056 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.69 145.72 31.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 71.230000000000004 111.088 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 162.78 40.7 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 65.109999999999999 112.347 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.07 -18.5 51.85 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.77 -0.728 . . . . 72.219999999999999 112.487 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.9 m -116.87 125.97 52.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 62.130000000000003 111.13 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.615 HG23 HG22 ' A' ' 26' ' ' THR . 24.0 m -71.25 137.57 48.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 73.519999999999996 111.17 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.712 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 70.2 m-85 -112.46 152.71 28.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 71.25 110.921 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -131.36 159.0 39.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 75.329999999999998 110.872 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.683 HG11 ' HE3' ' A' ' 5' ' ' LYS . 22.0 t -132.44 125.46 53.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 72.140000000000001 111.151 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.23 124.19 46.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 62.329999999999998 110.867 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.526 ' CD1' HD22 ' A' ' 97' ' ' LEU . 24.7 mm -110.54 113.17 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.540000000000006 111.122 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HG3' HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -99.97 133.21 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 73.239999999999995 110.921 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.22 160.29 16.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 60.439999999999998 112.475 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -117.46 -29.79 5.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 73.209999999999994 110.953 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 91' ' ' ASN . 97.5 p -168.21 143.54 3.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 63.539999999999999 110.783 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' SER . 39.1 t30 -33.04 109.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.505 . . . . 74.140000000000001 110.893 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.6 111.69 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 65.549999999999997 110.893 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 p -121.67 159.68 26.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 74.450000000000003 110.876 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 120.4 22.24 3.17 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.699 -0.762 . . . . 74.450000000000003 112.476 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.13 146.22 18.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.921 0.391 . . . . 71.209999999999994 111.113 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -101.26 132.54 46.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.510000000000005 111.131 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.792 ' CB ' HD11 ' A' ' 13' ' ' LEU . 7.8 tp -121.45 148.79 43.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 55.210000000000001 110.899 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HG2' HG11 ' A' ' 35' ' ' VAL . 1.6 ttpt -155.07 170.04 22.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.140000000000001 110.853 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.65 140.85 29.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.030000000000001 110.896 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.584 ' OE1' HD11 ' A' ' 46' ' ' LEU . 1.7 pm0 -103.1 108.64 19.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.530000000000001 110.889 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.882 ' CE1' HG11 ' A' ' 27' ' ' VAL . 3.3 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 63.119999999999997 110.932 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.519 -0.232 . . . . 63.219999999999999 112.519 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -129.4 -176.98 4.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 63.100000000000001 110.931 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.423 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.1 m -117.7 108.39 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.400000000000006 111.093 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.98 148.89 52.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 71.329999999999998 110.939 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.595 ' NZ ' HD21 ' A' ' 97' ' ' LEU . 17.8 tptt -164.0 -74.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 73.209999999999994 110.893 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.659 ' CG ' HD22 ' A' ' 99' ' ' LEU . 12.2 t-20 -65.87 156.66 32.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.937 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.5 t30 85.61 -69.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 73.239999999999995 110.913 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -119.34 120.84 30.6 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.565 0.697 . . . . 73.040000000000006 111.137 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 153.54 68.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.656 2.238 . . . . 72.5 112.372 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.685 HG12 HD22 ' A' ' 13' ' ' LEU . 87.4 t -84.05 115.34 26.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 111.158 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.05 162.07 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 65.519999999999996 110.876 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 40.52 65.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 75.349999999999994 110.838 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.685 HD22 HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -62.13 -173.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 75.310000000000002 110.915 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 p -143.2 139.15 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 73.209999999999994 111.146 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.77 64.89 0.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.792 -0.718 . . . . 75.239999999999995 112.522 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.5 160.49 30.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 72.310000000000002 110.876 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 90' ' ' SER . 31.0 mmtp -44.87 -70.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.453 . . . . 62.240000000000002 110.909 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.6 -45.59 2.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.68 -0.771 . . . . 73.200000000000003 112.496 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.89 151.88 13.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.342 . . . . 75.209999999999994 110.849 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.53 -179.4 8.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 74.340000000000003 110.896 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -128.56 144.76 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 62.210000000000001 111.119 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -137.43 145.27 42.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 71.239999999999995 110.852 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -144.09 166.09 25.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 74.040000000000006 110.942 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.423 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 2.5 m -141.96 138.58 32.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 72.150000000000006 111.128 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 2.0 t80 -160.53 162.98 33.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 74.549999999999997 110.882 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.668 HG22 HG23 ' A' ' 81' ' ' THR . 17.3 p -131.7 171.09 13.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.030000000000001 111.142 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.2 170.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 60.219999999999999 111.159 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -111.98 -39.31 4.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 41.009999999999998 110.848 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.95 157.87 45.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 110.886 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -79.93 116.45 20.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 65.099999999999994 110.891 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.98 142.86 32.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 23.34 111.122 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 32' ' ' THR . 2.5 t -99.17 107.84 20.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 72.219999999999999 111.105 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.08 147.23 45.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 74.510000000000005 111.098 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.1 p -107.87 111.37 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 71.230000000000004 111.165 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.8 t -127.83 140.33 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.349999999999994 111.13 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.502 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 2.0 p -132.36 167.16 20.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.854 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.455 HD11 ' H ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -110.38 142.66 22.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 74.530000000000001 111.121 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 p -179.32 -169.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 53.200000000000003 110.84 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.13 -147.92 19.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 74.109999999999999 112.518 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.44 -48.12 31.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.704 -0.76 . . . . 53.420000000000002 112.496 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.559 ' O ' HG22 ' A' ' 95' ' ' VAL . 4.4 m -107.05 163.96 12.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.368 . . . . 72.319999999999993 110.837 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.45 -130.5 2.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 54.119999999999997 112.455 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 60.04 30.21 19.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 74.439999999999998 110.863 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.56 108.38 14.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.040000000000006 111.069 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.0 144.58 54.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 73.310000000000002 110.853 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 71' ' ' SER . 5.9 tt -112.46 126.94 55.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 73.140000000000001 110.945 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -136.41 148.84 47.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 71.230000000000004 110.907 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.95 133.81 13.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 71.239999999999995 110.938 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -141.96 140.04 32.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.040000000000006 110.899 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.74 -48.45 13.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 72.230000000000004 111.148 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.61 -96.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 73.109999999999999 112.503 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -106.79 162.38 13.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.917 0.389 . . . . 62.119999999999997 110.828 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HA ' ' CB ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -45.12 128.35 5.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.575 0.702 . . . . 52.350000000000001 110.906 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 142.35 47.22 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.654 2.236 . . . . 41.420000000000002 112.305 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -113.42 179.77 3.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 55.439999999999998 111.15 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.5 p -60.96 -16.75 46.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 71.25 111.14 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -117.11 -26.03 6.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 74.040000000000006 110.848 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 124.94 49.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 73.319999999999993 110.862 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.34 152.97 31.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.92 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -114.76 -31.5 6.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 70.25 110.86 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.8 m -141.89 121.89 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.872 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.58 122.7 0.13 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.625 0.726 . . . . 71.030000000000001 110.855 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 53.6 Cg_endo -69.79 4.76 2.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.649 2.233 . . . . 33.25 112.325 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.409 ' CG ' ' C ' ' A' ' 63' ' ' PRO . 5.6 p90 38.73 72.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 71.329999999999998 110.945 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.49 -65.28 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 73.310000000000002 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.19 -166.39 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 75.299999999999997 110.911 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.14 -103.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 63.43 112.459 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -68.36 167.73 13.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 62.439999999999998 110.876 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.7 t30 64.13 14.61 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 60.340000000000003 110.914 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -126.88 98.1 5.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 41.399999999999999 110.876 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.502 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 3.5 m -135.81 171.43 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 71.439999999999998 110.862 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.83 150.86 38.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 72.340000000000003 110.907 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 34' ' ' VAL . 1.2 p -128.47 108.48 10.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 65.040000000000006 110.873 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -151.08 148.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 75.540000000000006 111.163 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.28 106.37 6.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 35.119999999999997 110.876 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.645 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.33 145.25 29.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 70.299999999999997 111.03 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.19 139.38 21.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 50.240000000000002 111.087 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 133.56 25.9 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.708 2.272 . . . . 62.25 112.326 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.88 -20.06 2.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 72.310000000000002 112.462 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.2 m -126.51 134.95 50.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.371 . . . . 60.32 111.15 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.668 HG23 HG22 ' A' ' 26' ' ' THR . 23.6 m -71.07 137.6 49.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 64.420000000000002 111.156 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.645 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 32.5 m-85 -104.77 139.6 39.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 73.549999999999997 110.948 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.405 ' CB ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -107.18 161.24 14.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 60.25 110.823 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.91 138.17 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 75.510000000000005 111.15 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.7 tpt -142.98 123.27 13.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 70.409999999999997 110.923 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.405 ' HB ' HG23 ' A' ' 21' ' ' VAL . 19.9 mm -118.95 112.15 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 71.219999999999999 111.094 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -95.77 157.18 16.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 63.140000000000001 110.924 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.34 145.95 16.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 75.140000000000001 112.467 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -112.16 -21.71 11.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 72.310000000000002 110.868 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 91' ' ' ASN . 7.1 p -165.74 127.97 2.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 70.430000000000007 110.877 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 90' ' ' SER . 9.1 t-20 -35.38 106.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 54.310000000000002 110.894 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.42 115.63 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 74.209999999999994 110.932 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 p -115.87 151.85 34.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 51.210000000000001 110.86 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.47 28.26 0.92 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 50.32 112.519 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 41' ' ' SER . 0.2 OUTLIER -113.33 147.38 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 61.5 111.088 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.03 114.14 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 74.400000000000006 111.107 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.67 ' HB3' HD21 ' A' ' 13' ' ' LEU . 1.7 tm? -104.25 132.78 50.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 55.119999999999997 110.935 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.651 ' N ' HD22 ' A' ' 97' ' ' LEU . 4.4 ttpt -144.18 163.72 32.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 71.230000000000004 110.832 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.659 HD22 ' CG ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -91.69 140.67 29.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 62.119999999999997 110.9 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.81 113.04 24.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.25 110.925 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.0 p90 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 110.953 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.481 -0.248 . . . . 53.100000000000001 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -90.88 -174.72 4.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 74.430000000000007 110.923 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 24' ' ' THR . 3.1 m -120.32 108.85 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 111.125 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.45 148.72 52.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.129999999999995 110.893 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.634 ' CD ' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -157.46 -69.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 55.0 110.859 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.574 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 54.1 t30 -77.68 158.73 29.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 41.140000000000001 110.904 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.574 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.4 t30 88.38 -68.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 110.918 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.7 m -123.4 113.73 29.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.552 0.691 . . . . 72.310000000000002 111.129 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.408 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.4 Cg_endo -69.76 150.28 68.0 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 74.409999999999997 112.34 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.563 HG12 HD22 ' A' ' 13' ' ' LEU . 76.5 t -77.99 113.8 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 73.030000000000001 111.091 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.21 140.02 41.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 71.540000000000006 110.854 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.35 84.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 74.120000000000005 110.89 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -72.35 -167.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 63.130000000000003 110.886 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 p -139.05 138.56 37.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 62.420000000000002 111.135 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.69 60.3 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 65.200000000000003 112.474 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -76.02 158.4 31.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 64.040000000000006 110.857 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -61.23 2.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.857 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.72 -50.63 1.94 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 75.409999999999997 112.503 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.74 140.63 14.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 73.409999999999997 110.88 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -141.19 170.46 15.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 43.539999999999999 110.859 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.29 137.06 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 64.439999999999998 111.161 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.25 152.27 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 54.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -143.34 165.56 27.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 63.530000000000001 110.934 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 3.2 m -135.24 139.07 44.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 75.140000000000001 111.125 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -160.01 162.58 34.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 71.540000000000006 110.863 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 81' ' ' THR . 20.4 p -136.72 171.04 15.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 73.329999999999998 111.154 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.732 HG11 ' CE1' ' A' ' 101' ' ' TYR . 22.3 m -108.38 172.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 70.200000000000003 111.123 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.6 -57.61 2.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 64.049999999999997 110.865 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.19 140.43 51.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 71.239999999999995 110.859 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -48.78 118.87 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 65.150000000000006 110.906 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.39 131.15 27.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 72.25 111.125 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 32' ' ' THR . 3.0 t -94.68 106.58 18.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 71.129999999999995 111.146 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.541 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -140.09 147.77 40.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.030000000000001 111.052 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.777 HG23 ' HB3' ' A' ' 73' ' ' SER . 2.8 p -113.9 109.24 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 111.157 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.82 HG11 ' HG2' ' A' ' 98' ' ' LYS . 3.7 t -130.95 141.19 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 73.340000000000003 111.153 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.495 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 29.1 p -129.12 167.68 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.409999999999997 110.873 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -109.96 147.18 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 64.120000000000005 111.132 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.22 163.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 62.439999999999998 110.914 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 176.08 -30.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.796 -0.716 . . . . 73.439999999999998 112.517 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.11 -117.2 1.1 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 50.219999999999999 112.496 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -113.93 161.3 17.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 63.219999999999999 110.858 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.04 126.08 29.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 73.219999999999999 112.503 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -170.81 -37.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.341 . . . . 72.200000000000003 110.905 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.12 128.59 46.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 52.329999999999998 111.104 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -102.45 124.49 48.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 75.010000000000005 110.905 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 71' ' ' SER . 0.9 OUTLIER -92.11 130.1 37.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.257 -0.429 . . . . 54.530000000000001 110.865 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -132.58 148.89 52.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.899 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -146.34 142.79 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 63.310000000000002 110.858 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.572 ' H ' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -151.91 117.72 5.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 110.926 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.52 123.92 20.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 64.400000000000006 111.115 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 -82.83 0.8 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 12.24 112.49 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.9 m -93.67 -179.19 4.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.952 0.406 . . . . 63.140000000000001 110.858 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 134.72 28.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 71.030000000000001 110.862 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 141.51 45.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 70.519999999999996 112.325 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -102.5 179.03 4.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 65.230000000000004 111.131 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.1 p -65.63 -13.7 59.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 54.109999999999999 111.145 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 m -121.36 -26.46 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 44.210000000000001 110.861 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.83 126.22 49.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 60.130000000000003 110.852 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.37 153.47 34.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 74.099999999999994 110.892 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -108.89 -29.11 8.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 75.530000000000001 110.844 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.9 m -136.93 124.0 21.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 60.329999999999998 110.88 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HG3' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -174.74 126.57 0.4 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.611 0.72 . . . . 73.540000000000006 110.904 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HD2' ' HG3' ' A' ' 62' ' ' ARG . 54.2 Cg_endo -69.77 -2.94 11.03 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.647 2.231 . . . . 63.43 112.363 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 70.15 92.18 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 75.120000000000005 110.916 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.94 -168.92 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 65.140000000000001 110.865 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.57 128.1 36.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.150000000000006 110.925 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.95 -178.75 36.34 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 74.409999999999997 112.488 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -172.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.803 0.335 . . . . 65.400000000000006 110.873 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.2 t30 63.94 19.63 11.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 110.862 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -123.16 88.74 2.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 75.019999999999996 110.907 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.614 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.5 m -132.23 170.16 15.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.540000000000006 110.852 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.24 154.01 34.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 55.229999999999997 110.899 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.777 ' HB3' HG23 ' A' ' 34' ' ' VAL . 89.7 p -128.25 104.19 7.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 74.040000000000006 110.834 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -152.22 152.73 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 72.519999999999996 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.1 p -84.32 104.39 14.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 75.030000000000001 110.884 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.767 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -81.68 154.72 25.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 74.409999999999997 111.066 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.39 139.71 20.42 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.629 0.728 . . . . 73.099999999999994 111.086 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.495 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.9 Cg_endo -69.78 140.03 41.62 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 53.020000000000003 112.328 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.26 -6.18 9.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.751 . . . . 73.25 112.51 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.5 m -126.41 129.6 49.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 73.209999999999994 111.127 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.48 ' HA ' HG22 ' A' ' 26' ' ' THR . 6.2 m -72.46 136.86 46.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 55.020000000000003 111.139 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.767 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 39.8 m-85 -111.88 134.44 53.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 74.219999999999999 110.936 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -106.07 162.76 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 62.409999999999997 110.863 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.634 HG21 ' CD ' ' A' ' 5' ' ' LYS . 73.2 t -134.79 140.0 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 54.240000000000002 111.129 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.13 121.07 14.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.109999999999999 110.894 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.604 HD11 HD22 ' A' ' 97' ' ' LEU . 14.8 mm -111.16 113.13 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 74.420000000000002 111.131 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 135.62 41.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 70.200000000000003 110.914 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.38 157.24 15.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.757 . . . . 61.049999999999997 112.486 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -117.12 -28.04 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.946 0.403 . . . . 73.209999999999994 110.904 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 91' ' ' ASN . 73.2 p -166.88 136.06 2.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 70.219999999999999 110.882 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 90' ' ' SER . 3.1 m120 -31.75 105.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 64.209999999999994 110.866 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -162.78 113.07 1.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 70.209999999999994 110.942 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.7 p -121.51 159.83 25.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 63.5 110.851 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.03 19.46 2.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.747 . . . . 74.209999999999994 112.532 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.42 141.45 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 65.140000000000001 111.169 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.7 m -99.32 122.84 43.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 60.229999999999997 111.141 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 86' ' ' ILE . 19.2 tp -102.04 142.7 32.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 74.230000000000004 110.877 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.82 ' HG2' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -151.22 153.0 34.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 72.349999999999994 110.946 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -88.52 140.85 29.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 110.895 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -93.9 113.66 25.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 74.049999999999997 110.889 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.732 ' CE1' HG11 ' A' ' 27' ' ' VAL . 4.9 t80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 71.329999999999998 110.959 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.503 -0.239 . . . . 63.240000000000002 112.503 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -104.72 -176.34 3.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 64.310000000000002 110.93 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.1 m -117.47 109.42 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 65.239999999999995 111.113 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.48 148.48 52.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 65.430000000000007 110.95 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.602 ' CD ' HD11 ' A' ' 97' ' ' LEU . 15.4 tptm -164.74 -65.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 64.430000000000007 110.914 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.635 ' OD1' HD22 ' A' ' 99' ' ' LEU . 8.4 t-20 -77.92 155.74 30.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 62.299999999999997 110.869 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 10.3 t-20 87.2 -68.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.219999999999999 110.867 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.5 m -121.5 120.89 28.64 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.594 0.712 . . . . 74.530000000000001 111.138 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 153.82 68.17 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.695 2.263 . . . . 73.430000000000007 112.327 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.6 t -83.21 115.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 73.25 111.076 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.07 142.25 31.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 75.319999999999993 110.864 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.28 86.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 74.209999999999994 110.906 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -79.88 -171.97 3.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 62.439999999999998 110.884 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 p -139.41 139.47 37.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 54.229999999999997 111.162 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.45 69.99 0.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 73.209999999999994 112.507 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -76.42 153.55 35.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 74.549999999999997 110.865 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.4 -34.29 23.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 74.219999999999999 110.879 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.66 -52.72 0.25 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 53.140000000000001 112.477 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 t -52.56 168.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 53.0 110.817 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.84 175.6 3.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 74.239999999999995 110.893 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -132.31 144.67 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 74.209999999999994 111.096 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -136.91 128.14 28.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.87 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -127.45 164.64 21.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 72.540000000000006 110.895 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.414 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 2.4 m -141.06 143.42 34.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 72.209999999999994 111.14 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -160.27 163.33 33.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 74.209999999999994 110.878 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.537 HG22 HG23 ' A' ' 81' ' ' THR . 18.8 p -132.5 170.31 15.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 54.210000000000001 111.117 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.511 HG11 ' HB1' ' A' ' 76' ' ' ALA . 13.6 m -109.2 167.47 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 72.420000000000002 111.12 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -97.43 -48.59 5.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.510000000000005 110.852 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 165.31 27.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 110.873 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -56.7 117.91 4.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 70.0 110.868 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.54 120.91 12.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 75.040000000000006 111.09 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 32' ' ' THR . 2.5 t -98.33 105.55 17.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 73.540000000000006 111.108 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.605 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -137.38 147.5 45.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 74.5 111.099 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.695 HG22 ' CB ' ' A' ' 73' ' ' SER . 96.8 t -108.49 110.6 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 62.149999999999999 111.137 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.432 HG11 ' HE3' ' A' ' 98' ' ' LYS . 21.7 t -127.3 141.11 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 64.010000000000005 111.12 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.48 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.62 166.49 17.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.450000000000003 110.851 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.44 147.33 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 73.400000000000006 111.168 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.93 172.09 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 62.130000000000003 110.85 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.38 -22.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.764 -0.732 . . . . 51.049999999999997 112.512 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.53 -104.01 0.23 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 31.120000000000001 112.485 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.3 m -130.17 155.1 46.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.953 0.406 . . . . 50.43 110.896 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -50.88 122.18 13.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 62.030000000000001 112.464 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -161.28 -38.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.833 0.349 . . . . 54.539999999999999 110.885 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.06 124.9 45.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.140000000000001 111.046 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.7 152.02 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 60.420000000000002 110.887 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.643 HD13 ' HA ' ' A' ' 71' ' ' SER . 2.4 tt -106.93 127.02 53.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 64.340000000000003 110.894 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -136.49 142.61 43.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 73.420000000000002 110.934 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -154.12 135.7 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 54.340000000000003 110.914 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.481 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.2 tttm -140.81 121.56 14.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 74.310000000000002 110.939 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.35 77.54 9.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.230000000000004 111.082 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.72 -59.98 0.3 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 62.310000000000002 112.454 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -142.21 141.78 32.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 51.549999999999997 110.834 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.73 120.15 1.4 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.574 0.702 . . . . 72.010000000000005 110.899 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 143.4 51.19 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.68 2.254 . . . . 55.310000000000002 112.38 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.35 178.31 4.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 65.319999999999993 111.138 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.0 p -61.48 -17.32 54.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 72.420000000000002 111.135 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 t -114.14 -26.86 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 74.209999999999994 110.844 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.86 123.49 47.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 72.25 110.891 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.23 153.58 32.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 110.945 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -110.71 -33.51 6.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.886 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.2 m -134.12 123.23 24.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 44.43 110.893 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -179.58 126.16 0.24 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 72.010000000000005 110.887 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 64' ' ' TYR . 53.8 Cg_endo -69.73 -5.9 17.29 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.74 2.293 . . . . 63.119999999999997 112.352 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' PRO . 19.7 p90 38.08 42.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 70.200000000000003 110.903 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.89 -34.32 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 74.420000000000002 110.895 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 178.38 -177.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 64.230000000000004 110.962 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.66 -106.42 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 42.32 112.497 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.42 160.67 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 74.349999999999994 110.872 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 67.11 13.59 9.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 74.319999999999993 110.836 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.05 101.97 6.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 73.549999999999997 110.844 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.643 ' HA ' HD13 ' A' ' 46' ' ' LEU . 10.6 m -133.75 175.02 9.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 73.239999999999995 110.876 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.66 158.76 24.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 54.210000000000001 110.916 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.695 ' CB ' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -127.64 113.89 16.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 72.319999999999993 110.863 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 t -146.38 158.37 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 73.209999999999994 111.143 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.9 p -78.33 129.63 35.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 50.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.734 ' HB2' ' CG ' ' A' ' 101' ' ' TYR . . . -78.9 151.54 31.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 73.129999999999995 111.051 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.05 121.57 18.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.556 0.693 . . . . 63.109999999999999 111.117 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 115.78 4.25 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.694 2.262 . . . . 74.540000000000006 112.331 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.96 -11.62 3.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 74.239999999999995 112.475 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.3 m -126.18 127.31 45.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.885 0.374 . . . . 63.310000000000002 111.092 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.537 HG23 HG22 ' A' ' 26' ' ' THR . 6.9 m -70.71 137.52 49.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 64.25 111.168 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -106.02 133.41 50.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 70.219999999999999 110.953 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -104.74 161.18 14.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 71.129999999999995 110.813 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.418 HG11 ' HE3' ' A' ' 5' ' ' LYS . 2.8 t -137.9 138.05 44.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 62.100000000000001 111.131 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -138.29 122.21 17.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 64.450000000000003 110.851 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 21' ' ' VAL . 26.8 mm -114.1 112.28 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 72.329999999999998 111.088 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.64 140.29 40.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 75.120000000000005 110.896 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -114.85 156.06 15.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.753 . . . . 63.030000000000001 112.464 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -114.34 -21.54 10.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.897 0.38 . . . . 71.129999999999995 110.921 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -161.35 128.2 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 64.129999999999995 110.874 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 90' ' ' SER . 15.2 t-20 -31.61 106.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 75.439999999999998 110.912 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -157.65 112.81 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 71.400000000000006 110.883 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 p -121.37 154.58 36.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.509 . . . . 55.020000000000003 110.835 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.46 20.88 2.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.716 -0.754 . . . . 75.239999999999995 112.492 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.26 147.23 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 74.120000000000005 111.177 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m -97.61 121.97 40.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 70.329999999999998 111.138 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.768 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -111.72 125.16 53.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 71.150000000000006 110.946 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.768 ' N ' HD22 ' A' ' 97' ' ' LEU . 8.5 ttpt -133.94 167.03 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 71.340000000000003 110.86 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -85.99 137.16 32.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.908 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.575 ' NE2' HD11 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -100.19 108.66 20.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 72.030000000000001 110.942 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.734 ' CG ' ' HB2' ' A' ' 76' ' ' ALA . 6.4 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.219999999999999 110.912 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.496 -0.241 . . . . 73.340000000000003 112.496 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -104.76 -175.82 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 74.200000000000003 110.918 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.7 m -116.52 108.2 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 73.329999999999998 111.142 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.65 149.14 52.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 110.907 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.648 ' CE ' HD11 ' A' ' 97' ' ' LEU . 19.8 tptm -164.05 -71.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 74.430000000000007 110.846 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 10.1 t-20 -68.32 157.8 34.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 73.420000000000002 110.912 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.3 t30 86.72 -68.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 70.140000000000001 110.943 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.5 m -125.15 119.68 25.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.537 0.685 . . . . 75.349999999999994 111.161 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 150.64 68.52 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.679 2.252 . . . . 74.450000000000003 112.372 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.411 ' HB ' HD21 ' A' ' 13' ' ' LEU . 60.9 t -77.99 115.77 20.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 71.409999999999997 111.119 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.59 143.9 31.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 64.439999999999998 110.835 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.23 80.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 60.140000000000001 110.879 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.411 HD21 ' HB ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -75.55 -172.77 1.93 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.477 . . . . 73.120000000000005 110.938 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 p -132.74 138.39 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.099999999999994 111.102 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.33 53.71 0.75 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.775 -0.726 . . . . 54.219999999999999 112.502 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -76.27 140.97 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 73.329999999999998 110.9 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -28.38 6.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 73.109999999999999 110.917 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.82 -64.61 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 62.229999999999997 112.443 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -52.22 134.14 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 62.409999999999997 110.844 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -131.21 172.58 11.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 73.099999999999994 110.894 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.465 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.22 138.53 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 72.030000000000001 111.109 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -136.66 147.08 46.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 73.310000000000002 110.894 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -143.59 164.82 29.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 73.030000000000001 110.926 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.442 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -138.28 139.77 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 74.530000000000001 111.18 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -159.53 162.8 35.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 71.109999999999999 110.855 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.694 HG22 HG23 ' A' ' 81' ' ' THR . 15.0 p -133.1 171.11 14.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 54.200000000000003 111.131 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -108.3 169.28 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 111.181 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -98.37 -48.86 4.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 72.219999999999999 110.898 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.67 173.34 11.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.841 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -80.0 117.2 20.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 74.129999999999995 110.913 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.11 144.59 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 72.049999999999997 111.086 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 32' ' ' THR . 2.3 t -104.59 106.4 16.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.425 . . . . 65.340000000000003 111.18 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.93 147.79 46.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 65.329999999999998 111.095 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -108.11 111.81 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 70.540000000000006 111.113 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.401 HG11 ' HG2' ' A' ' 98' ' ' LYS . 84.6 t -126.75 140.83 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 65.430000000000007 111.097 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.484 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 10.7 p -133.31 166.5 22.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 33.219999999999999 110.849 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.81 144.58 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 71.540000000000006 111.161 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.98 -174.99 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 72.319999999999993 110.901 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.21 -127.17 1.83 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.75 -0.738 . . . . 51.210000000000001 112.523 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.09 -23.84 9.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 64.209999999999994 112.487 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 95' ' ' VAL . 7.1 p -130.66 163.93 26.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 72.430000000000007 110.849 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.02 -135.33 4.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.729 . . . . 53.409999999999997 112.532 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 69.5 22.74 6.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.847 0.356 . . . . 43.43 110.861 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.48 114.75 26.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 63.439999999999998 111.115 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.11 135.67 36.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 71.319999999999993 110.891 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' A' ' 71' ' ' SER . 4.6 tt -102.34 126.84 49.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 71.519999999999996 110.893 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -134.61 149.0 50.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 74.140000000000001 110.91 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.429 HD12 ' NE2' ' A' ' 100' ' ' GLN . 0.4 OUTLIER -155.14 133.32 11.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 54.32 110.954 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HG2' ' HB2' ' A' ' 60' ' ' ASP . 11.5 tttt -144.86 123.42 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 110.851 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.36 71.59 7.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.099999999999994 111.116 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.46 -83.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 75.099999999999994 112.481 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -110.54 141.57 43.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.365 . . . . 73.430000000000007 110.917 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.19 121.85 3.15 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.609 0.719 . . . . 74.25 110.864 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 142.49 48.1 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.712 2.275 . . . . 71.510000000000005 112.335 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -109.66 178.74 4.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 65.420000000000002 111.142 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.1 p -60.07 -17.7 41.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 75.420000000000002 111.159 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 t -114.8 -26.3 7.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.319999999999993 110.85 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.86 124.19 47.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 54.109999999999999 110.847 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.99 153.22 32.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.105 -0.498 . . . . 75.239999999999995 110.909 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB2' ' HG2' ' A' ' 49' ' ' LYS . 8.1 t70 -115.67 -35.33 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 72.420000000000002 110.856 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.8 m -143.76 125.12 14.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.854 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 64' ' ' TYR . 1.4 ptt-85 179.65 157.08 0.72 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.658 0.742 . . . . 73.209999999999994 110.824 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 33.17 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.661 2.24 . . . . 64.450000000000003 112.321 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.476 ' H ' ' C ' ' A' ' 62' ' ' ARG . 0.1 OUTLIER 41.3 40.5 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.919 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.418 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -172.68 -176.2 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 71.549999999999997 110.932 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -128.74 153.57 47.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 73.239999999999995 110.931 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.19 140.93 6.2 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 60.399999999999999 112.496 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -51.12 169.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 65.450000000000003 110.851 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.77 14.14 9.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 74.420000000000002 110.959 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.418 ' HG2' ' HG2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -130.88 105.67 7.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 73.299999999999997 110.909 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.51 ' HA ' HD13 ' A' ' 46' ' ' LEU . 13.0 m -136.59 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 53.119999999999997 110.831 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.03 153.75 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 64.519999999999996 110.846 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 34' ' ' VAL . 1.1 p -128.24 110.28 12.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 62.130000000000003 110.901 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 t -149.31 153.11 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 73.349999999999994 111.119 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.4 p -73.3 110.85 7.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 63.32 110.854 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.441 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.4 130.79 35.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 53.439999999999998 111.103 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.33 139.23 20.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.59 0.709 . . . . 62.100000000000001 111.126 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 160.21 50.57 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.701 2.267 . . . . 74.439999999999998 112.328 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.5 -18.95 56.01 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.776 -0.726 . . . . 45.219999999999999 112.51 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 m -111.94 122.84 48.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.87 0.367 . . . . 71.25 111.163 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.694 HG23 HG22 ' A' ' 26' ' ' THR . 10.4 m -71.24 136.27 47.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 72.140000000000001 111.152 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.441 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 60.4 m-85 -103.76 141.68 35.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.928 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -107.36 160.75 15.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 71.040000000000006 110.837 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG11 ' HD3' ' A' ' 5' ' ' LYS . 2.4 t -138.19 138.36 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 111.108 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.89 122.98 13.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 71.420000000000002 110.88 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.465 ' HB ' HG23 ' A' ' 21' ' ' VAL . 18.0 mm -118.04 112.6 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.239999999999995 111.139 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -104.48 130.44 52.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 72.319999999999993 110.906 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.37 161.03 21.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 53.210000000000001 112.452 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.25 -28.59 5.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 72.5 110.923 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.51 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -166.56 132.64 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 64.230000000000004 110.817 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 90' ' ' SER . 1.5 p-10 -28.35 115.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 72.549999999999997 110.878 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.4 113.85 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.409999999999997 110.94 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 p -121.55 156.59 32.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 72.420000000000002 110.847 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.02 23.12 1.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 75.430000000000007 112.489 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 41' ' ' SER . 0.2 OUTLIER -112.04 145.98 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.962 0.41 . . . . 75.019999999999996 111.098 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.7 m -99.29 114.73 27.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 53.399999999999999 111.137 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.769 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -104.69 125.58 50.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 63.030000000000001 110.931 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.769 ' N ' HD22 ' A' ' 97' ' ' LEU . 5.1 ttpt -133.41 165.09 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.934 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.46 138.5 31.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.409999999999997 110.92 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.438 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 1.4 pm0 -98.87 112.84 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 110.93 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.9 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 60.530000000000001 110.929 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.494 -0.242 . . . . 65.420000000000002 112.494 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -133.09 -175.89 3.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 73.310000000000002 110.912 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.9 m -118.46 108.57 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 75.549999999999997 111.15 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.58 147.84 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 63.240000000000002 110.978 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.444 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 17.9 tptt -158.49 -39.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 75.150000000000006 110.871 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.638 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -108.24 158.1 17.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 72.409999999999997 110.95 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 5.9 t30 90.04 -68.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.340000000000003 110.883 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.4 m -126.34 113.83 23.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.576 0.703 . . . . 72.310000000000002 111.135 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.7 Cg_endo -69.78 153.51 68.76 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.658 2.239 . . . . 73.129999999999995 112.372 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.25 113.18 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 75.219999999999999 111.124 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.11 149.4 28.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 72.439999999999998 110.864 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 47.33 66.59 0.97 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 74.510000000000005 110.86 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -67.05 -174.16 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 74.120000000000005 110.902 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 p -131.14 138.24 49.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 73.340000000000003 111.188 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.64 57.19 0.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 74.209999999999994 112.489 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -75.65 139.35 41.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 34.130000000000003 110.921 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -27.6 7.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 110.87 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.12 -60.63 0.5 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 73.400000000000006 112.479 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.84 140.68 51.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 55.219999999999999 110.872 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -135.85 170.26 16.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 110.915 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.577 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.46 139.11 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 75.239999999999995 111.111 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -137.01 145.17 43.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 73.109999999999999 110.886 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -142.09 165.84 26.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 75.430000000000007 110.923 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.426 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 51.9 m -146.12 142.12 28.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 72.230000000000004 111.148 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 4.1 t80 -160.49 162.56 33.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 71.129999999999995 110.917 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.623 HG22 HG23 ' A' ' 81' ' ' THR . 18.1 p -128.88 170.44 13.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 71.319999999999993 111.164 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.754 HG11 ' CE1' ' A' ' 101' ' ' TYR . 15.9 m -108.12 173.26 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 63.43 111.146 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -110.44 -59.32 1.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 72.129999999999995 110.845 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.64 140.9 51.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 64.099999999999994 110.855 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.15 119.91 4.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.844 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.36 129.86 25.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.329999999999998 111.074 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 75' ' ' SER . 21.2 m -94.28 106.17 18.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 63.439999999999998 111.156 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.621 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -140.87 150.97 43.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.510000000000005 111.155 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.4 p -103.75 112.04 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 73.430000000000007 111.143 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.551 HG11 ' CG ' ' A' ' 98' ' ' LYS . 5.3 t -127.17 141.79 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 54.200000000000003 111.1 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 8.0 p -142.09 171.45 14.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 43.340000000000003 110.87 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.689 HD13 HD12 ' A' ' 46' ' ' LEU . 5.3 pt -107.04 158.69 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 74.239999999999995 111.128 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.56 165.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 73.239999999999995 110.88 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.39 -87.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 64.439999999999998 112.524 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.86 -116.51 4.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.725 -0.75 . . . . 74.140000000000001 112.505 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 m -104.99 161.23 14.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 72.209999999999994 110.889 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.39 133.17 51.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 35.130000000000003 112.486 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.35 -38.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.804 0.335 . . . . 71.109999999999999 110.868 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.68 111.58 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 44.310000000000002 111.11 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -80.26 164.55 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 55.229999999999997 110.819 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.689 HD12 HD13 ' A' ' 37' ' ' ILE . 8.5 tt -124.18 138.43 54.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 72.25 110.879 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.524 ' N ' HD23 ' A' ' 46' ' ' LEU . 94.9 m-85 -152.63 133.58 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.932 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp -139.26 153.02 47.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 62.329999999999998 110.904 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -156.36 145.99 20.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 75.239999999999995 110.912 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.66 101.56 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 61.200000000000003 111.086 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.84 -92.98 0.75 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 41.140000000000001 112.517 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 m -82.83 129.26 34.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.994 0.426 . . . . 61.100000000000001 110.837 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.44 137.12 5.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.554 0.692 . . . . 73.099999999999994 110.912 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.73 51.74 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.672 2.248 . . . . 73.409999999999997 112.33 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -101.38 178.54 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 74.219999999999999 111.155 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 p -64.94 -14.39 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 71.319999999999993 111.16 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.5 t -120.31 -26.14 5.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 60.200000000000003 110.899 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.75 125.48 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 74.430000000000007 110.876 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.64 153.59 34.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.925 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -110.71 -23.17 11.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 64.409999999999997 110.821 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.0 m -143.64 122.71 12.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 64.209999999999994 110.867 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 177.9 117.26 0.18 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 65.439999999999998 110.903 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HG2' ' CG ' ' A' ' 70' ' ' GLU . 53.7 Cg_endo -69.75 -18.07 37.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.671 2.247 . . . . 73.310000000000002 112.36 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.7 t80 62.62 87.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 73.040000000000006 110.916 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -132.41 -80.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 74.400000000000006 110.908 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.5 t80 177.38 107.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 74.129999999999995 110.948 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 49.69 -128.29 24.46 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 73.200000000000003 112.471 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -58.28 179.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 65.530000000000001 110.899 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.6 t30 53.79 27.9 7.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 70.329999999999998 110.923 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.4 ' CG ' ' HG2' ' A' ' 63' ' ' PRO . 3.3 tt0 -131.15 81.27 1.98 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 64.25 110.876 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.654 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -132.51 170.75 14.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 72.230000000000004 110.877 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -119.28 156.91 29.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 35.210000000000001 110.898 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.455 ' HB3' HG23 ' A' ' 34' ' ' VAL . 81.0 p -128.94 106.77 9.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 73.030000000000001 110.87 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -151.75 153.25 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 62.219999999999999 111.12 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.446 ' HB3' HG23 ' A' ' 32' ' ' THR . 83.8 p -84.93 107.68 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.209999999999994 110.888 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.683 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.09 154.9 25.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 60.310000000000002 111.077 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.17 138.57 19.56 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.549 0.69 . . . . 72.209999999999994 111.134 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.525 ' HA ' HG23 ' A' ' 27' ' ' VAL . 54.0 Cg_endo -69.72 134.23 27.56 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.694 2.262 . . . . 71.040000000000006 112.388 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.9 -21.98 4.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 23.149999999999999 112.505 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -114.3 131.68 56.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 72.129999999999995 111.142 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.623 HG23 HG22 ' A' ' 26' ' ' THR . 4.8 m -71.95 137.38 47.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 111.186 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.683 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 62.6 m-85 -112.05 133.0 54.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 75.340000000000003 110.921 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -107.08 161.19 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 52.409999999999997 110.892 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.416 HG21 ' HB2' ' A' ' 5' ' ' LYS . 2.1 t -137.08 138.35 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 74.450000000000003 111.148 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 tpt -134.82 122.84 22.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.219999999999999 110.876 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 21' ' ' VAL . 25.3 mm -112.5 116.01 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 111.134 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 145.54 29.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 62.329999999999998 110.864 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.45 151.74 18.23 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 71.420000000000002 112.457 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -107.33 -28.13 10.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 72.209999999999994 110.878 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.466 ' O ' ' C ' ' A' ' 91' ' ' ASN . 88.5 p -175.37 144.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 52.420000000000002 110.877 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 90' ' ' SER . 3.0 p30 -32.64 105.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.492 . . . . 63.409999999999997 110.942 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -166.77 118.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.897 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.9 p -122.01 160.82 24.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 61.329999999999998 110.852 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.36 23.44 2.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 44.329999999999998 112.475 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.528 ' O ' HD12 ' A' ' 13' ' ' LEU . 3.1 t -113.81 146.58 18.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.887 0.375 . . . . 64.349999999999994 111.156 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -106.86 135.06 49.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 72.329999999999998 111.146 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.699 HD13 ' C ' ' A' ' 97' ' ' LEU . 2.5 tm? -118.58 128.03 54.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 64.430000000000007 110.866 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.551 ' CG ' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -138.12 154.65 49.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 62.229999999999997 110.929 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -87.3 145.1 26.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 62.229999999999997 110.904 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.487 ' O ' ' CD ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -94.86 112.98 24.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 72.439999999999998 110.978 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.754 ' CE1' HG11 ' A' ' 27' ' ' VAL . 2.3 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.319999999999993 110.926 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.491 -0.244 . . . . 74.230000000000004 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -152.16 -173.34 4.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.834 0.349 . . . . 64.519999999999996 110.894 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.413 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.4 m -121.77 109.16 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 70.420000000000002 111.135 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.27 149.01 52.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 72.420000000000002 110.916 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.628 ' HE3' HD11 ' A' ' 97' ' ' LEU . 2.2 tppm? -155.73 -73.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 65.0 110.907 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.8 t-20 -64.22 158.66 22.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.030000000000001 110.874 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.6 t30 91.21 -68.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 73.549999999999997 110.886 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 m -132.71 121.79 17.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.576 0.703 . . . . 51.530000000000001 111.155 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.658 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.7 Cg_endo -69.8 154.85 67.1 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 71.510000000000005 112.341 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.44 115.36 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 111.136 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.49 166.39 13.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 70.0 110.872 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 39.97 52.05 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 73.340000000000003 110.876 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.758 HD11 ' CB ' ' A' ' 97' ' ' LEU . 2.4 mt -57.84 -178.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 71.310000000000002 110.944 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 p -137.19 138.15 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 61.219999999999999 111.078 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.66 56.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.751 . . . . 35.25 112.493 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -74.79 150.96 39.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 74.540000000000006 110.902 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.71 -33.49 10.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 110.872 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.59 -57.84 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 75.420000000000002 112.496 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.77 139.04 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 72.109999999999999 110.863 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -139.01 175.01 9.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 62.130000000000003 110.907 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.573 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.97 135.65 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 62.229999999999997 111.158 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -138.87 149.81 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.200000000000003 110.902 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -145.96 166.36 26.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 74.329999999999998 110.929 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.499 HG23 ' CD2' ' A' ' 83' ' ' HIS . 58.5 m -138.75 138.91 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 64.129999999999995 111.142 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CB ' ' HB3' ' A' ' 5' ' ' LYS . 2.3 t80 -160.94 153.17 20.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 74.439999999999998 110.915 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 81' ' ' THR . 10.9 p -127.92 170.44 12.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 71.109999999999999 111.14 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' A' ' 101' ' ' TYR . 13.9 m -113.02 170.83 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 64.540000000000006 111.109 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.15 11.45 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 65.530000000000001 110.84 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.58 137.79 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 74.450000000000003 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -72.85 118.85 16.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 64.030000000000001 110.871 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.31 145.57 37.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 61.130000000000003 111.094 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 32' ' ' THR . 1.8 t -107.92 104.95 14.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 72.140000000000001 111.1 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 101' ' ' TYR . . . -139.57 149.1 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.349999999999994 111.117 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.624 HG22 ' CB ' ' A' ' 73' ' ' SER . 90.9 t -113.63 111.85 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 63.539999999999999 111.113 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.01 140.86 47.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 53.299999999999997 111.078 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.507 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 6.0 p -124.86 166.74 15.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 60.039999999999999 110.826 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -111.21 151.07 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 71.349999999999994 111.136 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.53 168.0 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 72.129999999999995 110.866 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.77 -24.15 0.23 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 53.420000000000002 112.499 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.67 -120.01 1.28 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 51.229999999999997 112.457 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 m -119.41 162.46 18.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 54.130000000000003 110.85 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -50.29 103.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 63.420000000000002 112.515 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.01 -40.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 63.549999999999997 110.867 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.65 117.16 29.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 74.310000000000002 111.109 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -85.23 163.83 18.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 73.439999999999998 110.889 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.68 HD13 ' HA ' ' A' ' 71' ' ' SER . 6.3 tt -120.31 127.56 52.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.010000000000005 110.924 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -137.63 153.23 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 62.219999999999999 110.889 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 49' ' ' LYS . 1.5 tt -154.34 140.46 18.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 75.310000000000002 110.923 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.591 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -148.17 141.55 25.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 75.209999999999994 110.923 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.35 126.97 35.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 44.420000000000002 111.11 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.85 -61.02 0.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 54.329999999999998 112.527 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.75 -173.03 2.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.955 0.407 . . . . 63.43 110.837 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 134.13 30.56 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.566 0.698 . . . . 53.119999999999997 110.925 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 143.38 50.82 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.708 2.272 . . . . 74.120000000000005 112.32 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 p -104.49 178.71 4.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 65.540000000000006 111.123 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.9 p -64.03 -15.14 58.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 70.25 111.168 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.0 m -119.84 -26.06 5.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.120000000000005 110.864 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.11 126.08 48.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 72.109999999999999 110.843 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.99 154.03 36.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 72.099999999999994 110.888 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -115.88 -34.52 4.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 72.049999999999997 110.864 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.2 m -145.39 124.42 12.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 65.219999999999999 110.886 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.16 150.18 1.23 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 74.450000000000003 110.921 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 -5.72 16.87 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.714 2.276 . . . . 41.32 112.318 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 69.62 68.32 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.926 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -172.96 -173.92 1.02 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 64.239999999999995 110.861 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -135.36 137.65 42.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 110.924 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.65 162.66 21.43 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.742 -0.742 . . . . 54.399999999999999 112.432 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.1 179.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.339 . . . . 61.039999999999999 110.918 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.99 16.06 9.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 65.310000000000002 110.873 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -127.44 96.88 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 71.150000000000006 110.87 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.68 ' HA ' HD13 ' A' ' 46' ' ' LEU . 1.4 m -134.78 170.73 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 54.020000000000003 110.91 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.79 162.62 19.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 71.349999999999994 110.863 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.624 ' CB ' HG22 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -131.37 111.62 12.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 75.120000000000005 110.886 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.7 t -149.11 153.65 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 72.010000000000005 111.171 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.3 p -94.28 105.74 17.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 65.439999999999998 110.913 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.785 ' HB3' ' CD2' ' A' ' 101' ' ' TYR . . . -86.39 152.19 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 75.540000000000006 111.08 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.21 142.73 26.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.572 0.701 . . . . 71.019999999999996 111.119 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.3 Cg_endo -69.78 120.57 7.33 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 73.519999999999996 112.308 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.6 -19.94 0.9 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 32.229999999999997 112.465 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 m -122.76 136.57 54.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.372 . . . . 64.040000000000006 111.11 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.54 ' HA ' HG22 ' A' ' 26' ' ' THR . 62.5 m -71.77 138.02 48.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 72.439999999999998 111.109 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -118.3 142.84 47.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 110.927 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.499 ' CD2' HG23 ' A' ' 24' ' ' THR . 13.9 m-70 -121.94 160.76 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 74.209999999999994 110.88 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.551 HG11 ' HE3' ' A' ' 5' ' ' LYS . 16.5 t -133.45 125.31 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.540000000000006 111.173 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.65 128.98 55.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 110.886 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.573 ' HB ' HG23 ' A' ' 21' ' ' VAL . 34.0 mm -118.41 114.01 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 73.030000000000001 111.128 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.15 150.17 21.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 70.349999999999994 110.897 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -112.16 160.75 13.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 74.430000000000007 112.481 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -119.0 -24.56 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.918 0.389 . . . . 63.25 110.955 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 91' ' ' ASN . 52.1 p -176.77 144.13 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 54.310000000000002 110.87 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 90' ' ' SER . 42.4 t30 -32.69 106.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 74.310000000000002 110.893 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -166.54 115.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 110.903 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.1 p -121.76 155.35 35.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 63.450000000000003 110.838 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.05 26.74 1.82 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 62.25 112.508 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.417 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.2 t -113.91 139.62 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 73.299999999999997 111.122 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.658 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -100.58 114.89 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 52.509999999999998 111.153 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.799 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -105.13 128.64 53.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.909 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.799 ' N ' HD22 ' A' ' 97' ' ' LEU . 1.5 ttpt -133.34 171.2 14.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 51.509999999999998 110.91 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.755 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -88.14 137.47 32.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 71.450000000000003 110.952 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.463 ' C ' ' HD1' ' A' ' 101' ' ' TYR . 1.8 pp0? -108.76 112.58 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 70.400000000000006 110.908 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 5.1 m-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 74.549999999999997 110.946 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.444 -0.262 . . . . 71.340000000000003 112.444 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -134.47 -177.49 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 73.310000000000002 110.883 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.42 ' HB ' ' H ' ' A' ' 24' ' ' THR . 1.9 m -118.15 109.49 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.140000000000001 111.128 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.32 147.61 52.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 72.340000000000003 110.932 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.658 ' HE3' HG11 ' A' ' 84' ' ' VAL . 8.8 tptp -158.78 -69.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 74.230000000000004 110.895 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.688 ' CG ' HD22 ' A' ' 99' ' ' LEU . 17.0 t-20 -76.08 158.23 32.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 73.129999999999995 110.91 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.0 t-20 88.58 -68.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 72.519999999999996 110.902 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 m -125.28 115.02 25.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.599 0.714 . . . . 73.230000000000004 111.143 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.5 Cg_endo -69.76 150.24 67.97 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.663 2.242 . . . . 72.230000000000004 112.331 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.411 ' HB ' HD13 ' A' ' 13' ' ' LEU . 21.2 t -77.6 113.51 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 111.095 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.7 147.8 30.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 64.530000000000001 110.859 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.66 64.36 1.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 72.510000000000005 110.932 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 13' ' ' LEU . 5.0 tp -58.95 -175.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 61.229999999999997 110.897 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 p -136.09 139.29 42.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 75.340000000000003 111.128 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.83 60.48 0.58 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 43.340000000000003 112.458 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -76.48 138.71 40.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.896 0.379 . . . . 62.32 110.925 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -29.1 8.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 75.030000000000001 110.902 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.13 -62.08 0.46 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 65.129999999999995 112.49 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.6 m -60.67 151.44 29.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.887 0.375 . . . . 75.420000000000002 110.807 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.31 179.4 8.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 63.530000000000001 110.904 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.437 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.71 149.18 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 61.539999999999999 111.109 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -136.78 134.85 37.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 73.349999999999994 110.853 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.9 165.48 25.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 73.540000000000006 110.931 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.42 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 55.3 m -147.92 141.72 25.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.497 . . . . 74.040000000000006 111.154 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 2.1 t80 -159.34 163.28 35.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 110.89 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.695 ' CG2' HG23 ' A' ' 81' ' ' THR . 14.2 p -131.41 170.98 13.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 52.240000000000002 111.186 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 76' ' ' ALA . 26.9 m -106.91 169.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 71.230000000000004 111.131 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -108.42 -47.1 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 62.25 110.855 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -129.73 155.47 45.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 71.420000000000002 110.897 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -77.42 115.7 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 62.32 110.859 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.45 145.89 34.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 64.219999999999999 111.108 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 32' ' ' THR . 2.7 t -99.25 107.31 19.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.319999999999993 111.121 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.594 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -137.06 148.8 47.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 51.130000000000003 111.099 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 73' ' ' SER . 2.9 p -105.78 111.07 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 75.109999999999999 111.169 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.609 HG11 ' HG2' ' A' ' 98' ' ' LYS . 9.9 t -127.06 140.4 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 51.409999999999997 111.15 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.534 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 0.1 OUTLIER -139.6 169.02 18.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 72.150000000000006 110.873 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.708 HG21 HD12 ' A' ' 97' ' ' LEU . 1.3 pt -110.14 159.36 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 72.329999999999998 111.165 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 171.17 167.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 72.030000000000001 110.889 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.49 -31.68 0.43 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 55.229999999999997 112.49 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -150.1 -117.97 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 74.219999999999999 112.496 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.82 160.82 15.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 73.510000000000005 110.865 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.47 99.38 0.58 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.736 . . . . 53.25 112.49 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -132.92 -38.96 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.825 0.345 . . . . 65.340000000000003 110.838 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.562 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -90.44 123.88 34.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 61.32 111.119 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -80.35 147.31 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 74.540000000000006 110.879 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.54 HD12 HD13 ' A' ' 37' ' ' ILE . 7.0 tt -113.49 127.08 55.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 61.219999999999999 110.932 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.73 148.56 44.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 75.439999999999998 110.932 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 82' ' ' TYR . 0.5 OUTLIER -154.15 132.93 12.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 74.310000000000002 110.882 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.486 ' HG3' ' HB3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -144.71 131.12 19.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 72.129999999999995 110.894 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HB1' HG21 ' A' ' 80' ' ' THR . . . -65.53 -66.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 72.510000000000005 111.128 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -45.36 -90.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 61.340000000000003 112.49 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.18 -168.59 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 74.230000000000004 110.895 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 132.88 87.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 63.340000000000003 110.887 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HB3' ' HG3' ' A' ' 49' ' ' LYS . 53.6 Cg_endo -69.75 140.71 43.39 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 60.32 112.351 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.18 178.75 4.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 62.409999999999997 111.146 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -66.41 -13.1 60.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 71.530000000000001 111.173 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -124.08 -25.97 4.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.140000000000001 110.87 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.52 124.37 47.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 74.209999999999994 110.868 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.73 153.87 33.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.489 . . . . 74.109999999999999 110.896 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -102.02 -31.75 10.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 72.140000000000001 110.885 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.8 m -140.24 122.67 16.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 74.049999999999997 110.876 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -176.11 134.44 0.44 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 65.150000000000006 110.854 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -9.12 25.32 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.634 2.223 . . . . 72.109999999999999 112.341 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 63.84 100.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.921 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -178.94 -31.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 62.420000000000002 110.856 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.5 t80 72.2 125.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 63.229999999999997 110.888 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.74 158.07 18.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 72.510000000000005 112.523 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.836 ' ND2' HG11 ' A' ' 95' ' ' VAL . 11.8 m120 -53.83 176.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.36 . . . . 71.340000000000003 110.896 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 t30 61.5 28.03 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 74.209999999999994 110.915 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.65 89.92 2.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 65.530000000000001 110.877 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.534 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -129.05 172.6 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 60.310000000000002 110.883 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.19 162.07 18.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.119 -0.491 . . . . 74.420000000000002 110.881 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.726 ' HB3' HG23 ' A' ' 34' ' ' VAL . 32.3 p -128.51 109.14 11.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 55.020000000000003 110.847 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.98 152.99 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 74.340000000000003 111.114 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.8 p -80.53 113.82 18.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 72.099999999999994 110.839 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.73 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.29 131.04 35.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 34.229999999999997 111.091 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.74 136.49 22.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.594 0.711 . . . . 73.150000000000006 111.077 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 124.92 11.55 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 73.109999999999999 112.355 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.73 -18.55 2.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 73.310000000000002 112.516 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.461 HG21 ' HB1' ' A' ' 50' ' ' ALA . 39.7 m -125.6 131.51 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 52.530000000000001 111.149 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.695 HG23 ' CG2' ' A' ' 26' ' ' THR . 10.8 m -72.44 137.63 46.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 54.119999999999997 111.149 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.73 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 52.9 m-85 -107.81 131.65 54.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 70.109999999999999 110.957 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -107.14 158.96 16.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 65.140000000000001 110.867 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.658 HG11 ' HE3' ' A' ' 5' ' ' LYS . 67.8 t -137.71 138.17 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 62.340000000000003 111.157 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.3 tpt -129.03 121.54 28.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 64.519999999999996 110.847 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.449 HG23 ' HB1' ' A' ' 44' ' ' ALA . 25.3 mm -109.63 114.41 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 65.319999999999993 111.158 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -109.12 139.86 43.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 73.239999999999995 110.915 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.88 150.05 16.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 75.129999999999995 112.46 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -117.81 -17.07 9.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.878 0.37 . . . . 71.340000000000003 110.946 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -177.89 129.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 72.109999999999999 110.867 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 90' ' ' SER . 54.5 t-20 -29.62 109.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 63.149999999999999 110.844 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -166.5 112.72 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 72.400000000000006 110.925 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.1 p -120.71 166.42 13.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 54.549999999999997 110.844 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.9 23.07 4.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.747 -0.739 . . . . 41.43 112.471 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.836 HG11 ' ND2' ' A' ' 68' ' ' ASN . 9.6 t -113.29 148.34 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 65.109999999999999 111.107 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.3 m -106.68 126.17 51.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 71.319999999999993 111.161 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 37' ' ' ILE . 3.4 tp -108.4 135.13 50.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 63.140000000000001 110.896 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.609 ' HG2' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -144.79 154.63 42.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 110.884 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.688 HD22 ' CG ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -88.7 144.65 26.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 71.530000000000001 110.906 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.481 ' O ' ' CD ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -94.13 112.85 24.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 61.409999999999997 110.88 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.594 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 15.0 p90 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 64.239999999999995 110.947 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.48 -0.248 . . . . 34.43 112.48 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -111.95 -178.6 3.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.895 0.379 . . . . 74.549999999999997 110.884 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.428 ' HB ' ' H ' ' A' ' 24' ' ' THR . 1.9 m -117.94 107.96 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 74.030000000000001 111.138 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.975 HD12 HG22 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -133.34 149.0 51.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.0 110.905 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.679 ' HZ3' HD11 ' A' ' 97' ' ' LEU . 13.4 tptt -174.65 -74.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 62.009999999999998 110.921 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.613 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -70.13 153.17 43.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 72.239999999999995 110.858 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.2 t30 78.07 -58.88 0.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 64.310000000000002 110.906 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.5 m -122.75 119.32 28.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.615 0.722 . . . . 74.099999999999994 111.125 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 137.93 36.7 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.701 2.267 . . . . 71.099999999999994 112.357 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.975 HG22 HD12 ' A' ' 4' ' ' LEU . 46.4 t -77.27 114.93 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 72.209999999999994 111.17 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 p -87.62 163.2 16.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 41.539999999999999 110.859 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 40.18 64.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 74.349999999999994 110.888 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.552 HD22 HG12 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -64.35 -164.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 72.299999999999997 110.911 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.422 ' H ' HD12 ' A' ' 13' ' ' LEU . 3.5 p -147.4 136.73 22.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 63.130000000000003 111.145 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.4 67.17 0.47 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 75.299999999999997 112.452 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -76.05 135.49 39.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 63.420000000000002 110.912 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -30.64 23.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 61.399999999999999 110.944 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.34 -46.71 0.98 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 74.409999999999997 112.491 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.15 160.83 27.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 74.019999999999996 110.872 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -143.95 169.02 18.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 70.010000000000005 110.893 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.466 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -131.14 150.53 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.239999999999995 111.089 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -138.85 151.34 46.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.519999999999996 110.893 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -148.95 166.65 27.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 74.409999999999997 110.906 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.428 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 10.7 m -148.59 140.67 23.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 52.409999999999997 111.106 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' HD1' HD21 ' A' ' 6' ' ' ASN . 0.3 OUTLIER -160.74 162.71 32.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 72.099999999999994 110.854 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.436 ' CG2' HG23 ' A' ' 81' ' ' THR . 17.1 p -131.09 170.66 14.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 54.229999999999997 111.127 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 78' ' ' PRO . 17.5 m -108.27 170.01 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 75.430000000000007 111.122 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.46 -50.8 3.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 35.0 110.849 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 167.12 21.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 72.549999999999997 110.925 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -80.19 115.52 19.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 70.040000000000006 110.911 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.2 141.91 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 70.310000000000002 111.12 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 32' ' ' THR . 2.9 t -94.7 106.28 18.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.109999999999999 111.149 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.26 149.21 45.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.239999999999995 111.127 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.723 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.5 p -105.49 112.56 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 62.039999999999999 111.145 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.737 HG11 ' HG2' ' A' ' 98' ' ' LYS . 20.9 t -123.72 140.52 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 111.078 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.509 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 11.6 p -139.97 165.48 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 44.43 110.868 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.841 HG21 HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -111.77 154.64 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 73.219999999999999 111.124 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -167.51 153.11 7.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.400000000000006 110.827 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 95' ' ' VAL . . . -155.98 -154.37 6.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 60.329999999999998 112.529 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -122.42 -53.38 0.21 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 60.109999999999999 112.495 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 p -103.86 154.76 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.382 . . . . 74.319999999999993 110.893 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 58.42 172.79 0.38 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 63.25 112.48 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.403 ' CB ' ' HA2' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -138.77 110.98 7.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 51.329999999999998 110.861 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.547 ' HB1' HG23 ' A' ' 86' ' ' ILE . . . -89.54 131.53 35.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 71.109999999999999 111.119 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.52 133.33 35.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 61.140000000000001 110.906 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 71' ' ' SER . 2.4 tt -92.93 138.14 31.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 61.420000000000002 110.87 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -152.42 143.04 22.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 70.329999999999998 110.947 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -150.68 146.68 26.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 63.109999999999999 110.929 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' H ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -156.05 112.12 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 72.439999999999998 110.904 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.35 119.35 7.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 75.349999999999994 111.121 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.21 -81.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.734 . . . . 73.219999999999999 112.485 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.6 p -99.14 -174.28 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.965 0.412 . . . . 74.349999999999994 110.83 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.58 133.76 27.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.692 . . . . 70.230000000000004 110.892 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 141.69 45.72 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.711 2.274 . . . . 61.25 112.293 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 p -102.29 178.96 4.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 111.124 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 p -65.24 -14.39 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 111.163 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.2 m -120.03 -26.68 5.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 63.530000000000001 110.879 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.07 126.38 50.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 70.319999999999993 110.832 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.15 154.02 36.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 74.25 110.939 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.43 -31.86 6.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.423 . . . . 73.219999999999999 110.819 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.7 m -142.06 123.14 14.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 53.32 110.853 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.489 ' C ' ' H ' ' A' ' 64' ' ' TYR . 1.2 ttt-85 176.44 134.48 0.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.562 0.696 . . . . 75.540000000000006 110.904 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 23.69 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.268 . . . . 73.200000000000003 112.346 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 62' ' ' ARG . 0.2 OUTLIER 50.84 72.91 0.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 75.439999999999998 110.921 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.42 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER 179.66 -171.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 75.409999999999997 110.905 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.09 -175.94 3.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 71.530000000000001 110.935 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.403 ' HA2' ' CB ' ' A' ' 43' ' ' ASP . . . 62.1 160.3 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 72.129999999999995 112.52 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.596 ' HB3' HG11 ' A' ' 95' ' ' VAL . 7.7 p30 -57.01 -176.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 60.409999999999997 110.893 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 66.33 10.63 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.902 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.461 ' H ' HD11 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -126.47 91.33 3.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 70.409999999999997 110.912 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.509 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -133.8 171.66 13.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 73.349999999999994 110.853 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.45 157.94 27.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 64.409999999999997 110.877 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.723 ' HB3' HG23 ' A' ' 34' ' ' VAL . 2.6 p -128.41 109.57 11.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 53.299999999999997 110.867 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.8 t -150.13 152.82 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 72.409999999999997 111.133 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 85.6 p -74.1 104.57 4.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 72.420000000000002 110.826 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.27 131.41 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 71.329999999999998 111.105 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.92 142.25 24.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.561 0.696 . . . . 53.32 111.139 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.473 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.5 Cg_endo -69.71 162.06 43.52 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.741 2.294 . . . . 33.420000000000002 112.343 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.14 -21.69 42.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.792 -0.718 . . . . 74.230000000000004 112.488 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -106.77 123.63 48.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 65.219999999999999 111.146 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.436 HG23 ' CG2' ' A' ' 26' ' ' THR . 2.4 m -71.49 135.0 46.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 73.510000000000005 111.134 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.46 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 50.9 m-85 -108.68 133.69 52.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.905 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -109.17 147.79 31.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 73.329999999999998 110.855 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG11 HD21 ' A' ' 97' ' ' LEU . 3.2 t -123.54 138.81 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 63.109999999999999 111.136 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.81 122.41 25.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.310000000000002 110.858 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.547 HG23 ' HB1' ' A' ' 44' ' ' ALA . 15.5 mm -114.83 111.65 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 72.340000000000003 111.115 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 -65.11 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.907 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 44' ' ' ALA . . . 114.39 -146.84 18.76 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 73.329999999999998 112.482 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -175.78 -57.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.898 0.38 . . . . 73.420000000000002 110.932 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' ASN . 3.0 p -144.85 128.0 16.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 73.430000000000007 110.865 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 90' ' ' SER . 34.6 t30 -33.86 104.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 74.439999999999998 110.919 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.15 139.46 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.905 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.4 p -122.52 157.22 32.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 72.409999999999997 110.85 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 135.95 25.31 0.49 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.761 -0.733 . . . . 63.109999999999999 112.504 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.596 HG11 ' HB3' ' A' ' 68' ' ' ASN . 1.3 t -113.64 147.35 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.925 0.393 . . . . 72.219999999999999 111.098 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 1.3 m -106.17 112.81 26.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 73.040000000000006 111.181 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.841 HD12 HG21 ' A' ' 37' ' ' ILE . 5.2 tp -102.91 142.56 33.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 72.219999999999999 110.936 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.737 ' HG2' HG11 ' A' ' 35' ' ' VAL . 6.4 ttpt -153.74 161.99 41.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 71.109999999999999 110.865 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.613 HD22 ' HB2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -91.41 143.81 26.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.230000000000004 110.929 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.496 ' O ' ' CD ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.31 110.88 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 71.230000000000004 110.883 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.557 ' HB3' HD21 ' A' ' 99' ' ' LEU . 35.9 p90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 74.549999999999997 110.963 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.508 -0.237 . . . . 54.130000000000003 112.508 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.51 -174.21 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 75.140000000000001 110.88 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.428 ' HB ' ' H ' ' A' ' 24' ' ' THR . 1.8 m -115.12 109.19 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 72.519999999999996 111.115 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.14 148.34 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 74.540000000000006 110.923 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.68 ' HE3' HG11 ' A' ' 84' ' ' VAL . 1.7 tppm? -165.19 -74.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 70.049999999999997 110.919 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -63.96 155.18 31.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 73.140000000000001 110.893 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.2 t-20 88.23 -61.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 70.319999999999993 110.886 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 m -130.09 120.38 19.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 73.099999999999994 111.185 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.0 Cg_endo -69.79 153.38 68.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 41.450000000000003 112.341 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -85.22 114.23 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 75.340000000000003 111.188 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 p -88.69 167.45 13.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 61.520000000000003 110.856 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 40.5 53.23 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 70.129999999999995 110.87 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -54.75 178.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 55.219999999999999 110.905 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -135.37 138.08 42.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.349999999999994 111.112 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.47 68.91 0.53 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.759 . . . . 65.420000000000002 112.477 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -76.42 138.43 40.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 73.0 110.897 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -17.11 38.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 72.120000000000005 110.874 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.15 -41.44 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.805 -0.712 . . . . 64.140000000000001 112.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 m -90.68 168.66 11.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 73.549999999999997 110.929 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.0 -176.37 5.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 71.349999999999994 110.933 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.87 144.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 111.072 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -138.5 149.63 45.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 74.400000000000006 110.875 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -147.9 166.52 27.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 74.5 110.941 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.428 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 63.4 m -143.76 139.46 29.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 71.299999999999997 111.16 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -159.27 160.55 35.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 51.310000000000002 110.895 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.756 HG22 HG23 ' A' ' 81' ' ' THR . 10.9 p -129.88 171.76 12.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 71.140000000000001 111.114 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 78' ' ' PRO . 32.2 m -106.61 170.63 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 72.450000000000003 111.094 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -113.03 -41.58 3.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 74.219999999999999 110.888 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 158.6 39.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 65.040000000000006 110.851 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -80.53 115.2 19.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 74.109999999999999 110.842 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.19 140.3 30.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 53.350000000000001 111.119 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 32' ' ' THR . 2.8 t -95.71 105.93 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 72.25 111.127 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.97 148.58 45.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 63.530000000000001 111.143 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.696 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.1 p -106.63 111.47 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 71.340000000000003 111.116 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.91 140.14 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 75.109999999999999 111.138 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.51 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 92.9 p -142.72 167.72 21.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 54.329999999999998 110.831 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -108.87 144.14 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 44.210000000000001 111.114 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p -178.01 166.77 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 74.450000000000003 110.871 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.55 -23.28 0.22 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.761 -0.733 . . . . 71.120000000000005 112.484 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.08 -107.46 0.58 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.705 -0.759 . . . . 73.340000000000003 112.447 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -120.65 143.58 48.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 72.540000000000006 110.927 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.59 92.41 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.766 -0.73 . . . . 52.420000000000002 112.472 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -127.82 -37.58 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 55.229999999999997 110.883 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.52 ' HB1' ' CG2' ' A' ' 86' ' ' ILE . . . -91.81 110.65 21.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 51.439999999999998 111.106 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -72.44 155.55 39.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 71.219999999999999 110.886 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.74 HD22 ' HA ' ' A' ' 71' ' ' SER . 1.2 tt -127.55 138.28 52.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 110.938 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.547 ' CZ ' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -146.7 146.14 30.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 110.919 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.26 152.68 47.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 74.219999999999999 110.903 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -153.35 115.71 4.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 71.030000000000001 110.874 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 80' ' ' THR . . . -65.27 120.97 13.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 42.450000000000003 111.075 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.82 -76.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 75.430000000000007 112.452 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 t -107.82 -179.53 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 63.119999999999997 110.853 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.02 133.68 40.61 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.553 0.692 . . . . 72.349999999999994 110.917 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 143.92 52.15 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 71.409999999999997 112.339 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.19 179.03 4.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 71.239999999999995 111.148 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -67.79 -12.46 60.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 71.310000000000002 111.184 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 m -120.96 -28.28 4.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 51.229999999999997 110.885 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.19 124.01 48.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 73.150000000000006 110.817 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -152.86 153.99 34.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 72.430000000000007 110.941 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -107.15 -35.29 6.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 70.409999999999997 110.888 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.5 m -127.9 123.92 36.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 41.229999999999997 110.853 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -175.22 120.39 0.33 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.658 0.742 . . . . 71.150000000000006 110.877 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' C ' ' CG ' ' A' ' 64' ' ' TYR . 53.2 Cg_endo -69.83 1.53 4.4 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.26 . . . . 73.310000000000002 112.357 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' CG ' ' C ' ' A' ' 63' ' ' PRO . 4.5 p90 38.52 85.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 75.540000000000006 110.923 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.06 -69.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 71.349999999999994 110.856 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -157.04 -172.56 4.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 75.519999999999996 110.909 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.44 -124.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 64.040000000000006 112.509 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.629 ' ND2' HG11 ' A' ' 95' ' ' VAL . 24.6 m120 -49.8 164.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 75.049999999999997 110.889 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 72.01 16.28 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 110.888 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.42 103.75 5.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 64.109999999999999 110.86 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.74 ' HA ' HD22 ' A' ' 46' ' ' LEU . 2.3 m -134.32 174.68 10.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 74.420000000000002 110.855 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.67 152.54 32.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 110.893 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.696 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.1 p -127.73 111.51 13.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 45.5 110.851 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 t -149.28 152.29 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 65.129999999999995 111.141 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.9 p -71.71 106.9 4.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 75.420000000000002 110.908 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.3 131.48 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.340000000000003 111.093 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.32 142.58 24.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.594 0.712 . . . . 75.439999999999998 111.07 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.515 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.7 Cg_endo -69.75 126.37 13.24 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.747 2.298 . . . . 75.030000000000001 112.345 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.57 -27.13 3.41 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.711 -0.757 . . . . 72.409999999999997 112.467 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.561 HG21 ' HB1' ' A' ' 50' ' ' ALA . 16.4 m -106.53 124.64 49.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 60.119999999999997 111.135 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.756 HG23 HG22 ' A' ' 26' ' ' THR . 9.2 m -71.55 138.06 48.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 74.150000000000006 111.108 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.523 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 40.6 m-85 -112.15 150.5 30.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 71.230000000000004 110.901 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -131.56 145.16 51.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 73.030000000000001 110.873 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.68 HG11 ' HE3' ' A' ' 5' ' ' LYS . 14.9 t -121.96 133.59 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 61.210000000000001 111.092 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.403 ' O ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -126.8 133.54 50.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.409999999999997 110.832 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.52 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 30.4 mm -119.31 134.53 62.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 64.120000000000005 111.133 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.499 ' HB3' ' OH ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -140.23 113.47 8.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 73.030000000000001 110.883 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.09 161.2 25.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 75.439999999999998 112.517 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.75 -29.18 13.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.889 0.376 . . . . 72.510000000000005 110.908 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.494 ' O ' ' C ' ' A' ' 91' ' ' ASN . 54.6 p -156.12 137.37 13.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 73.230000000000004 110.819 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 90' ' ' SER . 70.4 m-20 -30.32 109.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 45.450000000000003 110.907 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -160.42 118.8 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 63.299999999999997 110.911 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.8 p -122.71 156.43 34.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 75.109999999999999 110.853 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.08 23.76 2.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 53.219999999999999 112.525 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.629 HG11 ' ND2' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -112.99 147.08 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.901 0.381 . . . . 44.32 111.148 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -105.23 124.75 50.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 71.510000000000005 111.115 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HB3' HD11 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -116.07 143.03 46.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 72.099999999999994 110.958 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -149.27 168.69 22.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.230000000000004 110.867 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -91.03 142.69 27.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 110.951 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.502 ' O ' ' CD ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.51 111.52 23.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 65.430000000000007 110.912 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.536 ' HB3' HD21 ' A' ' 99' ' ' LEU . 25.9 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 71.040000000000006 110.913 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.455 -0.258 . . . . 71.319999999999993 112.455 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -156.45 -176.21 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 72.450000000000003 110.939 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 24' ' ' THR . 3.5 m -123.57 109.02 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.430000000000007 111.138 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.18 150.18 52.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 75.239999999999995 110.903 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -155.56 -77.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 75.239999999999995 110.863 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 43.8 t30 -66.22 159.2 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 62.229999999999997 110.865 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.5 t-20 89.59 -70.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 65.019999999999996 110.859 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -133.35 118.32 14.86 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.556 0.694 . . . . 64.319999999999993 111.143 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.672 ' HB2' HG22 ' A' ' 96' ' ' THR . 54.1 Cg_endo -69.81 155.86 64.71 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.688 2.259 . . . . 51.119999999999997 112.324 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.8 t -75.56 112.43 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 73.109999999999999 111.099 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -82.08 163.63 21.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 53.240000000000002 110.883 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 39.82 57.14 2.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 75.030000000000001 110.922 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 13' ' ' LEU . 4.6 tp -57.93 -173.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 52.450000000000003 110.931 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 p -145.55 139.19 26.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 61.119999999999997 111.171 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.97 65.16 0.5 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.683 -0.77 . . . . 50.009999999999998 112.485 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -75.9 155.29 35.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 51.039999999999999 110.927 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.02 -31.0 16.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.879 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.88 -55.66 0.27 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 73.040000000000006 112.49 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.75 136.58 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.338 . . . . 71.239999999999995 110.858 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.79 170.07 16.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.899 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.39 140.67 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 54.219999999999999 111.104 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -137.75 151.0 47.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 53.310000000000002 110.905 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -146.24 164.95 30.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 62.43 110.94 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 31.7 m -140.06 138.79 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 55.32 111.14 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -160.2 163.15 33.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.340000000000003 110.887 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.702 HG22 HG23 ' A' ' 81' ' ' THR . 15.0 p -130.74 170.7 13.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.519999999999996 111.163 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 78' ' ' PRO . 16.8 m -107.55 169.3 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 74.239999999999995 111.163 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -104.54 -52.92 2.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 62.140000000000001 110.868 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -128.94 157.24 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 110.878 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -73.64 116.16 13.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 63.509999999999998 110.871 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.37 144.86 33.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 65.5 111.1 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 32' ' ' THR . 2.6 t -100.96 106.79 18.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 70.030000000000001 111.15 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.45 148.93 46.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 73.420000000000002 111.088 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 34' ' ' VAL . 3.2 p -106.05 111.72 36.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 62.340000000000003 111.155 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.636 HG11 ' HG2' ' A' ' 98' ' ' LYS . 7.5 t -126.77 139.99 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 54.329999999999998 111.138 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.5 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 34.5 p -136.56 167.06 22.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 62.32 110.863 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.409 HD11 ' H ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -110.01 142.75 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 64.310000000000002 111.119 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 p -169.57 172.57 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 72.319999999999993 110.85 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 157.31 -20.48 0.41 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 64.040000000000006 112.487 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -157.46 -96.72 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 51.32 112.493 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 m -130.54 148.79 52.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 70.219999999999999 110.878 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.61 91.42 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 43.149999999999999 112.499 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -35.03 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 70.299999999999997 110.851 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.578 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . . . -91.54 109.43 20.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 64.299999999999997 111.084 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.94 146.7 54.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 42.350000000000001 110.882 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 tt -110.86 127.08 55.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 64.209999999999994 110.92 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -131.28 154.19 48.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.906 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -154.03 133.11 12.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 72.329999999999998 110.948 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.467 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -141.03 125.72 17.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 110.853 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.4 126.17 28.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 73.200000000000003 111.119 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.41 -71.17 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 71.109999999999999 112.475 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 m -112.58 -175.47 2.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 61.350000000000001 110.86 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.31 136.04 32.21 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.57 0.7 . . . . 72.420000000000002 110.937 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 143.85 52.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.7 2.267 . . . . 53.229999999999997 112.35 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -100.79 178.08 4.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.219999999999999 111.153 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.6 p -64.86 -15.2 61.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 70.120000000000005 111.126 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.7 m -119.44 -25.8 5.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 62.439999999999998 110.827 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.95 126.39 50.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.319999999999993 110.803 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.5 154.07 36.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 72.450000000000003 110.935 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -112.45 -27.95 8.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 71.150000000000006 110.866 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.2 m -145.72 124.57 12.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.439999999999998 110.912 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -173.17 124.99 0.45 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 63.109999999999999 110.878 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -6.62 19.07 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.686 2.257 . . . . 65.430000000000007 112.351 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.9 t80 67.62 80.49 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 70.340000000000003 110.889 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.38 -176.1 4.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 73.040000000000006 110.837 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.92 -75.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 71.230000000000004 110.946 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.98 -125.38 1.79 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.746 . . . . 61.200000000000003 112.438 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.884 ' ND2' HG11 ' A' ' 95' ' ' VAL . 19.5 m120 -49.62 168.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.856 0.36 . . . . 64.010000000000005 110.88 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 74.41 5.99 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 72.120000000000005 110.884 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 70' ' ' GLU . 3.7 pt-20 -127.3 115.49 19.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 73.519999999999996 110.908 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.5 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 10.1 m -140.77 174.3 10.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.340000000000003 110.869 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.94 153.79 33.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 65.310000000000002 110.89 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -127.85 109.37 11.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 52.399999999999999 110.847 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -150.21 152.33 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 75.219999999999999 111.155 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.5 p -79.52 102.34 8.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 64.209999999999994 110.88 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.521 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.52 143.14 31.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 61.329999999999998 111.107 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.59 142.92 25.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.561 0.696 . . . . 70.010000000000005 111.102 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.483 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.7 Cg_endo -69.75 143.81 52.08 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.657 2.238 . . . . 73.409999999999997 112.342 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.23 -22.81 6.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.704 -0.76 . . . . 63.5 112.459 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.6 m -117.27 131.52 56.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 74.340000000000003 111.15 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.702 HG23 HG22 ' A' ' 26' ' ' THR . 14.3 m -74.23 136.5 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 73.409999999999997 111.113 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 56.8 m-85 -106.35 154.78 20.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 74.140000000000001 110.883 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -134.34 160.93 36.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 75.109999999999999 110.84 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG21 ' HD2' ' A' ' 5' ' ' LYS . 10.6 t -136.17 137.68 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 71.019999999999996 111.117 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.27 122.36 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 65.019999999999996 110.865 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.421 HG23 ' HB1' ' A' ' 44' ' ' ALA . 22.6 mm -104.98 112.83 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 74.530000000000001 111.116 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.79 104.08 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 72.439999999999998 110.939 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.51 160.16 37.54 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 33.409999999999997 112.511 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -115.79 -18.4 10.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 71.439999999999998 110.906 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 91' ' ' ASN . 60.7 p -166.24 136.23 3.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 63.229999999999997 110.888 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 90' ' ' SER . 57.7 t30 -33.84 108.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 72.540000000000006 110.92 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -160.84 112.68 1.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 74.519999999999996 110.923 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.0 p -119.44 163.87 16.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 72.030000000000001 110.875 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.86 26.36 4.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.743 . . . . 42.130000000000003 112.491 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.884 HG11 ' ND2' ' A' ' 68' ' ' ASN . 7.2 t -113.75 147.49 17.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 55.149999999999999 111.156 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.672 HG22 ' HB2' ' A' ' 9' ' ' PRO . 2.1 m -103.59 117.12 33.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.340000000000003 111.169 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.738 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -99.58 121.48 41.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 72.230000000000004 110.914 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.738 ' N ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -131.12 154.8 47.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 72.209999999999994 110.861 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -84.54 140.9 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 61.219999999999999 110.922 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.44 113.36 25.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 73.299999999999997 110.897 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 p90 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.467 . . . . 73.239999999999995 110.942 -179.892 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.501 -0.24 . . . . 55.5 112.501 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -113.12 -179.14 3.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.913 0.387 . . . . 50.020000000000003 110.874 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.5 m -117.75 108.86 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 73.230000000000004 111.112 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.65 149.82 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 70.310000000000002 110.913 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' CD ' HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -156.42 -73.37 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 74.150000000000006 110.951 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 16.9 t30 -67.98 158.09 33.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 74.409999999999997 110.945 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.8 t-20 88.95 -69.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 53.240000000000002 110.885 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -133.18 118.06 14.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.578 0.704 . . . . 64.409999999999997 111.108 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . 53.6 Cg_endo -69.79 157.2 61.14 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 73.030000000000001 112.341 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.93 113.9 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 62.310000000000002 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.04 144.25 30.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.120000000000005 110.85 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.411 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.8 OUTLIER 48.07 74.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 65.400000000000006 110.857 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 tp -65.02 -166.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.179 -0.464 . . . . 74.450000000000003 110.928 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -143.37 140.72 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 72.0 111.151 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.88 60.2 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 43.100000000000001 112.46 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 90' ' ' SER . 1.7 t-20 -78.47 139.14 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 63.119999999999997 110.897 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER -52.28 -48.16 65.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 60.409999999999997 110.904 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.04 -46.53 2.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 64.430000000000007 112.538 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.03 128.39 35.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 71.310000000000002 110.883 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.21 160.57 31.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 73.299999999999997 110.868 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -121.25 139.01 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 64.25 111.126 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -136.93 146.83 45.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.239999999999995 110.931 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.414 ' HB2' ' CE ' ' A' ' 5' ' ' LYS . 17.7 m-85 -144.08 165.02 28.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.856 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 26.0 m -143.81 138.74 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.513 . . . . 62.539999999999999 111.151 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -160.09 162.97 34.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 54.119999999999997 110.859 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.469 ' CG2' HG23 ' A' ' 81' ' ' THR . 17.5 p -129.86 170.78 13.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 72.0 111.138 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 78' ' ' PRO . 18.9 m -107.35 168.06 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 111.149 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -106.91 -49.93 3.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 63.420000000000002 110.857 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -126.13 156.76 39.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 73.549999999999997 110.843 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -78.85 114.84 18.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 73.530000000000001 110.925 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.71 145.5 33.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 55.130000000000003 111.086 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 m -97.96 107.54 20.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 63.0 111.133 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.582 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -136.97 148.91 47.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 64.439999999999998 111.034 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.706 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -106.55 113.0 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 62.210000000000001 111.148 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.425 HG11 ' HG2' ' A' ' 98' ' ' LYS . 19.4 t -126.12 139.97 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.219999999999999 111.125 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.547 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -138.86 166.72 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 53.299999999999997 110.888 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.41 147.51 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 111.153 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -178.41 170.73 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 70.129999999999995 110.831 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.7 -25.32 0.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 62.039999999999999 112.524 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.04 -119.76 1.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 12.41 112.5 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 m -109.29 161.95 14.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 64.120000000000005 110.853 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.16 94.57 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 64.040000000000006 112.52 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.85 -37.9 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 64.409999999999997 110.838 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.07 115.56 28.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 52.439999999999998 111.129 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.68 157.31 17.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 74.430000000000007 110.874 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.784 HD23 ' HA ' ' A' ' 71' ' ' SER . 1.8 tp -124.74 129.81 51.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 74.319999999999993 110.916 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.704 ' N ' HD12 ' A' ' 46' ' ' LEU . 30.1 m-85 -136.94 131.66 33.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 61.130000000000003 110.924 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -130.28 142.56 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 70.420000000000002 110.913 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.553 ' H ' HD23 ' A' ' 48' ' ' LEU . 1.3 tttm -143.73 117.67 9.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 73.150000000000006 110.951 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.97 124.37 20.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 73.409999999999997 111.119 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 -81.04 0.72 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 75.329999999999998 112.516 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.1 p -96.17 -169.7 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 74.409999999999997 110.9 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.33 135.02 21.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.631 0.729 . . . . 74.540000000000006 110.869 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 141.25 44.74 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.664 2.243 . . . . 74.349999999999994 112.364 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 p -105.36 178.93 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.135 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.4 p -63.1 -15.05 55.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.092 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -118.41 -26.72 6.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 73.450000000000003 110.886 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.87 126.44 50.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 55.130000000000003 110.837 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.28 153.73 35.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 74.230000000000004 110.929 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -117.72 -42.89 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 110.866 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.1 m -117.39 120.82 39.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.439999999999998 110.868 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -179.59 127.6 0.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 64.510000000000005 110.856 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HD2' ' HG2' ' A' ' 70' ' ' GLU . 53.2 Cg_endo -69.8 0.91 4.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.642 2.228 . . . . 73.219999999999999 112.352 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 72.06 62.41 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 70.430000000000007 110.902 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -168.89 2.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 74.510000000000005 110.9 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -136.79 127.62 27.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 73.540000000000006 110.888 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.04 -171.43 48.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.75 -0.738 . . . . 62.109999999999999 112.479 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -52.08 175.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 73.219999999999999 110.886 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.75 15.75 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 110.881 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 16.3 tt0 -121.4 82.95 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 60.350000000000001 110.853 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.784 ' HA ' HD23 ' A' ' 46' ' ' LEU . 1.5 m -133.23 170.2 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 65.540000000000006 110.874 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.06 152.42 37.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 45.329999999999998 110.861 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.706 ' HB3' HG23 ' A' ' 34' ' ' VAL . 54.7 p -128.38 108.98 11.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 44.020000000000003 110.858 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.1 t -150.46 152.76 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 71.439999999999998 111.122 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -77.6 103.64 7.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.219999999999999 110.88 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.657 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.19 134.33 35.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 72.420000000000002 111.085 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.5 139.27 23.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 73.340000000000003 111.127 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.496 ' HA ' HG23 ' A' ' 27' ' ' VAL . 54.1 Cg_endo -69.76 121.02 7.72 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.724 2.283 . . . . 73.530000000000001 112.348 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.58 -19.09 1.85 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 65.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.8 m -116.9 133.78 55.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.39 . . . . 73.040000000000006 111.109 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.469 HG23 ' CG2' ' A' ' 26' ' ' THR . 0.7 OUTLIER -74.07 131.41 41.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 43.219999999999999 111.13 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.657 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 50.7 m-85 -107.89 138.05 44.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 73.319999999999993 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -117.86 159.15 23.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 74.140000000000001 110.871 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.436 ' HB ' ' HE2' ' A' ' 5' ' ' LYS . 20.9 t -137.6 137.16 45.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 70.409999999999997 111.187 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 tpt -129.99 122.27 28.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 110.938 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.477 ' HB ' HG23 ' A' ' 21' ' ' VAL . 25.5 mm -104.2 112.7 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 54.32 111.144 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 124.55 49.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 75.140000000000001 110.937 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.8 162.88 30.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 64.230000000000004 112.441 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -95.16 -34.13 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 64.299999999999997 110.886 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.448 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 4.6 t -167.83 -62.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 72.329999999999998 110.829 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -171.81 86.68 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.219999999999999 110.871 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.63 119.9 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 74.200000000000003 110.948 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 p -122.88 153.4 39.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 110.817 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 12' ' ' ASN . . . 123.71 25.76 1.69 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 60.240000000000002 112.514 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.88 146.99 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.904 0.383 . . . . 63.420000000000002 111.128 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 m -101.34 115.52 30.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 61.310000000000002 111.095 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.679 HD22 ' N ' ' A' ' 98' ' ' LYS . 1.6 tm? -100.94 130.89 47.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 62.240000000000002 110.927 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.679 ' N ' HD22 ' A' ' 97' ' ' LEU . 6.6 ttpt -143.79 163.81 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 63.340000000000003 110.885 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -91.73 143.3 26.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 64.150000000000006 110.902 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.492 ' O ' ' CD ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -94.7 113.91 25.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 75.319999999999993 110.95 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.582 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 12.9 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 110.954 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.484 -0.246 . . . . 50.43 112.484 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -135.16 -177.46 4.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.886 0.374 . . . . 74.349999999999994 110.886 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.9 m -119.88 109.07 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 62.229999999999997 111.143 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.74 151.3 52.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 63.5 110.9 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.654 ' HD3' HG21 ' A' ' 84' ' ' VAL . 9.5 tptm -164.51 -39.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 74.209999999999994 110.864 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 5.8 t30 -103.98 155.37 18.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 72.120000000000005 110.882 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.6 t-20 87.43 -67.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 64.040000000000006 110.873 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.1 m -127.77 119.52 21.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 44.43 111.136 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 152.7 69.37 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.706 2.271 . . . . 74.140000000000001 112.296 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.44 115.45 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.230000000000004 111.126 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.8 142.11 32.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.832 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.59 80.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 74.209999999999994 110.878 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -70.28 -167.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 72.109999999999999 110.96 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 p -145.67 139.0 26.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.450000000000003 111.131 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.37 61.68 0.51 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.743 -0.741 . . . . 72.310000000000002 112.487 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -76.09 150.13 37.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.947 0.403 . . . . 62.420000000000002 110.862 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -35.89 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.420000000000002 110.917 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.82 -63.08 0.52 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 74.510000000000005 112.5 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.77 140.08 20.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 73.519999999999996 110.84 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -135.08 171.91 13.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 73.430000000000007 110.858 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.563 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.05 136.26 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 75.219999999999999 111.165 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -136.77 141.53 42.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.129999999999995 110.91 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -130.56 165.03 23.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.928 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.43 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 9.4 m -141.19 138.8 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 74.530000000000001 111.13 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.48 160.34 34.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 63.140000000000001 110.906 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.798 HG22 HG23 ' A' ' 81' ' ' THR . 17.8 p -126.62 171.59 10.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 73.140000000000001 111.139 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.585 HG13 ' CE1' ' A' ' 101' ' ' TYR . 12.1 t -108.18 141.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 75.219999999999999 111.148 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -92.24 -42.59 9.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 62.340000000000003 110.86 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -132.15 148.39 52.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 72.450000000000003 110.864 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -72.89 114.27 10.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 61.219999999999999 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.34 140.76 29.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 40.130000000000003 111.134 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 32' ' ' THR . 2.7 t -98.98 107.08 19.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 71.540000000000006 111.11 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -135.72 148.02 48.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 70.030000000000001 111.104 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.1 p -106.72 111.19 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 70.420000000000002 111.119 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.71 139.82 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 74.540000000000006 111.157 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -134.51 166.33 23.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 74.299999999999997 110.861 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.492 HG21 HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -111.11 142.23 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 64.140000000000001 111.162 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t 178.82 159.67 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 43.450000000000003 110.852 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.67 -32.02 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.7 -0.762 . . . . 45.229999999999997 112.471 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.03 -82.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 71.030000000000001 112.519 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 m -129.67 160.49 33.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 75.400000000000006 110.882 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.44 92.78 1.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 74.219999999999999 112.471 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -127.3 -34.97 2.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 74.310000000000002 110.843 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.601 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -92.54 113.93 26.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 111.108 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.32 166.16 24.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 75.230000000000004 110.856 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.665 HD13 ' HA ' ' A' ' 71' ' ' SER . 3.7 tt -123.86 145.67 48.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 64.519999999999996 110.912 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -152.85 148.89 27.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 75.040000000000006 110.924 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 49' ' ' LYS . 1.4 tt -152.73 140.13 19.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 71.140000000000001 110.899 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.551 ' N ' HD23 ' A' ' 48' ' ' LEU . 3.9 tttm -147.57 130.41 16.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 75.329999999999998 110.882 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.71 86.53 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 71.219999999999999 111.139 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.94 -86.01 0.22 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.739 . . . . 73.319999999999993 112.501 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.03 134.04 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.953 0.406 . . . . 72.140000000000001 110.855 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.64 128.09 3.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.624 0.726 . . . . 62.109999999999999 110.895 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 142.84 49.11 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 55.119999999999997 112.376 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -110.08 179.31 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 75.329999999999998 111.183 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.8 p -60.92 -16.62 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 65.209999999999994 111.158 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 t -117.43 -25.78 6.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 71.120000000000005 110.83 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 124.76 48.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 72.0 110.871 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.73 153.18 32.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 73.209999999999994 110.929 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -114.24 -48.59 2.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 74.120000000000005 110.852 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.6 m -123.24 122.51 38.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.209999999999994 110.871 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.47 137.27 0.35 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.63 0.728 . . . . 54.409999999999997 110.866 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 53.4 Cg_endo -69.82 -2.91 11.02 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 65.150000000000006 112.308 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 73.79 74.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 64.510000000000005 110.895 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -163.55 -169.94 2.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 74.409999999999997 110.888 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -139.79 160.04 40.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.510000000000005 110.913 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.03 165.85 9.57 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.671 -0.776 . . . . 45.43 112.491 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.774 ' ND2' HG21 ' A' ' 95' ' ' VAL . 52.2 m-80 -56.62 -176.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 60.009999999999998 110.907 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.9 t30 64.54 14.18 8.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 74.239999999999995 110.906 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.422 ' HG2' ' HG2' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -128.7 103.62 7.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 61.520000000000003 110.873 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.665 ' HA ' HD13 ' A' ' 46' ' ' LEU . 5.5 m -135.03 173.63 11.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 74.319999999999993 110.845 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.94 151.6 36.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 50.130000000000003 110.89 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.5 p -129.72 109.01 10.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 53.109999999999999 110.854 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.1 m -151.02 153.48 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 63.140000000000001 111.173 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -72.25 100.18 2.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 63.009999999999998 110.864 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.32 151.31 25.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 63.530000000000001 111.146 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.82 145.99 46.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.606 0.717 . . . . 64.219999999999999 111.086 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 173.37 11.06 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.669 2.246 . . . . 75.420000000000002 112.294 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.78 -46.86 1.72 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.742 . . . . 72.099999999999994 112.452 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.9 m -94.61 128.82 41.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 71.5 111.142 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.798 HG23 HG22 ' A' ' 26' ' ' THR . 10.5 m -70.7 137.75 50.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 52.450000000000003 111.138 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -109.52 137.84 46.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 70.519999999999996 110.874 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -106.46 157.91 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 63.549999999999997 110.874 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.654 HG21 ' HD3' ' A' ' 5' ' ' LYS . 21.3 t -137.96 137.98 44.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 65.340000000000003 111.169 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.5 tpt -136.09 123.87 22.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 72.200000000000003 110.913 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HB ' HG23 ' A' ' 21' ' ' VAL . 19.5 mm -111.94 111.91 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.111 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.84 149.76 23.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 64.450000000000003 110.864 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.8 157.81 16.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 50.329999999999998 112.539 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -114.18 -21.68 10.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 74.430000000000007 110.88 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 91' ' ' ASN . 72.3 p -169.99 134.97 1.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 53.350000000000001 110.863 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 90' ' ' SER . 0.4 OUTLIER -33.83 107.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.88 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -164.12 114.03 1.24 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 64.219999999999999 110.938 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 p -121.08 162.56 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 73.140000000000001 110.878 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.35 19.38 3.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.718 -0.754 . . . . 72.230000000000004 112.515 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.774 HG21 ' ND2' ' A' ' 68' ' ' ASN . 4.8 t -112.43 147.93 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 75.319999999999993 111.135 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -100.21 129.76 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 73.219999999999999 111.176 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.621 ' HB3' HD21 ' A' ' 13' ' ' LEU . 16.2 tp -113.11 148.31 35.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 62.43 110.913 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -157.4 166.39 33.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 72.439999999999998 110.859 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.793 HD21 ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -87.88 147.31 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 71.349999999999994 110.905 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.495 ' O ' ' CD ' ' A' ' 100' ' ' GLN . 3.9 pp0? -106.06 104.48 14.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 72.230000000000004 110.91 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.793 ' CE2' HD21 ' A' ' 99' ' ' LEU . 13.5 m-85 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 53.25 110.898 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.1 m120 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.866 0.365 . . . . 52.32 110.917 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -116.09 108.61 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 73.13 111.096 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.4 147.79 52.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.947 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.597 ' HE2' HD11 ' A' ' 97' ' ' LEU . 7.2 tptp -169.92 -37.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.31 110.926 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.656 ' OD1' HD22 ' A' ' 99' ' ' LEU . 12.6 t-20 -99.14 155.9 17.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 74.43 110.867 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 5.8 t30 81.54 -68.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 71.41 110.886 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.1 m -116.33 121.11 33.94 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 70.22 111.113 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.7 Cg_endo -69.79 153.14 69.13 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.715 2.277 . . . . 71.34 112.348 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.24 114.4 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.45 111.119 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -81.85 158.26 24.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 64.33 110.83 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER 37.15 66.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 72.23 110.908 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.58 -169.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 72.03 110.935 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 p -145.8 139.39 26.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 73.13 111.136 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.68 65.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 64.5 112.485 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -76.57 139.89 40.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 74.24 110.924 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.28 -28.7 12.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 75.12 110.933 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.92 -49.7 0.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.749 . . . . 74.2 112.487 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -76.45 149.4 36.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 72.11 110.861 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -141.85 170.55 15.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 71.42 110.886 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -129.07 138.24 55.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 75.13 111.157 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -137.07 150.66 48.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 62.54 110.91 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -148.58 166.1 29.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 71.21 110.922 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 9.8 m -137.75 138.15 39.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 72.53 111.16 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -160.4 162.95 33.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 72.23 110.868 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.608 HG22 ' HA ' ' A' ' 81' ' ' THR . 28.9 p -136.24 171.41 14.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 44.21 111.145 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 78' ' ' PRO . 28.1 m -106.84 167.58 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 75.11 111.14 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -109.1 -48.23 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 72.53 110.834 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -125.56 156.93 38.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 73.03 110.874 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -80.06 115.22 19.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 71.21 110.845 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.47 144.61 34.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 64.31 111.139 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.443 ' O ' HG23 ' A' ' 32' ' ' THR . 2.8 t -98.8 107.24 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 71.12 111.148 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.95 148.27 45.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 64.14 111.071 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.2 p -106.74 110.67 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 71.32 111.144 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.548 HG11 ' HG2' ' A' ' 98' ' ' LYS . 46.4 t -128.51 140.86 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 63.22 111.15 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.472 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 24.2 p -140.63 167.72 21.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 71.13 110.844 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.71 149.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 75.43 111.194 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -179.85 -175.5 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 64.43 110.824 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.774 -0.727 . . . . 62.31 112.484 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.829 0.347 . . . . 65.45 110.912 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.13 121.55 44.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 63.3 111.102 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -87.68 159.35 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.21 110.843 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 71' ' ' SER . 0.3 OUTLIER -121.93 130.56 53.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.41 110.928 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -125.82 147.75 49.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 72.54 110.901 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.654 HD12 ' NE2' ' A' ' 100' ' ' GLN . 1.4 tt -143.76 134.99 25.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 74.03 110.917 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.563 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.0 tttm -144.04 116.02 8.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 71.11 110.896 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.41 120.68 10.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 64.45 111.085 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.49 -80.89 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 51.11 112.469 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 m -98.14 -178.06 3.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.389 . . . . 65.05 110.862 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 134.68 31.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.534 0.683 . . . . 74.52 110.927 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 143.3 50.35 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.655 2.237 . . . . 64.05 112.319 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -104.45 178.72 4.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 72.23 111.137 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.8 p -65.15 -14.43 60.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.436 . . . . 75.44 111.152 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -119.99 -26.75 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 71.21 110.851 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.07 125.95 50.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 64.15 110.868 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.23 153.62 35.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 74.35 110.929 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -111.83 -24.49 9.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 74.13 110.877 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.3 m -143.75 123.78 13.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.864 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -176.88 118.74 0.27 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.606 0.717 . . . . 70.33 110.893 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.439 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 53.6 Cg_endo . . . . . 0 N--CA 1.465 -0.195 0 C-N-CA 122.684 2.256 . . . . 74.43 112.352 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.856 0.36 . . . . 75.11 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 t30 64.47 18.87 11.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.887 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 63' ' ' PRO . 19.9 tt0 -119.61 85.82 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 52.45 110.921 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.667 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.9 m -133.11 169.68 16.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.24 110.857 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.24 155.22 33.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 54.1 110.875 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -129.23 106.55 8.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 52.4 110.864 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.1 t -151.17 149.81 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 74.13 111.134 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.8 p -73.55 102.5 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 73.13 110.86 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.586 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.51 137.42 34.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.113 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.47 141.37 22.57 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 74.53 111.09 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.511 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.7 Cg_endo -69.77 132.2 22.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.71 2.273 . . . . 73.01 112.358 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.78 -18.93 4.01 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.741 . . . . 71.51 112.509 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.5 m -115.55 129.71 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 70.33 111.14 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.608 ' HA ' HG22 ' A' ' 26' ' ' THR . 17.4 m -72.19 137.06 46.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 62.12 111.135 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.586 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 34.1 m-85 -109.86 138.21 46.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 75.22 110.918 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -108.16 161.98 14.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 75.33 110.836 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG21 ' CG ' ' A' ' 5' ' ' LYS . 61.9 t -132.31 139.05 50.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 70.23 111.124 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.7 121.18 11.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 75.45 110.853 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.442 ' HB ' HG23 ' A' ' 21' ' ' VAL . 13.3 mm -115.64 116.17 51.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 71.11 111.113 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.7 128.99 56.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 70.34 110.896 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.43 159.5 13.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 75.11 112.499 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -98.83 -21.36 16.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.868 0.366 . . . . 73.33 110.899 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 91' ' ' ASN . 23.3 p -167.07 141.65 3.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 62.13 110.897 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 90' ' ' SER . 55.2 t-20 -35.64 107.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 75.2 110.889 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -160.11 116.85 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 61.42 110.921 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.1 p -119.62 161.25 20.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 73.12 110.892 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.45 22.85 2.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 70.1 112.49 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.49 147.03 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.909 0.385 . . . . 71.52 111.11 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.63 114.35 28.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 62.12 111.147 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.597 HD11 ' HE2' ' A' ' 5' ' ' LYS . 16.5 tp -99.44 144.01 29.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 65.35 110.91 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.548 ' HG2' HG11 ' A' ' 35' ' ' VAL . 3.6 ttpt -153.16 164.92 37.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.11 110.892 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.656 HD22 ' OD1' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -92.54 140.58 29.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 63.32 110.881 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.654 ' NE2' HD12 ' A' ' 48' ' ' LEU . 5.5 pm0 -100.43 111.17 23.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 64.35 110.885 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.7 p90 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.464 . . . . 64.24 110.922 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.865 0.364 . . . . 73.51 110.865 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 3' ' ' VAL . 14.5 m -108.03 108.15 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 75.31 111.14 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.61 149.69 52.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 63.31 110.897 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HE3' HD11 ' A' ' 97' ' ' LEU . 13.2 tptm -169.29 -38.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 60.14 110.876 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.682 HD22 HD22 ' A' ' 99' ' ' LEU . 8.8 t-20 -97.91 155.32 17.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 63.24 110.851 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 26.1 t30 82.0 -68.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 72.34 110.88 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 m -124.99 119.76 25.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.598 0.713 . . . . 74.45 111.163 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.53 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.9 Cg_endo -69.73 154.73 67.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.682 2.255 . . . . 45.42 112.355 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 t -76.47 114.01 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.03 111.131 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.64 144.98 29.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 74.35 110.83 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.09 77.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 75.21 110.896 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.752 HD11 ' CB ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -73.36 -172.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 64.12 110.902 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 p -136.55 137.95 40.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 75.51 111.15 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.18 60.73 0.55 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 75.42 112.529 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -77.07 163.04 27.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.373 . . . . 74.32 110.895 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 90' ' ' SER . 3.0 mmmt -45.4 -69.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 75.43 110.913 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.67 -50.72 3.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.729 . . . . 74.34 112.48 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.97 144.45 6.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 65.11 110.838 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -144.24 -179.81 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 63.02 110.887 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.474 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -141.4 135.76 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 73.44 111.115 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -137.03 148.54 46.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 71.3 110.896 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -148.54 165.01 32.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 65.03 110.912 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.736 HG22 ' HA ' ' A' ' 83' ' ' HIS . 1.2 p -143.14 142.4 31.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 52.2 111.123 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -159.32 159.38 33.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 63.2 110.884 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.611 ' CG2' HG23 ' A' ' 81' ' ' THR . 17.4 p -127.22 170.35 12.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.11 111.14 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.09 167.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 70.41 111.139 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.39 -43.23 4.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 63.51 110.884 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.43 162.74 31.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 64.15 110.904 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.26 116.09 19.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 65.05 110.91 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.78 141.06 31.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 44.1 111.145 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.617 HG23 ' HB3' ' A' ' 75' ' ' SER . 1.1 m -97.34 107.17 19.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 73.12 111.134 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.22 147.01 47.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 61.34 111.095 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.565 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.4 p -110.9 110.84 33.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.12 111.176 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.5 140.25 49.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 61.12 111.115 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.507 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 4.7 p -130.75 166.47 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.888 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.521 HG21 HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -112.58 152.57 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 52.12 111.129 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.01 177.23 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 63.54 110.813 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 74.43 112.482 -179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 CA--C 1.526 0.047 0 CA-C-O 120.815 0.34 . . . . 64.12 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.22 125.92 49.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 74.04 111.112 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.08 151.54 22.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 64.24 110.842 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.521 HD12 HG21 ' A' ' 37' ' ' ILE . 10.0 tt -116.09 127.8 55.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.917 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -138.43 143.11 39.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 65.44 110.904 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.537 HD23 ' N ' ' A' ' 49' ' ' LYS . 1.3 tt -149.21 135.96 19.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 73.21 110.918 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.537 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.1 tttm -143.64 138.25 28.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 54.32 110.897 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.52 101.02 11.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 62.3 111.126 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.05 -92.39 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.742 . . . . 44.43 112.476 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.9 p -87.5 131.4 34.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 70.4 110.851 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.68 134.8 6.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.589 0.709 . . . . 75.31 110.877 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 143.75 51.66 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.69 2.26 . . . . 74.43 112.311 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.18 177.5 5.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.436 . . . . 62.45 111.123 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 p -63.62 -15.92 59.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.138 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -119.63 -25.44 5.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 73.34 110.898 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.94 125.14 48.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 64.2 110.832 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.86 153.54 34.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 72.43 110.937 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -108.61 -29.12 8.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 74.01 110.825 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.5 m -136.32 123.73 22.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.13 110.882 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -175.04 132.52 0.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.626 0.727 . . . . 74.1 110.891 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.251 . . . . 63.41 112.315 -179.949 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.867 0.365 . . . . 64.15 110.856 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.3 t30 63.8 15.88 9.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.884 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -120.41 96.15 5.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.892 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.507 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -134.52 170.53 15.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 75.03 110.875 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -120.35 153.29 36.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 73.14 110.888 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.565 ' HB3' HG23 ' A' ' 34' ' ' VAL . 6.0 p -129.2 108.5 10.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 74.13 110.833 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.2 t -150.44 149.83 14.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 61.42 111.119 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.617 ' HB3' HG23 ' A' ' 32' ' ' THR . 63.1 p -75.68 102.4 5.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 63.21 110.896 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.543 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.49 143.81 30.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 72.05 111.111 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.15 142.91 26.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 61.4 111.107 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 141.09 44.24 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 64.43 112.337 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.67 -13.14 7.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.688 -0.767 . . . . 63.41 112.481 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -125.27 130.4 51.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 73.42 111.158 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.611 HG23 ' CG2' ' A' ' 26' ' ' THR . 3.5 m -73.19 137.8 45.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 51.43 111.13 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.543 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 51.6 m-85 -108.72 136.16 48.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 73.51 110.926 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.736 ' HA ' HG22 ' A' ' 24' ' ' THR . 12.2 m-70 -107.56 160.45 15.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.21 110.862 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.469 HG11 ' HE3' ' A' ' 5' ' ' LYS . 2.6 t -137.95 138.55 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 65.51 111.088 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.73 125.08 19.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 71.11 110.885 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.514 HD11 HD22 ' A' ' 97' ' ' LEU . 21.2 mm -114.79 130.28 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.32 111.141 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -111.49 149.85 30.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.44 110.899 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.19 152.27 16.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.721 -0.752 . . . . 53.43 112.544 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -120.39 -17.79 8.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 72.32 110.938 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -174.73 136.11 0.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 60.15 110.829 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 90' ' ' SER . 17.5 t-20 -35.06 103.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 74.23 110.889 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -155.38 100.18 2.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 74.23 110.906 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.6 p -109.47 151.85 26.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.071 -0.513 . . . . 63.41 110.82 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.08 24.16 1.34 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 73.12 112.476 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.643 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -111.63 142.63 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 62.24 111.121 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -102.43 117.07 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 74.11 111.152 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.752 ' CB ' HD11 ' A' ' 13' ' ' LEU . 13.1 tp -106.01 140.06 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.22 110.923 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -144.51 165.19 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 73.24 110.864 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.682 HD22 HD22 ' A' ' 6' ' ' ASN . 0.0 OUTLIER -92.3 137.68 32.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 72.34 110.93 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.59 113.12 24.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 63.01 110.892 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.4 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 73.22 110.89 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.6 m120 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.871 0.367 . . . . 52.33 110.894 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.429 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.3 m -117.63 108.55 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 72.13 111.121 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.94 150.23 52.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 74.54 110.907 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.727 ' HZ3' HD11 ' A' ' 97' ' ' LEU . 14.8 tptt -167.19 -35.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 73.34 110.922 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -101.39 155.61 17.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 64.35 110.891 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 24.4 t30 83.99 -69.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 65.31 110.891 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -123.08 121.3 27.19 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.569 0.7 . . . . 53.13 111.113 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.611 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.8 Cg_endo -69.76 153.51 68.84 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.267 . . . . 74.2 112.317 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.23 114.84 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 72.4 111.15 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -85.56 160.74 19.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.836 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 p30 40.2 62.17 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 73.42 110.89 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.03 -169.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 64.33 110.903 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 p -146.57 139.32 25.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 51.25 111.156 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.12 57.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.754 . . . . 33.25 112.486 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.94 152.95 36.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 72.14 110.914 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.24 -42.76 66.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 73.31 110.871 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.82 -48.69 1.07 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.778 -0.725 . . . . 42.52 112.508 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.28 134.1 54.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 62.03 110.799 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -134.65 172.6 12.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 74.24 110.874 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.445 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.41 139.23 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 70.11 111.12 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -136.78 151.23 48.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 74.22 110.871 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -145.14 165.97 26.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 72.23 110.933 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.429 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 8.7 m -141.69 138.13 32.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.075 -0.511 . . . . 61.41 111.157 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -160.61 158.19 28.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 74.11 110.887 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 81' ' ' THR . 27.7 p -128.07 171.22 12.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 73.02 111.093 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.558 HG12 ' CZ ' ' A' ' 101' ' ' TYR . 34.4 m -107.35 147.7 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 75.44 111.135 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -91.03 -49.83 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.884 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.14 161.39 26.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 73.15 110.878 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -81.06 114.12 19.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 73.22 110.858 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.99 138.96 28.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 64.53 111.078 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 75' ' ' SER . 3.2 m -94.37 106.7 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 61.12 111.139 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -136.26 146.23 46.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 44.23 111.066 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 73' ' ' SER . 68.9 t -109.39 111.88 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.11 111.148 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.7 t -127.02 139.27 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 72.34 111.136 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 42.6 p -134.03 166.48 22.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 60.4 110.877 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.777 HG21 HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -110.96 149.49 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 63.42 111.136 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.66 177.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 54.12 110.864 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.728 . . . . 61.05 112.511 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.833 0.349 . . . . 74.52 110.894 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.1 106.64 12.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.42 111.119 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.64 152.35 37.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 74.53 110.864 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.27 127.27 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.862 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -133.93 139.63 46.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 64.24 110.931 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 49' ' ' LYS . 2.0 tt -143.4 134.13 25.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.906 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.589 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.3 tttt -142.4 122.66 13.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 72.11 110.883 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.47 48.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 73.11 111.112 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.15 -81.9 1.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.719 -0.753 . . . . 55.41 112.501 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -93.67 177.48 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.907 0.384 . . . . 75.03 110.844 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.12 138.22 30.86 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.569 0.699 . . . . 75.43 110.895 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.15 49.93 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 75.43 112.332 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -103.34 178.99 4.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 53.4 111.194 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.7 p -65.47 -14.24 60.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 74.52 111.124 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.4 m -121.35 -26.25 5.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 64.32 110.858 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.13 126.47 49.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 64.45 110.878 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.28 153.7 35.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 65.44 110.944 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -111.69 -27.63 8.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 74.43 110.897 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.1 m -140.52 123.78 16.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.916 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -179.51 115.78 0.22 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.589 0.709 . . . . 71.34 110.87 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.42 ' HD2' ' HG2' ' A' ' 70' ' ' GLU . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.161 0 C-N-CA 122.664 2.243 . . . . 61.42 112.364 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.833 0.349 . . . . 71.32 110.902 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.7 t30 68.01 18.27 9.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 51.52 110.891 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.42 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 14.1 tt0 -122.19 88.82 3.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 65.31 110.831 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.464 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.4 m -134.63 169.03 17.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 70.1 110.854 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.22 152.34 38.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 63.3 110.879 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.8 ' HB2' HG22 ' A' ' 34' ' ' VAL . 1.9 p -127.03 109.29 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.43 110.881 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.5 m -150.96 152.74 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 72.23 111.112 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.478 ' HB3' HG23 ' A' ' 32' ' ' THR . 77.5 p -80.1 101.89 9.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 71.23 110.884 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.506 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.87 151.18 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 71.12 111.078 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.87 144.13 32.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.547 0.689 . . . . 74.41 111.104 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.525 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.6 Cg_endo -69.73 124.67 11.32 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.713 2.275 . . . . 75.11 112.306 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.03 -15.99 1.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 55.22 112.485 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.9 m -126.16 131.33 52.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.37 . . . . 74.12 111.134 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.599 ' HA ' HG22 ' A' ' 26' ' ' THR . 26.9 m -72.66 138.15 46.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.44 111.153 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.506 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 47.5 m-85 -108.57 139.58 43.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 60.24 110.926 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -107.25 160.19 15.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 73.42 110.831 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 t -137.8 126.14 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 75.15 111.148 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.04 123.06 27.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 65.31 110.845 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.469 HD11 HD13 ' A' ' 97' ' ' LEU . 15.1 mm -111.2 124.32 67.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 74.13 111.112 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 145.25 32.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.865 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -117.14 140.61 15.99 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 62.25 112.49 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -101.76 -24.3 14.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.923 0.392 . . . . 75.43 110.953 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 91' ' ' ASN . 72.2 p -174.52 139.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 64.21 110.835 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 90' ' ' SER . 5.1 p-10 -31.56 106.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 54.23 110.913 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -163.09 110.6 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 65.54 110.93 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 p -117.25 158.83 23.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 61.21 110.868 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.34 25.45 2.0 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 64.1 112.529 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.36 146.83 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.865 0.364 . . . . 55.24 111.162 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.611 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.71 113.72 27.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 63.32 111.171 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.777 HD12 HG21 ' A' ' 37' ' ' ILE . 7.7 tp -99.88 141.08 33.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 72.24 110.921 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -151.58 169.92 20.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.936 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.657 HD21 ' HD2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -89.42 144.8 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 74.04 110.903 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.437 ' OE1' HD12 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -106.39 101.79 11.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 44.34 110.888 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.657 ' HD2' HD21 ' A' ' 99' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 64.12 110.931 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.869 0.366 . . . . 44.34 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -117.83 108.84 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.44 111.13 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.07 149.74 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 52.04 110.875 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.611 ' CE ' HD11 ' A' ' 97' ' ' LEU . 18.4 tptm -162.7 -70.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.11 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.579 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -71.65 155.4 40.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 71.1 110.888 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 18.4 t30 89.03 -67.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.45 110.875 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 m -124.19 120.66 26.24 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.614 0.721 . . . . 75.25 111.171 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HB2' HG22 ' A' ' 96' ' ' THR . 54.3 Cg_endo -69.71 154.14 68.3 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.7 2.267 . . . . 71.42 112.384 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.9 t -87.48 113.78 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 51.44 111.131 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 p -91.31 175.14 7.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 53.44 110.858 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 p30 40.62 48.91 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 62.3 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.808 HD11 ' HB2' ' A' ' 97' ' ' LEU . 4.2 mt -57.38 -176.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 72.51 110.952 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 p -143.86 139.61 29.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 51.52 111.146 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.75 64.54 0.56 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.794 -0.717 . . . . 74.45 112.497 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -73.93 160.5 31.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.941 0.4 . . . . 52.4 110.858 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 90' ' ' SER . 0.9 OUTLIER -45.22 -64.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.905 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.9 -48.14 1.81 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 73.12 112.501 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.57 157.81 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.839 0.352 . . . . 65.41 110.881 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.65 -179.32 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 52.1 110.893 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -133.66 146.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.21 111.141 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -137.55 145.72 43.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 60.33 110.88 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -144.88 165.9 26.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 73.2 110.913 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 8.2 m -140.79 140.02 34.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 43.34 111.089 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -159.68 160.69 34.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 60.12 110.858 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 81' ' ' THR . 24.5 p -130.1 170.22 14.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.484 . . . . 73.32 111.125 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.875 HG11 ' CE1' ' A' ' 101' ' ' TYR . 26.8 m -109.11 170.76 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.42 111.121 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -99.46 -67.99 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.887 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -125.31 148.68 48.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 75.25 110.869 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -50.53 117.49 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 73.43 110.84 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.65 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . . . -141.97 144.42 33.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 74.04 111.079 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 32' ' ' THR . 2.5 t -103.05 107.13 17.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.436 . . . . 64.45 111.167 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.56 147.13 46.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 75.22 111.138 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.2 p -107.57 111.69 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 71.21 111.129 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.437 HG11 ' HG2' ' A' ' 98' ' ' LYS . 11.5 t -127.64 139.67 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.05 111.15 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.465 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 9.5 p -135.15 165.27 25.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 45.44 110.858 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.494 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -113.4 150.93 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 41.21 111.111 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 177.5 172.93 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 65.21 110.831 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 72.25 112.443 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.8 0.333 . . . . 73.43 110.864 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB1' ' CG2' ' A' ' 86' ' ' ILE . . . -88.67 116.36 26.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 62.03 111.108 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -78.21 147.2 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 62.23 110.844 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.719 HD11 HE22 ' A' ' 100' ' ' GLN . 5.9 tt -108.4 126.93 53.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 65.1 110.909 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -142.66 139.37 31.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 75.22 110.901 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.457 HD12 ' OE1' ' A' ' 100' ' ' GLN . 0.5 OUTLIER -147.09 133.64 19.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 73.34 110.908 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' H ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -143.35 133.86 24.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.466 . . . . 74.03 110.918 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.27 132.53 38.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 45.41 111.123 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.82 -80.63 1.81 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 33.53 112.509 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -92.92 175.95 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 64.51 110.842 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HD3' ' HE3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -88.15 137.75 31.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 72.42 110.895 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 142.65 48.38 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.691 2.26 . . . . 65.43 112.334 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.67 178.68 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 62.23 111.155 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 p -66.81 -13.38 61.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.54 111.113 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 m -123.01 -25.96 4.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 61.41 110.85 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.83 125.99 49.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 70.5 110.839 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.11 153.67 34.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 74.03 110.964 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -102.02 -32.19 10.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 64.45 110.85 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.2 m -138.03 123.57 19.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 63.24 110.856 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -177.29 127.16 0.3 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.568 0.699 . . . . 74.22 110.893 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 C--O 1.231 0.164 0 C-N-CA 122.726 2.284 . . . . 63.11 112.38 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.854 0.359 . . . . 54.15 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.8 25.57 11.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 70.44 110.906 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.32 96.13 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 63.24 110.865 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.591 ' HA ' HD13 ' A' ' 46' ' ' LEU . 1.7 m -133.85 170.95 14.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 42.3 110.862 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.46 149.56 41.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 65.54 110.951 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.487 ' HB3' HG23 ' A' ' 34' ' ' VAL . 13.6 p -126.72 109.27 11.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.44 110.864 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.2 t -150.91 152.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 52.11 111.139 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 p -81.41 102.14 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 70.02 110.85 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.787 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.55 149.96 26.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 43.55 111.13 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.58 144.23 28.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.595 0.712 . . . . 53.55 111.094 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.25 7.04 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.684 2.256 . . . . 74.33 112.314 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.68 -4.97 80.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.728 . . . . 62.01 112.494 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.9 m -126.22 125.48 42.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 73.1 111.125 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.48 ' HA ' HG22 ' A' ' 26' ' ' THR . 6.3 m -71.24 137.78 48.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 64.41 111.127 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.787 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 34.1 m-85 -111.66 137.98 48.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 75.53 110.936 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -105.98 162.41 13.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 71.35 110.841 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG21 ' HD3' ' A' ' 5' ' ' LYS . 2.7 t -135.89 138.57 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 54.41 111.147 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.412 ' HE3' ' HD3' ' A' ' 53' ' ' LYS . 6.8 tpp -140.3 121.77 15.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.83 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.416 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 20.4 mm -118.86 113.16 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.21 111.144 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -100.11 155.79 17.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 72.42 110.915 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.03 153.24 17.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 73.12 112.478 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.87 -21.98 8.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.895 0.379 . . . . 60.41 110.927 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.479 ' O ' ' C ' ' A' ' 91' ' ' ASN . 1.6 p -175.04 134.44 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 70.21 110.905 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 90' ' ' SER . 39.2 t30 -32.02 106.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 63.44 110.905 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -163.95 116.52 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.926 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.6 p -121.84 151.62 40.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 72.35 110.856 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.16 29.38 1.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 74.35 112.488 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.56 145.73 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.929 0.395 . . . . 72.21 111.127 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 9' ' ' PRO . 1.3 m -101.15 118.56 37.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 61.35 111.165 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.808 ' HB2' HD11 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -111.45 127.81 55.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 62.32 110.917 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.805 ' N ' HD22 ' A' ' 97' ' ' LEU . 3.9 ttpt -135.15 167.92 20.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.908 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.645 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -88.18 141.2 28.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 73.34 110.923 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.719 HE22 HD11 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -103.08 110.99 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.927 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.875 ' CE1' HG11 ' A' ' 27' ' ' VAL . 2.6 t80 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.928 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.847 0.356 . . . . 75.0 110.9 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.474 HG11 ' OG1' ' A' ' 24' ' ' THR . 11.1 m -106.39 108.45 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 72.11 111.097 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.14 149.93 52.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 61.02 110.904 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.636 ' HE3' HD11 ' A' ' 97' ' ' LEU . 13.7 tptm -166.71 -67.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.907 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.674 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.2 OUTLIER -76.09 153.93 35.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 74.04 110.918 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.1 t-20 87.32 -69.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.21 110.887 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.1 m -120.88 121.55 28.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.57 0.7 . . . . 61.52 111.105 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 154.38 67.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.692 2.262 . . . . 74.2 112.363 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.13 116.22 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 60.23 111.137 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 p -87.96 159.71 18.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 64.1 110.834 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 p30 40.08 69.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 73.11 110.855 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.743 HD11 ' CB ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -69.81 -174.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 65.24 110.889 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -140.49 138.0 34.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 73.23 111.146 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.52 64.05 0.58 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.693 -0.765 . . . . 63.53 112.454 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -75.59 148.18 39.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.357 . . . . 54.24 110.905 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.36 -57.02 7.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 72.04 110.881 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.63 -64.21 1.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 42.13 112.491 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.92 144.61 8.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 72.4 110.865 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -139.67 179.33 6.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 61.14 110.892 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.584 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.13 138.0 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 74.54 111.127 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -135.41 139.58 44.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 71.34 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -137.44 163.8 30.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 75.44 110.926 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.724 HG22 ' HA ' ' A' ' 83' ' ' HIS . 1.9 p -142.17 146.91 35.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 72.22 111.136 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.39 163.28 35.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 64.21 110.822 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.622 HG22 HG23 ' A' ' 81' ' ' THR . 11.0 p -125.58 169.74 12.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 53.14 111.183 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.2 t -108.33 145.09 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.13 111.089 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -86.21 -44.29 12.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.832 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -142.78 154.72 44.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 75.1 110.86 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -72.04 116.62 12.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 72.21 110.938 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.75 141.3 31.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 63.31 111.116 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -94.81 105.66 17.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 74.14 111.114 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.11 148.62 45.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 71.34 111.136 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -107.93 111.12 34.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 72.53 111.12 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.496 HG11 ' HG2' ' A' ' 98' ' ' LYS . 41.2 t -127.41 139.9 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 71.22 111.09 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.488 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 24.3 p -135.89 166.21 23.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 73.04 110.855 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.461 HG21 HD12 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -111.4 150.66 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 52.41 111.152 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.3 173.58 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 64.34 110.884 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 64.31 112.495 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.866 0.365 . . . . 70.11 110.861 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.93 127.12 54.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 74.52 111.073 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 1.7 m-20 -88.91 152.36 21.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 70.14 110.867 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.413 HD22 ' O ' ' A' ' 70' ' ' GLU . 5.6 tt -118.75 142.24 47.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 72.44 110.891 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -153.36 142.92 21.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 72.21 110.945 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.508 HD12 ' NE2' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -140.66 134.08 29.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 74.25 110.922 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.477 ' N ' HD23 ' A' ' 48' ' ' LEU . 7.7 tttt -149.16 129.64 13.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 64.4 110.906 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.3 98.98 8.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 64.1 111.091 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.07 -90.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 43.42 112.463 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.0 m -90.46 128.48 36.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.957 0.408 . . . . 63.44 110.849 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.26 133.93 3.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.574 0.702 . . . . 72.42 110.87 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 143.02 49.54 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.677 2.251 . . . . 72.24 112.336 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 p -107.63 178.73 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 74.42 111.164 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.8 p -63.28 -15.18 56.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 64.42 111.164 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 m -118.96 -26.33 6.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.858 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.73 125.49 49.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.852 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.97 153.4 34.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.909 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -108.18 -34.58 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 71.41 110.912 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 70.5 m -144.64 123.1 12.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.86 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -177.37 129.14 0.32 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.606 0.717 . . . . 73.22 110.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HG2' ' CG ' ' A' ' 70' ' ' GLU . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.237 . . . . 64.03 112.399 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.836 0.351 . . . . 73.32 110.897 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.3 t30 65.63 12.19 8.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 54.22 110.878 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.43 ' CG ' ' HG2' ' A' ' 63' ' ' PRO . 4.3 tt0 -116.68 87.5 2.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.876 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.488 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -133.28 169.26 17.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 64.31 110.846 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.74 156.73 31.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 52.44 110.865 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.68 107.22 9.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 52.04 110.832 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -150.65 153.12 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.1 111.168 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -70.21 104.72 2.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.22 110.863 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.93 131.5 35.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 70.23 111.127 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.99 139.94 20.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.589 0.709 . . . . 43.44 111.078 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 170.45 16.55 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.683 2.255 . . . . 75.23 112.349 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.16 -39.24 2.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 45.01 112.474 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.6 m -97.04 128.93 44.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 71.34 111.155 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.622 HG23 HG22 ' A' ' 26' ' ' THR . 3.1 m -71.43 133.24 45.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 72.31 111.141 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -104.03 136.02 44.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 64.22 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.724 ' HA ' HG22 ' A' ' 24' ' ' THR . 17.9 m-70 -106.97 159.14 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 64.32 110.834 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.452 HG11 ' CE ' ' A' ' 5' ' ' LYS . 4.5 t -138.93 139.39 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 63.14 111.108 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.82 123.65 25.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 72.1 110.892 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.584 ' HB ' HG23 ' A' ' 21' ' ' VAL . 16.1 mm -118.81 113.61 42.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 72.44 111.099 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 10.3 mmmm -98.29 165.32 11.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 41.41 110.927 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.88 135.08 8.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.713 -0.756 . . . . 54.34 112.449 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -96.61 -31.54 12.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 75.21 110.943 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 91' ' ' ASN . 78.1 p -167.62 136.92 2.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 65.42 110.859 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 90' ' ' SER . 13.5 t-20 -34.62 105.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 55.01 110.898 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -164.37 119.25 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 74.04 110.953 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 p -121.56 155.76 34.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 70.53 110.891 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.65 23.29 1.52 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 63.1 112.468 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.659 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.7 t -114.15 143.12 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.911 0.386 . . . . 70.4 111.123 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.403 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 0.8 OUTLIER -100.08 132.26 45.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.3 111.158 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.743 ' CB ' HD11 ' A' ' 13' ' ' LEU . 13.8 tp -118.99 149.71 41.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.928 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HG2' HG11 ' A' ' 35' ' ' VAL . 3.4 ttpt -157.87 164.27 37.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 74.51 110.919 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.674 HD22 ' HB2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -90.96 138.95 31.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.25 -0.432 . . . . 70.44 110.907 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.508 ' NE2' HD12 ' A' ' 48' ' ' LEU . 1.3 pm0 -98.09 112.0 24.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 54.44 110.941 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.422 ' HB3' HD21 ' A' ' 99' ' ' LEU . 29.6 p90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 70.45 110.926 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.893 0.378 . . . . 74.12 110.831 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.6 m -118.56 109.25 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 63.22 111.103 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.636 HD12 HG22 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -131.47 148.95 52.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 75.32 110.936 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.584 ' HE3' HD11 ' A' ' 97' ' ' LEU . 13.8 tptm -166.66 -68.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 65.44 110.883 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.651 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -75.01 154.98 37.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.54 110.877 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.0 t-20 88.38 -65.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 71.31 110.906 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 m -129.35 121.67 20.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.551 0.691 . . . . 64.33 111.098 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.41 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.7 Cg_endo -69.81 154.07 67.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.653 2.236 . . . . 73.05 112.359 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.636 HG22 HD12 ' A' ' 4' ' ' LEU . 37.3 t -84.83 115.09 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 61.14 111.134 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.2 146.12 28.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 74.02 110.853 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.66 81.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 75.14 110.942 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.73 HD11 ' CB ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -79.58 -172.69 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 52.33 110.924 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -136.98 138.72 40.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 75.12 111.139 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.77 71.87 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.746 -0.74 . . . . 52.0 112.505 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -76.98 134.54 38.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 61.21 110.89 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -24.57 8.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 55.11 110.901 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.13 -40.64 1.37 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 61.44 112.439 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.27 -173.12 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.356 . . . . 72.23 110.871 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.12 -178.01 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 73.54 110.918 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.0 145.76 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 72.3 111.168 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -137.21 143.4 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.51 110.849 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -140.15 165.25 27.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 71.12 110.926 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.43 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 7.8 m -147.11 142.32 27.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 64.1 111.137 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -159.36 162.51 35.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 74.25 110.868 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.491 HG22 HG23 ' A' ' 81' ' ' THR . 19.6 p -130.34 169.94 14.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 72.11 111.115 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 m -108.68 169.89 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.197 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -108.73 -45.16 3.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 54.41 110.895 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -133.38 158.82 42.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 75.1 110.881 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.7 116.27 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 55.21 110.896 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.38 139.19 31.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 65.23 111.127 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.3 m -96.21 106.77 19.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 63.33 111.154 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.59 147.29 46.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 70.31 111.117 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.2 p -107.5 111.29 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 52.21 111.132 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -127.45 140.22 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 75.01 111.115 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.497 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 5.4 p -133.53 166.25 23.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 61.15 110.891 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.497 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -111.91 152.44 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 64.31 111.169 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.79 173.9 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.886 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 54.22 112.496 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.812 0.339 . . . . 53.02 110.826 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.64 120.55 39.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.55 111.159 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.55 161.99 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 75.52 110.887 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.685 HD13 ' HA ' ' A' ' 71' ' ' SER . 9.4 tt -118.78 129.82 55.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 72.24 110.959 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -133.85 146.54 50.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.913 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -153.52 133.47 13.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 75.33 110.922 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.415 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -144.87 121.58 11.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 70.44 110.854 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.49 89.46 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 74.33 111.109 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.89 -83.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 61.12 112.456 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -106.41 133.96 50.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.925 0.393 . . . . 70.04 110.862 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.66 127.34 2.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 75.44 110.932 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 142.87 49.23 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.708 2.272 . . . . 60.1 112.305 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.48 178.32 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 74.02 111.152 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.3 p -60.63 -17.04 44.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 75.51 111.152 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.6 m -117.04 -25.45 7.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.833 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.46 124.87 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.847 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.87 153.41 33.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.91 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -115.51 -34.91 4.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 75.33 110.886 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.9 m -140.37 122.68 15.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 74.13 110.873 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.32 140.69 0.4 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.582 0.706 . . . . 70.42 110.907 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 122.69 2.26 . . . . 72.25 112.313 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 CA--C 1.526 0.034 0 CA-C-O 120.856 0.36 . . . . 74.31 110.865 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.9 t30 66.86 16.55 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.15 110.905 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.92 96.98 4.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 63.4 110.899 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.685 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.4 m -134.32 171.2 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.901 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.29 152.96 35.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 74.53 110.882 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 34' ' ' VAL . 1.3 p -128.64 109.26 11.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 63.21 110.854 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.6 m -150.89 152.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 62.42 111.135 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.6 p -73.2 106.97 5.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 64.01 110.8 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.71 132.55 35.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.11 111.066 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.63 139.23 19.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.525 0.678 . . . . 70.15 111.101 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 142.11 46.88 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.629 2.219 . . . . 72.22 112.325 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.97 -12.77 8.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.774 -0.727 . . . . 73.11 112.461 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.1 m -126.41 129.23 48.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 54.41 111.165 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.491 HG23 HG22 ' A' ' 26' ' ' THR . 5.2 m -70.98 138.07 49.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 74.35 111.159 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' O ' HG23 ' A' ' 24' ' ' THR . 42.4 m-85 -108.6 135.86 49.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 70.54 110.946 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -107.24 158.91 16.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 61.41 110.879 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.467 HG11 ' HE3' ' A' ' 5' ' ' LYS . 4.3 t -138.3 138.57 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 72.41 111.14 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.97 123.05 17.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' A' ' 21' ' ' VAL . 28.8 mm -113.44 112.96 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 60.24 111.169 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -110.38 134.31 52.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 74.45 110.874 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.74 144.67 17.66 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.753 . . . . 24.32 112.456 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.77 -22.27 20.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.902 0.382 . . . . 74.43 110.962 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 91' ' ' ASN . 2.7 p -163.85 139.76 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 72.54 110.891 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 90' ' ' SER . 13.3 t-20 -35.07 106.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 64.35 110.882 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -155.47 115.59 3.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 71.31 110.946 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.1 p -122.17 151.5 40.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 63.03 110.849 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.46 23.65 2.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 73.14 112.469 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.662 ' O ' HD12 ' A' ' 13' ' ' LEU . 1.4 t -111.74 143.94 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 72.01 111.096 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -100.94 124.19 46.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 62.34 111.124 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.73 ' CB ' HD11 ' A' ' 13' ' ' LEU . 15.5 tp -112.32 148.38 34.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 62.35 110.951 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -153.79 164.7 37.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 61.32 110.878 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.651 HD22 ' HB2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -91.43 136.91 32.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.236 -0.438 . . . . 72.53 110.922 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.416 HE22 HD11 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -97.38 112.18 24.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.01 110.931 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 75.45 110.871 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 m120 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.856 0.36 . . . . 71.22 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.5 m -117.9 108.27 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 71.24 111.146 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.54 150.66 52.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 61.01 110.95 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.722 ' HG2' HG21 ' A' ' 84' ' ' VAL . 2.2 tppm? -166.09 -73.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 74.41 110.883 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.641 ' ND2' HD22 ' A' ' 99' ' ' LEU . 9.8 t-20 -63.39 157.75 22.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 73.01 110.919 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.3 t30 88.52 -60.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.868 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.4 m -133.59 121.62 16.32 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 42.11 111.161 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 152.28 69.54 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 2.243 . . . . 63.33 112.353 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.561 HG12 HD22 ' A' ' 13' ' ' LEU . 99.0 t -79.37 115.02 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 71.13 111.175 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.49 146.31 31.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 53.12 110.844 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.59 81.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 73.3 110.841 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.561 HD22 HG12 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -71.4 -168.72 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 62.14 110.911 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 p -139.61 138.34 36.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 73.3 111.137 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.63 58.82 0.65 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.721 -0.752 . . . . 43.15 112.517 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -76.56 139.17 40.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.874 0.368 . . . . 73.25 110.848 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -26.11 9.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 71.42 110.942 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.98 -56.33 0.4 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.735 -0.745 . . . . 73.1 112.503 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.13 158.73 6.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.854 0.359 . . . . 60.01 110.868 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -152.6 167.58 28.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 70.25 110.922 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -137.61 136.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 64.01 111.102 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -137.42 147.15 45.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 72.13 110.825 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -146.22 166.11 27.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 70.44 110.968 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 27.6 m -140.04 140.7 36.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 61.31 111.108 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -160.74 155.06 23.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 72.42 110.925 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.618 HG22 ' HA ' ' A' ' 81' ' ' THR . 19.1 p -128.07 170.49 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 64.22 111.178 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -108.5 170.21 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 61.13 111.11 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.05 -52.83 3.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 44.41 110.873 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.43 172.67 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.25 110.873 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -75.93 117.13 17.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 73.13 110.845 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.81 133.5 25.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 45.32 111.143 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.6 m -95.18 107.98 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 74.45 111.118 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.2 148.33 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 64.04 111.067 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -106.92 111.03 33.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 74.01 111.099 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.735 HG11 ' HG2' ' A' ' 98' ' ' LYS . 49.0 t -126.16 139.34 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 60.15 111.115 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.495 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 17.0 p -135.48 170.23 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.4 110.889 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.507 HD13 HD12 ' A' ' 46' ' ' LEU . 4.6 pt -108.01 157.49 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 73.23 111.112 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 174.12 171.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 75.53 110.838 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.679 -0.772 . . . . 71.34 112.429 -179.968 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.818 0.342 . . . . 65.12 110.89 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.76 120.92 36.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 73.23 111.1 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.64 172.64 11.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.891 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 71' ' ' SER . 8.5 tt -124.63 141.82 51.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 73.04 110.914 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -150.37 146.62 26.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.949 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.618 HD12 ' NE2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -153.87 146.23 23.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 64.11 110.934 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.595 ' H ' HD23 ' A' ' 48' ' ' LEU . 7.1 tttt -149.62 123.12 9.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 60.41 110.923 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.54 84.28 6.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 72.34 111.109 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.89 -64.22 0.4 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 72.55 112.527 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -139.99 137.7 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.949 0.404 . . . . 75.35 110.833 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -32.52 127.2 0.36 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.522 0.677 . . . . 75.55 110.929 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 143.45 50.76 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.668 2.245 . . . . 71.13 112.329 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -103.35 178.35 4.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 55.14 111.106 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.5 p -62.69 -15.71 53.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 70.35 111.172 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.3 m -117.21 -26.23 6.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 71.11 110.858 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.94 123.52 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 52.35 110.838 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.39 153.55 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 73.21 110.903 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 49' ' ' LYS . 35.6 m-20 -112.27 -45.67 3.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 55.2 110.847 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 36.9 m -121.9 123.57 42.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.869 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -175.77 127.61 0.37 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 74.51 110.848 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.183 0 C-N-CA 122.694 2.263 . . . . 63.03 112.344 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 p30 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.81 0.338 . . . . 73.13 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.3 t30 61.09 24.2 14.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.31 110.876 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -128.98 90.23 3.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 74.15 110.908 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.709 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.6 m -133.04 169.97 16.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 62.51 110.86 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.57 154.76 34.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 75.2 110.869 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.458 ' HB3' HG23 ' A' ' 34' ' ' VAL . 60.6 p -128.29 109.67 11.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.846 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.1 t -150.33 153.02 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 64.11 111.123 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -75.41 105.38 6.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.3 110.857 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.13 138.41 34.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.41 111.064 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.29 146.52 32.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.711 . . . . 55.31 111.13 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 164.55 34.09 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 73.21 112.374 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.0 -21.18 38.3 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.713 -0.756 . . . . 71.13 112.482 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.0 m -108.75 124.01 49.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 53.53 111.111 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.618 ' HA ' HG22 ' A' ' 26' ' ' THR . 22.0 m -72.89 134.06 44.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 44.11 111.127 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.532 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 52.2 m-85 -109.13 136.91 47.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.885 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -118.55 139.56 51.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 73.42 110.851 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.722 HG21 ' HG2' ' A' ' 5' ' ' LYS . 13.7 t -116.03 126.83 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 62.24 111.091 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 tpt -123.51 128.82 50.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 51.41 110.846 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.558 HD11 ' CD2' ' A' ' 97' ' ' LEU . 30.6 mm -113.97 126.43 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 53.34 111.109 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.19 146.3 30.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 73.35 110.9 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.39 150.13 18.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 41.03 112.472 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.15 -37.9 5.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.35 . . . . 73.2 110.868 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 91' ' ' ASN . 7.6 p -161.74 137.64 7.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 73.03 110.908 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.482 ' C ' ' O ' ' A' ' 90' ' ' SER . 4.8 p-10 -31.65 108.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 73.2 110.877 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.63 121.66 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.5 110.919 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.5 p -121.59 168.23 11.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 64.11 110.82 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.39 22.66 2.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 70.43 112.478 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -113.38 140.75 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 74.13 111.123 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.54 120.04 39.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 71.32 111.185 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' CD2' HD11 ' A' ' 86' ' ' ILE . 19.4 tp -106.22 149.99 26.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.912 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.735 ' HG2' HG11 ' A' ' 35' ' ' VAL . 5.7 ttpt -156.92 162.91 39.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 74.42 110.866 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.641 HD22 ' ND2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -90.27 140.34 29.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 54.33 110.909 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.618 ' NE2' HD12 ' A' ' 48' ' ' LEU . 4.5 pm0 -103.5 112.42 25.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.916 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.8 p90 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.52 110.903 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.3 m120 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.82 0.343 . . . . 74.4 110.921 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.4 m -121.9 108.26 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.54 111.103 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.03 149.34 52.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 75.01 110.927 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.683 ' HE3' HG11 ' A' ' 84' ' ' VAL . 1.4 tppm? -163.55 -75.34 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.928 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.578 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -62.27 155.11 25.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 70.14 110.903 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.7 t-20 89.03 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.03 110.834 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.2 m -121.67 121.01 28.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 73.24 111.144 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.621 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.4 Cg_endo -69.76 153.57 68.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.266 . . . . 72.42 112.326 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.4 t -84.48 114.49 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 64.52 111.152 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 p -86.69 167.89 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 55.21 110.862 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 39.75 55.76 2.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 54.13 110.855 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.792 HD11 ' CB ' ' A' ' 97' ' ' LEU . 3.1 mt -58.9 -175.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 75.14 110.884 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.9 p -141.76 138.33 32.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 64.33 111.101 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.96 55.17 0.7 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 73.21 112.477 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -75.84 140.44 42.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 70.11 110.86 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -26.9 5.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 70.22 110.884 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.23 -61.43 0.48 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 64.22 112.455 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -58.16 144.42 40.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 62.33 110.893 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -138.99 170.7 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 70.2 110.845 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.503 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.61 135.55 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 43.51 111.118 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -138.23 154.16 49.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.02 110.886 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -148.0 166.77 26.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.948 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.421 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 58.3 m -137.44 140.45 41.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 54.13 111.132 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -159.95 158.13 30.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 75.14 110.847 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.615 HG22 HG23 ' A' ' 81' ' ' THR . 22.4 p -127.39 170.51 12.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 72.42 111.141 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.882 HG11 ' CE1' ' A' ' 101' ' ' TYR . 31.1 m -109.45 171.02 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 72.41 111.134 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.75 -66.57 0.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 70.13 110.898 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -127.08 149.73 49.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.43 110.879 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -51.02 117.04 2.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 63.42 110.837 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.656 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . . . -141.95 145.12 34.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 61.22 111.095 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -104.77 106.67 17.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 52.14 111.181 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.29 147.23 47.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 73.25 111.111 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.509 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -107.51 112.32 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 71.53 111.179 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG11 ' HG2' ' A' ' 98' ' ' LYS . 8.8 t -127.5 139.77 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 63.0 111.152 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.471 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 9.9 p -134.68 166.41 22.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 70.43 110.866 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.04 146.41 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 72.33 111.115 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.3 t 177.9 161.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.894 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 73.41 112.485 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.853 0.358 . . . . 72.31 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.32 120.12 35.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 74.43 111.067 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.74 143.75 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 72.12 110.849 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 71' ' ' SER . 4.7 tt -103.48 131.34 50.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 52.25 110.905 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -130.65 154.45 47.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 63.25 110.949 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.6 133.63 12.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 52.14 110.863 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -148.95 124.48 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.882 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.58 82.9 7.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 60.3 111.083 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.72 -82.51 0.19 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 51.11 112.508 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 m -109.08 136.92 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 73.13 110.83 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.64 126.01 2.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 64.33 110.919 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 142.58 48.25 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.723 2.282 . . . . 73.22 112.299 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.84 177.98 4.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 62.24 111.151 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 87' ' ' LYS . 58.9 p -62.71 -16.78 58.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 73.05 111.094 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m -116.78 -26.24 7.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 72.01 110.823 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.94 124.11 47.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 72.24 110.845 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.61 153.38 33.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 73.45 110.907 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -107.85 -44.99 4.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.03 110.852 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.5 m -145.17 122.21 11.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 54.11 110.879 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -177.38 153.94 1.05 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.604 0.716 . . . . 61.11 110.885 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.526 ' CD ' HD22 ' A' ' 46' ' ' LEU . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.147 0 C-N-CA 122.705 2.27 . . . . 70.21 112.313 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.792 0.329 . . . . 61.02 110.928 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 63.94 16.76 10.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 71.23 110.923 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -127.25 100.09 5.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.872 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.733 ' HA ' HD13 ' A' ' 46' ' ' LEU . 4.9 m -136.77 173.13 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 72.13 110.894 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.71 150.53 38.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 54.11 110.904 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.509 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.4 p -126.09 109.86 12.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 74.21 110.878 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -150.75 148.73 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 63.31 111.134 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.27 102.37 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 72.33 110.848 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.712 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.7 151.42 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 63.15 111.056 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.69 145.72 31.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 71.23 111.088 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 162.78 40.7 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 65.11 112.347 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.07 -18.5 51.85 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.77 -0.728 . . . . 72.22 112.487 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.9 m -116.87 125.97 52.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 62.13 111.13 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.615 HG23 HG22 ' A' ' 26' ' ' THR . 24.0 m -71.25 137.57 48.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 73.52 111.17 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.712 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 70.2 m-85 -112.46 152.71 28.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 71.25 110.921 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -131.36 159.0 39.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 75.33 110.872 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.683 HG11 ' HE3' ' A' ' 5' ' ' LYS . 22.0 t -132.44 125.46 53.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 72.14 111.151 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.23 124.19 46.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 62.33 110.867 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.526 ' CD1' HD22 ' A' ' 97' ' ' LEU . 24.7 mm -110.54 113.17 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.54 111.122 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HG3' HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -99.97 133.21 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 73.24 110.921 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.22 160.29 16.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 60.44 112.475 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -117.46 -29.79 5.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 73.21 110.953 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 91' ' ' ASN . 97.5 p -168.21 143.54 3.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 63.54 110.783 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' SER . 39.1 t30 -33.04 109.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.505 . . . . 74.14 110.893 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.6 111.69 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 65.55 110.893 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 p -121.67 159.68 26.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 74.45 110.876 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 120.4 22.24 3.17 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.699 -0.762 . . . . 74.45 112.476 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.13 146.22 18.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.921 0.391 . . . . 71.21 111.113 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -101.26 132.54 46.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.51 111.131 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.792 ' CB ' HD11 ' A' ' 13' ' ' LEU . 7.8 tp -121.45 148.79 43.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 55.21 110.899 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HG2' HG11 ' A' ' 35' ' ' VAL . 1.6 ttpt -155.07 170.04 22.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.853 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.659 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.65 140.85 29.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.03 110.896 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.584 ' OE1' HD11 ' A' ' 46' ' ' LEU . 1.7 pm0 -103.1 108.64 19.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.53 110.889 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.882 ' CE1' HG11 ' A' ' 27' ' ' VAL . 3.3 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 63.12 110.932 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.802 0.334 . . . . 63.1 110.931 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.423 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.1 m -117.7 108.39 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.4 111.093 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.98 148.89 52.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 71.33 110.939 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.595 ' NZ ' HD21 ' A' ' 97' ' ' LEU . 17.8 tptt -164.0 -74.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.893 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.659 ' CG ' HD22 ' A' ' 99' ' ' LEU . 12.2 t-20 -65.87 156.66 32.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.31 110.937 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.5 t30 85.61 -69.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 73.24 110.913 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -119.34 120.84 30.6 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.565 0.697 . . . . 73.04 111.137 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 153.54 68.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.656 2.238 . . . . 72.5 112.372 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.685 HG12 HD22 ' A' ' 13' ' ' LEU . 87.4 t -84.05 115.34 26.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.158 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.05 162.07 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 65.52 110.876 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 40.52 65.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 75.35 110.838 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.685 HD22 HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -62.13 -173.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 75.31 110.915 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 p -143.2 139.15 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 73.21 111.146 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.77 64.89 0.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.792 -0.718 . . . . 75.24 112.522 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.5 160.49 30.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 72.31 110.876 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 90' ' ' SER . 31.0 mmtp -44.87 -70.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.453 . . . . 62.24 110.909 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.6 -45.59 2.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.68 -0.771 . . . . 73.2 112.496 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.89 151.88 13.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.342 . . . . 75.21 110.849 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.53 -179.4 8.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 74.34 110.896 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -128.56 144.76 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 62.21 111.119 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -137.43 145.27 42.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 71.24 110.852 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -144.09 166.09 25.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 74.04 110.942 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.423 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 2.5 m -141.96 138.58 32.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 72.15 111.128 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 2.0 t80 -160.53 162.98 33.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 74.55 110.882 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.668 HG22 HG23 ' A' ' 81' ' ' THR . 17.3 p -131.7 171.09 13.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.03 111.142 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.2 170.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 60.22 111.159 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -111.98 -39.31 4.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 41.01 110.848 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.95 157.87 45.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.43 110.886 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -79.93 116.45 20.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 65.1 110.891 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.98 142.86 32.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 23.34 111.122 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 32' ' ' THR . 2.5 t -99.17 107.84 20.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 72.22 111.105 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.08 147.23 45.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 74.51 111.098 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.1 p -107.87 111.37 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 71.23 111.165 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.8 t -127.83 140.33 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.35 111.13 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.502 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 2.0 p -132.36 167.16 20.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.854 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.455 HD11 ' H ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -110.38 142.66 22.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 74.53 111.121 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 p -179.32 -169.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 53.2 110.84 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 74.11 112.518 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.755 0.312 . . . . 74.44 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.56 108.38 14.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.04 111.069 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.0 144.58 54.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.853 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 71' ' ' SER . 5.9 tt -112.46 126.94 55.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 73.14 110.945 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -136.41 148.84 47.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 71.23 110.907 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.95 133.81 13.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 71.24 110.938 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -141.96 140.04 32.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.04 110.899 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.74 -48.45 13.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 72.23 111.148 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.61 -96.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 73.11 112.503 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -106.79 162.38 13.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.917 0.389 . . . . 62.12 110.828 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HA ' ' CB ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -45.12 128.35 5.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.575 0.702 . . . . 52.35 110.906 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 142.35 47.22 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.654 2.236 . . . . 41.42 112.305 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -113.42 179.77 3.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 55.44 111.15 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.5 p -60.96 -16.75 46.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 71.25 111.14 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -117.11 -26.03 6.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 74.04 110.848 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 124.94 49.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 73.32 110.862 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.34 152.97 31.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.92 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -114.76 -31.5 6.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 70.25 110.86 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.8 m -141.89 121.89 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.872 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.58 122.7 0.13 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.625 0.726 . . . . 71.03 110.855 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.202 0 C-N-CA 122.649 2.233 . . . . 33.25 112.325 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.871 0.367 . . . . 62.44 110.876 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.7 t30 64.13 14.61 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 60.34 110.914 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -126.88 98.1 5.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 41.4 110.876 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.502 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 3.5 m -135.81 171.43 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 71.44 110.862 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.83 150.86 38.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 72.34 110.907 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 34' ' ' VAL . 1.2 p -128.47 108.48 10.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 65.04 110.873 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -151.08 148.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 75.54 111.163 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.28 106.37 6.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 35.12 110.876 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.645 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.33 145.25 29.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 70.3 111.03 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.19 139.38 21.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 50.24 111.087 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 133.56 25.9 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.708 2.272 . . . . 62.25 112.326 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.88 -20.06 2.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 72.31 112.462 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.2 m -126.51 134.95 50.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.371 . . . . 60.32 111.15 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.668 HG23 HG22 ' A' ' 26' ' ' THR . 23.6 m -71.07 137.6 49.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 64.42 111.156 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.645 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 32.5 m-85 -104.77 139.6 39.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 73.55 110.948 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.405 ' CB ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -107.18 161.24 14.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 60.25 110.823 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.91 138.17 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 75.51 111.15 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.7 tpt -142.98 123.27 13.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 70.41 110.923 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.405 ' HB ' HG23 ' A' ' 21' ' ' VAL . 19.9 mm -118.95 112.15 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 71.22 111.094 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -95.77 157.18 16.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 63.14 110.924 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.34 145.95 16.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 75.14 112.467 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -112.16 -21.71 11.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 72.31 110.868 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 91' ' ' ASN . 7.1 p -165.74 127.97 2.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 70.43 110.877 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 90' ' ' SER . 9.1 t-20 -35.38 106.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 54.31 110.894 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.42 115.63 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.932 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 p -115.87 151.85 34.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 51.21 110.86 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.47 28.26 0.92 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 50.32 112.519 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.33 147.38 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 61.5 111.088 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.03 114.14 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 74.4 111.107 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.67 ' HB3' HD21 ' A' ' 13' ' ' LEU . 1.7 tm? -104.25 132.78 50.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 55.12 110.935 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.651 ' N ' HD22 ' A' ' 97' ' ' LEU . 4.4 ttpt -144.18 163.72 32.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 71.23 110.832 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.659 HD22 ' CG ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -91.69 140.67 29.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 62.12 110.9 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.81 113.04 24.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.25 110.925 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.0 p90 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 74.32 110.953 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.855 0.36 . . . . 74.43 110.923 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 24' ' ' THR . 3.1 m -120.32 108.85 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.31 111.125 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.45 148.72 52.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.13 110.893 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.634 ' CD ' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -157.46 -69.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 55.0 110.859 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.574 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 8.6 t-20 -77.68 158.73 29.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 41.14 110.904 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.574 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.4 t30 88.38 -68.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.918 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.7 m -123.4 113.73 29.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.552 0.691 . . . . 72.31 111.129 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.408 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.4 Cg_endo -69.76 150.28 68.0 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 74.41 112.34 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.563 HG12 HD22 ' A' ' 13' ' ' LEU . 76.5 t -77.99 113.8 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 73.03 111.091 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.21 140.02 41.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 71.54 110.854 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.35 84.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 74.12 110.89 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -72.35 -167.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 63.13 110.886 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 p -139.05 138.56 37.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 62.42 111.135 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.69 60.3 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 65.2 112.474 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -76.02 158.4 31.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 64.04 110.857 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -61.23 2.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.857 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.72 -50.63 1.94 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 75.41 112.503 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.74 140.63 14.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 73.41 110.88 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -141.19 170.46 15.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 43.54 110.859 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.29 137.06 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 64.44 111.161 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.25 152.27 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 54.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -143.34 165.56 27.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 63.53 110.934 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 3.2 m -135.24 139.07 44.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 75.14 111.125 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -160.01 162.58 34.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 71.54 110.863 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 81' ' ' THR . 20.4 p -136.72 171.04 15.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 73.33 111.154 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.732 HG11 ' CE1' ' A' ' 101' ' ' TYR . 22.3 m -108.38 172.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 70.2 111.123 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.6 -57.61 2.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 64.05 110.865 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.19 140.43 51.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 71.24 110.859 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -48.78 118.87 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 65.15 110.906 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.39 131.15 27.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 72.25 111.125 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 32' ' ' THR . 3.0 t -94.68 106.58 18.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 71.13 111.146 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.541 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -140.09 147.77 40.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.03 111.052 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.777 HG23 ' HB3' ' A' ' 73' ' ' SER . 2.8 p -113.9 109.24 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.13 111.157 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.82 HG11 ' HG2' ' A' ' 98' ' ' LYS . 3.7 t -130.95 141.19 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 73.34 111.153 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.495 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 29.1 p -129.12 167.68 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.41 110.873 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.492 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -109.96 147.18 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 64.12 111.132 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.22 163.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 62.44 110.914 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.796 -0.716 . . . . 73.44 112.517 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.817 0.341 . . . . 72.2 110.905 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.12 128.59 46.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 52.33 111.104 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -102.45 124.49 48.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 75.01 110.905 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 71' ' ' SER . 0.9 OUTLIER -92.11 130.1 37.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.257 -0.429 . . . . 54.53 110.865 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -132.58 148.89 52.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.899 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -146.34 142.79 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 63.31 110.858 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.572 ' H ' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -151.91 117.72 5.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.926 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.52 123.92 20.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 64.4 111.115 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 -82.83 0.8 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 12.24 112.49 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.9 m -93.67 -179.19 4.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.952 0.406 . . . . 63.14 110.858 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 134.72 28.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 71.03 110.862 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 141.51 45.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 70.52 112.325 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -102.5 179.03 4.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 65.23 111.131 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.1 p -65.63 -13.7 59.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 54.11 111.145 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 m -121.36 -26.46 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 44.21 110.861 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.83 126.22 49.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 60.13 110.852 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.37 153.47 34.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 74.1 110.892 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -108.89 -29.11 8.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 75.53 110.844 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.9 m -136.93 124.0 21.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 60.33 110.88 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HG3' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -174.74 126.57 0.4 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.611 0.72 . . . . 73.54 110.904 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HD2' ' HG3' ' A' ' 62' ' ' ARG . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.158 0 C-N-CA 122.647 2.231 . . . . 63.43 112.363 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.803 0.335 . . . . 65.4 110.873 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.2 t30 63.94 19.63 11.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 73.41 110.862 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -123.16 88.74 2.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 75.02 110.907 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.614 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.5 m -132.23 170.16 15.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.54 110.852 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.24 154.01 34.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 55.23 110.899 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.777 ' HB3' HG23 ' A' ' 34' ' ' VAL . 89.7 p -128.25 104.19 7.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 74.04 110.834 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -152.22 152.73 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 72.52 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.1 p -84.32 104.39 14.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 75.03 110.884 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.767 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -81.68 154.72 25.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 74.41 111.066 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.39 139.71 20.42 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.629 0.728 . . . . 73.1 111.086 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.495 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.9 Cg_endo -69.78 140.03 41.62 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 53.02 112.328 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.26 -6.18 9.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.751 . . . . 73.25 112.51 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.5 m -126.41 129.6 49.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 73.21 111.127 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.48 ' HA ' HG22 ' A' ' 26' ' ' THR . 6.2 m -72.46 136.86 46.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 55.02 111.139 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.767 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 39.8 m-85 -111.88 134.44 53.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.936 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -106.07 162.76 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 62.41 110.863 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.634 HG21 ' CD ' ' A' ' 5' ' ' LYS . 73.2 t -134.79 140.0 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 54.24 111.129 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.13 121.07 14.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.11 110.894 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.604 HD11 HD22 ' A' ' 97' ' ' LEU . 14.8 mm -111.16 113.13 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 74.42 111.131 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 135.62 41.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 70.2 110.914 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.38 157.24 15.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.757 . . . . 61.05 112.486 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -117.12 -28.04 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.946 0.403 . . . . 73.21 110.904 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 91' ' ' ASN . 73.2 p -166.88 136.06 2.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 70.22 110.882 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 90' ' ' SER . 3.1 m120 -31.75 105.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 64.21 110.866 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -162.78 113.07 1.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 70.21 110.942 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.7 p -121.51 159.83 25.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 63.5 110.851 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.03 19.46 2.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.747 . . . . 74.21 112.532 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.42 141.45 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 65.14 111.169 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.7 m -99.32 122.84 43.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 60.23 111.141 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 86' ' ' ILE . 19.2 tp -102.04 142.7 32.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.877 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.82 ' HG2' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -151.22 153.0 34.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 72.35 110.946 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.644 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -88.52 140.85 29.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 73.12 110.895 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -93.9 113.66 25.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 74.05 110.889 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.732 ' CE1' HG11 ' A' ' 27' ' ' VAL . 4.9 t80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 71.33 110.959 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.836 0.351 . . . . 64.31 110.93 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.1 m -117.47 109.42 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 65.24 111.113 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.48 148.48 52.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 65.43 110.95 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.602 ' CD ' HD11 ' A' ' 97' ' ' LEU . 15.4 tptm -164.74 -65.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 64.43 110.914 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.635 ' OD1' HD22 ' A' ' 99' ' ' LEU . 8.4 t-20 -77.92 155.74 30.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 62.3 110.869 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 10.3 t-20 87.2 -68.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.22 110.867 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.5 m -121.5 120.89 28.64 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.594 0.712 . . . . 74.53 111.138 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 153.82 68.17 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.695 2.263 . . . . 73.43 112.327 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.6 t -83.21 115.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 73.25 111.076 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.07 142.25 31.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 75.32 110.864 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.28 86.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 74.21 110.906 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -79.88 -171.97 3.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 62.44 110.884 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 p -139.41 139.47 37.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 54.23 111.162 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.45 69.99 0.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 73.21 112.507 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -76.42 153.55 35.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 74.55 110.865 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.4 -34.29 23.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.879 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.66 -52.72 0.25 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 53.14 112.477 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 t -52.56 168.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 53.0 110.817 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.84 175.6 3.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 74.24 110.893 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -132.31 144.67 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 74.21 111.096 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -136.91 128.14 28.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 73.11 110.87 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -127.45 164.64 21.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 72.54 110.895 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.414 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 2.4 m -141.06 143.42 34.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 72.21 111.14 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -160.27 163.33 33.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 74.21 110.878 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.537 HG22 HG23 ' A' ' 81' ' ' THR . 18.8 p -132.5 170.31 15.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 54.21 111.117 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.511 HG11 ' HB1' ' A' ' 76' ' ' ALA . 13.6 m -109.2 167.47 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 72.42 111.12 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -97.43 -48.59 5.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.51 110.852 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 165.31 27.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 73.53 110.873 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -56.7 117.91 4.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 70.0 110.868 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.54 120.91 12.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 75.04 111.09 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 32' ' ' THR . 2.5 t -98.33 105.55 17.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 73.54 111.108 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.605 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -137.38 147.5 45.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 74.5 111.099 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.695 HG22 ' CB ' ' A' ' 73' ' ' SER . 96.8 t -108.49 110.6 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 62.15 111.137 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.432 HG11 ' HE3' ' A' ' 98' ' ' LYS . 21.7 t -127.3 141.11 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 64.01 111.12 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.48 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.62 166.49 17.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.45 110.851 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.44 147.33 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 73.4 111.168 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.93 172.09 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 62.13 110.85 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.764 -0.732 . . . . 51.05 112.512 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.833 0.349 . . . . 54.54 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.06 124.9 45.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.14 111.046 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.7 152.02 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 60.42 110.887 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.643 HD13 ' HA ' ' A' ' 71' ' ' SER . 2.4 tt -106.93 127.02 53.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 64.34 110.894 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -136.49 142.61 43.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.934 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -154.12 135.7 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 54.34 110.914 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.481 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.2 tttm -140.81 121.56 14.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.939 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.35 77.54 9.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.23 111.082 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.72 -59.98 0.3 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 62.31 112.454 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -142.21 141.78 32.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 51.55 110.834 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.73 120.15 1.4 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.574 0.702 . . . . 72.01 110.899 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 143.4 51.19 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.68 2.254 . . . . 55.31 112.38 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.35 178.31 4.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 65.32 111.138 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.0 p -61.48 -17.32 54.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 72.42 111.135 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 t -114.14 -26.86 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.844 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.86 123.49 47.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 72.25 110.891 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.23 153.58 32.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 74.53 110.945 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -110.71 -33.51 6.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.886 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.2 m -134.12 123.23 24.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 44.43 110.893 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -179.58 126.16 0.24 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 72.01 110.887 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.172 0 C-N-CA 122.74 2.293 . . . . 63.12 112.352 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.865 0.364 . . . . 74.35 110.872 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 67.11 13.59 9.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 74.32 110.836 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.05 101.97 6.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 73.55 110.844 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.643 ' HA ' HD13 ' A' ' 46' ' ' LEU . 10.6 m -133.75 175.02 9.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 73.24 110.876 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.66 158.76 24.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 54.21 110.916 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.695 ' CB ' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -127.64 113.89 16.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.863 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 t -146.38 158.37 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 73.21 111.143 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.9 p -78.33 129.63 35.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 50.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.734 ' HB2' ' CG ' ' A' ' 101' ' ' TYR . . . -78.9 151.54 31.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 73.13 111.051 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.05 121.57 18.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.556 0.693 . . . . 63.11 111.117 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 115.78 4.25 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.694 2.262 . . . . 74.54 112.331 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.96 -11.62 3.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 74.24 112.475 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.3 m -126.18 127.31 45.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.885 0.374 . . . . 63.31 111.092 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.537 HG23 HG22 ' A' ' 26' ' ' THR . 6.9 m -70.71 137.52 49.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 64.25 111.168 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -106.02 133.41 50.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 70.22 110.953 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -104.74 161.18 14.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 71.13 110.813 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.418 HG11 ' HE3' ' A' ' 5' ' ' LYS . 2.8 t -137.9 138.05 44.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 62.1 111.131 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -138.29 122.21 17.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 64.45 110.851 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 21' ' ' VAL . 26.8 mm -114.1 112.28 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 72.33 111.088 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.64 140.29 40.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 75.12 110.896 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -114.85 156.06 15.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.753 . . . . 63.03 112.464 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -114.34 -21.54 10.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.897 0.38 . . . . 71.13 110.921 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -161.35 128.2 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 64.13 110.874 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 90' ' ' SER . 15.2 t-20 -31.61 106.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 75.44 110.912 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -157.65 112.81 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 71.4 110.883 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 p -121.37 154.58 36.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.509 . . . . 55.02 110.835 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.46 20.88 2.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.716 -0.754 . . . . 75.24 112.492 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.26 147.23 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 74.12 111.177 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m -97.61 121.97 40.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 70.33 111.138 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.768 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -111.72 125.16 53.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 71.15 110.946 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.768 ' N ' HD22 ' A' ' 97' ' ' LEU . 8.5 ttpt -133.94 167.03 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 71.34 110.86 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -85.99 137.16 32.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.908 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.575 ' NE2' HD11 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -100.19 108.66 20.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 72.03 110.942 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.734 ' CG ' ' HB2' ' A' ' 76' ' ' ALA . 6.4 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.22 110.912 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.843 0.354 . . . . 74.2 110.918 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.7 m -116.52 108.2 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 73.33 111.142 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.65 149.14 52.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.31 110.907 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.648 ' CE ' HD11 ' A' ' 97' ' ' LEU . 19.8 tptm -164.05 -71.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 74.43 110.846 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 10.1 t-20 -68.32 157.8 34.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 73.42 110.912 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.3 t30 86.72 -68.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 70.14 110.943 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.5 m -125.15 119.68 25.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.537 0.685 . . . . 75.35 111.161 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 150.64 68.52 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.679 2.252 . . . . 74.45 112.372 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.411 ' HB ' HD21 ' A' ' 13' ' ' LEU . 60.9 t -77.99 115.77 20.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 71.41 111.119 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.59 143.9 31.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 64.44 110.835 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.23 80.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 60.14 110.879 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.411 HD21 ' HB ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -75.55 -172.77 1.93 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.477 . . . . 73.12 110.938 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 p -132.74 138.39 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.1 111.102 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.33 53.71 0.75 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.775 -0.726 . . . . 54.22 112.502 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -76.27 140.97 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 73.33 110.9 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -28.38 6.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.917 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.82 -64.61 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 62.23 112.443 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -52.22 134.14 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 62.41 110.844 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -131.21 172.58 11.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 73.1 110.894 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.465 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.22 138.53 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 72.03 111.109 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -136.66 147.08 46.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 73.31 110.894 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -143.59 164.82 29.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 73.03 110.926 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.442 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -138.28 139.77 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.18 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -159.53 162.8 35.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.855 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.694 ' CG2' HG23 ' A' ' 81' ' ' THR . 15.0 p -133.1 171.11 14.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 54.2 111.131 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -108.3 169.28 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.43 111.181 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -98.37 -48.86 4.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.898 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.67 173.34 11.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.841 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -80.0 117.2 20.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 74.13 110.913 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.11 144.59 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 72.05 111.086 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 32' ' ' THR . 2.3 t -104.59 106.4 16.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.425 . . . . 65.34 111.18 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.93 147.79 46.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 65.33 111.095 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -108.11 111.81 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 70.54 111.113 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.401 HG11 ' HG2' ' A' ' 98' ' ' LYS . 84.6 t -126.75 140.83 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 65.43 111.097 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.484 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 10.7 p -133.31 166.5 22.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 33.22 110.849 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.81 144.58 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 71.54 111.161 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.98 -174.99 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 72.32 110.901 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.75 -0.738 . . . . 51.21 112.523 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.847 0.356 . . . . 43.43 110.861 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.48 114.75 26.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 63.44 111.115 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.11 135.67 36.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 71.32 110.891 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' A' ' 71' ' ' SER . 4.6 tt -102.34 126.84 49.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 71.52 110.893 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -134.61 149.0 50.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.91 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.429 HD12 ' NE2' ' A' ' 100' ' ' GLN . 0.4 OUTLIER -155.14 133.32 11.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 54.32 110.954 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HG2' ' HB2' ' A' ' 60' ' ' ASP . 11.5 tttt -144.86 123.42 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.4 110.851 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.36 71.59 7.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.1 111.116 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.46 -83.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 75.1 112.481 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -110.54 141.57 43.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.365 . . . . 73.43 110.917 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.19 121.85 3.15 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.609 0.719 . . . . 74.25 110.864 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 142.49 48.1 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.712 2.275 . . . . 71.51 112.335 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -109.66 178.74 4.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 65.42 111.142 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.1 p -60.07 -17.7 41.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.159 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 t -114.8 -26.3 7.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.32 110.85 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.86 124.19 47.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 54.11 110.847 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.99 153.22 32.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.105 -0.498 . . . . 75.24 110.909 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB2' ' HG2' ' A' ' 49' ' ' LYS . 8.1 t70 -115.67 -35.33 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 72.42 110.856 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.8 m -143.76 125.12 14.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 72.43 110.854 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 179.65 157.08 0.72 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.658 0.742 . . . . 73.21 110.824 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.204 0 C-N-CA 122.661 2.24 . . . . 64.45 112.321 -179.999 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.862 0.363 . . . . 65.45 110.851 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.77 14.14 9.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.959 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.88 105.67 7.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 73.3 110.909 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.51 ' HA ' HD13 ' A' ' 46' ' ' LEU . 13.0 m -136.59 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 53.12 110.831 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.03 153.75 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 64.52 110.846 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 34' ' ' VAL . 1.1 p -128.24 110.28 12.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 62.13 110.901 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 t -149.31 153.11 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 73.35 111.119 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.4 p -73.3 110.85 7.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 63.32 110.854 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.441 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.4 130.79 35.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 53.44 111.103 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.33 139.23 20.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.59 0.709 . . . . 62.1 111.126 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 160.21 50.57 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.701 2.267 . . . . 74.44 112.328 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.5 -18.95 56.01 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.776 -0.726 . . . . 45.22 112.51 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 m -111.94 122.84 48.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.87 0.367 . . . . 71.25 111.163 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.694 HG23 ' CG2' ' A' ' 26' ' ' THR . 10.4 m -71.24 136.27 47.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 72.14 111.152 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.441 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 60.4 m-85 -103.76 141.68 35.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 72.24 110.928 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -107.36 160.75 15.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 71.04 110.837 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG11 ' HD3' ' A' ' 5' ' ' LYS . 2.4 t -138.19 138.36 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 73.34 111.108 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.89 122.98 13.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 71.42 110.88 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.465 ' HB ' HG23 ' A' ' 21' ' ' VAL . 18.0 mm -118.04 112.6 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.24 111.139 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -104.48 130.44 52.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.906 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.37 161.03 21.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 53.21 112.452 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.25 -28.59 5.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 72.5 110.923 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.51 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -166.56 132.64 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 64.23 110.817 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 90' ' ' SER . 1.5 p-10 -28.35 115.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 72.55 110.878 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.4 113.85 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.41 110.94 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 p -121.55 156.59 32.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 72.42 110.847 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.02 23.12 1.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 75.43 112.489 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.04 145.98 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.962 0.41 . . . . 75.02 111.098 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.7 m -99.29 114.73 27.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 53.4 111.137 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.769 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -104.69 125.58 50.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 63.03 110.931 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.769 ' N ' HD22 ' A' ' 97' ' ' LEU . 5.1 ttpt -133.41 165.09 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 74.11 110.934 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.59 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.46 138.5 31.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.41 110.92 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.438 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 1.4 pm0 -98.87 112.84 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 73.44 110.93 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.9 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 60.53 110.929 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.856 0.36 . . . . 73.31 110.912 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.9 m -118.46 108.57 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 75.55 111.15 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.58 147.84 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 63.24 110.978 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.444 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 17.9 tptt -158.49 -39.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.871 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.638 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -108.24 158.1 17.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 72.41 110.95 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 5.9 t30 90.04 -68.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.34 110.883 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.4 m -126.34 113.83 23.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.576 0.703 . . . . 72.31 111.135 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.7 Cg_endo -69.78 153.51 68.76 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.658 2.239 . . . . 73.13 112.372 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.25 113.18 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 75.22 111.124 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.11 149.4 28.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 72.44 110.864 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 47.33 66.59 0.97 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 74.51 110.86 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -67.05 -174.16 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 74.12 110.902 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 p -131.14 138.24 49.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 73.34 111.188 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.64 57.19 0.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 74.21 112.489 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -75.65 139.35 41.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 34.13 110.921 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -27.6 7.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.87 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.12 -60.63 0.5 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 73.4 112.479 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.84 140.68 51.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 55.22 110.872 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -135.85 170.26 16.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.915 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.577 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.46 139.11 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 75.24 111.111 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -137.01 145.17 43.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 73.11 110.886 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -142.09 165.84 26.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.923 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.426 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 51.9 m -146.12 142.12 28.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 72.23 111.148 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 4.1 t80 -160.49 162.56 33.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 71.13 110.917 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.623 HG22 HG23 ' A' ' 81' ' ' THR . 18.1 p -128.88 170.44 13.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 71.32 111.164 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.754 HG11 ' CE1' ' A' ' 101' ' ' TYR . 15.9 m -108.12 173.26 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 63.43 111.146 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -110.44 -59.32 1.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.845 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.64 140.9 51.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 64.1 110.855 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -50.15 119.91 4.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.844 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.36 129.86 25.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.33 111.074 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 75' ' ' SER . 21.2 m -94.28 106.17 18.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 63.44 111.156 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.621 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -140.87 150.97 43.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.51 111.155 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.4 p -103.75 112.04 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 73.43 111.143 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.551 HG11 ' CG ' ' A' ' 98' ' ' LYS . 5.3 t -127.17 141.79 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 54.2 111.1 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 8.0 p -142.09 171.45 14.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 43.34 110.87 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.689 HD13 HD12 ' A' ' 46' ' ' LEU . 5.3 pt -107.04 158.69 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 74.24 111.128 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.56 165.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 73.24 110.88 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 64.44 112.524 -179.98 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.804 0.335 . . . . 71.11 110.868 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.68 111.58 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 44.31 111.11 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -80.26 164.55 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 55.23 110.819 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.689 HD12 HD13 ' A' ' 37' ' ' ILE . 8.5 tt -124.18 138.43 54.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 72.25 110.879 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.524 ' N ' HD23 ' A' ' 46' ' ' LEU . 94.9 m-85 -152.63 133.58 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 73.11 110.932 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp -139.26 153.02 47.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 62.33 110.904 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -156.36 145.99 20.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 75.24 110.912 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.66 101.56 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 61.2 111.086 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.84 -92.98 0.75 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 41.14 112.517 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 m -82.83 129.26 34.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.994 0.426 . . . . 61.1 110.837 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.44 137.12 5.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.554 0.692 . . . . 73.1 110.912 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.73 51.74 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.672 2.248 . . . . 73.41 112.33 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -101.38 178.54 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 74.22 111.155 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 p -64.94 -14.39 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 71.32 111.16 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.5 t -120.31 -26.14 5.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 60.2 110.899 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.75 125.48 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 74.43 110.876 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.64 153.59 34.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.925 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -110.71 -23.17 11.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 64.41 110.821 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.0 m -143.64 122.71 12.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 64.21 110.867 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 177.9 117.26 0.18 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 65.44 110.903 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HG2' ' CG ' ' A' ' 70' ' ' GLU . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.174 0 C-N-CA 122.671 2.247 . . . . 73.31 112.36 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.809 0.338 . . . . 65.53 110.899 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.6 t30 53.79 27.9 7.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 70.33 110.923 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.4 ' CG ' ' HG2' ' A' ' 63' ' ' PRO . 3.3 tt0 -131.15 81.27 1.98 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 64.25 110.876 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.654 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -132.51 170.75 14.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 72.23 110.877 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -119.28 156.91 29.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 35.21 110.898 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.455 ' HB3' HG23 ' A' ' 34' ' ' VAL . 81.0 p -128.94 106.77 9.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 73.03 110.87 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -151.75 153.25 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 62.22 111.12 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.446 ' HB3' HG23 ' A' ' 32' ' ' THR . 83.8 p -84.93 107.68 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.888 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.683 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.09 154.9 25.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 60.31 111.077 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.17 138.57 19.56 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.549 0.69 . . . . 72.21 111.134 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.525 ' HA ' HG23 ' A' ' 27' ' ' VAL . 54.0 Cg_endo -69.72 134.23 27.56 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.694 2.262 . . . . 71.04 112.388 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.9 -21.98 4.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 23.15 112.505 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -114.3 131.68 56.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 72.13 111.142 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.623 HG23 HG22 ' A' ' 26' ' ' THR . 4.8 m -71.95 137.38 47.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 73.33 111.186 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.683 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 62.6 m-85 -112.05 133.0 54.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 75.34 110.921 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -107.08 161.19 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 52.41 110.892 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.416 HG21 ' HB2' ' A' ' 5' ' ' LYS . 2.1 t -137.08 138.35 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 74.45 111.148 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 tpt -134.82 122.84 22.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.876 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 21' ' ' VAL . 25.3 mm -112.5 116.01 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 74.31 111.134 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 145.54 29.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 62.33 110.864 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.45 151.74 18.23 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 71.42 112.457 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -107.33 -28.13 10.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 72.21 110.878 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.466 ' O ' ' C ' ' A' ' 91' ' ' ASN . 88.5 p -175.37 144.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 52.42 110.877 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 90' ' ' SER . 3.0 p30 -32.64 105.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.492 . . . . 63.41 110.942 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -166.77 118.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.897 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.9 p -122.01 160.82 24.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 61.33 110.852 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.36 23.44 2.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 44.33 112.475 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.528 ' O ' HD12 ' A' ' 13' ' ' LEU . 3.1 t -113.81 146.58 18.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.887 0.375 . . . . 64.35 111.156 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -106.86 135.06 49.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 72.33 111.146 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.699 ' C ' HD13 ' A' ' 97' ' ' LEU . 2.5 tm? -118.58 128.03 54.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 64.43 110.866 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.551 ' CG ' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -138.12 154.65 49.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 62.23 110.929 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.644 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -87.3 145.1 26.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 62.23 110.904 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.487 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -94.86 112.98 24.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 72.44 110.978 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.754 ' CE1' HG11 ' A' ' 27' ' ' VAL . 2.3 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.926 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.3 m120 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.834 0.349 . . . . 64.52 110.894 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.413 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.4 m -121.77 109.16 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 70.42 111.135 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.27 149.01 52.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 72.42 110.916 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.628 ' HE3' HD11 ' A' ' 97' ' ' LEU . 2.2 tppm? -155.73 -73.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 65.0 110.907 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.8 t-20 -64.22 158.66 22.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.03 110.874 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.6 t30 91.21 -68.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 73.55 110.886 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 m -132.71 121.79 17.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.576 0.703 . . . . 51.53 111.155 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.658 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.7 Cg_endo -69.8 154.85 67.1 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 71.51 112.341 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.44 115.36 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 73.33 111.136 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.49 166.39 13.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 70.0 110.872 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 39.97 52.05 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 73.34 110.876 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.758 HD11 ' CB ' ' A' ' 97' ' ' LEU . 2.4 mt -57.84 -178.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 71.31 110.944 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 p -137.19 138.15 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 61.22 111.078 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.66 56.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.751 . . . . 35.25 112.493 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -74.79 150.96 39.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 74.54 110.902 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.71 -33.49 10.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.872 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.59 -57.84 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 75.42 112.496 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.77 139.04 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 72.11 110.863 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -139.01 175.01 9.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 62.13 110.907 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.573 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.97 135.65 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 62.23 111.158 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -138.87 149.81 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.2 110.902 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -145.96 166.36 26.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 74.33 110.929 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.499 HG23 ' CD2' ' A' ' 83' ' ' HIS . 58.5 m -138.75 138.91 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 64.13 111.142 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CB ' ' HB3' ' A' ' 5' ' ' LYS . 2.3 t80 -160.94 153.17 20.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 74.44 110.915 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 81' ' ' THR . 10.9 p -127.92 170.44 12.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 71.11 111.14 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' A' ' 101' ' ' TYR . 13.9 m -113.02 170.83 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 64.54 111.109 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.15 11.45 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 65.53 110.84 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.58 137.79 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 74.45 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.406 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 3.0 p30 -72.85 118.85 16.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 64.03 110.871 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.31 145.57 37.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 61.13 111.094 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 32' ' ' THR . 1.8 t -107.92 104.95 14.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 72.14 111.1 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 101' ' ' TYR . . . -139.57 149.1 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.35 111.117 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.624 HG22 ' CB ' ' A' ' 73' ' ' SER . 90.9 t -113.63 111.85 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 63.54 111.113 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.01 140.86 47.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 53.3 111.078 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.507 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 6.0 p -124.86 166.74 15.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 60.04 110.826 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.47 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -111.21 151.07 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 71.35 111.136 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.53 168.0 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.866 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 53.42 112.499 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.847 0.356 . . . . 63.55 110.867 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.65 117.16 29.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 74.31 111.109 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -85.23 163.83 18.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 73.44 110.889 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.68 HD13 ' HA ' ' A' ' 71' ' ' SER . 6.3 tt -120.31 127.56 52.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.01 110.924 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -137.63 153.23 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 62.22 110.889 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 49' ' ' LYS . 1.5 tt -154.34 140.46 18.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 75.31 110.923 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.591 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -148.17 141.55 25.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 75.21 110.923 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.35 126.97 35.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 44.42 111.11 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.85 -61.02 0.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 54.33 112.527 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.75 -173.03 2.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.955 0.407 . . . . 63.43 110.837 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 134.13 30.56 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.566 0.698 . . . . 53.12 110.925 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 143.38 50.82 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.708 2.272 . . . . 74.12 112.32 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 p -104.49 178.71 4.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 65.54 111.123 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.9 p -64.03 -15.14 58.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 70.25 111.168 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.0 m -119.84 -26.06 5.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.864 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.11 126.08 48.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 72.11 110.843 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.99 154.03 36.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 72.1 110.888 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -115.88 -34.52 4.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 72.05 110.864 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.2 m -145.39 124.42 12.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 65.22 110.886 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.16 150.18 1.23 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 74.45 110.921 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.231 0.159 0 C-N-CA 122.714 2.276 . . . . 41.32 112.318 -179.977 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.813 0.339 . . . . 61.04 110.918 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.99 16.06 9.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 65.31 110.873 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -127.44 96.88 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 71.15 110.87 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.68 ' HA ' HD13 ' A' ' 46' ' ' LEU . 1.4 m -134.78 170.73 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 54.02 110.91 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.79 162.62 19.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 71.35 110.863 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.624 ' CB ' HG22 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -131.37 111.62 12.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 75.12 110.886 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.7 t -149.11 153.65 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 72.01 111.171 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.3 p -94.28 105.74 17.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 65.44 110.913 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.785 ' HB3' ' CD2' ' A' ' 101' ' ' TYR . . . -86.39 152.19 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 75.54 111.08 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.21 142.73 26.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.572 0.701 . . . . 71.02 111.119 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.3 Cg_endo -69.78 120.57 7.33 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 73.52 112.308 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.6 -19.94 0.9 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 32.23 112.465 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 m -122.76 136.57 54.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.372 . . . . 64.04 111.11 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.54 ' HA ' HG22 ' A' ' 26' ' ' THR . 62.5 m -71.77 138.02 48.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 72.44 111.109 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -118.3 142.84 47.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.927 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.499 ' CD2' HG23 ' A' ' 24' ' ' THR . 13.9 m-70 -121.94 160.76 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 74.21 110.88 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.551 HG11 ' HE3' ' A' ' 5' ' ' LYS . 16.5 t -133.45 125.31 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.54 111.173 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.65 128.98 55.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 71.32 110.886 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.573 ' HB ' HG23 ' A' ' 21' ' ' VAL . 34.0 mm -118.41 114.01 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 73.03 111.128 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.15 150.17 21.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 70.35 110.897 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -112.16 160.75 13.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 74.43 112.481 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -119.0 -24.56 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.918 0.389 . . . . 63.25 110.955 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 91' ' ' ASN . 52.1 p -176.77 144.13 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 54.31 110.87 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 90' ' ' SER . 42.4 t30 -32.69 106.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 74.31 110.893 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -166.54 115.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 74.32 110.903 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.1 p -121.76 155.35 35.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 63.45 110.838 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.05 26.74 1.82 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 62.25 112.508 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.417 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.2 t -113.91 139.62 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 73.3 111.122 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.658 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -100.58 114.89 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 52.51 111.153 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.799 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -105.13 128.64 53.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.909 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.799 ' N ' HD22 ' A' ' 97' ' ' LEU . 1.5 ttpt -133.34 171.2 14.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 51.51 110.91 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.755 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -88.14 137.47 32.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 71.45 110.952 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.463 ' C ' ' HD1' ' A' ' 101' ' ' TYR . 1.8 pp0? -108.76 112.58 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 70.4 110.908 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 5.1 m-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 74.55 110.946 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.842 0.353 . . . . 73.31 110.883 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.42 ' HB ' ' H ' ' A' ' 24' ' ' THR . 1.9 m -118.15 109.49 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.14 111.128 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.32 147.61 52.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 72.34 110.932 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.658 ' HE3' HG11 ' A' ' 84' ' ' VAL . 8.8 tptp -158.78 -69.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 74.23 110.895 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.688 ' CG ' HD22 ' A' ' 99' ' ' LEU . 17.0 t-20 -76.08 158.23 32.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.91 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.0 t-20 88.58 -68.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 72.52 110.902 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 m -125.28 115.02 25.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.599 0.714 . . . . 73.23 111.143 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.5 Cg_endo -69.76 150.24 67.97 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.663 2.242 . . . . 72.23 112.331 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.411 ' HB ' HD13 ' A' ' 13' ' ' LEU . 21.2 t -77.6 113.51 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 74.54 111.095 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.7 147.8 30.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 64.53 110.859 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.66 64.36 1.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 72.51 110.932 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 13' ' ' LEU . 5.0 tp -58.95 -175.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 61.23 110.897 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 p -136.09 139.29 42.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 75.34 111.128 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.83 60.48 0.58 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 43.34 112.458 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -76.48 138.71 40.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.896 0.379 . . . . 62.32 110.925 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -29.1 8.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 75.03 110.902 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.13 -62.08 0.46 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 65.13 112.49 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.6 m -60.67 151.44 29.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.887 0.375 . . . . 75.42 110.807 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.31 179.4 8.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 63.53 110.904 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.437 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.71 149.18 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 61.54 111.109 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -136.78 134.85 37.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 73.35 110.853 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.9 165.48 25.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 73.54 110.931 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.42 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 55.3 m -147.92 141.72 25.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.497 . . . . 74.04 111.154 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 2.1 t80 -159.34 163.28 35.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.89 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.695 ' CG2' HG23 ' A' ' 81' ' ' THR . 14.2 p -131.41 170.98 13.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 52.24 111.186 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 76' ' ' ALA . 26.9 m -106.91 169.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 71.23 111.131 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -108.42 -47.1 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 62.25 110.855 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -129.73 155.47 45.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.897 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -77.42 115.7 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 62.32 110.859 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.45 145.89 34.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 64.22 111.108 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 32' ' ' THR . 2.7 t -99.25 107.31 19.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.32 111.121 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.594 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -137.06 148.8 47.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 51.13 111.099 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 73' ' ' SER . 2.9 p -105.78 111.07 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 75.11 111.169 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.609 HG11 ' HG2' ' A' ' 98' ' ' LYS . 9.9 t -127.06 140.4 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 51.41 111.15 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.534 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 0.1 OUTLIER -139.6 169.02 18.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 72.15 110.873 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.708 HG21 HD12 ' A' ' 97' ' ' LEU . 1.3 pt -110.14 159.36 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 72.33 111.165 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 171.17 167.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 72.03 110.889 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 55.23 112.49 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.825 0.345 . . . . 65.34 110.838 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.565 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -90.44 123.88 34.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 61.32 111.119 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -80.35 147.31 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.879 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.54 HD12 HD13 ' A' ' 37' ' ' ILE . 7.0 tt -113.49 127.08 55.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 61.22 110.932 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.73 148.56 44.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 75.44 110.932 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 82' ' ' TYR . 0.5 OUTLIER -154.15 132.93 12.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 74.31 110.882 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.486 ' HG3' ' HB3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -144.71 131.12 19.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 72.13 110.894 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HB1' HG21 ' A' ' 80' ' ' THR . . . -65.53 -66.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 72.51 111.128 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -45.36 -90.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 61.34 112.49 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.18 -168.59 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 74.23 110.895 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 132.88 87.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 63.34 110.887 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HB3' ' HG3' ' A' ' 49' ' ' LYS . 53.6 Cg_endo -69.75 140.71 43.39 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 60.32 112.351 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.18 178.75 4.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 62.41 111.146 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -66.41 -13.1 60.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 71.53 111.173 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -124.08 -25.97 4.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.14 110.87 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.52 124.37 47.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 74.21 110.868 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.73 153.87 33.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.489 . . . . 74.11 110.896 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -102.02 -31.75 10.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 72.14 110.885 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.8 m -140.24 122.67 16.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 74.05 110.876 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -176.11 134.44 0.44 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 65.15 110.854 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--O 1.231 0.159 0 C-N-CA 122.634 2.223 . . . . 72.11 112.341 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.751 ' ND2' HG21 ' A' ' 95' ' ' VAL . 41.6 m-80 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.857 0.36 . . . . 71.34 110.896 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 61.5 28.03 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.915 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.65 89.92 2.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 65.53 110.877 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.534 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -129.05 172.6 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 60.31 110.883 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.19 162.07 18.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.119 -0.491 . . . . 74.42 110.881 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.726 ' HB3' HG23 ' A' ' 34' ' ' VAL . 32.3 p -128.51 109.14 11.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 55.02 110.847 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.98 152.99 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 74.34 111.114 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.8 p -80.53 113.82 18.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 72.1 110.839 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.73 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.29 131.04 35.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 34.23 111.091 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.74 136.49 22.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.594 0.711 . . . . 73.15 111.077 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 124.92 11.55 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 73.11 112.355 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.73 -18.55 2.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 73.31 112.516 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.461 HG21 ' HB1' ' A' ' 50' ' ' ALA . 39.7 m -125.6 131.51 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 52.53 111.149 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.695 HG23 ' CG2' ' A' ' 26' ' ' THR . 10.8 m -72.44 137.63 46.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 54.12 111.149 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.73 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 52.9 m-85 -107.81 131.65 54.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 70.11 110.957 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -107.14 158.96 16.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 65.14 110.867 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.658 HG11 ' HE3' ' A' ' 5' ' ' LYS . 67.8 t -137.71 138.17 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 62.34 111.157 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.3 tpt -129.03 121.54 28.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 64.52 110.847 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.449 HG23 ' HB1' ' A' ' 44' ' ' ALA . 25.3 mm -109.63 114.41 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 65.32 111.158 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -109.12 139.86 43.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 73.24 110.915 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.88 150.05 16.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 75.13 112.46 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -117.81 -17.07 9.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.878 0.37 . . . . 71.34 110.946 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -177.89 129.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 72.11 110.867 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 90' ' ' SER . 54.5 t-20 -29.62 109.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 63.15 110.844 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -166.5 112.72 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 72.4 110.925 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.1 p -120.71 166.42 13.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 54.55 110.844 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.9 23.07 4.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.747 -0.739 . . . . 41.43 112.471 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.751 HG21 ' ND2' ' A' ' 68' ' ' ASN . 9.6 t -113.29 148.34 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 65.11 111.107 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.3 m -106.68 126.17 51.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 71.32 111.161 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 37' ' ' ILE . 3.4 tp -108.4 135.13 50.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 63.14 110.896 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.609 ' HG2' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -144.79 154.63 42.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.884 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.688 HD22 ' CG ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -88.7 144.65 26.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 71.53 110.906 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.481 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -94.13 112.85 24.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 61.41 110.88 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.594 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 15.0 p90 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 64.24 110.947 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.895 0.379 . . . . 74.55 110.884 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.428 ' HB ' ' H ' ' A' ' 24' ' ' THR . 1.9 m -117.94 107.96 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 74.03 111.138 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.975 HD12 HG22 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -133.34 149.0 51.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.0 110.905 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.679 ' HZ3' HD11 ' A' ' 97' ' ' LEU . 13.4 tptt -174.65 -74.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 62.01 110.921 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.613 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -70.13 153.17 43.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 72.24 110.858 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.2 t30 78.07 -58.88 0.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 64.31 110.906 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.5 m -122.75 119.32 28.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.615 0.722 . . . . 74.1 111.125 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 137.93 36.7 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.701 2.267 . . . . 71.1 112.357 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.975 HG22 HD12 ' A' ' 4' ' ' LEU . 46.4 t -77.27 114.93 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 72.21 111.17 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 p -87.62 163.2 16.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 41.54 110.859 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 40.18 64.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 74.35 110.888 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.552 HD22 HG12 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -64.35 -164.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 72.3 110.911 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.422 ' H ' HD12 ' A' ' 13' ' ' LEU . 3.5 p -147.4 136.73 22.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 63.13 111.145 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.4 67.17 0.47 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 75.3 112.452 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -76.05 135.49 39.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 63.42 110.912 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -30.64 23.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 61.4 110.944 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.34 -46.71 0.98 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 74.41 112.491 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.15 160.83 27.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 74.02 110.872 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -143.95 169.02 18.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 70.01 110.893 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.466 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -131.14 150.53 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.24 111.089 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -138.85 151.34 46.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.52 110.893 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -148.95 166.65 27.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 74.41 110.906 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.428 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 10.7 m -148.59 140.67 23.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 52.41 111.106 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -160.74 162.71 32.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 72.1 110.854 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.436 ' CG2' HG23 ' A' ' 81' ' ' THR . 17.1 p -131.09 170.66 14.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 54.23 111.127 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 78' ' ' PRO . 17.5 m -108.27 170.01 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 75.43 111.122 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.46 -50.8 3.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 35.0 110.849 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 167.12 21.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 72.55 110.925 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -80.19 115.52 19.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 70.04 110.911 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.2 141.91 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 70.31 111.12 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 32' ' ' THR . 2.9 t -94.7 106.28 18.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.11 111.149 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.26 149.21 45.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.24 111.127 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.723 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.5 p -105.49 112.56 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 62.04 111.145 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.737 HG11 ' HG2' ' A' ' 98' ' ' LYS . 20.9 t -123.72 140.52 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.12 111.078 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.509 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 11.6 p -139.97 165.48 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 44.43 110.868 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.841 HG21 HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -111.77 154.64 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 73.22 111.124 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -167.51 153.11 7.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.4 110.827 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 95' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 60.33 112.529 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.825 0.345 . . . . 51.33 110.861 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.547 ' HB1' HG23 ' A' ' 86' ' ' ILE . . . -89.54 131.53 35.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 71.11 111.119 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.52 133.33 35.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 61.14 110.906 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 71' ' ' SER . 2.4 tt -92.93 138.14 31.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 61.42 110.87 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -152.42 143.04 22.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 70.33 110.947 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -150.68 146.68 26.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 63.11 110.929 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' H ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -156.05 112.12 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 72.44 110.904 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.35 119.35 7.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 75.35 111.121 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.21 -81.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.734 . . . . 73.22 112.485 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.6 p -99.14 -174.28 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.965 0.412 . . . . 74.35 110.83 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.58 133.76 27.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.692 . . . . 70.23 110.892 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 141.69 45.72 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.711 2.274 . . . . 61.25 112.293 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 p -102.29 178.96 4.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 73.3 111.124 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 p -65.24 -14.39 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 75.11 111.163 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.2 m -120.03 -26.68 5.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 63.53 110.879 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.07 126.38 50.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 70.32 110.832 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.15 154.02 36.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 74.25 110.939 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.43 -31.86 6.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.423 . . . . 73.22 110.819 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.7 m -142.06 123.14 14.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 53.32 110.853 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 176.44 134.48 0.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.562 0.696 . . . . 75.54 110.904 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.268 . . . . 73.2 112.346 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.596 ' HB3' HG11 ' A' ' 95' ' ' VAL . 7.7 p30 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.858 0.361 . . . . 60.41 110.893 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 66.33 10.63 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 74.14 110.902 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.461 ' H ' HD11 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -126.47 91.33 3.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 70.41 110.912 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.509 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -133.8 171.66 13.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 73.35 110.853 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.45 157.94 27.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 64.41 110.877 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.723 ' HB3' HG23 ' A' ' 34' ' ' VAL . 2.6 p -128.41 109.57 11.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 53.3 110.867 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.8 t -150.13 152.82 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 72.41 111.133 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 85.6 p -74.1 104.57 4.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 72.42 110.826 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.27 131.41 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 71.33 111.105 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.92 142.25 24.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.561 0.696 . . . . 53.32 111.139 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.473 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.5 Cg_endo -69.71 162.06 43.52 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.741 2.294 . . . . 33.42 112.343 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.14 -21.69 42.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.792 -0.718 . . . . 74.23 112.488 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -106.77 123.63 48.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 65.22 111.146 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.436 HG23 ' CG2' ' A' ' 26' ' ' THR . 2.4 m -71.49 135.0 46.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 73.51 111.134 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.46 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 50.9 m-85 -108.68 133.69 52.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.905 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -109.17 147.79 31.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 73.33 110.855 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG11 HD21 ' A' ' 97' ' ' LEU . 3.2 t -123.54 138.81 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 63.11 111.136 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.81 122.41 25.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.858 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.547 HG23 ' HB1' ' A' ' 44' ' ' ALA . 15.5 mm -114.83 111.65 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 72.34 111.115 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 -65.11 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.907 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 44' ' ' ALA . . . 114.39 -146.84 18.76 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 73.33 112.482 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -175.78 -57.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.898 0.38 . . . . 73.42 110.932 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' ASN . 3.0 p -144.85 128.0 16.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 73.43 110.865 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 90' ' ' SER . 34.6 t30 -33.86 104.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 74.44 110.919 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.15 139.46 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.905 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.4 p -122.52 157.22 32.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 72.41 110.85 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 135.95 25.31 0.49 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.761 -0.733 . . . . 63.11 112.504 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.596 HG11 ' HB3' ' A' ' 68' ' ' ASN . 1.3 t -113.64 147.35 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.925 0.393 . . . . 72.22 111.098 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 1.3 m -106.17 112.81 26.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 73.04 111.181 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.841 HD12 HG21 ' A' ' 37' ' ' ILE . 5.2 tp -102.91 142.56 33.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 72.22 110.936 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.737 ' HG2' HG11 ' A' ' 35' ' ' VAL . 6.4 ttpt -153.74 161.99 41.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 71.11 110.865 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.613 HD22 ' HB2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -91.41 143.81 26.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.23 110.929 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.496 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.31 110.88 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 71.23 110.883 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.557 ' HB3' HD21 ' A' ' 99' ' ' LEU . 35.9 p90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 74.55 110.963 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.4 m120 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.861 0.363 . . . . 75.14 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.428 ' HB ' ' H ' ' A' ' 24' ' ' THR . 1.8 m -115.12 109.19 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 72.52 111.115 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.14 148.34 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 74.54 110.923 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.68 ' HE3' HG11 ' A' ' 84' ' ' VAL . 1.7 tppm? -165.19 -74.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 70.05 110.919 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -63.96 155.18 31.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 73.14 110.893 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.2 t-20 88.23 -61.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 70.32 110.886 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 m -130.09 120.38 19.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 73.1 111.185 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.0 Cg_endo -69.79 153.38 68.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 41.45 112.341 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -85.22 114.23 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 75.34 111.188 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 p -88.69 167.45 13.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 61.52 110.856 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 p30 40.5 53.23 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 70.13 110.87 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -54.75 178.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 55.22 110.905 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -135.37 138.08 42.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.35 111.112 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.47 68.91 0.53 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.759 . . . . 65.42 112.477 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -76.42 138.43 40.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 73.0 110.897 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -17.11 38.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 72.12 110.874 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.15 -41.44 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.805 -0.712 . . . . 64.14 112.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 m -90.68 168.66 11.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 73.55 110.929 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.0 -176.37 5.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 71.35 110.933 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.87 144.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.072 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -138.5 149.63 45.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 74.4 110.875 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -147.9 166.52 27.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 74.5 110.941 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.428 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 63.4 m -143.76 139.46 29.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 71.3 111.16 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -159.27 160.55 35.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 51.31 110.895 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.756 HG22 HG23 ' A' ' 81' ' ' THR . 10.9 p -129.88 171.76 12.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 71.14 111.114 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 78' ' ' PRO . 32.2 m -106.61 170.63 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 72.45 111.094 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -113.03 -41.58 3.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 74.22 110.888 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 158.6 39.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 65.04 110.851 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -80.53 115.2 19.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 74.11 110.842 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.19 140.3 30.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 53.35 111.119 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 32' ' ' THR . 2.8 t -95.71 105.93 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 72.25 111.127 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.97 148.58 45.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 63.53 111.143 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.696 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.1 p -106.63 111.47 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 71.34 111.116 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.91 140.14 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.138 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.51 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 92.9 p -142.72 167.72 21.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 54.33 110.831 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -108.87 144.14 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 44.21 111.114 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p -178.01 166.77 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 74.45 110.871 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.761 -0.733 . . . . 71.12 112.484 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.859 0.361 . . . . 55.23 110.883 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.52 ' HB1' ' CG2' ' A' ' 86' ' ' ILE . . . -91.81 110.65 21.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 51.44 111.106 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -72.44 155.55 39.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 71.22 110.886 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.74 HD22 ' HA ' ' A' ' 71' ' ' SER . 1.2 tt -127.55 138.28 52.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 72.21 110.938 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.547 ' CZ ' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -146.7 146.14 30.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.919 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.26 152.68 47.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 74.22 110.903 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -153.35 115.71 4.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 71.03 110.874 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 80' ' ' THR . . . -65.27 120.97 13.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 42.45 111.075 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.82 -76.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 75.43 112.452 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 t -107.82 -179.53 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 63.12 110.853 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.02 133.68 40.61 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.553 0.692 . . . . 72.35 110.917 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 143.92 52.15 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 71.41 112.339 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.19 179.03 4.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 71.24 111.148 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -67.79 -12.46 60.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 71.31 111.184 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 m -120.96 -28.28 4.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 51.23 110.885 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.19 124.01 48.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 73.15 110.817 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -152.86 153.99 34.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 72.43 110.941 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -107.15 -35.29 6.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 70.41 110.888 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.5 m -127.9 123.92 36.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 41.23 110.853 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -175.22 120.39 0.33 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.658 0.742 . . . . 71.15 110.877 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.26 . . . . 73.31 112.357 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.629 ' ND2' HG11 ' A' ' 95' ' ' VAL . 24.6 m120 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.812 0.339 . . . . 75.05 110.889 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 72.01 16.28 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.42 110.888 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.42 103.75 5.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 64.11 110.86 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.74 ' HA ' HD22 ' A' ' 46' ' ' LEU . 2.3 m -134.32 174.68 10.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 74.42 110.855 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.67 152.54 32.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 63.44 110.893 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.696 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.1 p -127.73 111.51 13.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 45.5 110.851 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 t -149.28 152.29 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 65.13 111.141 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.9 p -71.71 106.9 4.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 75.42 110.908 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.3 131.48 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.34 111.093 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.32 142.58 24.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.594 0.712 . . . . 75.44 111.07 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.515 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.7 Cg_endo -69.75 126.37 13.24 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.747 2.298 . . . . 75.03 112.345 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.57 -27.13 3.41 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.711 -0.757 . . . . 72.41 112.467 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.561 HG21 ' HB1' ' A' ' 50' ' ' ALA . 16.4 m -106.53 124.64 49.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 60.12 111.135 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.756 HG23 HG22 ' A' ' 26' ' ' THR . 9.2 m -71.55 138.06 48.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 74.15 111.108 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.523 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 40.6 m-85 -112.15 150.5 30.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 71.23 110.901 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -131.56 145.16 51.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 73.03 110.873 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.68 HG11 ' HE3' ' A' ' 5' ' ' LYS . 14.9 t -121.96 133.59 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 61.21 111.092 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.403 ' O ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -126.8 133.54 50.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.41 110.832 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.52 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 30.4 mm -119.31 134.53 62.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 64.12 111.133 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.499 ' HB3' ' OH ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -140.23 113.47 8.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 73.03 110.883 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.09 161.2 25.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 75.44 112.517 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.75 -29.18 13.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.889 0.376 . . . . 72.51 110.908 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.494 ' O ' ' C ' ' A' ' 91' ' ' ASN . 54.6 p -156.12 137.37 13.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 73.23 110.819 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 90' ' ' SER . 70.4 m-20 -30.32 109.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 45.45 110.907 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -160.42 118.8 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 63.3 110.911 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.8 p -122.71 156.43 34.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.853 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.08 23.76 2.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 53.22 112.525 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.629 HG11 ' ND2' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -112.99 147.08 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.901 0.381 . . . . 44.32 111.148 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -105.23 124.75 50.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 71.51 111.115 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HB3' HD11 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -116.07 143.03 46.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 72.1 110.958 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -149.27 168.69 22.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.23 110.867 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.56 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -91.03 142.69 27.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.951 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.502 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.51 111.52 23.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 65.43 110.912 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.536 ' HB3' HD21 ' A' ' 99' ' ' LEU . 25.9 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 71.04 110.913 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 m120 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.821 0.343 . . . . 72.45 110.939 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 24' ' ' THR . 3.5 m -123.57 109.02 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.43 111.138 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.18 150.18 52.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 75.24 110.903 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.484 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -155.56 -77.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.863 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.9 t-20 -66.22 159.2 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 62.23 110.865 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.5 t-20 89.59 -70.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 65.02 110.859 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -133.35 118.32 14.86 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.556 0.694 . . . . 64.32 111.143 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.672 ' HB2' HG22 ' A' ' 96' ' ' THR . 54.1 Cg_endo -69.81 155.86 64.71 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.688 2.259 . . . . 51.12 112.324 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.8 t -75.56 112.43 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 73.11 111.099 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -82.08 163.63 21.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 53.24 110.883 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 39.82 57.14 2.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 75.03 110.922 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 13' ' ' LEU . 4.6 tp -57.93 -173.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 52.45 110.931 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 p -145.55 139.19 26.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 61.12 111.171 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.97 65.16 0.5 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.683 -0.77 . . . . 50.01 112.485 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -75.9 155.29 35.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 51.04 110.927 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.02 -31.0 16.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.879 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.88 -55.66 0.27 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 73.04 112.49 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.75 136.58 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.338 . . . . 71.24 110.858 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.79 170.07 16.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 71.21 110.899 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.39 140.67 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 54.22 111.104 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -137.75 151.0 47.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 53.31 110.905 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -146.24 164.95 30.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 62.43 110.94 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 31.7 m -140.06 138.79 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 55.32 111.14 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -160.2 163.15 33.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.34 110.887 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.702 HG22 HG23 ' A' ' 81' ' ' THR . 15.0 p -130.74 170.7 13.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.52 111.163 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 78' ' ' PRO . 16.8 m -107.55 169.3 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 74.24 111.163 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -104.54 -52.92 2.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 62.14 110.868 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -128.94 157.24 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.878 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -73.64 116.16 13.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 63.51 110.871 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.37 144.86 33.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 65.5 111.1 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 32' ' ' THR . 2.6 t -100.96 106.79 18.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 70.03 111.15 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.45 148.93 46.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 73.42 111.088 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 34' ' ' VAL . 3.2 p -106.05 111.72 36.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 62.34 111.155 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.636 HG11 ' HG2' ' A' ' 98' ' ' LYS . 7.5 t -126.77 139.99 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 54.33 111.138 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.5 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 34.5 p -136.56 167.06 22.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 62.32 110.863 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.409 HD11 ' H ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -110.01 142.75 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 64.31 111.119 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 p -169.57 172.57 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 72.32 110.85 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 64.04 112.487 -179.968 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.813 0.34 . . . . 70.3 110.851 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.49 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -91.54 109.43 20.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 64.3 111.084 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.94 146.7 54.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 42.35 110.882 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 tt -110.86 127.08 55.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 64.21 110.92 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -131.28 154.19 48.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.906 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -154.03 133.11 12.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 72.33 110.948 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.467 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -141.03 125.72 17.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.853 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.4 126.17 28.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 73.2 111.119 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.41 -71.17 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 71.11 112.475 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 m -112.58 -175.47 2.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 61.35 110.86 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.31 136.04 32.21 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.57 0.7 . . . . 72.42 110.937 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 143.85 52.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.7 2.267 . . . . 53.23 112.35 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -100.79 178.08 4.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.22 111.153 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.6 p -64.86 -15.2 61.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 70.12 111.126 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.7 m -119.44 -25.8 5.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 62.44 110.827 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.95 126.39 50.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.32 110.803 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.5 154.07 36.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 72.45 110.935 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -112.45 -27.95 8.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 71.15 110.866 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.2 m -145.72 124.57 12.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.912 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -173.17 124.99 0.45 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 63.11 110.878 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.686 2.257 . . . . 65.43 112.351 -179.962 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.767 ' ND2' HG21 ' A' ' 95' ' ' VAL . 62.3 m-20 . . . . . 0 CA--C 1.526 0.045 0 CA-C-O 120.856 0.36 . . . . 64.01 110.88 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 74.41 5.99 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 72.12 110.884 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 70' ' ' GLU . 3.7 pt-20 -127.3 115.49 19.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 73.52 110.908 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.5 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 10.1 m -140.77 174.3 10.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.34 110.869 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.94 153.79 33.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 65.31 110.89 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -127.85 109.37 11.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 52.4 110.847 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -150.21 152.33 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 75.22 111.155 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.5 p -79.52 102.34 8.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 64.21 110.88 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.521 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.52 143.14 31.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 61.33 111.107 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.59 142.92 25.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.561 0.696 . . . . 70.01 111.102 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.483 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.7 Cg_endo -69.75 143.81 52.08 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.657 2.238 . . . . 73.41 112.342 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.23 -22.81 6.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.704 -0.76 . . . . 63.5 112.459 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.6 m -117.27 131.52 56.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 74.34 111.15 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.702 HG23 HG22 ' A' ' 26' ' ' THR . 14.3 m -74.23 136.5 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 73.41 111.113 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 56.8 m-85 -106.35 154.78 20.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 74.14 110.883 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -134.34 160.93 36.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 75.11 110.84 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG21 ' HD2' ' A' ' 5' ' ' LYS . 10.6 t -136.17 137.68 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 71.02 111.117 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.27 122.36 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 65.02 110.865 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.421 HG23 ' HB1' ' A' ' 44' ' ' ALA . 22.6 mm -104.98 112.83 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 74.53 111.116 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.79 104.08 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 72.44 110.939 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.51 160.16 37.54 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 33.41 112.511 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -115.79 -18.4 10.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 71.44 110.906 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 91' ' ' ASN . 60.7 p -166.24 136.23 3.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 63.23 110.888 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 90' ' ' SER . 57.7 t30 -33.84 108.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 72.54 110.92 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -160.84 112.68 1.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 74.52 110.923 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.0 p -119.44 163.87 16.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 72.03 110.875 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.86 26.36 4.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.743 . . . . 42.13 112.491 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.767 HG21 ' ND2' ' A' ' 68' ' ' ASN . 7.2 t -113.75 147.49 17.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 55.15 111.156 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.672 HG22 ' HB2' ' A' ' 9' ' ' PRO . 2.1 m -103.59 117.12 33.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.34 111.169 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.738 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -99.58 121.48 41.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 72.23 110.914 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.738 ' N ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -131.12 154.8 47.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 72.21 110.861 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.669 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -84.54 140.9 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 61.22 110.922 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.44 113.36 25.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.897 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 p90 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.467 . . . . 73.24 110.942 -179.892 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.913 0.387 . . . . 50.02 110.874 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.5 m -117.75 108.86 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 73.23 111.112 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.65 149.82 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 70.31 110.913 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.464 ' CD ' HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -156.42 -73.37 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 74.15 110.951 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 16.9 t30 -67.98 158.09 33.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 74.41 110.945 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.8 t-20 88.95 -69.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 53.24 110.885 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -133.18 118.06 14.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.578 0.704 . . . . 64.41 111.108 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . 53.6 Cg_endo -69.79 157.2 61.14 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 73.03 112.341 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.93 113.9 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 62.31 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.04 144.25 30.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.12 110.85 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.411 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.8 OUTLIER 48.07 74.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 65.4 110.857 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 tp -65.02 -166.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.928 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -143.37 140.72 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 72.0 111.151 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.88 60.2 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 43.1 112.46 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 90' ' ' SER . 1.7 t-20 -78.47 139.14 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 63.12 110.897 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER -52.28 -48.16 65.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 60.41 110.904 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.04 -46.53 2.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 64.43 112.538 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.03 128.39 35.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 71.31 110.883 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.21 160.57 31.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 73.3 110.868 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -121.25 139.01 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 64.25 111.126 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -136.93 146.83 45.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.931 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.414 ' HB2' ' CE ' ' A' ' 5' ' ' LYS . 17.7 m-85 -144.08 165.02 28.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 75.15 110.856 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 26.0 m -143.81 138.74 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.513 . . . . 62.54 111.151 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -160.09 162.97 34.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 54.12 110.859 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.469 ' CG2' HG23 ' A' ' 81' ' ' THR . 17.5 p -129.86 170.78 13.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 72.0 111.138 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 78' ' ' PRO . 18.9 m -107.35 168.06 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 73.54 111.149 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -106.91 -49.93 3.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 63.42 110.857 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -126.13 156.76 39.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 73.55 110.843 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -78.85 114.84 18.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 73.53 110.925 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.71 145.5 33.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 55.13 111.086 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 m -97.96 107.54 20.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 63.0 111.133 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.582 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -136.97 148.91 47.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 64.44 111.034 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.706 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -106.55 113.0 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 62.21 111.148 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.425 HG11 ' HG2' ' A' ' 98' ' ' LYS . 19.4 t -126.12 139.97 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.22 111.125 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.547 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -138.86 166.72 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 53.3 110.888 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.41 147.51 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.153 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -178.41 170.73 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 70.13 110.831 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 62.04 112.524 -179.983 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.83 0.348 . . . . 64.41 110.838 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.07 115.56 28.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 52.44 111.129 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.68 157.31 17.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 74.43 110.874 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.784 HD23 ' HA ' ' A' ' 71' ' ' SER . 1.8 tp -124.74 129.81 51.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 74.32 110.916 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.704 ' N ' HD12 ' A' ' 46' ' ' LEU . 30.1 m-85 -136.94 131.66 33.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 61.13 110.924 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -130.28 142.56 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 70.42 110.913 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.553 ' H ' HD23 ' A' ' 48' ' ' LEU . 1.3 tttm -143.73 117.67 9.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 73.15 110.951 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.97 124.37 20.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 73.41 111.119 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 -81.04 0.72 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 75.33 112.516 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.1 p -96.17 -169.7 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 74.41 110.9 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.33 135.02 21.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.631 0.729 . . . . 74.54 110.869 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 141.25 44.74 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.664 2.243 . . . . 74.35 112.364 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 p -105.36 178.93 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.135 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.4 p -63.1 -15.05 55.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 73.21 111.092 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -118.41 -26.72 6.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 73.45 110.886 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.87 126.44 50.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 55.13 110.837 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.28 153.73 35.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 74.23 110.929 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -117.72 -42.89 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.866 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.1 m -117.39 120.82 39.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.44 110.868 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -179.59 127.6 0.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 64.51 110.856 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HD2' ' HG2' ' A' ' 70' ' ' GLU . 53.2 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.642 2.228 . . . . 73.22 112.352 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.805 0.336 . . . . 73.22 110.886 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.75 15.75 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.881 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 16.3 tt0 -121.4 82.95 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 60.35 110.853 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.784 ' HA ' HD23 ' A' ' 46' ' ' LEU . 1.5 m -133.23 170.2 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 65.54 110.874 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.06 152.42 37.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 45.33 110.861 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.706 ' HB3' HG23 ' A' ' 34' ' ' VAL . 54.7 p -128.38 108.98 11.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 44.02 110.858 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.1 t -150.46 152.76 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 71.44 111.122 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -77.6 103.64 7.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.22 110.88 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.657 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.19 134.33 35.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 72.42 111.085 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.5 139.27 23.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 73.34 111.127 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.496 ' HA ' HG23 ' A' ' 27' ' ' VAL . 54.1 Cg_endo -69.76 121.02 7.72 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.724 2.283 . . . . 73.53 112.348 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.58 -19.09 1.85 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 65.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.8 m -116.9 133.78 55.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.39 . . . . 73.04 111.109 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.469 HG23 ' CG2' ' A' ' 26' ' ' THR . 0.7 OUTLIER -74.07 131.41 41.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 43.22 111.13 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.657 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 50.7 m-85 -107.89 138.05 44.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 73.32 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -117.86 159.15 23.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 74.14 110.871 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.436 ' HB ' ' HE2' ' A' ' 5' ' ' LYS . 20.9 t -137.6 137.16 45.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 70.41 111.187 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 tpt -129.99 122.27 28.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 75.11 110.938 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.477 ' HB ' HG23 ' A' ' 21' ' ' VAL . 25.5 mm -104.2 112.7 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 54.32 111.144 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 124.55 49.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.937 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.8 162.88 30.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 64.23 112.441 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -95.16 -34.13 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 64.3 110.886 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.448 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 4.6 t -167.83 -62.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 72.33 110.829 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -171.81 86.68 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.871 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.63 119.9 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 74.2 110.948 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 p -122.88 153.4 39.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.43 110.817 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 12' ' ' ASN . . . 123.71 25.76 1.69 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 60.24 112.514 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.88 146.99 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.904 0.383 . . . . 63.42 111.128 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 m -101.34 115.52 30.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 61.31 111.095 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.679 HD22 ' N ' ' A' ' 98' ' ' LYS . 1.6 tm? -100.94 130.89 47.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 62.24 110.927 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.679 ' N ' HD22 ' A' ' 97' ' ' LEU . 6.6 ttpt -143.79 163.81 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 63.34 110.885 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.636 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -91.73 143.3 26.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 64.15 110.902 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.492 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -94.7 113.91 25.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 75.32 110.95 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.582 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 12.9 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 74.42 110.954 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.886 0.374 . . . . 74.35 110.886 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.9 m -119.88 109.07 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 62.23 111.143 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.74 151.3 52.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 63.5 110.9 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.654 ' HD3' HG21 ' A' ' 84' ' ' VAL . 9.5 tptm -164.51 -39.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 74.21 110.864 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.0 t-20 -103.98 155.37 18.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 72.12 110.882 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.6 t-20 87.43 -67.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 64.04 110.873 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.1 m -127.77 119.52 21.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 44.43 111.136 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 152.7 69.37 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.706 2.271 . . . . 74.14 112.296 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.44 115.45 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.23 111.126 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.8 142.11 32.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.832 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.59 80.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 74.21 110.878 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -70.28 -167.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 72.11 110.96 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 p -145.67 139.0 26.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.45 111.131 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.37 61.68 0.51 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.743 -0.741 . . . . 72.31 112.487 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -76.09 150.13 37.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.947 0.403 . . . . 62.42 110.862 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -35.89 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.42 110.917 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.82 -63.08 0.52 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 74.51 112.5 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.77 140.08 20.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 73.52 110.84 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -135.08 171.91 13.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 73.43 110.858 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.563 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.05 136.26 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 75.22 111.165 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -136.77 141.53 42.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.91 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -130.56 165.03 23.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.928 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.43 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 9.4 m -141.19 138.8 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 74.53 111.13 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.48 160.34 34.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 63.14 110.906 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.798 HG22 HG23 ' A' ' 81' ' ' THR . 17.8 p -126.62 171.59 10.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 73.14 111.139 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.585 HG13 ' CE1' ' A' ' 101' ' ' TYR . 12.1 t -108.18 141.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 75.22 111.148 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -92.24 -42.59 9.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 62.34 110.86 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -132.15 148.39 52.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 72.45 110.864 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -72.89 114.27 10.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 61.22 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.34 140.76 29.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 40.13 111.134 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 32' ' ' THR . 2.7 t -98.98 107.08 19.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 71.54 111.11 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -135.72 148.02 48.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 70.03 111.104 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.1 p -106.72 111.19 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 70.42 111.119 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.71 139.82 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 74.54 111.157 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -134.51 166.33 23.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 74.3 110.861 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.492 HG21 HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -111.11 142.23 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 64.14 111.162 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t 178.82 159.67 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 43.45 110.852 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.7 -0.762 . . . . 45.23 112.471 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.8 0.333 . . . . 74.31 110.843 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.601 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -92.54 113.93 26.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 74.42 111.108 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.32 166.16 24.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 75.23 110.856 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.665 HD13 ' HA ' ' A' ' 71' ' ' SER . 3.7 tt -123.86 145.67 48.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.912 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -152.85 148.89 27.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 75.04 110.924 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 49' ' ' LYS . 1.4 tt -152.73 140.13 19.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 71.14 110.899 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.551 ' N ' HD23 ' A' ' 48' ' ' LEU . 3.9 tttm -147.57 130.41 16.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 75.33 110.882 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.71 86.53 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 71.22 111.139 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.94 -86.01 0.22 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.739 . . . . 73.32 112.501 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.03 134.04 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.953 0.406 . . . . 72.14 110.855 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.64 128.09 3.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.624 0.726 . . . . 62.11 110.895 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 142.84 49.11 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 55.12 112.376 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -110.08 179.31 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 75.33 111.183 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.8 p -60.92 -16.62 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 65.21 111.158 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 t -117.43 -25.78 6.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 71.12 110.83 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 124.76 48.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 72.0 110.871 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.73 153.18 32.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 73.21 110.929 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -114.24 -48.59 2.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 74.12 110.852 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.6 m -123.24 122.51 38.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.871 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.47 137.27 0.35 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.63 0.728 . . . . 54.41 110.866 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 65.15 112.308 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.774 ' ND2' HG21 ' A' ' 95' ' ' VAL . 52.2 m-80 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.855 0.36 . . . . 60.01 110.907 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.9 t30 64.54 14.18 8.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 74.24 110.906 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.422 ' HG2' ' HG2' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -128.7 103.62 7.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 61.52 110.873 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.665 ' HA ' HD13 ' A' ' 46' ' ' LEU . 5.5 m -135.03 173.63 11.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 74.32 110.845 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.94 151.6 36.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 50.13 110.89 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.5 p -129.72 109.01 10.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 53.11 110.854 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.749 HG22 HE22 ' A' ' 100' ' ' GLN . 19.1 m -151.02 153.48 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 63.14 111.173 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -72.25 100.18 2.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 63.01 110.864 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.32 151.31 25.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 63.53 111.146 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.82 145.99 46.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.606 0.717 . . . . 64.22 111.086 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 173.37 11.06 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.669 2.246 . . . . 75.42 112.294 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.78 -46.86 1.72 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.742 . . . . 72.1 112.452 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.9 m -94.61 128.82 41.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 71.5 111.142 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.798 HG23 HG22 ' A' ' 26' ' ' THR . 10.5 m -70.7 137.75 50.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 52.45 111.138 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -109.52 137.84 46.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 70.52 110.874 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -106.46 157.91 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 63.55 110.874 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.654 HG21 ' HD3' ' A' ' 5' ' ' LYS . 21.3 t -137.96 137.98 44.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 65.34 111.169 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.5 tpt -136.09 123.87 22.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 72.2 110.913 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HB ' HG23 ' A' ' 21' ' ' VAL . 19.5 mm -111.94 111.91 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 72.02 111.111 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.84 149.76 23.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 64.45 110.864 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.8 157.81 16.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 50.33 112.539 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -114.18 -21.68 10.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 74.43 110.88 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 91' ' ' ASN . 72.3 p -169.99 134.97 1.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 53.35 110.863 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 90' ' ' SER . 1.7 p30 -33.83 107.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.88 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -164.12 114.03 1.24 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 64.22 110.938 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 p -121.08 162.56 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 73.14 110.878 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.35 19.38 3.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.718 -0.754 . . . . 72.23 112.515 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.774 HG21 ' ND2' ' A' ' 68' ' ' ASN . 4.8 t -112.43 147.93 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 75.32 111.135 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -100.21 129.76 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 73.22 111.176 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.621 ' HB3' HD21 ' A' ' 13' ' ' LEU . 16.2 tp -113.11 148.31 35.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 62.43 110.913 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -157.4 166.39 33.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 72.44 110.859 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.793 HD21 ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -87.88 147.31 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 71.35 110.905 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.749 HE22 HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -106.06 104.48 14.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 72.23 110.91 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.793 ' CE2' HD21 ' A' ' 99' ' ' LEU . 13.5 m-85 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 53.25 110.898 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.502 -0.239 . . . . 74.4 112.502 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -110.8 -177.95 3.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 52.32 110.917 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -116.09 108.61 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 73.13 111.096 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.4 147.79 52.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.947 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.597 ' HE2' HD11 ' A' ' 97' ' ' LEU . 7.2 tptp -169.92 -37.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.31 110.926 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.656 ' OD1' HD22 ' A' ' 99' ' ' LEU . 12.6 t-20 -99.14 155.9 17.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 74.43 110.867 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 5.8 t30 81.54 -68.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 71.41 110.886 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.1 m -116.33 121.11 33.94 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 70.22 111.113 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.7 Cg_endo -69.79 153.14 69.13 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.715 2.277 . . . . 71.34 112.348 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.24 114.4 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.45 111.119 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -81.85 158.26 24.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 64.33 110.83 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER 37.15 66.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 72.23 110.908 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.58 -169.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 72.03 110.935 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 p -145.8 139.39 26.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 73.13 111.136 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.68 65.4 0.48 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 64.5 112.485 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -76.57 139.89 40.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 74.24 110.924 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.28 -28.7 12.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 75.12 110.933 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.92 -49.7 0.62 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.749 . . . . 74.2 112.487 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -76.45 149.4 36.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 72.11 110.861 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -141.85 170.55 15.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 71.42 110.886 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -129.07 138.24 55.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 75.13 111.157 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -137.07 150.66 48.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 62.54 110.91 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -148.58 166.1 29.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 71.21 110.922 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 9.8 m -137.75 138.15 39.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 72.53 111.16 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -160.4 162.95 33.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 72.23 110.868 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.608 HG22 ' HA ' ' A' ' 81' ' ' THR . 28.9 p -136.24 171.41 14.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 44.21 111.145 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 78' ' ' PRO . 28.1 m -106.84 167.58 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 75.11 111.14 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -109.1 -48.23 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 72.53 110.834 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -125.56 156.93 38.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 73.03 110.874 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -80.06 115.22 19.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 71.21 110.845 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.47 144.61 34.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 64.31 111.139 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.443 ' O ' HG23 ' A' ' 32' ' ' THR . 2.8 t -98.8 107.24 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 71.12 111.148 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.95 148.27 45.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 64.14 111.071 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.2 p -106.74 110.67 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 71.32 111.144 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.548 HG11 ' HG2' ' A' ' 98' ' ' LYS . 46.4 t -128.51 140.86 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 63.22 111.15 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.472 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 24.2 p -140.63 167.72 21.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 71.13 110.844 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.71 149.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 75.43 111.194 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -179.85 -175.5 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 64.43 110.824 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.27 -18.81 0.92 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.774 -0.727 . . . . 62.31 112.484 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.45 -104.25 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 74.41 112.464 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.2 m -129.23 161.55 29.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 64.25 110.863 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.26 96.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 64.31 112.519 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 -38.21 1.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.829 0.347 . . . . 65.45 110.912 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.13 121.55 44.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 63.3 111.102 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -87.68 159.35 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.21 110.843 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 71' ' ' SER . 0.3 OUTLIER -121.93 130.56 53.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.41 110.928 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -125.82 147.75 49.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 72.54 110.901 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.654 HD12 ' NE2' ' A' ' 100' ' ' GLN . 1.4 tt -143.76 134.99 25.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 74.03 110.917 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.563 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.0 tttm -144.04 116.02 8.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 71.11 110.896 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.41 120.68 10.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 64.45 111.085 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.49 -80.89 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 51.11 112.469 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 m -98.14 -178.06 3.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.389 . . . . 65.05 110.862 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 134.68 31.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.534 0.683 . . . . 74.52 110.927 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 143.3 50.35 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.655 2.237 . . . . 64.05 112.319 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -104.45 178.72 4.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 72.23 111.137 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.8 p -65.15 -14.43 60.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.436 . . . . 75.44 111.152 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -119.99 -26.75 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 71.21 110.851 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.07 125.95 50.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 64.15 110.868 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.23 153.62 35.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 74.35 110.929 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -111.83 -24.49 9.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 74.13 110.877 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.3 m -143.75 123.78 13.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.864 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -176.88 118.74 0.27 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.606 0.717 . . . . 70.33 110.893 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.439 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 53.6 Cg_endo -69.78 -6.07 17.73 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.684 2.256 . . . . 74.43 112.352 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 67.91 59.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 71.31 110.893 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.73 -172.38 2.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.866 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -100.14 108.39 20.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 73.14 110.922 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.63 -129.12 29.6 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.736 -0.745 . . . . 54.24 112.485 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -50.91 170.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 75.11 110.902 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 t30 64.47 18.87 11.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.887 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 63' ' ' PRO . 19.9 tt0 -119.61 85.82 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 52.45 110.921 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.667 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.9 m -133.11 169.68 16.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.24 110.857 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.24 155.22 33.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 54.1 110.875 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -129.23 106.55 8.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 52.4 110.864 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.1 t -151.17 149.81 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 74.13 111.134 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.8 p -73.55 102.5 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 73.13 110.86 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.586 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.51 137.42 34.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.113 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.47 141.37 22.57 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 74.53 111.09 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.511 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.7 Cg_endo -69.77 132.2 22.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.71 2.273 . . . . 73.01 112.358 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.78 -18.93 4.01 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.741 . . . . 71.51 112.509 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.5 m -115.55 129.71 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 70.33 111.14 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.608 ' HA ' HG22 ' A' ' 26' ' ' THR . 17.4 m -72.19 137.06 46.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 62.12 111.135 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.586 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 34.1 m-85 -109.86 138.21 46.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 75.22 110.918 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -108.16 161.98 14.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 75.33 110.836 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG21 ' CG ' ' A' ' 5' ' ' LYS . 61.9 t -132.31 139.05 50.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 70.23 111.124 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.7 121.18 11.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 75.45 110.853 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.442 ' HB ' HG23 ' A' ' 21' ' ' VAL . 13.3 mm -115.64 116.17 51.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 71.11 111.113 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.7 128.99 56.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 70.34 110.896 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.43 159.5 13.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 75.11 112.499 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -98.83 -21.36 16.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.868 0.366 . . . . 73.33 110.899 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 91' ' ' ASN . 23.3 p -167.07 141.65 3.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 62.13 110.897 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 90' ' ' SER . 55.2 t-20 -35.64 107.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 75.2 110.889 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -160.11 116.85 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 61.42 110.921 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.1 p -119.62 161.25 20.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 73.12 110.892 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.45 22.85 2.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 70.1 112.49 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.49 147.03 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.909 0.385 . . . . 71.52 111.11 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.63 114.35 28.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 62.12 111.147 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.597 HD11 ' HE2' ' A' ' 5' ' ' LYS . 16.5 tp -99.44 144.01 29.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 65.35 110.91 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.548 ' HG2' HG11 ' A' ' 35' ' ' VAL . 3.6 ttpt -153.16 164.92 37.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.11 110.892 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.656 HD22 ' OD1' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -92.54 140.58 29.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 63.32 110.881 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.654 ' NE2' HD12 ' A' ' 48' ' ' LEU . 5.5 pm0 -100.43 111.17 23.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 64.35 110.885 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.7 p90 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.464 . . . . 64.24 110.922 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.519 -0.233 . . . . 65.3 112.519 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -102.63 178.33 4.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 73.51 110.865 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 3' ' ' VAL . 14.5 m -108.03 108.15 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 75.31 111.14 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.61 149.69 52.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 63.31 110.897 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HE3' HD11 ' A' ' 97' ' ' LEU . 13.2 tptm -169.29 -38.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 60.14 110.876 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.682 HD22 HD22 ' A' ' 99' ' ' LEU . 8.8 t-20 -97.91 155.32 17.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 63.24 110.851 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 26.1 t30 82.0 -68.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 72.34 110.88 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 m -124.99 119.76 25.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.598 0.713 . . . . 74.45 111.163 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.53 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.9 Cg_endo -69.73 154.73 67.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.682 2.255 . . . . 45.42 112.355 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 t -76.47 114.01 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.03 111.131 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.64 144.98 29.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 74.35 110.83 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.09 77.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 75.21 110.896 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.752 HD11 ' CB ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -73.36 -172.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 64.12 110.902 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 p -136.55 137.95 40.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 75.51 111.15 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.18 60.73 0.55 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 75.42 112.529 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -77.07 163.04 27.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.373 . . . . 74.32 110.895 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 90' ' ' SER . 3.0 mmmt -45.4 -69.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 75.43 110.913 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.67 -50.72 3.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.729 . . . . 74.34 112.48 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.97 144.45 6.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 65.11 110.838 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -144.24 -179.81 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 63.02 110.887 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.474 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -141.4 135.76 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 73.44 111.115 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -137.03 148.54 46.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 71.3 110.896 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -148.54 165.01 32.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 65.03 110.912 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.736 HG22 ' HA ' ' A' ' 83' ' ' HIS . 1.2 p -143.14 142.4 31.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 52.2 111.123 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -159.32 159.38 33.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 63.2 110.884 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.611 ' CG2' HG23 ' A' ' 81' ' ' THR . 17.4 p -127.22 170.35 12.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.11 111.14 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.09 167.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 70.41 111.139 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.39 -43.23 4.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 63.51 110.884 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.43 162.74 31.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 64.15 110.904 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -79.26 116.09 19.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 65.05 110.91 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.78 141.06 31.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 44.1 111.145 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.617 HG23 ' HB3' ' A' ' 75' ' ' SER . 1.1 m -97.34 107.17 19.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 73.12 111.134 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.22 147.01 47.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 61.34 111.095 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.565 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.4 p -110.9 110.84 33.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.12 111.176 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.5 t -128.5 140.25 49.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 61.12 111.115 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.507 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 4.7 p -130.75 166.47 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.888 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.521 HG21 HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -112.58 152.57 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 52.12 111.129 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.01 177.23 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 63.54 110.813 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.82 -23.39 0.22 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 74.43 112.482 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.21 -116.04 0.52 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 61.53 112.482 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 78.8 p -120.16 162.49 19.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 61.44 110.866 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -47.78 120.89 6.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.783 -0.723 . . . . 71.42 112.47 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -165.81 -37.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.815 0.34 . . . . 64.12 110.856 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.22 125.92 49.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 74.04 111.112 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.08 151.54 22.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 64.24 110.842 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.521 HD12 HG21 ' A' ' 37' ' ' ILE . 10.0 tt -116.09 127.8 55.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.917 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -138.43 143.11 39.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 65.44 110.904 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.537 HD23 ' N ' ' A' ' 49' ' ' LYS . 1.3 tt -149.21 135.96 19.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 73.21 110.918 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.537 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.1 tttm -143.64 138.25 28.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 54.32 110.897 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.52 101.02 11.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 62.3 111.126 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.05 -92.39 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.742 . . . . 44.43 112.476 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.9 p -87.5 131.4 34.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.99 0.424 . . . . 70.4 110.851 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.68 134.8 6.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.589 0.709 . . . . 75.31 110.877 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 143.75 51.66 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.69 2.26 . . . . 74.43 112.311 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.18 177.5 5.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.436 . . . . 62.45 111.123 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 p -63.62 -15.92 59.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.138 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -119.63 -25.44 5.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 73.34 110.898 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.94 125.14 48.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 64.2 110.832 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.86 153.54 34.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 72.43 110.937 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -108.61 -29.12 8.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 74.01 110.825 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.5 m -136.32 123.73 22.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.13 110.882 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' A' ' 64' ' ' TYR . 1.4 ttt-85 -175.04 132.52 0.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.626 0.727 . . . . 74.1 110.891 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -1.33 8.3 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.251 . . . . 63.41 112.315 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.414 ' H ' ' HG2' ' A' ' 62' ' ' ARG . 0.2 OUTLIER 70.47 77.87 0.19 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 73.22 110.925 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -174.79 -169.54 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 75.1 110.85 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -134.96 140.22 45.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 73.51 110.951 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.94 172.45 39.03 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.711 -0.757 . . . . 61.21 112.513 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -175.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 64.15 110.856 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.3 t30 63.8 15.88 9.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.884 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.43 ' HG3' ' HB3' ' A' ' 65' ' ' ARG . 35.2 mm-40 -120.41 96.15 5.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.892 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.507 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -134.52 170.53 15.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 75.03 110.875 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -120.35 153.29 36.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 73.14 110.888 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.565 ' HB3' HG23 ' A' ' 34' ' ' VAL . 6.0 p -129.2 108.5 10.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 74.13 110.833 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.2 t -150.44 149.83 14.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 61.42 111.119 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.617 ' HB3' HG23 ' A' ' 32' ' ' THR . 63.1 p -75.68 102.4 5.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 63.21 110.896 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.543 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.49 143.81 30.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 72.05 111.111 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.15 142.91 26.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 61.4 111.107 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 141.09 44.24 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 64.43 112.337 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.67 -13.14 7.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.688 -0.767 . . . . 63.41 112.481 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -125.27 130.4 51.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 73.42 111.158 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.611 HG23 ' CG2' ' A' ' 26' ' ' THR . 3.5 m -73.19 137.8 45.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 51.43 111.13 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.543 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 51.6 m-85 -108.72 136.16 48.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 73.51 110.926 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.736 ' HA ' HG22 ' A' ' 24' ' ' THR . 12.2 m-70 -107.56 160.45 15.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.21 110.862 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.469 HG11 ' HE3' ' A' ' 5' ' ' LYS . 2.6 t -137.95 138.55 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 65.51 111.088 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.73 125.08 19.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 71.11 110.885 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.514 HD11 HD22 ' A' ' 97' ' ' LEU . 21.2 mm -114.79 130.28 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.32 111.141 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -111.49 149.85 30.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.44 110.899 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.19 152.27 16.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.721 -0.752 . . . . 53.43 112.544 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -120.39 -17.79 8.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 72.32 110.938 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -174.73 136.11 0.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 60.15 110.829 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 90' ' ' SER . 17.5 t-20 -35.06 103.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 74.23 110.889 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -155.38 100.18 2.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 74.23 110.906 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.6 p -109.47 151.85 26.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.071 -0.513 . . . . 63.41 110.82 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.08 24.16 1.34 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 73.12 112.476 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.643 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -111.63 142.63 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 62.24 111.121 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -102.43 117.07 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 74.11 111.152 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.752 ' CB ' HD11 ' A' ' 13' ' ' LEU . 13.1 tp -106.01 140.06 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.22 110.923 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -144.51 165.19 28.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 73.24 110.864 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.682 HD22 HD22 ' A' ' 6' ' ' ASN . 0.0 OUTLIER -92.3 137.68 32.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 72.34 110.93 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.59 113.12 24.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 63.01 110.892 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.4 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 73.22 110.89 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.454 -0.258 . . . . 73.32 112.454 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -122.93 179.37 4.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 52.33 110.894 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.429 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.3 m -117.63 108.55 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 72.13 111.121 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.94 150.23 52.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 74.54 110.907 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.727 ' HZ3' HD11 ' A' ' 97' ' ' LEU . 14.8 tptt -167.19 -35.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 73.34 110.922 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.516 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -101.39 155.61 17.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 64.35 110.891 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 24.4 t30 83.99 -69.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 65.31 110.891 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -123.08 121.3 27.19 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.569 0.7 . . . . 53.13 111.113 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.611 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.8 Cg_endo -69.76 153.51 68.84 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.267 . . . . 74.2 112.317 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.23 114.84 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 72.4 111.15 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -85.56 160.74 19.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.836 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 p30 40.2 62.17 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 73.42 110.89 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.03 -169.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 64.33 110.903 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 p -146.57 139.32 25.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 51.25 111.156 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.12 57.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.754 . . . . 33.25 112.486 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.94 152.95 36.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 72.14 110.914 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.24 -42.76 66.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 73.31 110.871 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.82 -48.69 1.07 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.778 -0.725 . . . . 42.52 112.508 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.28 134.1 54.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 62.03 110.799 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -134.65 172.6 12.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 74.24 110.874 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.445 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.41 139.23 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 70.11 111.12 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -136.78 151.23 48.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 74.22 110.871 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -145.14 165.97 26.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 72.23 110.933 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.429 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 8.7 m -141.69 138.13 32.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.075 -0.511 . . . . 61.41 111.157 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -160.61 158.19 28.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 74.11 110.887 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 81' ' ' THR . 27.7 p -128.07 171.22 12.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 73.02 111.093 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.558 HG12 ' CZ ' ' A' ' 101' ' ' TYR . 34.4 m -107.35 147.7 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 75.44 111.135 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -91.03 -49.83 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.884 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.14 161.39 26.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 73.15 110.878 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -81.06 114.12 19.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 73.22 110.858 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.99 138.96 28.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 64.53 111.078 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 75' ' ' SER . 3.2 m -94.37 106.7 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 61.12 111.139 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -136.26 146.23 46.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 44.23 111.066 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 73' ' ' SER . 68.9 t -109.39 111.88 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.11 111.148 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.7 t -127.02 139.27 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 72.34 111.136 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 42.6 p -134.03 166.48 22.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 60.4 110.877 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.777 HG21 HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -110.96 149.49 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 63.42 111.136 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.66 177.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 54.12 110.864 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.77 -45.32 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.728 . . . . 61.05 112.511 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.02 -106.22 0.62 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.721 -0.752 . . . . 40.05 112.47 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.6 p -103.95 158.51 16.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.942 0.401 . . . . 74.45 110.82 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.27 90.78 0.82 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 54.21 112.474 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -135.4 2.31 2.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 74.52 110.894 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.1 106.64 12.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.42 111.119 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.64 152.35 37.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 74.53 110.864 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.27 127.27 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.862 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -133.93 139.63 46.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 64.24 110.931 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 49' ' ' LYS . 2.0 tt -143.4 134.13 25.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.906 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.589 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.3 tttt -142.4 122.66 13.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 72.11 110.883 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.47 48.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 73.11 111.112 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.15 -81.9 1.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.719 -0.753 . . . . 55.41 112.501 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -93.67 177.48 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.907 0.384 . . . . 75.03 110.844 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.12 138.22 30.86 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.569 0.699 . . . . 75.43 110.895 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.15 49.93 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 75.43 112.332 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -103.34 178.99 4.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 53.4 111.194 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.7 p -65.47 -14.24 60.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 74.52 111.124 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.4 m -121.35 -26.25 5.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 64.32 110.858 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.13 126.47 49.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 64.45 110.878 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.28 153.7 35.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 65.44 110.944 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -111.69 -27.63 8.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 74.43 110.897 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.1 m -140.52 123.78 16.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.916 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -179.51 115.78 0.22 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.589 0.709 . . . . 71.34 110.87 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.42 ' HD2' ' HG2' ' A' ' 70' ' ' GLU . 53.9 Cg_endo -69.74 -7.95 22.36 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.664 2.243 . . . . 61.42 112.364 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 67.34 74.57 0.31 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 74.25 110.877 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.65 -167.84 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.21 110.889 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -101.99 105.37 16.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 70.2 110.895 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 49.8 -130.78 27.36 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 70.42 112.528 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -48.12 167.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 71.32 110.902 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.7 t30 68.01 18.27 9.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 51.52 110.891 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.42 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 14.1 tt0 -122.19 88.82 3.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 65.31 110.831 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.464 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.4 m -134.63 169.03 17.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 70.1 110.854 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.22 152.34 38.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 63.3 110.879 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.8 ' HB2' HG22 ' A' ' 34' ' ' VAL . 1.9 p -127.03 109.29 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.43 110.881 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.5 m -150.96 152.74 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 72.23 111.112 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.478 ' HB3' HG23 ' A' ' 32' ' ' THR . 77.5 p -80.1 101.89 9.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 71.23 110.884 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.506 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.87 151.18 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 71.12 111.078 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.87 144.13 32.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.547 0.689 . . . . 74.41 111.104 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.525 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.6 Cg_endo -69.73 124.67 11.32 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.713 2.275 . . . . 75.11 112.306 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.03 -15.99 1.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 55.22 112.485 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.9 m -126.16 131.33 52.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.37 . . . . 74.12 111.134 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.599 ' HA ' HG22 ' A' ' 26' ' ' THR . 26.9 m -72.66 138.15 46.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.44 111.153 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.506 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 47.5 m-85 -108.57 139.58 43.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 60.24 110.926 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -107.25 160.19 15.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 73.42 110.831 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 t -137.8 126.14 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 75.15 111.148 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.04 123.06 27.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 65.31 110.845 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.469 HD11 HD13 ' A' ' 97' ' ' LEU . 15.1 mm -111.2 124.32 67.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 74.13 111.112 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 145.25 32.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.865 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -117.14 140.61 15.99 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 62.25 112.49 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -101.76 -24.3 14.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.923 0.392 . . . . 75.43 110.953 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 91' ' ' ASN . 72.2 p -174.52 139.17 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 64.21 110.835 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.47 ' C ' ' O ' ' A' ' 90' ' ' SER . 5.1 p-10 -31.56 106.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 54.23 110.913 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -163.09 110.6 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 65.54 110.93 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 p -117.25 158.83 23.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 61.21 110.868 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.34 25.45 2.0 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 64.1 112.529 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.36 146.83 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.865 0.364 . . . . 55.24 111.162 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.611 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.71 113.72 27.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 63.32 111.171 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.777 HD12 HG21 ' A' ' 37' ' ' ILE . 7.7 tp -99.88 141.08 33.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 72.24 110.921 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -151.58 169.92 20.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.936 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.657 HD21 ' HD2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -89.42 144.8 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 74.04 110.903 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.437 ' OE1' HD12 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -106.39 101.79 11.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 44.34 110.888 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.657 ' HD2' HD21 ' A' ' 99' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 64.12 110.931 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.498 -0.241 . . . . 34.53 112.498 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -103.9 -175.29 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 44.34 110.891 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.4 m -117.83 108.84 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.44 111.13 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.07 149.74 52.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 52.04 110.875 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.611 ' CE ' HD11 ' A' ' 97' ' ' LEU . 18.4 tptm -162.7 -70.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.11 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.579 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -71.65 155.4 40.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 71.1 110.888 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 18.4 t30 89.03 -67.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.45 110.875 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 m -124.19 120.66 26.24 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.614 0.721 . . . . 75.25 111.171 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HB2' HG22 ' A' ' 96' ' ' THR . 54.3 Cg_endo -69.71 154.14 68.3 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.7 2.267 . . . . 71.42 112.384 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.9 t -87.48 113.78 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 51.44 111.131 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 p -91.31 175.14 7.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 53.44 110.858 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 p30 40.62 48.91 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 62.3 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.808 HD11 ' HB2' ' A' ' 97' ' ' LEU . 4.2 mt -57.38 -176.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 72.51 110.952 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 p -143.86 139.61 29.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 51.52 111.146 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.75 64.54 0.56 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.794 -0.717 . . . . 74.45 112.497 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -73.93 160.5 31.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.941 0.4 . . . . 52.4 110.858 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 90' ' ' SER . 0.9 OUTLIER -45.22 -64.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.905 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.9 -48.14 1.81 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 73.12 112.501 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.57 157.81 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.839 0.352 . . . . 65.41 110.881 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.65 -179.32 5.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 52.1 110.893 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -133.66 146.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.21 111.141 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -137.55 145.72 43.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 60.33 110.88 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -144.88 165.9 26.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 73.2 110.913 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 8.2 m -140.79 140.02 34.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 43.34 111.089 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -159.68 160.69 34.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 60.12 110.858 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 81' ' ' THR . 24.5 p -130.1 170.22 14.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.484 . . . . 73.32 111.125 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.875 HG11 ' CE1' ' A' ' 101' ' ' TYR . 26.8 m -109.11 170.76 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.42 111.121 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -99.46 -67.99 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.887 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -125.31 148.68 48.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 75.25 110.869 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -50.53 117.49 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 73.43 110.84 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.65 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . . . -141.97 144.42 33.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 74.04 111.079 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 32' ' ' THR . 2.5 t -103.05 107.13 17.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.436 . . . . 64.45 111.167 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.56 147.13 46.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 75.22 111.138 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.2 p -107.57 111.69 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 71.21 111.129 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.437 HG11 ' HG2' ' A' ' 98' ' ' LYS . 11.5 t -127.64 139.67 51.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.05 111.15 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.465 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 9.5 p -135.15 165.27 25.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 45.44 110.858 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.494 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -113.4 150.93 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 41.21 111.111 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 177.5 172.93 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 65.21 110.831 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.46 -23.6 0.23 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 72.25 112.443 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.27 -115.37 0.44 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 73.45 112.487 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 m -112.43 160.57 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 52.51 110.891 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.56 106.45 0.59 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 72.14 112.479 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -144.09 -45.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.333 . . . . 73.43 110.864 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB1' ' CG2' ' A' ' 86' ' ' ILE . . . -88.67 116.36 26.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 62.03 111.108 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -78.21 147.2 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 62.23 110.844 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.719 HD11 HE22 ' A' ' 100' ' ' GLN . 5.9 tt -108.4 126.93 53.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 65.1 110.909 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -142.66 139.37 31.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 75.22 110.901 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.457 HD12 ' OE1' ' A' ' 100' ' ' GLN . 0.5 OUTLIER -147.09 133.64 19.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 73.34 110.908 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' H ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -143.35 133.86 24.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.466 . . . . 74.03 110.918 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.27 132.53 38.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 45.41 111.123 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.82 -80.63 1.81 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 33.53 112.509 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -92.92 175.95 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 64.51 110.842 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HD3' ' HE3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -88.15 137.75 31.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 72.42 110.895 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 142.65 48.38 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.691 2.26 . . . . 65.43 112.334 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.67 178.68 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 62.23 111.155 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 p -66.81 -13.38 61.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.54 111.113 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 m -123.01 -25.96 4.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 61.41 110.85 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.83 125.99 49.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 70.5 110.839 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.11 153.67 34.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 74.03 110.964 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -102.02 -32.19 10.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 64.45 110.85 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.2 m -138.03 123.57 19.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 63.24 110.856 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -177.29 127.16 0.3 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.568 0.699 . . . . 74.22 110.893 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -12.02 32.08 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.726 2.284 . . . . 63.11 112.38 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.1 t80 65.45 83.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 72.22 110.88 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 178.98 -166.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 75.42 110.886 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -46.52 160.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 74.1 110.948 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.24 -93.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.75 . . . . 33.41 112.499 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.34 161.26 2.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 54.15 110.892 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.8 25.57 11.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 70.44 110.906 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.32 96.13 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 63.24 110.865 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.591 ' HA ' HD13 ' A' ' 46' ' ' LEU . 1.7 m -133.85 170.95 14.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 42.3 110.862 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.46 149.56 41.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 65.54 110.951 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.487 ' HB3' HG23 ' A' ' 34' ' ' VAL . 13.6 p -126.72 109.27 11.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.44 110.864 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.2 t -150.91 152.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 52.11 111.139 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 p -81.41 102.14 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 70.02 110.85 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.787 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.55 149.96 26.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 43.55 111.13 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.58 144.23 28.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.595 0.712 . . . . 53.55 111.094 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.25 7.04 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.684 2.256 . . . . 74.33 112.314 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.68 -4.97 80.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.728 . . . . 62.01 112.494 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.9 m -126.22 125.48 42.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 73.1 111.125 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.48 ' HA ' HG22 ' A' ' 26' ' ' THR . 6.3 m -71.24 137.78 48.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 64.41 111.127 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.787 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 34.1 m-85 -111.66 137.98 48.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 75.53 110.936 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -105.98 162.41 13.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 71.35 110.841 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG21 ' HD3' ' A' ' 5' ' ' LYS . 2.7 t -135.89 138.57 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 54.41 111.147 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.412 ' HE3' ' HD3' ' A' ' 53' ' ' LYS . 6.8 tpp -140.3 121.77 15.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.83 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.416 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 20.4 mm -118.86 113.16 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.21 111.144 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -100.11 155.79 17.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 72.42 110.915 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.03 153.24 17.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 73.12 112.478 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.87 -21.98 8.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.895 0.379 . . . . 60.41 110.927 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.479 ' O ' ' C ' ' A' ' 91' ' ' ASN . 1.6 p -175.04 134.44 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 70.21 110.905 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 90' ' ' SER . 39.2 t30 -32.02 106.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 63.44 110.905 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -163.95 116.52 1.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.926 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.6 p -121.84 151.62 40.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 72.35 110.856 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.16 29.38 1.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 74.35 112.488 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.56 145.73 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.929 0.395 . . . . 72.21 111.127 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 9' ' ' PRO . 1.3 m -101.15 118.56 37.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 61.35 111.165 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.808 ' HB2' HD11 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -111.45 127.81 55.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 62.32 110.917 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.805 ' N ' HD22 ' A' ' 97' ' ' LEU . 3.9 ttpt -135.15 167.92 20.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.908 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.645 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -88.18 141.2 28.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 73.34 110.923 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.719 HE22 HD11 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -103.08 110.99 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.927 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.875 ' CE1' HG11 ' A' ' 27' ' ' VAL . 2.6 t80 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.928 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.488 -0.245 . . . . 70.1 112.488 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -95.06 -177.32 4.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.847 0.356 . . . . 75.0 110.9 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.474 HG11 ' OG1' ' A' ' 24' ' ' THR . 11.1 m -106.39 108.45 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 72.11 111.097 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.14 149.93 52.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 61.02 110.904 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.636 ' HE3' HD11 ' A' ' 97' ' ' LEU . 13.7 tptm -166.71 -67.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.907 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.674 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.2 OUTLIER -76.09 153.93 35.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 74.04 110.918 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.1 t-20 87.32 -69.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.21 110.887 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.1 m -120.88 121.55 28.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.57 0.7 . . . . 61.52 111.105 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 154.38 67.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.692 2.262 . . . . 74.2 112.363 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.13 116.22 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 60.23 111.137 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 p -87.96 159.71 18.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 64.1 110.834 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.3 p30 40.08 69.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 73.11 110.855 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.743 HD11 ' CB ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -69.81 -174.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 65.24 110.889 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -140.49 138.0 34.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 73.23 111.146 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.52 64.05 0.58 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.693 -0.765 . . . . 63.53 112.454 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -75.59 148.18 39.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.357 . . . . 54.24 110.905 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.36 -57.02 7.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 72.04 110.881 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.63 -64.21 1.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 42.13 112.491 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.92 144.61 8.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 72.4 110.865 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -139.67 179.33 6.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 61.14 110.892 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.584 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.13 138.0 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 74.54 111.127 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -135.41 139.58 44.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 71.34 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -137.44 163.8 30.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 75.44 110.926 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.724 HG22 ' HA ' ' A' ' 83' ' ' HIS . 1.9 p -142.17 146.91 35.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 72.22 111.136 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.39 163.28 35.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 64.21 110.822 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.622 HG22 HG23 ' A' ' 81' ' ' THR . 11.0 p -125.58 169.74 12.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 53.14 111.183 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.2 t -108.33 145.09 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.13 111.089 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -86.21 -44.29 12.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.832 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -142.78 154.72 44.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 75.1 110.86 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -72.04 116.62 12.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 72.21 110.938 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.75 141.3 31.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 63.31 111.116 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -94.81 105.66 17.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 74.14 111.114 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.11 148.62 45.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 71.34 111.136 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -107.93 111.12 34.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 72.53 111.12 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.496 HG11 ' HG2' ' A' ' 98' ' ' LYS . 41.2 t -127.41 139.9 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 71.22 111.09 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.488 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 24.3 p -135.89 166.21 23.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 73.04 110.855 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.461 HG21 HD12 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -111.4 150.66 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 52.41 111.152 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.3 173.58 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 64.34 110.884 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.0 -27.31 0.13 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 64.31 112.495 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.62 -114.97 0.34 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.711 -0.757 . . . . 74.45 112.508 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.1 p -111.97 162.18 15.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 72.45 110.871 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.85 134.67 21.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.732 -0.747 . . . . 54.1 112.462 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -174.39 -35.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 70.11 110.861 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.93 127.12 54.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 74.52 111.073 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 1.7 m-20 -88.91 152.36 21.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 70.14 110.867 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.413 HD22 ' O ' ' A' ' 70' ' ' GLU . 5.6 tt -118.75 142.24 47.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 72.44 110.891 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -153.36 142.92 21.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 72.21 110.945 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.508 HD12 ' NE2' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -140.66 134.08 29.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 74.25 110.922 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.477 ' N ' HD23 ' A' ' 48' ' ' LEU . 7.7 tttt -149.16 129.64 13.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 64.4 110.906 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.3 98.98 8.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 64.1 111.091 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.07 -90.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.721 -0.752 . . . . 43.42 112.463 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.0 m -90.46 128.48 36.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.957 0.408 . . . . 63.44 110.849 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.26 133.93 3.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.574 0.702 . . . . 72.42 110.87 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 143.02 49.54 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.677 2.251 . . . . 72.24 112.336 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.2 p -107.63 178.73 4.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 74.42 111.164 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.8 p -63.28 -15.18 56.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 64.42 111.164 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 m -118.96 -26.33 6.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.858 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.73 125.49 49.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.852 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.97 153.4 34.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 75.25 110.909 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -108.18 -34.58 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 71.41 110.912 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 70.5 m -144.64 123.1 12.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.86 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -177.37 129.14 0.32 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.606 0.717 . . . . 73.22 110.867 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HG2' ' CG ' ' A' ' 70' ' ' GLU . 53.8 Cg_endo -69.76 -4.78 14.72 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.237 . . . . 64.03 112.399 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 6.5 t80 69.1 101.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 72.44 110.913 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.68 -169.49 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 73.45 110.86 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -87.41 -77.1 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 65.33 110.966 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 68' ' ' ASN . . . -150.98 145.35 13.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 61.41 112.46 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER 58.93 150.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 73.32 110.897 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.3 t30 65.63 12.19 8.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 54.22 110.878 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.43 ' CG ' ' HG2' ' A' ' 63' ' ' PRO . 4.3 tt0 -116.68 87.5 2.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.876 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.488 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 1.5 m -133.28 169.26 17.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 64.31 110.846 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.74 156.73 31.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 52.44 110.865 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.68 107.22 9.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 52.04 110.832 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -150.65 153.12 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.1 111.168 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -70.21 104.72 2.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.22 110.863 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.93 131.5 35.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 70.23 111.127 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.99 139.94 20.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.589 0.709 . . . . 43.44 111.078 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 170.45 16.55 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.683 2.255 . . . . 75.23 112.349 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.16 -39.24 2.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 45.01 112.474 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.6 m -97.04 128.93 44.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 71.34 111.155 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.622 HG23 HG22 ' A' ' 26' ' ' THR . 3.1 m -71.43 133.24 45.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 72.31 111.141 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -104.03 136.02 44.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 64.22 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.724 ' HA ' HG22 ' A' ' 24' ' ' THR . 17.9 m-70 -106.97 159.14 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 64.32 110.834 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.452 HG11 ' CE ' ' A' ' 5' ' ' LYS . 4.5 t -138.93 139.39 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 63.14 111.108 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.82 123.65 25.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 72.1 110.892 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.584 ' HB ' HG23 ' A' ' 21' ' ' VAL . 16.1 mm -118.81 113.61 42.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 72.44 111.099 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 10.3 mmmm -98.29 165.32 11.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 41.41 110.927 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.88 135.08 8.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.713 -0.756 . . . . 54.34 112.449 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -96.61 -31.54 12.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 75.21 110.943 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 91' ' ' ASN . 78.1 p -167.62 136.92 2.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 65.42 110.859 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 90' ' ' SER . 13.5 t-20 -34.62 105.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 55.01 110.898 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -164.37 119.25 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 74.04 110.953 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 p -121.56 155.76 34.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 70.53 110.891 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.65 23.29 1.52 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 63.1 112.468 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.659 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.7 t -114.15 143.12 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.911 0.386 . . . . 70.4 111.123 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.403 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 0.8 OUTLIER -100.08 132.26 45.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.3 111.158 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.743 ' CB ' HD11 ' A' ' 13' ' ' LEU . 13.8 tp -118.99 149.71 41.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.928 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HG2' HG11 ' A' ' 35' ' ' VAL . 3.4 ttpt -157.87 164.27 37.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 74.51 110.919 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.674 HD22 ' HB2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -90.96 138.95 31.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.25 -0.432 . . . . 70.44 110.907 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.508 ' NE2' HD12 ' A' ' 48' ' ' LEU . 1.3 pm0 -98.09 112.0 24.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 54.44 110.941 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.422 ' HB3' HD21 ' A' ' 99' ' ' LEU . 29.6 p90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 70.45 110.926 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.512 -0.235 . . . . 70.3 112.512 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -102.57 -176.95 3.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.893 0.378 . . . . 74.12 110.831 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.6 m -118.56 109.25 26.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 63.22 111.103 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.636 HD12 HG22 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -131.47 148.95 52.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 75.32 110.936 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.584 ' HE3' HD11 ' A' ' 97' ' ' LEU . 13.8 tptm -166.66 -68.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 65.44 110.883 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.651 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -75.01 154.98 37.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.54 110.877 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.0 t-20 88.38 -65.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 71.31 110.906 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 m -129.35 121.67 20.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.551 0.691 . . . . 64.33 111.098 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.41 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.7 Cg_endo -69.81 154.07 67.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.653 2.236 . . . . 73.05 112.359 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.636 HG22 HD12 ' A' ' 4' ' ' LEU . 37.3 t -84.83 115.09 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 61.14 111.134 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.2 146.12 28.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 74.02 110.853 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.66 81.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 75.14 110.942 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.73 HD11 ' CB ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -79.58 -172.69 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 52.33 110.924 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -136.98 138.72 40.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 75.12 111.139 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.77 71.87 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.746 -0.74 . . . . 52.0 112.505 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -76.98 134.54 38.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 61.21 110.89 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -24.57 8.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 55.11 110.901 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.13 -40.64 1.37 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 61.44 112.439 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.27 -173.12 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.356 . . . . 72.23 110.871 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.12 -178.01 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 73.54 110.918 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.0 145.76 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 72.3 111.168 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -137.21 143.4 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.51 110.849 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -140.15 165.25 27.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 71.12 110.926 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.43 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 7.8 m -147.11 142.32 27.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 64.1 111.137 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -159.36 162.51 35.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 74.25 110.868 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.491 HG22 HG23 ' A' ' 81' ' ' THR . 19.6 p -130.34 169.94 14.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 72.11 111.115 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 m -108.68 169.89 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.197 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -108.73 -45.16 3.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 54.41 110.895 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -133.38 158.82 42.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 75.1 110.881 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.7 116.27 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 55.21 110.896 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.38 139.19 31.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 65.23 111.127 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.3 m -96.21 106.77 19.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 63.33 111.154 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.59 147.29 46.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 70.31 111.117 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.2 p -107.5 111.29 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 52.21 111.132 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -127.45 140.22 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 75.01 111.115 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.497 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 5.4 p -133.53 166.25 23.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 61.15 110.891 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.497 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -111.91 152.44 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 64.31 111.169 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.79 173.9 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.886 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 165.58 -25.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 54.22 112.496 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.2 -110.05 0.32 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 71.4 112.485 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 m -114.86 160.57 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 51.31 110.862 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.03 96.86 0.11 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.694 -0.765 . . . . 71.14 112.488 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -133.41 -39.69 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 53.02 110.826 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.64 120.55 39.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.55 111.159 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.55 161.99 23.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 75.52 110.887 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.685 HD13 ' HA ' ' A' ' 71' ' ' SER . 9.4 tt -118.78 129.82 55.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 72.24 110.959 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -133.85 146.54 50.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.913 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -153.52 133.47 13.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 75.33 110.922 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.415 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -144.87 121.58 11.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 70.44 110.854 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.49 89.46 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 74.33 111.109 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.89 -83.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 61.12 112.456 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -106.41 133.96 50.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.925 0.393 . . . . 70.04 110.862 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.66 127.34 2.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 75.44 110.932 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 142.87 49.23 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.708 2.272 . . . . 60.1 112.305 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.48 178.32 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 74.02 111.152 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.3 p -60.63 -17.04 44.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 75.51 111.152 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.6 m -117.04 -25.45 7.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.833 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.46 124.87 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.847 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.87 153.41 33.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 74.33 110.91 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -115.51 -34.91 4.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 75.33 110.886 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.9 m -140.37 122.68 15.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 74.13 110.873 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.481 ' C ' ' H ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -178.32 140.69 0.4 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.582 0.706 . . . . 70.42 110.907 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 64' ' ' TYR . 53.6 Cg_endo -69.77 32.97 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.69 2.26 . . . . 72.25 112.313 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER 36.69 68.98 0.22 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 65.21 110.88 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.414 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -170.63 -175.31 1.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 51.15 110.822 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -135.53 149.94 49.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.13 110.896 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.86 161.54 34.42 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.755 -0.736 . . . . 73.05 112.485 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -53.76 177.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 74.31 110.865 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.9 t30 66.86 16.55 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.15 110.905 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -126.92 96.98 4.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 63.4 110.899 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.685 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.4 m -134.32 171.2 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.901 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.29 152.96 35.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 74.53 110.882 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 34' ' ' VAL . 1.3 p -128.64 109.26 11.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 63.21 110.854 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.6 m -150.89 152.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 62.42 111.135 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.6 p -73.2 106.97 5.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 64.01 110.8 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.71 132.55 35.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.11 111.066 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.63 139.23 19.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.525 0.678 . . . . 70.15 111.101 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 142.11 46.88 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.629 2.219 . . . . 72.22 112.325 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.97 -12.77 8.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.774 -0.727 . . . . 73.11 112.461 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.1 m -126.41 129.23 48.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 54.41 111.165 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.491 HG23 HG22 ' A' ' 26' ' ' THR . 5.2 m -70.98 138.07 49.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 74.35 111.159 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' O ' HG23 ' A' ' 24' ' ' THR . 42.4 m-85 -108.6 135.86 49.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 70.54 110.946 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -107.24 158.91 16.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 61.41 110.879 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.467 HG11 ' HE3' ' A' ' 5' ' ' LYS . 4.3 t -138.3 138.57 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 72.41 111.14 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.97 123.05 17.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' A' ' 21' ' ' VAL . 28.8 mm -113.44 112.96 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 60.24 111.169 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -110.38 134.31 52.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 74.45 110.874 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.74 144.67 17.66 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.753 . . . . 24.32 112.456 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.77 -22.27 20.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.902 0.382 . . . . 74.43 110.962 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 91' ' ' ASN . 2.7 p -163.85 139.76 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 72.54 110.891 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 90' ' ' SER . 13.3 t-20 -35.07 106.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 64.35 110.882 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -155.47 115.59 3.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 71.31 110.946 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.1 p -122.17 151.5 40.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 63.03 110.849 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.46 23.65 2.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 73.14 112.469 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.662 ' O ' HD12 ' A' ' 13' ' ' LEU . 1.4 t -111.74 143.94 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 72.01 111.096 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -100.94 124.19 46.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 62.34 111.124 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.73 ' CB ' HD11 ' A' ' 13' ' ' LEU . 15.5 tp -112.32 148.38 34.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 62.35 110.951 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -153.79 164.7 37.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 61.32 110.878 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.651 HD22 ' HB2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -91.43 136.91 32.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.236 -0.438 . . . . 72.53 110.922 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.416 HE22 HD11 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -97.38 112.18 24.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.01 110.931 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 75.45 110.871 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.456 -0.258 . . . . 53.03 112.456 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -155.43 -175.86 5.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 71.22 110.885 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.5 m -117.9 108.27 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 71.24 111.146 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.54 150.66 52.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 61.01 110.95 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.722 ' HG2' HG21 ' A' ' 84' ' ' VAL . 2.2 tppm? -166.09 -73.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 74.41 110.883 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.641 ' ND2' HD22 ' A' ' 99' ' ' LEU . 9.8 t-20 -63.39 157.75 22.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 73.01 110.919 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.3 t30 88.52 -60.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.868 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.4 m -133.59 121.62 16.32 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 42.11 111.161 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 152.28 69.54 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 2.243 . . . . 63.33 112.353 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.561 HG12 HD22 ' A' ' 13' ' ' LEU . 99.0 t -79.37 115.02 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 71.13 111.175 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.49 146.31 31.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 53.12 110.844 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.59 81.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 73.3 110.841 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.561 HD22 HG12 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -71.4 -168.72 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 62.14 110.911 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 p -139.61 138.34 36.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 73.3 111.137 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.63 58.82 0.65 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.721 -0.752 . . . . 43.15 112.517 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -76.56 139.17 40.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.874 0.368 . . . . 73.25 110.848 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -26.11 9.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 71.42 110.942 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.98 -56.33 0.4 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.735 -0.745 . . . . 73.1 112.503 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.13 158.73 6.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.854 0.359 . . . . 60.01 110.868 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -152.6 167.58 28.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 70.25 110.922 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -137.61 136.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 64.01 111.102 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -137.42 147.15 45.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 72.13 110.825 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -146.22 166.11 27.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 70.44 110.968 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 27.6 m -140.04 140.7 36.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 61.31 111.108 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -160.74 155.06 23.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 72.42 110.925 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.618 HG22 ' HA ' ' A' ' 81' ' ' THR . 19.1 p -128.07 170.49 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 64.22 111.178 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -108.5 170.21 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 61.13 111.11 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.05 -52.83 3.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 44.41 110.873 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.43 172.67 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.25 110.873 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -75.93 117.13 17.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 73.13 110.845 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.81 133.5 25.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 45.32 111.143 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.6 m -95.18 107.98 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 74.45 111.118 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.2 148.33 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 64.04 111.067 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -106.92 111.03 33.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 74.01 111.099 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.735 HG11 ' HG2' ' A' ' 98' ' ' LYS . 49.0 t -126.16 139.34 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 60.15 111.115 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.495 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 17.0 p -135.48 170.23 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.4 110.889 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.507 HD13 HD12 ' A' ' 46' ' ' LEU . 4.6 pt -108.01 157.49 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 73.23 111.112 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 174.12 171.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 75.53 110.838 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 164.62 -25.68 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.679 -0.772 . . . . 71.34 112.429 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.49 -91.24 0.18 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.79 -0.719 . . . . 72.55 112.473 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.1 m -130.13 145.82 51.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.937 0.399 . . . . 65.34 110.82 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.5 ' HA3' HG23 ' A' ' 95' ' ' VAL . . . 177.09 -30.4 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 63.33 112.51 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.404 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 1.0 OUTLIER 68.08 33.76 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.818 0.342 . . . . 65.12 110.89 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.76 120.92 36.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 73.23 111.1 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.64 172.64 11.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.891 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 71' ' ' SER . 8.5 tt -124.63 141.82 51.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 73.04 110.914 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -150.37 146.62 26.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.949 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.618 HD12 ' NE2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -153.87 146.23 23.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 64.11 110.934 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.595 ' H ' HD23 ' A' ' 48' ' ' LEU . 7.1 tttt -149.62 123.12 9.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 60.41 110.923 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.54 84.28 6.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 72.34 111.109 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.89 -64.22 0.4 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 72.55 112.527 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -139.99 137.7 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.949 0.404 . . . . 75.35 110.833 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -32.52 127.2 0.36 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.522 0.677 . . . . 75.55 110.929 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 143.45 50.76 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.668 2.245 . . . . 71.13 112.329 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -103.35 178.35 4.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 55.14 111.106 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.5 p -62.69 -15.71 53.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 70.35 111.172 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.3 m -117.21 -26.23 6.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 71.11 110.858 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.94 123.52 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 52.35 110.838 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.39 153.55 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 73.21 110.903 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 49' ' ' LYS . 35.6 m-20 -112.27 -45.67 3.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 55.2 110.847 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 36.9 m -121.9 123.57 42.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.869 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.479 ' HG2' ' H ' ' A' ' 64' ' ' TYR . 26.7 ttp180 -175.77 127.61 0.37 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 74.51 110.848 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -3.29 11.73 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.694 2.263 . . . . 63.03 112.344 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' H ' ' HG2' ' A' ' 62' ' ' ARG . 10.3 m-85 68.21 84.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 63.3 110.91 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.53 -173.36 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 62.4 110.893 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -121.96 175.83 6.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 74.11 110.963 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 43' ' ' ASP . . . 59.85 170.79 0.47 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.699 -0.763 . . . . 65.35 112.507 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -60.39 -167.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 73.13 110.921 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.3 t30 61.09 24.2 14.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.31 110.876 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -128.98 90.23 3.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 74.15 110.908 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.709 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.6 m -133.04 169.97 16.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 62.51 110.86 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.57 154.76 34.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 75.2 110.869 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.458 ' HB3' HG23 ' A' ' 34' ' ' VAL . 60.6 p -128.29 109.67 11.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.846 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.1 t -150.33 153.02 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 64.11 111.123 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -75.41 105.38 6.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.3 110.857 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.13 138.41 34.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.41 111.064 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.29 146.52 32.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.592 0.711 . . . . 55.31 111.13 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 164.55 34.09 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 73.21 112.374 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.0 -21.18 38.3 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.713 -0.756 . . . . 71.13 112.482 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.0 m -108.75 124.01 49.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 53.53 111.111 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.618 ' HA ' HG22 ' A' ' 26' ' ' THR . 22.0 m -72.89 134.06 44.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 44.11 111.127 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.532 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 52.2 m-85 -109.13 136.91 47.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.885 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -118.55 139.56 51.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 73.42 110.851 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.722 HG21 ' HG2' ' A' ' 5' ' ' LYS . 13.7 t -116.03 126.83 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 62.24 111.091 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 tpt -123.51 128.82 50.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 51.41 110.846 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.558 HD11 ' CD2' ' A' ' 97' ' ' LEU . 30.6 mm -113.97 126.43 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 53.34 111.109 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.19 146.3 30.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 73.35 110.9 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.39 150.13 18.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 41.03 112.472 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.15 -37.9 5.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.35 . . . . 73.2 110.868 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 91' ' ' ASN . 7.6 p -161.74 137.64 7.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 73.03 110.908 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.482 ' C ' ' O ' ' A' ' 90' ' ' SER . 4.8 p-10 -31.65 108.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 73.2 110.877 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.63 121.66 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.5 110.919 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.5 p -121.59 168.23 11.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 64.11 110.82 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.39 22.66 2.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 70.43 112.478 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.5 HG23 ' HA3' ' A' ' 42' ' ' GLY . 43.5 t -113.38 140.75 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 74.13 111.123 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.54 120.04 39.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 71.32 111.185 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' CD2' HD11 ' A' ' 86' ' ' ILE . 19.4 tp -106.22 149.99 26.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.912 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.735 ' HG2' HG11 ' A' ' 35' ' ' VAL . 5.7 ttpt -156.92 162.91 39.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 74.42 110.866 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.641 HD22 ' ND2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -90.27 140.34 29.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 54.33 110.909 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.618 ' NE2' HD12 ' A' ' 48' ' ' LEU . 4.5 pm0 -103.5 112.42 25.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.916 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.8 p90 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.52 110.903 -179.826 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.536 -0.226 . . . . 55.02 112.536 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -121.61 -176.4 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 74.4 110.921 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.4 m -121.9 108.26 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 75.54 111.103 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.03 149.34 52.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 75.01 110.927 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.683 ' HE3' HG11 ' A' ' 84' ' ' VAL . 1.4 tppm? -163.55 -75.34 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.928 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.578 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -62.27 155.11 25.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 70.14 110.903 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.7 t-20 89.03 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.03 110.834 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.2 m -121.67 121.01 28.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 73.24 111.144 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.621 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.4 Cg_endo -69.76 153.57 68.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.266 . . . . 72.42 112.326 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.4 t -84.48 114.49 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 64.52 111.152 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 p -86.69 167.89 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 55.21 110.862 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 39.75 55.76 2.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 54.13 110.855 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.792 HD11 ' CB ' ' A' ' 97' ' ' LEU . 3.1 mt -58.9 -175.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 75.14 110.884 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.9 p -141.76 138.33 32.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 64.33 111.101 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.96 55.17 0.7 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 73.21 112.477 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -75.84 140.44 42.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 70.11 110.86 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -26.9 5.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 70.22 110.884 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.23 -61.43 0.48 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.78 -0.724 . . . . 64.22 112.455 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -58.16 144.42 40.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 62.33 110.893 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -138.99 170.7 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 70.2 110.845 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.503 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.61 135.55 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 43.51 111.118 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -138.23 154.16 49.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.02 110.886 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -148.0 166.77 26.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.948 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.421 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 58.3 m -137.44 140.45 41.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 54.13 111.132 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -159.95 158.13 30.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 75.14 110.847 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.615 HG22 HG23 ' A' ' 81' ' ' THR . 22.4 p -127.39 170.51 12.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 72.42 111.141 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.882 HG11 ' CE1' ' A' ' 101' ' ' TYR . 31.1 m -109.45 171.02 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 72.41 111.134 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.75 -66.57 0.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 70.13 110.898 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -127.08 149.73 49.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.43 110.879 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -51.02 117.04 2.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 63.42 110.837 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.656 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . . . -141.95 145.12 34.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 61.22 111.095 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -104.77 106.67 17.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 52.14 111.181 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.29 147.23 47.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 73.25 111.111 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.509 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -107.51 112.32 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 71.53 111.179 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.411 HG11 ' HG2' ' A' ' 98' ' ' LYS . 8.8 t -127.5 139.77 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 63.0 111.152 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.471 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 9.9 p -134.68 166.41 22.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 70.43 110.866 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.04 146.41 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 72.33 111.115 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.3 t 177.9 161.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.894 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 165.42 -58.54 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 73.41 112.485 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.49 -120.57 4.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 54.14 112.479 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 m -103.99 161.85 13.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.378 . . . . 52.32 110.861 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.3 84.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.787 -0.72 . . . . 74.55 112.462 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.79 8.75 2.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.358 . . . . 72.31 110.859 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.32 120.12 35.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 74.43 111.067 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.74 143.75 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 72.12 110.849 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 71' ' ' SER . 4.7 tt -103.48 131.34 50.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 52.25 110.905 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -130.65 154.45 47.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 63.25 110.949 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.6 133.63 12.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 52.14 110.863 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -148.95 124.48 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.882 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.58 82.9 7.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 60.3 111.083 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.72 -82.51 0.19 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 51.11 112.508 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 m -109.08 136.92 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 73.13 110.83 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.64 126.01 2.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 64.33 110.919 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 142.58 48.25 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.723 2.282 . . . . 73.22 112.299 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.84 177.98 4.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 62.24 111.151 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 87' ' ' LYS . 58.9 p -62.71 -16.78 58.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 73.05 111.094 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m -116.78 -26.24 7.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 72.01 110.823 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.94 124.11 47.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 72.24 110.845 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.61 153.38 33.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 73.45 110.907 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -107.85 -44.99 4.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 72.03 110.852 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.5 m -145.17 122.21 11.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 54.11 110.879 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -177.38 153.94 1.05 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.604 0.716 . . . . 61.11 110.885 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.526 ' CD ' HD22 ' A' ' 46' ' ' LEU . 54.2 Cg_endo -69.75 -163.67 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.705 2.27 . . . . 70.21 112.313 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -152.1 73.79 1.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 74.43 110.898 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -148.21 -163.23 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 73.24 110.843 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -47.5 -77.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 70.04 110.919 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.15 -89.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 51.42 112.49 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.14 160.91 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 61.02 110.928 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 63.94 16.76 10.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 71.23 110.923 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -127.25 100.09 5.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.872 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.733 ' HA ' HD13 ' A' ' 46' ' ' LEU . 4.9 m -136.77 173.13 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 72.13 110.894 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.71 150.53 38.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 54.11 110.904 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.509 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.4 p -126.09 109.86 12.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 74.21 110.878 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -150.75 148.73 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 63.31 111.134 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.27 102.37 10.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 72.33 110.848 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.712 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.7 151.42 25.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 63.15 111.056 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.69 145.72 31.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 71.23 111.088 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 162.78 40.7 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 65.11 112.347 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.07 -18.5 51.85 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.77 -0.728 . . . . 72.22 112.487 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.9 m -116.87 125.97 52.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 62.13 111.13 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.615 HG23 HG22 ' A' ' 26' ' ' THR . 24.0 m -71.25 137.57 48.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 73.52 111.17 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.712 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 70.2 m-85 -112.46 152.71 28.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 71.25 110.921 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -131.36 159.0 39.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 75.33 110.872 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.683 HG11 ' HE3' ' A' ' 5' ' ' LYS . 22.0 t -132.44 125.46 53.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 72.14 111.151 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.23 124.19 46.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 62.33 110.867 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.526 ' CD1' HD22 ' A' ' 97' ' ' LEU . 24.7 mm -110.54 113.17 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.54 111.122 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HG3' HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -99.97 133.21 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 73.24 110.921 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.22 160.29 16.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 60.44 112.475 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -117.46 -29.79 5.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 73.21 110.953 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 91' ' ' ASN . 97.5 p -168.21 143.54 3.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 63.54 110.783 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' SER . 39.1 t30 -33.04 109.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.505 . . . . 74.14 110.893 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.6 111.69 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 65.55 110.893 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 p -121.67 159.68 26.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 74.45 110.876 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 120.4 22.24 3.17 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.699 -0.762 . . . . 74.45 112.476 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.13 146.22 18.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.921 0.391 . . . . 71.21 111.113 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -101.26 132.54 46.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.51 111.131 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.792 ' CB ' HD11 ' A' ' 13' ' ' LEU . 7.8 tp -121.45 148.79 43.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 55.21 110.899 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HG2' HG11 ' A' ' 35' ' ' VAL . 1.6 ttpt -155.07 170.04 22.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.853 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.659 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.65 140.85 29.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.03 110.896 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.584 ' OE1' HD11 ' A' ' 46' ' ' LEU . 1.7 pm0 -103.1 108.64 19.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.53 110.889 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.882 ' CE1' HG11 ' A' ' 27' ' ' VAL . 3.3 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 63.12 110.932 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.519 -0.232 . . . . 63.22 112.519 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -129.4 -176.98 4.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 63.1 110.931 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.423 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.1 m -117.7 108.39 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.4 111.093 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.98 148.89 52.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 71.33 110.939 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.595 ' NZ ' HD21 ' A' ' 97' ' ' LEU . 17.8 tptt -164.0 -74.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.893 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.659 ' CG ' HD22 ' A' ' 99' ' ' LEU . 12.2 t-20 -65.87 156.66 32.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.31 110.937 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.5 t30 85.61 -69.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 73.24 110.913 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -119.34 120.84 30.6 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.565 0.697 . . . . 73.04 111.137 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 153.54 68.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.656 2.238 . . . . 72.5 112.372 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.685 HG12 HD22 ' A' ' 13' ' ' LEU . 87.4 t -84.05 115.34 26.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.158 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.05 162.07 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 65.52 110.876 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 40.52 65.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 75.35 110.838 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.685 HD22 HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -62.13 -173.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 75.31 110.915 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 p -143.2 139.15 30.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 73.21 111.146 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.77 64.89 0.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.792 -0.718 . . . . 75.24 112.522 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.5 160.49 30.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 72.31 110.876 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 90' ' ' SER . 31.0 mmtp -44.87 -70.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.453 . . . . 62.24 110.909 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.6 -45.59 2.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.68 -0.771 . . . . 73.2 112.496 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.89 151.88 13.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.342 . . . . 75.21 110.849 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.53 -179.4 8.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 74.34 110.896 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -128.56 144.76 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 62.21 111.119 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -137.43 145.27 42.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 71.24 110.852 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -144.09 166.09 25.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 74.04 110.942 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.423 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 2.5 m -141.96 138.58 32.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 72.15 111.128 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 2.0 t80 -160.53 162.98 33.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 74.55 110.882 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.668 HG22 HG23 ' A' ' 81' ' ' THR . 17.3 p -131.7 171.09 13.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.03 111.142 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.2 170.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 60.22 111.159 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -111.98 -39.31 4.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 41.01 110.848 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.95 157.87 45.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.43 110.886 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -79.93 116.45 20.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 65.1 110.891 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.98 142.86 32.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 23.34 111.122 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 32' ' ' THR . 2.5 t -99.17 107.84 20.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 72.22 111.105 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.08 147.23 45.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 74.51 111.098 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.1 p -107.87 111.37 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 71.23 111.165 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.8 t -127.83 140.33 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.35 111.13 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.502 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 2.0 p -132.36 167.16 20.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.854 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.455 HD11 ' H ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -110.38 142.66 22.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 74.53 111.121 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 p -179.32 -169.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 53.2 110.84 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.13 -147.92 19.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 74.11 112.518 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.44 -48.12 31.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.704 -0.76 . . . . 53.42 112.496 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.559 ' O ' HG22 ' A' ' 95' ' ' VAL . 4.4 m -107.05 163.96 12.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.368 . . . . 72.32 110.837 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.45 -130.5 2.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 54.12 112.455 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 60.04 30.21 19.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 74.44 110.863 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.56 108.38 14.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.04 111.069 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.0 144.58 54.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.853 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 71' ' ' SER . 5.9 tt -112.46 126.94 55.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 73.14 110.945 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -136.41 148.84 47.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 71.23 110.907 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.95 133.81 13.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 71.24 110.938 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -141.96 140.04 32.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.04 110.899 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.74 -48.45 13.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 72.23 111.148 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.61 -96.86 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 73.11 112.503 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -106.79 162.38 13.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.917 0.389 . . . . 62.12 110.828 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HA ' ' CB ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -45.12 128.35 5.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.575 0.702 . . . . 52.35 110.906 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 142.35 47.22 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.654 2.236 . . . . 41.42 112.305 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -113.42 179.77 3.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 55.44 111.15 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.5 p -60.96 -16.75 46.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 71.25 111.14 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -117.11 -26.03 6.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 74.04 110.848 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 124.94 49.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 73.32 110.862 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.34 152.97 31.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.92 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -114.76 -31.5 6.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 70.25 110.86 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.8 m -141.89 121.89 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.872 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.58 122.7 0.13 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.625 0.726 . . . . 71.03 110.855 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 53.6 Cg_endo -69.79 4.76 2.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.649 2.233 . . . . 33.25 112.325 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.409 ' CG ' ' C ' ' A' ' 63' ' ' PRO . 5.6 p90 38.73 72.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 71.33 110.945 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.49 -65.28 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 73.31 110.89 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.19 -166.39 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 75.3 110.911 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.14 -103.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 63.43 112.459 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -68.36 167.73 13.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 62.44 110.876 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.7 t30 64.13 14.61 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 60.34 110.914 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -126.88 98.1 5.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 41.4 110.876 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.502 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 3.5 m -135.81 171.43 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 71.44 110.862 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.83 150.86 38.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 72.34 110.907 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 34' ' ' VAL . 1.2 p -128.47 108.48 10.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 65.04 110.873 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -151.08 148.7 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 75.54 111.163 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.28 106.37 6.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 35.12 110.876 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.645 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -83.33 145.25 29.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 70.3 111.03 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.19 139.38 21.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 50.24 111.087 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 133.56 25.9 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.708 2.272 . . . . 62.25 112.326 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.88 -20.06 2.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 72.31 112.462 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.2 m -126.51 134.95 50.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.371 . . . . 60.32 111.15 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.668 HG23 HG22 ' A' ' 26' ' ' THR . 23.6 m -71.07 137.6 49.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 64.42 111.156 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.645 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 32.5 m-85 -104.77 139.6 39.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 73.55 110.948 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.405 ' CB ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -107.18 161.24 14.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 60.25 110.823 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.91 138.17 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 75.51 111.15 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.7 tpt -142.98 123.27 13.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 70.41 110.923 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.405 ' HB ' HG23 ' A' ' 21' ' ' VAL . 19.9 mm -118.95 112.15 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 71.22 111.094 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -95.77 157.18 16.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 63.14 110.924 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.34 145.95 16.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 75.14 112.467 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -112.16 -21.71 11.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 72.31 110.868 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 91' ' ' ASN . 7.1 p -165.74 127.97 2.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 70.43 110.877 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 90' ' ' SER . 9.1 t-20 -35.38 106.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 54.31 110.894 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.42 115.63 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.932 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 p -115.87 151.85 34.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 51.21 110.86 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.47 28.26 0.92 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.747 -0.74 . . . . 50.32 112.519 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 41' ' ' SER . 0.2 OUTLIER -113.33 147.38 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.961 0.41 . . . . 61.5 111.088 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.03 114.14 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 74.4 111.107 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.67 ' HB3' HD21 ' A' ' 13' ' ' LEU . 1.7 tm? -104.25 132.78 50.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 55.12 110.935 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.651 ' N ' HD22 ' A' ' 97' ' ' LEU . 4.4 ttpt -144.18 163.72 32.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 71.23 110.832 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.659 HD22 ' CG ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -91.69 140.67 29.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 62.12 110.9 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.81 113.04 24.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.25 110.925 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.0 p90 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 74.32 110.953 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.481 -0.248 . . . . 53.1 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -90.88 -174.72 4.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 74.43 110.923 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 24' ' ' THR . 3.1 m -120.32 108.85 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.31 111.125 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.45 148.72 52.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.13 110.893 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.634 ' CD ' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -157.46 -69.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 55.0 110.859 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.574 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 8.6 t-20 -77.68 158.73 29.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 41.14 110.904 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.574 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.4 t30 88.38 -68.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.918 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.7 m -123.4 113.73 29.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.552 0.691 . . . . 72.31 111.129 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.408 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.4 Cg_endo -69.76 150.28 68.0 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 74.41 112.34 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.563 HG12 HD22 ' A' ' 13' ' ' LEU . 76.5 t -77.99 113.8 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 73.03 111.091 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.21 140.02 41.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 71.54 110.854 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.35 84.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 74.12 110.89 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -72.35 -167.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 63.13 110.886 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 p -139.05 138.56 37.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 62.42 111.135 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.69 60.3 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 65.2 112.474 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -76.02 158.4 31.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 64.04 110.857 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.03 -61.23 2.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.857 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.72 -50.63 1.94 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 75.41 112.503 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.74 140.63 14.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 73.41 110.88 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -141.19 170.46 15.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 43.54 110.859 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.29 137.06 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 64.44 111.161 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.25 152.27 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 54.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -143.34 165.56 27.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 63.53 110.934 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 3.2 m -135.24 139.07 44.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 75.14 111.125 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -160.01 162.58 34.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 71.54 110.863 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 81' ' ' THR . 20.4 p -136.72 171.04 15.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 73.33 111.154 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.732 HG11 ' CE1' ' A' ' 101' ' ' TYR . 22.3 m -108.38 172.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 70.2 111.123 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.6 -57.61 2.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 64.05 110.865 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.19 140.43 51.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 71.24 110.859 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -48.78 118.87 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 65.15 110.906 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.39 131.15 27.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 72.25 111.125 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 32' ' ' THR . 3.0 t -94.68 106.58 18.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 71.13 111.146 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.541 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -140.09 147.77 40.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.03 111.052 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.777 HG23 ' HB3' ' A' ' 73' ' ' SER . 2.8 p -113.9 109.24 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.13 111.157 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.82 HG11 ' HG2' ' A' ' 98' ' ' LYS . 3.7 t -130.95 141.19 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 73.34 111.153 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.495 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 29.1 p -129.12 167.68 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.41 110.873 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.492 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -109.96 147.18 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 64.12 111.132 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.22 163.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 62.44 110.914 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 176.08 -30.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.796 -0.716 . . . . 73.44 112.517 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.11 -117.2 1.1 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 50.22 112.496 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -113.93 161.3 17.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 63.22 110.858 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.04 126.08 29.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.503 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -170.81 -37.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.341 . . . . 72.2 110.905 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.12 128.59 46.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 52.33 111.104 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -102.45 124.49 48.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 75.01 110.905 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 71' ' ' SER . 0.9 OUTLIER -92.11 130.1 37.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.257 -0.429 . . . . 54.53 110.865 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -132.58 148.89 52.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.899 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -146.34 142.79 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 63.31 110.858 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.572 ' H ' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -151.91 117.72 5.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.926 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.52 123.92 20.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 64.4 111.115 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 -82.83 0.8 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 12.24 112.49 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.9 m -93.67 -179.19 4.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.952 0.406 . . . . 63.14 110.858 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 134.72 28.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 71.03 110.862 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 141.51 45.28 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 70.52 112.325 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 p -102.5 179.03 4.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 65.23 111.131 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.1 p -65.63 -13.7 59.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 54.11 111.145 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 m -121.36 -26.46 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 44.21 110.861 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.83 126.22 49.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 60.13 110.852 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.37 153.47 34.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 74.1 110.892 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -108.89 -29.11 8.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 75.53 110.844 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.9 m -136.93 124.0 21.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 60.33 110.88 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HG3' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -174.74 126.57 0.4 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.611 0.72 . . . . 73.54 110.904 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HD2' ' HG3' ' A' ' 62' ' ' ARG . 54.2 Cg_endo -69.77 -2.94 11.03 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.647 2.231 . . . . 63.43 112.363 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 70.15 92.18 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 75.12 110.916 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.94 -168.92 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 65.14 110.865 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.57 128.1 36.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.15 110.925 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.95 -178.75 36.34 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 74.41 112.488 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -172.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.803 0.335 . . . . 65.4 110.873 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.2 t30 63.94 19.63 11.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 73.41 110.862 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -123.16 88.74 2.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 75.02 110.907 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.614 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.5 m -132.23 170.16 15.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.54 110.852 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.24 154.01 34.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 55.23 110.899 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.777 ' HB3' HG23 ' A' ' 34' ' ' VAL . 89.7 p -128.25 104.19 7.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 74.04 110.834 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -152.22 152.73 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 72.52 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.1 p -84.32 104.39 14.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 75.03 110.884 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.767 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -81.68 154.72 25.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 74.41 111.066 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.39 139.71 20.42 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.629 0.728 . . . . 73.1 111.086 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.495 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.9 Cg_endo -69.78 140.03 41.62 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.702 2.268 . . . . 53.02 112.328 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.26 -6.18 9.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.724 -0.751 . . . . 73.25 112.51 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.5 m -126.41 129.6 49.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 73.21 111.127 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.48 ' HA ' HG22 ' A' ' 26' ' ' THR . 6.2 m -72.46 136.86 46.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 55.02 111.139 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.767 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 39.8 m-85 -111.88 134.44 53.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.936 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -106.07 162.76 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 62.41 110.863 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.634 HG21 ' CD ' ' A' ' 5' ' ' LYS . 73.2 t -134.79 140.0 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 54.24 111.129 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.13 121.07 14.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.11 110.894 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.604 HD11 HD22 ' A' ' 97' ' ' LEU . 14.8 mm -111.16 113.13 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 74.42 111.131 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 135.62 41.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 70.2 110.914 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.38 157.24 15.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.757 . . . . 61.05 112.486 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -117.12 -28.04 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.946 0.403 . . . . 73.21 110.904 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 91' ' ' ASN . 73.2 p -166.88 136.06 2.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 70.22 110.882 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 90' ' ' SER . 3.1 m120 -31.75 105.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 64.21 110.866 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -162.78 113.07 1.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 70.21 110.942 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.7 p -121.51 159.83 25.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 63.5 110.851 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.03 19.46 2.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.747 . . . . 74.21 112.532 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.42 141.45 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 65.14 111.169 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.7 m -99.32 122.84 43.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 60.23 111.141 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 86' ' ' ILE . 19.2 tp -102.04 142.7 32.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.877 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.82 ' HG2' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -151.22 153.0 34.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 72.35 110.946 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.644 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -88.52 140.85 29.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 73.12 110.895 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -93.9 113.66 25.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 74.05 110.889 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.732 ' CE1' HG11 ' A' ' 27' ' ' VAL . 4.9 t80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 71.33 110.959 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.503 -0.239 . . . . 63.24 112.503 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -104.72 -176.34 3.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 64.31 110.93 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.1 m -117.47 109.42 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 65.24 111.113 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.48 148.48 52.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 65.43 110.95 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.602 ' CD ' HD11 ' A' ' 97' ' ' LEU . 15.4 tptm -164.74 -65.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 64.43 110.914 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.635 ' OD1' HD22 ' A' ' 99' ' ' LEU . 8.4 t-20 -77.92 155.74 30.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 62.3 110.869 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 10.3 t-20 87.2 -68.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.22 110.867 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.5 m -121.5 120.89 28.64 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.594 0.712 . . . . 74.53 111.138 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 153.82 68.17 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.695 2.263 . . . . 73.43 112.327 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.6 t -83.21 115.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 73.25 111.076 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.07 142.25 31.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 75.32 110.864 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.28 86.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 74.21 110.906 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -79.88 -171.97 3.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 62.44 110.884 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 p -139.41 139.47 37.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 54.23 111.162 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.45 69.99 0.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 73.21 112.507 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -76.42 153.55 35.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 74.55 110.865 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.4 -34.29 23.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.879 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.66 -52.72 0.25 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 53.14 112.477 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 t -52.56 168.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 53.0 110.817 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.84 175.6 3.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 74.24 110.893 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -132.31 144.67 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 74.21 111.096 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -136.91 128.14 28.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 73.11 110.87 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -127.45 164.64 21.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 72.54 110.895 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.414 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 2.4 m -141.06 143.42 34.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 72.21 111.14 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -160.27 163.33 33.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 74.21 110.878 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.537 HG22 HG23 ' A' ' 81' ' ' THR . 18.8 p -132.5 170.31 15.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 54.21 111.117 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.511 HG11 ' HB1' ' A' ' 76' ' ' ALA . 13.6 m -109.2 167.47 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 72.42 111.12 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -97.43 -48.59 5.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.51 110.852 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 165.31 27.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 73.53 110.873 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -56.7 117.91 4.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 70.0 110.868 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.54 120.91 12.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 75.04 111.09 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 32' ' ' THR . 2.5 t -98.33 105.55 17.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 73.54 111.108 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.605 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -137.38 147.5 45.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 74.5 111.099 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.695 HG22 ' CB ' ' A' ' 73' ' ' SER . 96.8 t -108.49 110.6 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 62.15 111.137 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.432 HG11 ' HE3' ' A' ' 98' ' ' LYS . 21.7 t -127.3 141.11 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 64.01 111.12 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.48 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.62 166.49 17.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.45 110.851 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.44 147.33 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 73.4 111.168 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.93 172.09 2.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 62.13 110.85 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.38 -22.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.764 -0.732 . . . . 51.05 112.512 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.53 -104.01 0.23 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 31.12 112.485 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.3 m -130.17 155.1 46.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.953 0.406 . . . . 50.43 110.896 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -50.88 122.18 13.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 62.03 112.464 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -161.28 -38.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.833 0.349 . . . . 54.54 110.885 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.06 124.9 45.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.14 111.046 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.7 152.02 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 60.42 110.887 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.643 HD13 ' HA ' ' A' ' 71' ' ' SER . 2.4 tt -106.93 127.02 53.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 64.34 110.894 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -136.49 142.61 43.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.934 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -154.12 135.7 14.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 54.34 110.914 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.481 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.2 tttm -140.81 121.56 14.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.939 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.35 77.54 9.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.23 111.082 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.72 -59.98 0.3 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 62.31 112.454 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 m -142.21 141.78 32.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.964 0.412 . . . . 51.55 110.834 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.73 120.15 1.4 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.574 0.702 . . . . 72.01 110.899 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 143.4 51.19 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.68 2.254 . . . . 55.31 112.38 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.35 178.31 4.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 65.32 111.138 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.0 p -61.48 -17.32 54.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 72.42 111.135 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 t -114.14 -26.86 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.844 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.86 123.49 47.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 72.25 110.891 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.23 153.58 32.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 74.53 110.945 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -110.71 -33.51 6.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.886 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.2 m -134.12 123.23 24.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 44.43 110.893 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -179.58 126.16 0.24 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.72 . . . . 72.01 110.887 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 64' ' ' TYR . 53.8 Cg_endo -69.73 -5.9 17.29 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.74 2.293 . . . . 63.12 112.352 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' PRO . 19.7 p90 38.08 42.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 70.2 110.903 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.89 -34.32 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 74.42 110.895 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 178.38 -177.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 64.23 110.962 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.66 -106.42 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 42.32 112.497 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.42 160.67 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 74.35 110.872 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 67.11 13.59 9.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 74.32 110.836 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.05 101.97 6.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 73.55 110.844 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.643 ' HA ' HD13 ' A' ' 46' ' ' LEU . 10.6 m -133.75 175.02 9.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 73.24 110.876 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.66 158.76 24.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 54.21 110.916 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.695 ' CB ' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -127.64 113.89 16.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.863 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 t -146.38 158.37 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.491 . . . . 73.21 111.143 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.9 p -78.33 129.63 35.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 50.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.734 ' HB2' ' CG ' ' A' ' 101' ' ' TYR . . . -78.9 151.54 31.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 73.13 111.051 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.05 121.57 18.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.556 0.693 . . . . 63.11 111.117 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 115.78 4.25 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.694 2.262 . . . . 74.54 112.331 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.96 -11.62 3.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 74.24 112.475 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.3 m -126.18 127.31 45.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.885 0.374 . . . . 63.31 111.092 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.537 HG23 HG22 ' A' ' 26' ' ' THR . 6.9 m -70.71 137.52 49.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 64.25 111.168 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -106.02 133.41 50.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 70.22 110.953 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -104.74 161.18 14.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 71.13 110.813 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.418 HG11 ' HE3' ' A' ' 5' ' ' LYS . 2.8 t -137.9 138.05 44.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 62.1 111.131 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -138.29 122.21 17.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 64.45 110.851 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 21' ' ' VAL . 26.8 mm -114.1 112.28 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 72.33 111.088 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.64 140.29 40.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 75.12 110.896 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -114.85 156.06 15.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.753 . . . . 63.03 112.464 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -114.34 -21.54 10.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.897 0.38 . . . . 71.13 110.921 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -161.35 128.2 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 64.13 110.874 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 90' ' ' SER . 15.2 t-20 -31.61 106.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 75.44 110.912 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -157.65 112.81 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 71.4 110.883 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 p -121.37 154.58 36.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.509 . . . . 55.02 110.835 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.46 20.88 2.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.716 -0.754 . . . . 75.24 112.492 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.26 147.23 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 74.12 111.177 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m -97.61 121.97 40.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 70.33 111.138 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.768 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -111.72 125.16 53.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 71.15 110.946 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.768 ' N ' HD22 ' A' ' 97' ' ' LEU . 8.5 ttpt -133.94 167.03 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 71.34 110.86 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -85.99 137.16 32.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.908 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.575 ' NE2' HD11 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -100.19 108.66 20.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 72.03 110.942 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.734 ' CG ' ' HB2' ' A' ' 76' ' ' ALA . 6.4 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.22 110.912 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.496 -0.241 . . . . 73.34 112.496 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -104.76 -175.82 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 74.2 110.918 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.7 m -116.52 108.2 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 73.33 111.142 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.65 149.14 52.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.31 110.907 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.648 ' CE ' HD11 ' A' ' 97' ' ' LEU . 19.8 tptm -164.05 -71.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 74.43 110.846 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 10.1 t-20 -68.32 157.8 34.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 73.42 110.912 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.3 t30 86.72 -68.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 70.14 110.943 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.5 m -125.15 119.68 25.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.537 0.685 . . . . 75.35 111.161 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 150.64 68.52 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.679 2.252 . . . . 74.45 112.372 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.411 ' HB ' HD21 ' A' ' 13' ' ' LEU . 60.9 t -77.99 115.77 20.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 71.41 111.119 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.59 143.9 31.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 64.44 110.835 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.23 80.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 60.14 110.879 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.411 HD21 ' HB ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -75.55 -172.77 1.93 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.477 . . . . 73.12 110.938 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 p -132.74 138.39 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.1 111.102 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.33 53.71 0.75 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.775 -0.726 . . . . 54.22 112.502 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -76.27 140.97 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 73.33 110.9 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -28.38 6.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.917 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.82 -64.61 0.41 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 62.23 112.443 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -52.22 134.14 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 62.41 110.844 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -131.21 172.58 11.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 73.1 110.894 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.465 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.22 138.53 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 72.03 111.109 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -136.66 147.08 46.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 73.31 110.894 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -143.59 164.82 29.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 73.03 110.926 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.442 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -138.28 139.77 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.18 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -159.53 162.8 35.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.855 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.694 ' CG2' HG23 ' A' ' 81' ' ' THR . 15.0 p -133.1 171.11 14.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 54.2 111.131 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -108.3 169.28 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.43 111.181 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -98.37 -48.86 4.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.898 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.67 173.34 11.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.841 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -80.0 117.2 20.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 74.13 110.913 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.11 144.59 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 72.05 111.086 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 32' ' ' THR . 2.3 t -104.59 106.4 16.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.425 . . . . 65.34 111.18 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.93 147.79 46.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 65.33 111.095 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -108.11 111.81 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 70.54 111.113 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.401 HG11 ' HG2' ' A' ' 98' ' ' LYS . 84.6 t -126.75 140.83 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 65.43 111.097 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.484 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 10.7 p -133.31 166.5 22.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 33.22 110.849 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.81 144.58 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 71.54 111.161 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.98 -174.99 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 72.32 110.901 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.21 -127.17 1.83 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.75 -0.738 . . . . 51.21 112.523 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.09 -23.84 9.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 64.21 112.487 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 95' ' ' VAL . 7.1 p -130.66 163.93 26.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 72.43 110.849 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.02 -135.33 4.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.729 . . . . 53.41 112.532 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 69.5 22.74 6.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.847 0.356 . . . . 43.43 110.861 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.48 114.75 26.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 63.44 111.115 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.11 135.67 36.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 71.32 110.891 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' A' ' 71' ' ' SER . 4.6 tt -102.34 126.84 49.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 71.52 110.893 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -134.61 149.0 50.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.91 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.429 HD12 ' NE2' ' A' ' 100' ' ' GLN . 0.4 OUTLIER -155.14 133.32 11.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 54.32 110.954 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HG2' ' HB2' ' A' ' 60' ' ' ASP . 11.5 tttt -144.86 123.42 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.4 110.851 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.36 71.59 7.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.1 111.116 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.46 -83.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 75.1 112.481 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -110.54 141.57 43.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.365 . . . . 73.43 110.917 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.19 121.85 3.15 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.609 0.719 . . . . 74.25 110.864 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 142.49 48.1 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.712 2.275 . . . . 71.51 112.335 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -109.66 178.74 4.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 65.42 111.142 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.1 p -60.07 -17.7 41.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.159 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 t -114.8 -26.3 7.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.32 110.85 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.86 124.19 47.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 54.11 110.847 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.99 153.22 32.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.105 -0.498 . . . . 75.24 110.909 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB2' ' HG2' ' A' ' 49' ' ' LYS . 8.1 t70 -115.67 -35.33 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 72.42 110.856 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.8 m -143.76 125.12 14.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 72.43 110.854 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 64' ' ' TYR . 1.4 ptt-85 179.65 157.08 0.72 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.658 0.742 . . . . 73.21 110.824 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 33.17 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.661 2.24 . . . . 64.45 112.321 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.476 ' H ' ' C ' ' A' ' 62' ' ' ARG . 0.1 OUTLIER 41.3 40.5 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.919 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.418 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -172.68 -176.2 1.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 71.55 110.932 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -128.74 153.57 47.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.931 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.19 140.93 6.2 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 60.4 112.496 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -51.12 169.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 65.45 110.851 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.77 14.14 9.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.959 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.418 ' HG2' ' HG2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -130.88 105.67 7.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 73.3 110.909 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.51 ' HA ' HD13 ' A' ' 46' ' ' LEU . 13.0 m -136.59 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 53.12 110.831 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.03 153.75 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 64.52 110.846 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 34' ' ' VAL . 1.1 p -128.24 110.28 12.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 62.13 110.901 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 t -149.31 153.11 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 73.35 111.119 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.4 p -73.3 110.85 7.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 63.32 110.854 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.441 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.4 130.79 35.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 53.44 111.103 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.33 139.23 20.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.59 0.709 . . . . 62.1 111.126 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 160.21 50.57 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.701 2.267 . . . . 74.44 112.328 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.5 -18.95 56.01 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.776 -0.726 . . . . 45.22 112.51 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 m -111.94 122.84 48.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.87 0.367 . . . . 71.25 111.163 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.694 HG23 ' CG2' ' A' ' 26' ' ' THR . 10.4 m -71.24 136.27 47.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 72.14 111.152 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.441 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 60.4 m-85 -103.76 141.68 35.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 72.24 110.928 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -107.36 160.75 15.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 71.04 110.837 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG11 ' HD3' ' A' ' 5' ' ' LYS . 2.4 t -138.19 138.36 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 73.34 111.108 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.89 122.98 13.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 71.42 110.88 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.465 ' HB ' HG23 ' A' ' 21' ' ' VAL . 18.0 mm -118.04 112.6 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.24 111.139 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -104.48 130.44 52.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.906 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.37 161.03 21.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.759 -0.734 . . . . 53.21 112.452 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.25 -28.59 5.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 72.5 110.923 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.51 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -166.56 132.64 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 64.23 110.817 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 90' ' ' SER . 1.5 p-10 -28.35 115.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 72.55 110.878 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.4 113.85 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.41 110.94 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 p -121.55 156.59 32.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 72.42 110.847 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.02 23.12 1.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 75.43 112.489 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 41' ' ' SER . 0.2 OUTLIER -112.04 145.98 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.962 0.41 . . . . 75.02 111.098 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.7 m -99.29 114.73 27.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 53.4 111.137 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.769 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -104.69 125.58 50.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 63.03 110.931 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.769 ' N ' HD22 ' A' ' 97' ' ' LEU . 5.1 ttpt -133.41 165.09 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 74.11 110.934 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.59 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.46 138.5 31.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.41 110.92 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.438 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 1.4 pm0 -98.87 112.84 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 73.44 110.93 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.9 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 60.53 110.929 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.494 -0.242 . . . . 65.42 112.494 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -133.09 -175.89 3.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 73.31 110.912 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.9 m -118.46 108.57 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 75.55 111.15 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.58 147.84 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 63.24 110.978 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.444 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 17.9 tptt -158.49 -39.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.871 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.638 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -108.24 158.1 17.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 72.41 110.95 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 5.9 t30 90.04 -68.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.34 110.883 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.4 m -126.34 113.83 23.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.576 0.703 . . . . 72.31 111.135 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.7 Cg_endo -69.78 153.51 68.76 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.658 2.239 . . . . 73.13 112.372 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.25 113.18 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 75.22 111.124 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.11 149.4 28.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 72.44 110.864 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 47.33 66.59 0.97 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 74.51 110.86 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -67.05 -174.16 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 74.12 110.902 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 p -131.14 138.24 49.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 73.34 111.188 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.64 57.19 0.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 74.21 112.489 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -75.65 139.35 41.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 34.13 110.921 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -27.6 7.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.87 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.12 -60.63 0.5 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 73.4 112.479 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.84 140.68 51.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 55.22 110.872 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -135.85 170.26 16.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.915 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.577 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.46 139.11 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 75.24 111.111 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -137.01 145.17 43.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 73.11 110.886 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -142.09 165.84 26.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.923 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.426 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 51.9 m -146.12 142.12 28.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 72.23 111.148 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 4.1 t80 -160.49 162.56 33.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 71.13 110.917 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.623 HG22 HG23 ' A' ' 81' ' ' THR . 18.1 p -128.88 170.44 13.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 71.32 111.164 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.754 HG11 ' CE1' ' A' ' 101' ' ' TYR . 15.9 m -108.12 173.26 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 63.43 111.146 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -110.44 -59.32 1.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.845 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.64 140.9 51.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 64.1 110.855 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -50.15 119.91 4.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.844 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.36 129.86 25.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.33 111.074 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 75' ' ' SER . 21.2 m -94.28 106.17 18.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 63.44 111.156 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.621 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -140.87 150.97 43.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.51 111.155 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.4 p -103.75 112.04 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 73.43 111.143 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.551 HG11 ' CG ' ' A' ' 98' ' ' LYS . 5.3 t -127.17 141.79 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 54.2 111.1 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 8.0 p -142.09 171.45 14.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 43.34 110.87 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.689 HD13 HD12 ' A' ' 46' ' ' LEU . 5.3 pt -107.04 158.69 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 74.24 111.128 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.56 165.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 73.24 110.88 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.39 -87.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 64.44 112.524 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.86 -116.51 4.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.725 -0.75 . . . . 74.14 112.505 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 m -104.99 161.23 14.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 72.21 110.889 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.39 133.17 51.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 35.13 112.486 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.35 -38.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.804 0.335 . . . . 71.11 110.868 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.68 111.58 23.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 44.31 111.11 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -80.26 164.55 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 55.23 110.819 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.689 HD12 HD13 ' A' ' 37' ' ' ILE . 8.5 tt -124.18 138.43 54.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 72.25 110.879 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.524 ' N ' HD23 ' A' ' 46' ' ' LEU . 94.9 m-85 -152.63 133.58 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 73.11 110.932 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp -139.26 153.02 47.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 62.33 110.904 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -156.36 145.99 20.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 75.24 110.912 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.66 101.56 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 61.2 111.086 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.84 -92.98 0.75 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 41.14 112.517 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 m -82.83 129.26 34.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.994 0.426 . . . . 61.1 110.837 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.44 137.12 5.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.554 0.692 . . . . 73.1 110.912 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.73 51.74 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.672 2.248 . . . . 73.41 112.33 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -101.38 178.54 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 74.22 111.155 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 p -64.94 -14.39 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 71.32 111.16 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.5 t -120.31 -26.14 5.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 60.2 110.899 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.75 125.48 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 74.43 110.876 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.64 153.59 34.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.925 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -110.71 -23.17 11.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 64.41 110.821 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.0 m -143.64 122.71 12.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 64.21 110.867 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 177.9 117.26 0.18 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 65.44 110.903 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HG2' ' CG ' ' A' ' 70' ' ' GLU . 53.7 Cg_endo -69.75 -18.07 37.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.671 2.247 . . . . 73.31 112.36 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.7 t80 62.62 87.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 73.04 110.916 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -132.41 -80.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 74.4 110.908 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.5 t80 177.38 107.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 74.13 110.948 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 49.69 -128.29 24.46 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 73.2 112.471 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.28 179.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 65.53 110.899 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.6 t30 53.79 27.9 7.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 70.33 110.923 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.4 ' CG ' ' HG2' ' A' ' 63' ' ' PRO . 3.3 tt0 -131.15 81.27 1.98 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 64.25 110.876 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.654 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -132.51 170.75 14.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 72.23 110.877 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -119.28 156.91 29.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 35.21 110.898 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.455 ' HB3' HG23 ' A' ' 34' ' ' VAL . 81.0 p -128.94 106.77 9.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 73.03 110.87 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -151.75 153.25 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 62.22 111.12 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.446 ' HB3' HG23 ' A' ' 32' ' ' THR . 83.8 p -84.93 107.68 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.888 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.683 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.09 154.9 25.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 60.31 111.077 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.17 138.57 19.56 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.549 0.69 . . . . 72.21 111.134 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.525 ' HA ' HG23 ' A' ' 27' ' ' VAL . 54.0 Cg_endo -69.72 134.23 27.56 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.694 2.262 . . . . 71.04 112.388 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.9 -21.98 4.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 23.15 112.505 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.9 m -114.3 131.68 56.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 72.13 111.142 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.623 HG23 HG22 ' A' ' 26' ' ' THR . 4.8 m -71.95 137.38 47.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 73.33 111.186 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.683 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 62.6 m-85 -112.05 133.0 54.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 75.34 110.921 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -107.08 161.19 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 52.41 110.892 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.416 HG21 ' HB2' ' A' ' 5' ' ' LYS . 2.1 t -137.08 138.35 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 74.45 111.148 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 tpt -134.82 122.84 22.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.876 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 21' ' ' VAL . 25.3 mm -112.5 116.01 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 74.31 111.134 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 145.54 29.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 62.33 110.864 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -113.45 151.74 18.23 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 71.42 112.457 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -107.33 -28.13 10.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 72.21 110.878 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.466 ' O ' ' C ' ' A' ' 91' ' ' ASN . 88.5 p -175.37 144.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 52.42 110.877 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 90' ' ' SER . 3.0 p30 -32.64 105.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.492 . . . . 63.41 110.942 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -166.77 118.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.897 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.9 p -122.01 160.82 24.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 61.33 110.852 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.36 23.44 2.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 44.33 112.475 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.528 ' O ' HD12 ' A' ' 13' ' ' LEU . 3.1 t -113.81 146.58 18.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.887 0.375 . . . . 64.35 111.156 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -106.86 135.06 49.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 72.33 111.146 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.699 ' C ' HD13 ' A' ' 97' ' ' LEU . 2.5 tm? -118.58 128.03 54.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 64.43 110.866 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.551 ' CG ' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -138.12 154.65 49.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 62.23 110.929 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.644 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -87.3 145.1 26.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 62.23 110.904 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.487 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -94.86 112.98 24.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 72.44 110.978 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.754 ' CE1' HG11 ' A' ' 27' ' ' VAL . 2.3 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.926 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.491 -0.244 . . . . 74.23 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -152.16 -173.34 4.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.834 0.349 . . . . 64.52 110.894 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.413 ' HB ' ' H ' ' A' ' 24' ' ' THR . 2.4 m -121.77 109.16 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 70.42 111.135 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.27 149.01 52.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 72.42 110.916 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.628 ' HE3' HD11 ' A' ' 97' ' ' LEU . 2.2 tppm? -155.73 -73.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 65.0 110.907 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.8 t-20 -64.22 158.66 22.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.03 110.874 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.6 t30 91.21 -68.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 73.55 110.886 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 m -132.71 121.79 17.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.576 0.703 . . . . 51.53 111.155 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.658 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.7 Cg_endo -69.8 154.85 67.1 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 71.51 112.341 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.44 115.36 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 73.33 111.136 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.49 166.39 13.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 70.0 110.872 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 39.97 52.05 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 73.34 110.876 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.758 HD11 ' CB ' ' A' ' 97' ' ' LEU . 2.4 mt -57.84 -178.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 71.31 110.944 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 p -137.19 138.15 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 61.22 111.078 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.66 56.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.751 . . . . 35.25 112.493 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -74.79 150.96 39.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 74.54 110.902 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.71 -33.49 10.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.872 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.59 -57.84 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.715 -0.755 . . . . 75.42 112.496 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.77 139.04 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 72.11 110.863 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -139.01 175.01 9.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 62.13 110.907 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.573 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.97 135.65 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 62.23 111.158 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -138.87 149.81 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.2 110.902 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -145.96 166.36 26.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 74.33 110.929 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.499 HG23 ' CD2' ' A' ' 83' ' ' HIS . 58.5 m -138.75 138.91 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 64.13 111.142 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CB ' ' HB3' ' A' ' 5' ' ' LYS . 2.3 t80 -160.94 153.17 20.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 74.44 110.915 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 81' ' ' THR . 10.9 p -127.92 170.44 12.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 71.11 111.14 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' A' ' 101' ' ' TYR . 13.9 m -113.02 170.83 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 64.54 111.109 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.15 11.45 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 65.53 110.84 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.58 137.79 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 74.45 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.406 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 3.0 p30 -72.85 118.85 16.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 64.03 110.871 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.31 145.57 37.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 61.13 111.094 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 32' ' ' THR . 1.8 t -107.92 104.95 14.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 72.14 111.1 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 101' ' ' TYR . . . -139.57 149.1 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.35 111.117 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.624 HG22 ' CB ' ' A' ' 73' ' ' SER . 90.9 t -113.63 111.85 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 63.54 111.113 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.01 140.86 47.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 53.3 111.078 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.507 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 6.0 p -124.86 166.74 15.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 60.04 110.826 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.47 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -111.21 151.07 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 71.35 111.136 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.53 168.0 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.866 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.77 -24.15 0.23 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 53.42 112.499 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.67 -120.01 1.28 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 51.23 112.457 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 m -119.41 162.46 18.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 54.13 110.85 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -50.29 103.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 63.42 112.515 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.01 -40.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 63.55 110.867 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.65 117.16 29.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 74.31 111.109 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -85.23 163.83 18.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 73.44 110.889 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.68 HD13 ' HA ' ' A' ' 71' ' ' SER . 6.3 tt -120.31 127.56 52.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.01 110.924 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -137.63 153.23 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 62.22 110.889 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 49' ' ' LYS . 1.5 tt -154.34 140.46 18.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 75.31 110.923 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.591 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -148.17 141.55 25.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 75.21 110.923 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.35 126.97 35.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 44.42 111.11 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.85 -61.02 0.83 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 54.33 112.527 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.75 -173.03 2.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.955 0.407 . . . . 63.43 110.837 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 134.13 30.56 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.566 0.698 . . . . 53.12 110.925 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 143.38 50.82 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.708 2.272 . . . . 74.12 112.32 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 p -104.49 178.71 4.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 65.54 111.123 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.9 p -64.03 -15.14 58.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 70.25 111.168 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.0 m -119.84 -26.06 5.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.864 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.11 126.08 48.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 72.11 110.843 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.99 154.03 36.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 72.1 110.888 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -115.88 -34.52 4.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 72.05 110.864 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.2 m -145.39 124.42 12.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 65.22 110.886 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.16 150.18 1.23 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 74.45 110.921 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 -5.72 16.87 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.714 2.276 . . . . 41.32 112.318 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 69.62 68.32 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.926 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -172.96 -173.92 1.02 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 64.24 110.861 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -135.36 137.65 42.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.33 110.924 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.65 162.66 21.43 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.742 -0.742 . . . . 54.4 112.432 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.1 179.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.339 . . . . 61.04 110.918 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.99 16.06 9.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 65.31 110.873 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -127.44 96.88 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 71.15 110.87 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.68 ' HA ' HD13 ' A' ' 46' ' ' LEU . 1.4 m -134.78 170.73 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 54.02 110.91 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.79 162.62 19.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 71.35 110.863 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.624 ' CB ' HG22 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -131.37 111.62 12.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 75.12 110.886 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.7 t -149.11 153.65 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 72.01 111.171 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.3 p -94.28 105.74 17.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 65.44 110.913 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.785 ' HB3' ' CD2' ' A' ' 101' ' ' TYR . . . -86.39 152.19 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 75.54 111.08 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.21 142.73 26.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.572 0.701 . . . . 71.02 111.119 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.3 Cg_endo -69.78 120.57 7.33 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 73.52 112.308 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.6 -19.94 0.9 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 32.23 112.465 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 m -122.76 136.57 54.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.372 . . . . 64.04 111.11 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.54 ' HA ' HG22 ' A' ' 26' ' ' THR . 62.5 m -71.77 138.02 48.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 72.44 111.109 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -118.3 142.84 47.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.927 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.499 ' CD2' HG23 ' A' ' 24' ' ' THR . 13.9 m-70 -121.94 160.76 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 74.21 110.88 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.551 HG11 ' HE3' ' A' ' 5' ' ' LYS . 16.5 t -133.45 125.31 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.54 111.173 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.65 128.98 55.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 71.32 110.886 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.573 ' HB ' HG23 ' A' ' 21' ' ' VAL . 34.0 mm -118.41 114.01 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 73.03 111.128 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.15 150.17 21.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 70.35 110.897 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -112.16 160.75 13.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 74.43 112.481 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -119.0 -24.56 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.918 0.389 . . . . 63.25 110.955 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.453 ' O ' ' C ' ' A' ' 91' ' ' ASN . 52.1 p -176.77 144.13 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 54.31 110.87 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 90' ' ' SER . 42.4 t30 -32.69 106.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 74.31 110.893 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -166.54 115.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 74.32 110.903 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.1 p -121.76 155.35 35.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 63.45 110.838 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.05 26.74 1.82 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 62.25 112.508 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.417 ' O ' HD12 ' A' ' 13' ' ' LEU . 2.2 t -113.91 139.62 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 73.3 111.122 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.658 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -100.58 114.89 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 52.51 111.153 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.799 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -105.13 128.64 53.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.909 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.799 ' N ' HD22 ' A' ' 97' ' ' LEU . 1.5 ttpt -133.34 171.2 14.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 51.51 110.91 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.755 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -88.14 137.47 32.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 71.45 110.952 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.463 ' C ' ' HD1' ' A' ' 101' ' ' TYR . 1.8 pp0? -108.76 112.58 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 70.4 110.908 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 5.1 m-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 74.55 110.946 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.444 -0.262 . . . . 71.34 112.444 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -134.47 -177.49 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 73.31 110.883 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.42 ' HB ' ' H ' ' A' ' 24' ' ' THR . 1.9 m -118.15 109.49 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.14 111.128 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.32 147.61 52.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 72.34 110.932 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.658 ' HE3' HG11 ' A' ' 84' ' ' VAL . 8.8 tptp -158.78 -69.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 74.23 110.895 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.688 ' CG ' HD22 ' A' ' 99' ' ' LEU . 17.0 t-20 -76.08 158.23 32.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.91 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.0 t-20 88.58 -68.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 72.52 110.902 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 m -125.28 115.02 25.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.599 0.714 . . . . 73.23 111.143 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' CA ' ' HE3' ' A' ' 98' ' ' LYS . 53.5 Cg_endo -69.76 150.24 67.97 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.663 2.242 . . . . 72.23 112.331 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.411 ' HB ' HD13 ' A' ' 13' ' ' LEU . 21.2 t -77.6 113.51 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 74.54 111.095 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.7 147.8 30.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 64.53 110.859 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.66 64.36 1.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 72.51 110.932 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 13' ' ' LEU . 5.0 tp -58.95 -175.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 61.23 110.897 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.5 p -136.09 139.29 42.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 75.34 111.128 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.83 60.48 0.58 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 43.34 112.458 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -76.48 138.71 40.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.896 0.379 . . . . 62.32 110.925 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -29.1 8.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 75.03 110.902 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.13 -62.08 0.46 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 65.13 112.49 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.6 m -60.67 151.44 29.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.887 0.375 . . . . 75.42 110.807 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.31 179.4 8.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 63.53 110.904 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.437 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -140.71 149.18 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 61.54 111.109 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -136.78 134.85 37.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 73.35 110.853 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.9 165.48 25.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 73.54 110.931 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.42 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 55.3 m -147.92 141.72 25.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.497 . . . . 74.04 111.154 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 2.1 t80 -159.34 163.28 35.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.89 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.695 ' CG2' HG23 ' A' ' 81' ' ' THR . 14.2 p -131.41 170.98 13.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 52.24 111.186 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 76' ' ' ALA . 26.9 m -106.91 169.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 71.23 111.131 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -108.42 -47.1 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 62.25 110.855 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -129.73 155.47 45.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.897 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -77.42 115.7 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 62.32 110.859 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.45 145.89 34.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 64.22 111.108 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 32' ' ' THR . 2.7 t -99.25 107.31 19.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.32 111.121 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.594 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -137.06 148.8 47.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 51.13 111.099 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 73' ' ' SER . 2.9 p -105.78 111.07 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 75.11 111.169 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.609 HG11 ' HG2' ' A' ' 98' ' ' LYS . 9.9 t -127.06 140.4 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 51.41 111.15 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.534 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 0.1 OUTLIER -139.6 169.02 18.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 72.15 110.873 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.708 HG21 HD12 ' A' ' 97' ' ' LEU . 1.3 pt -110.14 159.36 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 72.33 111.165 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 171.17 167.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 72.03 110.889 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.49 -31.68 0.43 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 55.23 112.49 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -150.1 -117.97 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 74.22 112.496 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.82 160.82 15.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 73.51 110.865 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.47 99.38 0.58 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.736 . . . . 53.25 112.49 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -132.92 -38.96 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.825 0.345 . . . . 65.34 110.838 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.565 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -90.44 123.88 34.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 61.32 111.119 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -80.35 147.31 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.879 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.54 HD12 HD13 ' A' ' 37' ' ' ILE . 7.0 tt -113.49 127.08 55.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 61.22 110.932 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.73 148.56 44.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 75.44 110.932 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 82' ' ' TYR . 0.5 OUTLIER -154.15 132.93 12.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 74.31 110.882 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.486 ' HG3' ' HB3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -144.71 131.12 19.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 72.13 110.894 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HB1' HG21 ' A' ' 80' ' ' THR . . . -65.53 -66.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 72.51 111.128 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -45.36 -90.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 61.34 112.49 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.18 -168.59 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 74.23 110.895 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.12 132.88 87.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 63.34 110.887 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HB3' ' HG3' ' A' ' 49' ' ' LYS . 53.6 Cg_endo -69.75 140.71 43.39 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 60.32 112.351 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.18 178.75 4.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 62.41 111.146 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -66.41 -13.1 60.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 71.53 111.173 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -124.08 -25.97 4.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.14 110.87 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.52 124.37 47.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 74.21 110.868 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.73 153.87 33.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.489 . . . . 74.11 110.896 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -102.02 -31.75 10.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 72.14 110.885 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.8 m -140.24 122.67 16.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 74.05 110.876 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -176.11 134.44 0.44 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 65.15 110.854 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -9.12 25.32 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.634 2.223 . . . . 72.11 112.341 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 63.84 100.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.921 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -178.94 -31.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 62.42 110.856 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.5 t80 72.2 125.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 63.23 110.888 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.74 158.07 18.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 72.51 112.523 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.751 ' ND2' HG21 ' A' ' 95' ' ' VAL . 41.6 m-80 -53.83 176.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.36 . . . . 71.34 110.896 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 61.5 28.03 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.915 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.65 89.92 2.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 65.53 110.877 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.534 ' HB2' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -129.05 172.6 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 60.31 110.883 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.19 162.07 18.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.119 -0.491 . . . . 74.42 110.881 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.726 ' HB3' HG23 ' A' ' 34' ' ' VAL . 32.3 p -128.51 109.14 11.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 55.02 110.847 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.98 152.99 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 74.34 111.114 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.8 p -80.53 113.82 18.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 72.1 110.839 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.73 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.29 131.04 35.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 34.23 111.091 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.74 136.49 22.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.594 0.711 . . . . 73.15 111.077 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 124.92 11.55 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 73.11 112.355 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.73 -18.55 2.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 73.31 112.516 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.461 HG21 ' HB1' ' A' ' 50' ' ' ALA . 39.7 m -125.6 131.51 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 52.53 111.149 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.695 HG23 ' CG2' ' A' ' 26' ' ' THR . 10.8 m -72.44 137.63 46.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 54.12 111.149 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.73 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 52.9 m-85 -107.81 131.65 54.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 70.11 110.957 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -107.14 158.96 16.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 65.14 110.867 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.658 HG11 ' HE3' ' A' ' 5' ' ' LYS . 67.8 t -137.71 138.17 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 62.34 111.157 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.3 tpt -129.03 121.54 28.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 64.52 110.847 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.449 HG23 ' HB1' ' A' ' 44' ' ' ALA . 25.3 mm -109.63 114.41 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 65.32 111.158 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -109.12 139.86 43.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 73.24 110.915 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.88 150.05 16.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 75.13 112.46 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -117.81 -17.07 9.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.878 0.37 . . . . 71.34 110.946 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -177.89 129.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 72.11 110.867 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 90' ' ' SER . 54.5 t-20 -29.62 109.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 63.15 110.844 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -166.5 112.72 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 72.4 110.925 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.1 p -120.71 166.42 13.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 54.55 110.844 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.9 23.07 4.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.747 -0.739 . . . . 41.43 112.471 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.751 HG21 ' ND2' ' A' ' 68' ' ' ASN . 9.6 t -113.29 148.34 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 65.11 111.107 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.3 m -106.68 126.17 51.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 71.32 111.161 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 37' ' ' ILE . 3.4 tp -108.4 135.13 50.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 63.14 110.896 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.609 ' HG2' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -144.79 154.63 42.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.884 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.688 HD22 ' CG ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -88.7 144.65 26.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 71.53 110.906 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.481 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -94.13 112.85 24.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 61.41 110.88 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.594 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 15.0 p90 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 64.24 110.947 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.48 -0.248 . . . . 34.43 112.48 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -111.95 -178.6 3.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.895 0.379 . . . . 74.55 110.884 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.428 ' HB ' ' H ' ' A' ' 24' ' ' THR . 1.9 m -117.94 107.96 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 74.03 111.138 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.975 HD12 HG22 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -133.34 149.0 51.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.0 110.905 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.679 ' HZ3' HD11 ' A' ' 97' ' ' LEU . 13.4 tptt -174.65 -74.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 62.01 110.921 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.613 ' HB2' HD22 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -70.13 153.17 43.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 72.24 110.858 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.2 t30 78.07 -58.88 0.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 64.31 110.906 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.5 m -122.75 119.32 28.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.615 0.722 . . . . 74.1 111.125 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 137.93 36.7 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.701 2.267 . . . . 71.1 112.357 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.975 HG22 HD12 ' A' ' 4' ' ' LEU . 46.4 t -77.27 114.93 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 72.21 111.17 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 p -87.62 163.2 16.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 41.54 110.859 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 40.18 64.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 74.35 110.888 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.552 HD22 HG12 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -64.35 -164.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 72.3 110.911 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.422 ' H ' HD12 ' A' ' 13' ' ' LEU . 3.5 p -147.4 136.73 22.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 63.13 111.145 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.4 67.17 0.47 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 75.3 112.452 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -76.05 135.49 39.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 63.42 110.912 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -30.64 23.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 61.4 110.944 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.34 -46.71 0.98 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.689 -0.767 . . . . 74.41 112.491 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.15 160.83 27.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 74.02 110.872 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -143.95 169.02 18.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 70.01 110.893 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.466 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -131.14 150.53 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.24 111.089 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -138.85 151.34 46.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.52 110.893 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -148.95 166.65 27.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 74.41 110.906 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.428 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 10.7 m -148.59 140.67 23.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 52.41 111.106 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -160.74 162.71 32.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 72.1 110.854 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.436 ' CG2' HG23 ' A' ' 81' ' ' THR . 17.1 p -131.09 170.66 14.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 54.23 111.127 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 78' ' ' PRO . 17.5 m -108.27 170.01 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 75.43 111.122 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.46 -50.8 3.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 35.0 110.849 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 167.12 21.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 72.55 110.925 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -80.19 115.52 19.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 70.04 110.911 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.2 141.91 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 70.31 111.12 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 32' ' ' THR . 2.9 t -94.7 106.28 18.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.11 111.149 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.26 149.21 45.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.24 111.127 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.723 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.5 p -105.49 112.56 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 62.04 111.145 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.737 HG11 ' HG2' ' A' ' 98' ' ' LYS . 20.9 t -123.72 140.52 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.12 111.078 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.509 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 11.6 p -139.97 165.48 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 44.43 110.868 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.841 HG21 HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -111.77 154.64 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 73.22 111.124 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -167.51 153.11 7.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.4 110.827 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 95' ' ' VAL . . . -155.98 -154.37 6.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 60.33 112.529 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -122.42 -53.38 0.21 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 60.11 112.495 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.4 p -103.86 154.76 19.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.382 . . . . 74.32 110.893 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 58.42 172.79 0.38 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 63.25 112.48 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.403 ' CB ' ' HA2' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -138.77 110.98 7.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 51.33 110.861 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.547 ' HB1' HG23 ' A' ' 86' ' ' ILE . . . -89.54 131.53 35.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 71.11 111.119 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.52 133.33 35.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 61.14 110.906 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 71' ' ' SER . 2.4 tt -92.93 138.14 31.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 61.42 110.87 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -152.42 143.04 22.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 70.33 110.947 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -150.68 146.68 26.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 63.11 110.929 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' H ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -156.05 112.12 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 72.44 110.904 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.35 119.35 7.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 75.35 111.121 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.21 -81.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.734 . . . . 73.22 112.485 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.6 p -99.14 -174.28 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.965 0.412 . . . . 74.35 110.83 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.58 133.76 27.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.692 . . . . 70.23 110.892 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 141.69 45.72 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.711 2.274 . . . . 61.25 112.293 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 p -102.29 178.96 4.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 73.3 111.124 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 p -65.24 -14.39 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 75.11 111.163 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.2 m -120.03 -26.68 5.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 63.53 110.879 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.07 126.38 50.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 70.32 110.832 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.15 154.02 36.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 74.25 110.939 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.43 -31.86 6.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.423 . . . . 73.22 110.819 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.7 m -142.06 123.14 14.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 53.32 110.853 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.489 ' C ' ' H ' ' A' ' 64' ' ' TYR . 1.2 ttt-85 176.44 134.48 0.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.562 0.696 . . . . 75.54 110.904 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 23.69 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.268 . . . . 73.2 112.346 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 62' ' ' ARG . 0.2 OUTLIER 50.84 72.91 0.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 75.44 110.921 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.42 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER 179.66 -171.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 75.41 110.905 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.09 -175.94 3.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 71.53 110.935 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.403 ' HA2' ' CB ' ' A' ' 43' ' ' ASP . . . 62.1 160.3 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 72.13 112.52 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.596 ' HB3' HG11 ' A' ' 95' ' ' VAL . 7.7 p30 -57.01 -176.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 60.41 110.893 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 66.33 10.63 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 74.14 110.902 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.461 ' H ' HD11 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -126.47 91.33 3.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 70.41 110.912 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.509 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -133.8 171.66 13.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 73.35 110.853 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.45 157.94 27.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 64.41 110.877 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.723 ' HB3' HG23 ' A' ' 34' ' ' VAL . 2.6 p -128.41 109.57 11.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 53.3 110.867 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.8 t -150.13 152.82 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 72.41 111.133 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 85.6 p -74.1 104.57 4.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 72.42 110.826 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.27 131.41 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 71.33 111.105 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.92 142.25 24.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.561 0.696 . . . . 53.32 111.139 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.473 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.5 Cg_endo -69.71 162.06 43.52 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.741 2.294 . . . . 33.42 112.343 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.14 -21.69 42.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.792 -0.718 . . . . 74.23 112.488 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -106.77 123.63 48.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 65.22 111.146 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.436 HG23 ' CG2' ' A' ' 26' ' ' THR . 2.4 m -71.49 135.0 46.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 73.51 111.134 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.46 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 50.9 m-85 -108.68 133.69 52.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.905 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -109.17 147.79 31.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 73.33 110.855 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG11 HD21 ' A' ' 97' ' ' LEU . 3.2 t -123.54 138.81 52.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 63.11 111.136 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.81 122.41 25.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.858 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.547 HG23 ' HB1' ' A' ' 44' ' ' ALA . 15.5 mm -114.83 111.65 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 72.34 111.115 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 -65.11 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.907 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 44' ' ' ALA . . . 114.39 -146.84 18.76 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 73.33 112.482 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -175.78 -57.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.898 0.38 . . . . 73.42 110.932 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' ASN . 3.0 p -144.85 128.0 16.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 73.43 110.865 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 90' ' ' SER . 34.6 t30 -33.86 104.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 74.44 110.919 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.15 139.46 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.905 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.4 p -122.52 157.22 32.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 72.41 110.85 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 135.95 25.31 0.49 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.761 -0.733 . . . . 63.11 112.504 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.596 HG11 ' HB3' ' A' ' 68' ' ' ASN . 1.3 t -113.64 147.35 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.925 0.393 . . . . 72.22 111.098 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 1.3 m -106.17 112.81 26.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 73.04 111.181 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.841 HD12 HG21 ' A' ' 37' ' ' ILE . 5.2 tp -102.91 142.56 33.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 72.22 110.936 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.737 ' HG2' HG11 ' A' ' 35' ' ' VAL . 6.4 ttpt -153.74 161.99 41.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 71.11 110.865 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.613 HD22 ' HB2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -91.41 143.81 26.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.23 110.929 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.496 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.31 110.88 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 71.23 110.883 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.557 ' HB3' HD21 ' A' ' 99' ' ' LEU . 35.9 p90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 74.55 110.963 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.508 -0.237 . . . . 54.13 112.508 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.51 -174.21 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 75.14 110.88 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.428 ' HB ' ' H ' ' A' ' 24' ' ' THR . 1.8 m -115.12 109.19 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 72.52 111.115 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.14 148.34 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 74.54 110.923 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.68 ' HE3' HG11 ' A' ' 84' ' ' VAL . 1.7 tppm? -165.19 -74.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 70.05 110.919 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -63.96 155.18 31.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 73.14 110.893 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.2 t-20 88.23 -61.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 70.32 110.886 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 m -130.09 120.38 19.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 73.1 111.185 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HB2' HG22 ' A' ' 96' ' ' THR . 53.0 Cg_endo -69.79 153.38 68.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 2.251 . . . . 41.45 112.341 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -85.22 114.23 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 75.34 111.188 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 p -88.69 167.45 13.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 61.52 110.856 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 p30 40.5 53.23 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 70.13 110.87 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -54.75 178.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 55.22 110.905 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -135.37 138.08 42.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.35 111.112 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.47 68.91 0.53 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.759 . . . . 65.42 112.477 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -76.42 138.43 40.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 73.0 110.897 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -17.11 38.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 72.12 110.874 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.15 -41.44 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.805 -0.712 . . . . 64.14 112.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 m -90.68 168.66 11.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 73.55 110.929 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.0 -176.37 5.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 71.35 110.933 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.87 144.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.072 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -138.5 149.63 45.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 74.4 110.875 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -147.9 166.52 27.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 74.5 110.941 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.428 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 63.4 m -143.76 139.46 29.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 71.3 111.16 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -159.27 160.55 35.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 51.31 110.895 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.756 HG22 HG23 ' A' ' 81' ' ' THR . 10.9 p -129.88 171.76 12.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 71.14 111.114 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 78' ' ' PRO . 32.2 m -106.61 170.63 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 72.45 111.094 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -113.03 -41.58 3.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 74.22 110.888 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 158.6 39.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 65.04 110.851 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -80.53 115.2 19.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 74.11 110.842 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.19 140.3 30.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 53.35 111.119 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 32' ' ' THR . 2.8 t -95.71 105.93 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 72.25 111.127 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.97 148.58 45.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 63.53 111.143 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.696 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.1 p -106.63 111.47 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 71.34 111.116 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.91 140.14 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.138 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.51 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 92.9 p -142.72 167.72 21.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 54.33 110.831 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -108.87 144.14 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 44.21 111.114 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p -178.01 166.77 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 74.45 110.871 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.55 -23.28 0.22 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.761 -0.733 . . . . 71.12 112.484 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.08 -107.46 0.58 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.705 -0.759 . . . . 73.34 112.447 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -120.65 143.58 48.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 72.54 110.927 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.59 92.41 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.766 -0.73 . . . . 52.42 112.472 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -127.82 -37.58 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 55.23 110.883 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.52 ' HB1' ' CG2' ' A' ' 86' ' ' ILE . . . -91.81 110.65 21.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 51.44 111.106 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -72.44 155.55 39.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 71.22 110.886 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.74 HD22 ' HA ' ' A' ' 71' ' ' SER . 1.2 tt -127.55 138.28 52.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 72.21 110.938 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.547 ' CZ ' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -146.7 146.14 30.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.919 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.26 152.68 47.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 74.22 110.903 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -153.35 115.71 4.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 71.03 110.874 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 80' ' ' THR . . . -65.27 120.97 13.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 42.45 111.075 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.82 -76.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 75.43 112.452 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 t -107.82 -179.53 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 63.12 110.853 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.02 133.68 40.61 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.553 0.692 . . . . 72.35 110.917 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 143.92 52.15 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 71.41 112.339 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.19 179.03 4.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 71.24 111.148 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -67.79 -12.46 60.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 71.31 111.184 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 m -120.96 -28.28 4.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 51.23 110.885 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.19 124.01 48.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 73.15 110.817 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -152.86 153.99 34.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 72.43 110.941 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -107.15 -35.29 6.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 70.41 110.888 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.5 m -127.9 123.92 36.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 41.23 110.853 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -175.22 120.39 0.33 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.658 0.742 . . . . 71.15 110.877 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' C ' ' CG ' ' A' ' 64' ' ' TYR . 53.2 Cg_endo -69.83 1.53 4.4 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.26 . . . . 73.31 112.357 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' CG ' ' C ' ' A' ' 63' ' ' PRO . 4.5 p90 38.52 85.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 75.54 110.923 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.06 -69.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 71.35 110.856 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -157.04 -172.56 4.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 75.52 110.909 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.44 -124.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 64.04 112.509 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.629 ' ND2' HG11 ' A' ' 95' ' ' VAL . 24.6 m120 -49.8 164.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 75.05 110.889 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 72.01 16.28 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.42 110.888 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.42 103.75 5.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 64.11 110.86 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.74 ' HA ' HD22 ' A' ' 46' ' ' LEU . 2.3 m -134.32 174.68 10.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 74.42 110.855 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.67 152.54 32.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 63.44 110.893 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.696 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.1 p -127.73 111.51 13.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 45.5 110.851 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 t -149.28 152.29 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 65.13 111.141 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.9 p -71.71 106.9 4.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 75.42 110.908 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.3 131.48 35.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.34 111.093 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.32 142.58 24.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.594 0.712 . . . . 75.44 111.07 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.515 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.7 Cg_endo -69.75 126.37 13.24 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.747 2.298 . . . . 75.03 112.345 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.57 -27.13 3.41 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.711 -0.757 . . . . 72.41 112.467 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.561 HG21 ' HB1' ' A' ' 50' ' ' ALA . 16.4 m -106.53 124.64 49.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 60.12 111.135 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.756 HG23 HG22 ' A' ' 26' ' ' THR . 9.2 m -71.55 138.06 48.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 74.15 111.108 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.523 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 40.6 m-85 -112.15 150.5 30.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 71.23 110.901 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -131.56 145.16 51.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 73.03 110.873 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.68 HG11 ' HE3' ' A' ' 5' ' ' LYS . 14.9 t -121.96 133.59 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 61.21 111.092 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.403 ' O ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -126.8 133.54 50.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.41 110.832 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.52 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 30.4 mm -119.31 134.53 62.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 64.12 111.133 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.499 ' HB3' ' OH ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -140.23 113.47 8.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 73.03 110.883 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.09 161.2 25.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 75.44 112.517 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.75 -29.18 13.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.889 0.376 . . . . 72.51 110.908 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.494 ' O ' ' C ' ' A' ' 91' ' ' ASN . 54.6 p -156.12 137.37 13.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 73.23 110.819 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 90' ' ' SER . 70.4 m-20 -30.32 109.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 45.45 110.907 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -160.42 118.8 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 63.3 110.911 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.8 p -122.71 156.43 34.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.853 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 121.08 23.76 2.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 53.22 112.525 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.629 HG11 ' ND2' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -112.99 147.08 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.901 0.381 . . . . 44.32 111.148 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -105.23 124.75 50.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 71.51 111.115 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HB3' HD11 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -116.07 143.03 46.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 72.1 110.958 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -149.27 168.69 22.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.23 110.867 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.56 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -91.03 142.69 27.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.951 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.502 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.51 111.52 23.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 65.43 110.912 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.536 ' HB3' HD21 ' A' ' 99' ' ' LEU . 25.9 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 71.04 110.913 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.455 -0.258 . . . . 71.32 112.455 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -156.45 -176.21 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 72.45 110.939 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 24' ' ' THR . 3.5 m -123.57 109.02 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.43 111.138 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.18 150.18 52.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 75.24 110.903 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' HG3' ' CB ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -155.56 -77.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.863 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.9 t-20 -66.22 159.2 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 62.23 110.865 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.5 t-20 89.59 -70.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 65.02 110.859 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -133.35 118.32 14.86 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.556 0.694 . . . . 64.32 111.143 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.672 ' HB2' HG22 ' A' ' 96' ' ' THR . 54.1 Cg_endo -69.81 155.86 64.71 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.688 2.259 . . . . 51.12 112.324 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.8 t -75.56 112.43 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 73.11 111.099 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -82.08 163.63 21.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 53.24 110.883 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 39.82 57.14 2.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 75.03 110.922 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 13' ' ' LEU . 4.6 tp -57.93 -173.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 52.45 110.931 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 p -145.55 139.19 26.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 61.12 111.171 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.97 65.16 0.5 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.683 -0.77 . . . . 50.01 112.485 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -75.9 155.29 35.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 51.04 110.927 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.02 -31.0 16.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.879 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.88 -55.66 0.27 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 73.04 112.49 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.75 136.58 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.338 . . . . 71.24 110.858 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.79 170.07 16.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 71.21 110.899 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.39 140.67 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 54.22 111.104 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -137.75 151.0 47.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 53.31 110.905 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -146.24 164.95 30.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 62.43 110.94 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 31.7 m -140.06 138.79 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 55.32 111.14 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -160.2 163.15 33.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.34 110.887 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.702 HG22 HG23 ' A' ' 81' ' ' THR . 15.0 p -130.74 170.7 13.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.52 111.163 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 78' ' ' PRO . 16.8 m -107.55 169.3 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 74.24 111.163 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -104.54 -52.92 2.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 62.14 110.868 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -128.94 157.24 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.878 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -73.64 116.16 13.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 63.51 110.871 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.37 144.86 33.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 65.5 111.1 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 32' ' ' THR . 2.6 t -100.96 106.79 18.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 70.03 111.15 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.45 148.93 46.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 73.42 111.088 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 34' ' ' VAL . 3.2 p -106.05 111.72 36.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 62.34 111.155 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.636 HG11 ' HG2' ' A' ' 98' ' ' LYS . 7.5 t -126.77 139.99 50.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 54.33 111.138 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.5 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 34.5 p -136.56 167.06 22.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 62.32 110.863 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.409 HD11 ' H ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -110.01 142.75 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 64.31 111.119 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 p -169.57 172.57 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 72.32 110.85 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 157.31 -20.48 0.41 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 64.04 112.487 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -157.46 -96.72 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 51.32 112.493 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 m -130.54 148.79 52.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 70.22 110.878 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.61 91.42 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 43.15 112.499 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -35.03 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 70.3 110.851 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.49 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -91.54 109.43 20.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 64.3 111.084 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.94 146.7 54.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 42.35 110.882 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 tt -110.86 127.08 55.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 64.21 110.92 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -131.28 154.19 48.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.906 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -154.03 133.11 12.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 72.33 110.948 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.467 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -141.03 125.72 17.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.853 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.4 126.17 28.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 73.2 111.119 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.41 -71.17 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 71.11 112.475 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 m -112.58 -175.47 2.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 61.35 110.86 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.31 136.04 32.21 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.57 0.7 . . . . 72.42 110.937 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 143.85 52.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.7 2.267 . . . . 53.23 112.35 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -100.79 178.08 4.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.22 111.153 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.6 p -64.86 -15.2 61.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 70.12 111.126 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.7 m -119.44 -25.8 5.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 62.44 110.827 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.95 126.39 50.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.32 110.803 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.5 154.07 36.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 72.45 110.935 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -112.45 -27.95 8.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.281 -0.418 . . . . 71.15 110.866 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.2 m -145.72 124.57 12.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.912 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -173.17 124.99 0.45 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 63.11 110.878 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -6.62 19.07 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.686 2.257 . . . . 65.43 112.351 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.9 t80 67.62 80.49 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 70.34 110.889 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.38 -176.1 4.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 73.04 110.837 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.92 -75.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 71.23 110.946 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.98 -125.38 1.79 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.746 . . . . 61.2 112.438 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.767 ' ND2' HG21 ' A' ' 95' ' ' VAL . 62.3 m-20 -49.62 168.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.856 0.36 . . . . 64.01 110.88 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 74.41 5.99 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 72.12 110.884 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 70' ' ' GLU . 3.7 pt-20 -127.3 115.49 19.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 73.52 110.908 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.5 ' CB ' ' HA ' ' A' ' 36' ' ' SER . 10.1 m -140.77 174.3 10.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.34 110.869 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.94 153.79 33.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 65.31 110.89 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -127.85 109.37 11.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 52.4 110.847 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.7 t -150.21 152.33 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 75.22 111.155 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.5 p -79.52 102.34 8.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 64.21 110.88 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.521 ' HB1' ' OH ' ' A' ' 82' ' ' TYR . . . -82.52 143.14 31.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 61.33 111.107 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.59 142.92 25.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.561 0.696 . . . . 70.01 111.102 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.483 ' HA ' HG23 ' A' ' 27' ' ' VAL . 53.7 Cg_endo -69.75 143.81 52.08 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.657 2.238 . . . . 73.41 112.342 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.23 -22.81 6.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.704 -0.76 . . . . 63.5 112.459 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.6 m -117.27 131.52 56.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 74.34 111.15 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.702 HG23 HG22 ' A' ' 26' ' ' THR . 14.3 m -74.23 136.5 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 73.41 111.113 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' OH ' ' HB1' ' A' ' 76' ' ' ALA . 56.8 m-85 -106.35 154.78 20.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 74.14 110.883 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -134.34 160.93 36.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.101 -0.5 . . . . 75.11 110.84 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG21 ' HD2' ' A' ' 5' ' ' LYS . 10.6 t -136.17 137.68 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 71.02 111.117 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.27 122.36 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 65.02 110.865 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.421 HG23 ' HB1' ' A' ' 44' ' ' ALA . 22.6 mm -104.98 112.83 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 74.53 111.116 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.79 104.08 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 72.44 110.939 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.51 160.16 37.54 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 33.41 112.511 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -115.79 -18.4 10.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 71.44 110.906 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 91' ' ' ASN . 60.7 p -166.24 136.23 3.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 63.23 110.888 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 90' ' ' SER . 57.7 t30 -33.84 108.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 72.54 110.92 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -160.84 112.68 1.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 74.52 110.923 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.0 p -119.44 163.87 16.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 72.03 110.875 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.86 26.36 4.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.743 . . . . 42.13 112.491 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.767 HG21 ' ND2' ' A' ' 68' ' ' ASN . 7.2 t -113.75 147.49 17.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 55.15 111.156 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.672 HG22 ' HB2' ' A' ' 9' ' ' PRO . 2.1 m -103.59 117.12 33.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.34 111.169 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.738 HD22 ' N ' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -99.58 121.48 41.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 72.23 110.914 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.738 ' N ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -131.12 154.8 47.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 72.21 110.861 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.669 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -84.54 140.9 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 61.22 110.922 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.44 113.36 25.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.897 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 p90 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.467 . . . . 73.24 110.942 -179.892 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.501 -0.24 . . . . 55.5 112.501 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -113.12 -179.14 3.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.913 0.387 . . . . 50.02 110.874 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.5 m -117.75 108.86 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 73.23 111.112 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.65 149.82 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 70.31 110.913 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' CD ' HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -156.42 -73.37 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 74.15 110.951 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 16.9 t30 -67.98 158.09 33.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 74.41 110.945 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.8 t-20 88.95 -69.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 53.24 110.885 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -133.18 118.06 14.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.578 0.704 . . . . 64.41 111.108 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . 53.6 Cg_endo -69.79 157.2 61.14 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 73.03 112.341 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.93 113.9 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 62.31 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.04 144.25 30.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.12 110.85 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.411 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 0.8 OUTLIER 48.07 74.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 65.4 110.857 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 tp -65.02 -166.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.928 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -143.37 140.72 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 72.0 111.151 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.88 60.2 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 43.1 112.46 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 90' ' ' SER . 1.7 t-20 -78.47 139.14 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 63.12 110.897 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER -52.28 -48.16 65.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 60.41 110.904 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.04 -46.53 2.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 64.43 112.538 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.03 128.39 35.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 71.31 110.883 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.21 160.57 31.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 73.3 110.868 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -121.25 139.01 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 64.25 111.126 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -136.93 146.83 45.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.931 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.414 ' HB2' ' CE ' ' A' ' 5' ' ' LYS . 17.7 m-85 -144.08 165.02 28.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 75.15 110.856 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 26.0 m -143.81 138.74 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.513 . . . . 62.54 111.151 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -160.09 162.97 34.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 54.12 110.859 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.469 ' CG2' HG23 ' A' ' 81' ' ' THR . 17.5 p -129.86 170.78 13.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 72.0 111.138 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 78' ' ' PRO . 18.9 m -107.35 168.06 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 73.54 111.149 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -106.91 -49.93 3.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 63.42 110.857 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -126.13 156.76 39.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 73.55 110.843 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -78.85 114.84 18.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 73.53 110.925 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.71 145.5 33.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 55.13 111.086 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 m -97.96 107.54 20.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 63.0 111.133 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.582 ' HB3' ' C ' ' A' ' 101' ' ' TYR . . . -136.97 148.91 47.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 64.44 111.034 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.706 HG23 ' HB3' ' A' ' 73' ' ' SER . 3.3 p -106.55 113.0 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 62.21 111.148 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.425 HG11 ' HG2' ' A' ' 98' ' ' LYS . 19.4 t -126.12 139.97 50.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.22 111.125 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.547 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -138.86 166.72 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 53.3 110.888 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.41 147.51 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.153 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -178.41 170.73 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 70.13 110.831 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.7 -25.32 0.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 62.04 112.524 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.04 -119.76 1.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 12.41 112.5 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 m -109.29 161.95 14.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 64.12 110.853 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.16 94.57 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 64.04 112.52 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.85 -37.9 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 64.41 110.838 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.07 115.56 28.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 52.44 111.129 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.68 157.31 17.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 74.43 110.874 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.784 HD23 ' HA ' ' A' ' 71' ' ' SER . 1.8 tp -124.74 129.81 51.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 74.32 110.916 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.704 ' N ' HD12 ' A' ' 46' ' ' LEU . 30.1 m-85 -136.94 131.66 33.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 61.13 110.924 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -130.28 142.56 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 70.42 110.913 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.553 ' H ' HD23 ' A' ' 48' ' ' LEU . 1.3 tttm -143.73 117.67 9.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 73.15 110.951 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.97 124.37 20.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 73.41 111.119 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 -81.04 0.72 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 75.33 112.516 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.1 p -96.17 -169.7 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 74.41 110.9 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.33 135.02 21.39 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.631 0.729 . . . . 74.54 110.869 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 141.25 44.74 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.664 2.243 . . . . 74.35 112.364 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 p -105.36 178.93 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.135 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.4 p -63.1 -15.05 55.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 73.21 111.092 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -118.41 -26.72 6.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 73.45 110.886 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.87 126.44 50.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 55.13 110.837 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.28 153.73 35.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 74.23 110.929 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -117.72 -42.89 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.866 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.1 m -117.39 120.82 39.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.44 110.868 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -179.59 127.6 0.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.628 0.728 . . . . 64.51 110.856 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HD2' ' HG2' ' A' ' 70' ' ' GLU . 53.2 Cg_endo -69.8 0.91 4.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.642 2.228 . . . . 73.22 112.352 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 72.06 62.41 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 70.43 110.902 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -168.89 2.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 74.51 110.9 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -136.79 127.62 27.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 73.54 110.888 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.04 -171.43 48.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.75 -0.738 . . . . 62.11 112.479 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -52.08 175.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 73.22 110.886 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.75 15.75 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.881 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 16.3 tt0 -121.4 82.95 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 60.35 110.853 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.784 ' HA ' HD23 ' A' ' 46' ' ' LEU . 1.5 m -133.23 170.2 15.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 65.54 110.874 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.06 152.42 37.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 45.33 110.861 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.706 ' HB3' HG23 ' A' ' 34' ' ' VAL . 54.7 p -128.38 108.98 11.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 44.02 110.858 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.1 t -150.46 152.76 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 71.44 111.122 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -77.6 103.64 7.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.22 110.88 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.657 ' HB1' ' CE2' ' A' ' 82' ' ' TYR . . . -82.19 134.33 35.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 72.42 111.085 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.5 139.27 23.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 73.34 111.127 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.496 ' HA ' HG23 ' A' ' 27' ' ' VAL . 54.1 Cg_endo -69.76 121.02 7.72 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.724 2.283 . . . . 73.53 112.348 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.58 -19.09 1.85 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 65.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.8 m -116.9 133.78 55.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.39 . . . . 73.04 111.109 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.469 HG23 ' CG2' ' A' ' 26' ' ' THR . 0.7 OUTLIER -74.07 131.41 41.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 43.22 111.13 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.657 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 50.7 m-85 -107.89 138.05 44.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 73.32 110.926 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -117.86 159.15 23.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 74.14 110.871 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.436 ' HB ' ' HE2' ' A' ' 5' ' ' LYS . 20.9 t -137.6 137.16 45.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 70.41 111.187 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 tpt -129.99 122.27 28.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 75.11 110.938 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.477 ' HB ' HG23 ' A' ' 21' ' ' VAL . 25.5 mm -104.2 112.7 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 54.32 111.144 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 124.55 49.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.937 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.8 162.88 30.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 64.23 112.441 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -95.16 -34.13 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 64.3 110.886 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.448 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 4.6 t -167.83 -62.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 72.33 110.829 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -171.81 86.68 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.871 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.63 119.9 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 74.2 110.948 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 p -122.88 153.4 39.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.43 110.817 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 12' ' ' ASN . . . 123.71 25.76 1.69 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 60.24 112.514 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.88 146.99 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.904 0.383 . . . . 63.42 111.128 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 m -101.34 115.52 30.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 61.31 111.095 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.679 HD22 ' N ' ' A' ' 98' ' ' LYS . 1.6 tm? -100.94 130.89 47.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 62.24 110.927 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.679 ' N ' HD22 ' A' ' 97' ' ' LEU . 6.6 ttpt -143.79 163.81 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 63.34 110.885 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.636 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -91.73 143.3 26.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 64.15 110.902 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.492 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -94.7 113.91 25.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 75.32 110.95 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.582 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 12.9 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 74.42 110.954 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.484 -0.246 . . . . 50.43 112.484 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -135.16 -177.46 4.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.886 0.374 . . . . 74.35 110.886 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.9 m -119.88 109.07 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 62.23 111.143 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.74 151.3 52.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 63.5 110.9 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.654 ' HD3' HG21 ' A' ' 84' ' ' VAL . 9.5 tptm -164.51 -39.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 74.21 110.864 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 7' ' ' ASN . 6.0 t-20 -103.98 155.37 18.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 72.12 110.882 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 7.6 t-20 87.43 -67.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 64.04 110.873 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.1 m -127.77 119.52 21.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 44.43 111.136 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 152.7 69.37 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.706 2.271 . . . . 74.14 112.296 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.44 115.45 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.23 111.126 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.8 142.11 32.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.832 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.59 80.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 74.21 110.878 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -70.28 -167.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 72.11 110.96 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 p -145.67 139.0 26.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.45 111.131 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.37 61.68 0.51 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.743 -0.741 . . . . 72.31 112.487 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -76.09 150.13 37.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.947 0.403 . . . . 62.42 110.862 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -35.89 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 75.42 110.917 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.82 -63.08 0.52 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 74.51 112.5 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.77 140.08 20.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 73.52 110.84 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -135.08 171.91 13.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 73.43 110.858 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.563 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.05 136.26 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 75.22 111.165 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -136.77 141.53 42.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.91 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -130.56 165.03 23.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.928 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.43 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 9.4 m -141.19 138.8 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 74.53 111.13 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.48 160.34 34.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 63.14 110.906 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.798 HG22 HG23 ' A' ' 81' ' ' THR . 17.8 p -126.62 171.59 10.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 73.14 111.139 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.585 HG13 ' CE1' ' A' ' 101' ' ' TYR . 12.1 t -108.18 141.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 75.22 111.148 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -92.24 -42.59 9.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 62.34 110.86 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -132.15 148.39 52.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 72.45 110.864 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -72.89 114.27 10.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 61.22 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.34 140.76 29.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 40.13 111.134 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 32' ' ' THR . 2.7 t -98.98 107.08 19.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 71.54 111.11 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 101' ' ' TYR . . . -135.72 148.02 48.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 70.03 111.104 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.1 p -106.72 111.19 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 70.42 111.119 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.71 139.82 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 74.54 111.157 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -134.51 166.33 23.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 74.3 110.861 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.492 HG21 HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -111.11 142.23 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 64.14 111.162 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t 178.82 159.67 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 43.45 110.852 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.67 -32.02 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.7 -0.762 . . . . 45.23 112.471 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.03 -82.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 71.03 112.519 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 m -129.67 160.49 33.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 75.4 110.882 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.44 92.78 1.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.737 . . . . 74.22 112.471 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -127.3 -34.97 2.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 74.31 110.843 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.601 ' H ' ' ND2' ' A' ' 68' ' ' ASN . . . -92.54 113.93 26.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 74.42 111.108 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.32 166.16 24.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 75.23 110.856 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.665 HD13 ' HA ' ' A' ' 71' ' ' SER . 3.7 tt -123.86 145.67 48.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.912 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -152.85 148.89 27.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 75.04 110.924 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 49' ' ' LYS . 1.4 tt -152.73 140.13 19.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 71.14 110.899 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.551 ' N ' HD23 ' A' ' 48' ' ' LEU . 3.9 tttm -147.57 130.41 16.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 75.33 110.882 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.71 86.53 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 71.22 111.139 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.94 -86.01 0.22 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.739 . . . . 73.32 112.501 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.03 134.04 45.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.953 0.406 . . . . 72.14 110.855 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.64 128.09 3.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.624 0.726 . . . . 62.11 110.895 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 142.84 49.11 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 55.12 112.376 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -110.08 179.31 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 75.33 111.183 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.8 p -60.92 -16.62 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 65.21 111.158 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.5 t -117.43 -25.78 6.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 71.12 110.83 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 124.76 48.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 72.0 110.871 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.73 153.18 32.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 73.21 110.929 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -114.24 -48.59 2.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 74.12 110.852 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.6 m -123.24 122.51 38.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.871 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.47 137.27 0.35 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.63 0.728 . . . . 54.41 110.866 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 53.4 Cg_endo -69.82 -2.91 11.02 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 65.15 112.308 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 73.79 74.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 64.51 110.895 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -163.55 -169.94 2.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 74.41 110.888 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -139.79 160.04 40.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.51 110.913 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.03 165.85 9.57 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.671 -0.776 . . . . 45.43 112.491 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.774 ' ND2' HG21 ' A' ' 95' ' ' VAL . 52.2 m-80 -56.62 -176.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 60.01 110.907 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.9 t30 64.54 14.18 8.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 74.24 110.906 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.422 ' HG2' ' HG2' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -128.7 103.62 7.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 61.52 110.873 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.665 ' HA ' HD13 ' A' ' 46' ' ' LEU . 5.5 m -135.03 173.63 11.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 74.32 110.845 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.94 151.6 36.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 50.13 110.89 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.5 p -129.72 109.01 10.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 53.11 110.854 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.749 HG22 HE22 ' A' ' 100' ' ' GLN . 19.1 m -151.02 153.48 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 63.14 111.173 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -72.25 100.18 2.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 63.01 110.864 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.32 151.31 25.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 63.53 111.146 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.82 145.99 46.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.606 0.717 . . . . 64.22 111.086 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 173.37 11.06 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.669 2.246 . . . . 75.42 112.294 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.78 -46.86 1.72 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.742 . . . . 72.1 112.452 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.9 m -94.61 128.82 41.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 71.5 111.142 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.798 HG23 HG22 ' A' ' 26' ' ' THR . 10.5 m -70.7 137.75 50.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 52.45 111.138 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -109.52 137.84 46.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 70.52 110.874 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -106.46 157.91 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 63.55 110.874 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.654 HG21 ' HD3' ' A' ' 5' ' ' LYS . 21.3 t -137.96 137.98 44.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 65.34 111.169 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.5 tpt -136.09 123.87 22.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 72.2 110.913 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HB ' HG23 ' A' ' 21' ' ' VAL . 19.5 mm -111.94 111.91 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 72.02 111.111 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.84 149.76 23.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 64.45 110.864 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.8 157.81 16.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 50.33 112.539 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -114.18 -21.68 10.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 74.43 110.88 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 91' ' ' ASN . 72.3 p -169.99 134.97 1.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 53.35 110.863 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 90' ' ' SER . 1.7 p30 -33.83 107.21 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.88 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -164.12 114.03 1.24 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 64.22 110.938 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 p -121.08 162.56 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 73.14 110.878 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.35 19.38 3.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.718 -0.754 . . . . 72.23 112.515 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.774 HG21 ' ND2' ' A' ' 68' ' ' ASN . 4.8 t -112.43 147.93 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 75.32 111.135 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -100.21 129.76 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 73.22 111.176 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.621 ' HB3' HD21 ' A' ' 13' ' ' LEU . 16.2 tp -113.11 148.31 35.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 62.43 110.913 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -157.4 166.39 33.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 72.44 110.859 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.793 HD21 ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -87.88 147.31 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 71.35 110.905 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.749 HE22 HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -106.06 104.48 14.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 72.23 110.91 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.793 ' CE2' HD21 ' A' ' 99' ' ' LEU . 13.5 m-85 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 53.25 110.898 -179.84 . . . . . . . . 1 1 . 1 stop_ save_